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ABSTRACT 
 
This thesis describes isolation, structure elucidation and biological activity 
evaluation of secondary metabolites of the marine sponge Iotrochota baculifera, 
collected from the Gulf of Thailand, as well as those produced by the cultures of the 
marine-derived fungi, Aspergillus similanensis KUFA 0013, isolated from the marine 
sponge Rhabdermia sp., and Neosartorya quadricincta KUFA 0081, isolated from the 
marine sponge Clathria reinwardti. The structures of the isolated compounds were 
established based on extensive analyses of their 1D and 2D NMR, High Resolution Mass 
and Infrared spectra. The absolute configurations of the chiral compounds were 
determined by X-ray crystallographic analysis for chevalone E (348), quadricinctone A 
(381), quadricinctapyran A (382), quadricinctone B (386), quadricinctone C (387), 
quadricinctafuran A (388) and quadricinctone D (390). In the case of the 
cyclohexapeptide, similanamide (380), the configurations of its amino acid constituents 
were determined by HPLC analysis of its hydrolysate by a Chirobiotic T column using the 
amino acid standards as controls.  
From the ethyl acetate extract of the marine sponge I. baculifera, two previously 
described bromoindoles, 6-bromo-1H-indole-3-carbaldehyde (40) and methyl (2E)-3-(6-
bromo-1H-indol-3-yl)-prop-2-enoate (370), were isolated. 
The ethyl acetate extract of the culture of A. similanensis KUFA 0013 furnished 
three previously undescribed isocoumarin derivatives, similanpyrones A (375), B (373) 
and C (376), one previously undescribed chevalone derivative, chevalone E (356), two 
previously undescribed pyripyropene derivatives, pyripyropene  S (378) and T (379), and 
one previously unreported cyclohexapeptide, similanamide (380), together with seven 
previously reported 6,8-dihydroxy-3-methylisocoumarin (372), reticulol (374), p-hydroxy-
benzaldehyde (371), chevalones B (348) and C (349), S14-95 (377) and pyripyropene E 
(154). Compounds 154, 357, 373 – 376 and 378 – 380 were evaluated for their 
antimicrobial activity against reference strains of Gram-positive and Gram-negative 
bacteria and the multidrug-resistant isolates (MRS and VRE) from the environment as 
well as Candida albicans ATCC 10231. None of the tested compounds exhibited any 
activity at the highest concentration tested (256 μg/mL). Furthermore, these compounds 
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were also evaluated for their synergistic capacity with antibiotics against the multidrug-
resistant isolates from the environment. However, only chevalone E (356) was found to 
show synergism with oxacillin against methicillin resistant Staphylococcus aureus 
(MRSA). In addition, pyripyropene T (379) and similanamide (380) were tested for their 
in vitro growth inhibitory activity against MCF-7 (breast adenocarcinoma), NCI-H460 (non-
small cell lung cancer) and A373 (melanoma) cancer cell lines. Only similanamide (380) 
showed weak activity against the three tested cell lines. 
From the ethyl acetate extract of the culture of N. quadricincta KUFA 0081, two 
previously undescribed pentaketides, quadricinctones A (381) and C (387), and seven 
previously unreported benzoic acid derivatives, quadricinctapyrans A (382) and B (383), 
quadricinctoxepine (384), quadricinctones B (386) and D (390), and quadricinctofurans A 
(389) and B (389), were isolated, together with the previously reported 6-hydroxy-2,2-
dimethyl-2,3-dihydro-4H-chromen-4-one (385). The isolated compounds were evaluated 
for their antibacterial activity against reference strains of Gram-positive and Gram-
negative bacteria and the multidrug-resistant isolates from the environment, and 
antifungal activity against reference strains of yeast, filamentous fungi and dermatophyte, 
as well as the in vitro growth inhibitory activity against the MCF-7, NCI-H460 and A375-
C5 cancer cell lines by the protein binding dye SRB method, however none of the tested 
compounds were active in all these assays. 
 
Keywords: Iotrochota baculifera; Aspergillus similanensis KUFA 0013; Neosartorya 
quadricincta KUFA 0081; bromoindoles; similanpyrones; isocoumarins; pyripyropenes; 
chevalones; cyclic hexapeptide; similanamide; pentaketides; benzoic acid derivatives 
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 RESUMO 
RESUMO 
 
Nesta tese é descrito o isolamento, a elucidação estrutural e a avaliação da 
atividade biológica de metabolitos secundários da esponja marinha Iotrochota 
baculifera, coletada no Golfo da Tailândia, e também produzidos por culturas dos fungos 
marinhos Aspergillus similanensis KUFA 0013, isolado da esponja marinha 
Rhabdermia sp., e Neosartorya quadricincta KUFA 0081, isolado da esponja marinha 
Clathria reinwardti. As estruturas dos compostos isolados foram estabelecidas por 
análise de espectros de RMN (1D e 2D), massa de alta resolução e espectrometria no 
infravermelho. A configuração absoluta dos compostos quirais foi determinada por 
cristalografia de raios X para chevalona E (348), quadricinctona A (381), 
quadricinctapirano A (382), quadricinctona B (386), quadricinctona C (387), 
quadricinctafurano A (388) e quadricinctona D (390). No caso do ciclo-hexapeptideo 
similanamida (380), as configurações dos aminoácidos constituintes foram determinadas 
por análise cromatográfica (HPLC) do respetivo hidrolisado, usando uma coluna 
Chirobiotic T e aminoácidos padrão como controlo. 
Do extrato de acetato de etilo da esponja marinha I. baculifera, foram isolados 
dois bromoindolos já descritos, 6-bromo-1H-indole-3-carbaldeído (40) e metil-(2E)-3-(6-
bromo-1H-indole-3-il)-prop-2-enoato (370). 
O extrato de acetato de etilo da cultura de A. similanensis KUFA 0013 forneceu 
três derivados isocumarínicos já descritos, similanpironas A (375), B (373) e C (376), um 
derivado já descrito de chevalona, chevalona E (356), dois derivados não descritos de 
pyripyropeno, o pyripyropenos S (378) e o T (379), e um derivado ciclo-hexapeptideo não 
descrito, similanamida (380), juntamente com sete outros compostos já descritos, 6,8-di-
hidroxi-3-metillisocumarina (372), reticulol (374), p-hidroxibenzaldeído (371), chevalonas 
B (348) e C (349), S14-95 (377) e pyripyropeno E (154). Os compostos 154, 357, 373-
376 e 378- 380 foram avaliados para atividade antimicrobiana em estipes de referência 
de bactérias de Gram-positivo e de Gram-negativo e isolados resistentes a múltiplos 
fármacos (SRM and ERV) de ambiente, assim como Candida albicans ATCC 10231. 
Nenhum dos compostos testados exibiu atividade mesmo a alta concentração (256 
μg/mL). Estes compostos foram também avaliados para capacidade sinergista com 
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antibióticos contra isolados resistentes a múltiplos fármacos de ambiente. Somente 
chevalona E (356) manifestou sinergismo com oxacilina contra Staphylococcus aureus 
resistentes à meticilina (SARM). 
Adicionalmente pyripyropeno T (379) e similanamida (380) foram testados in vitro 
para avaliação da atividade inibidora do crescimento das linhas celulares tumorais MCF-
7 (adenocarcinoma da mama), NCI-H460 (cancro do pulmão de células não pequenas) 
e A373 (melanoma).Somente similanamida (380) mostrou fraca atividade contra estas 
linhas celulares. 
Do extrato de acetato de etilo da cultura de N. quadricincta KUFA 0081, foram 
isolados dois pentacetideos ainda não descritos, quadricinctonas A (381) e C (387), sete 
derivados do ácido benzóico ainda não descritos, quadricinctapiranos A (382) e B (383), 
quadricinctoxepina (384), quadricinctonas B (386) e D (390) equadricinctofuranos A (389) 
and B (389), e a já descrita 6-hidroxi-2,2-dimetil-2,3-di-hidro-4H-chromen-4-ona (385).  
Os compostos isolados foram avaliados para atividade antibacteriana em estipes 
de referência de bactérias de Gram-positivo e de Gram-negativo e isolados resistentes 
a múltiplos fármacos de ambiente e também atividade antifúngica contra estirpes de 
referência de leveduras, fungos filamentosos e dermatófitos, assim como para avaliação 
da atividade inibidora do crescimento da linhas celulares tumorais MCF-7, NCI-H460 e 
A373, pelo método de SRB. Nenhum dos compostos testados manifestou atividade. 
 
Palavras-chave: Iotrochota baculifera; Aspergillus similanensis KUFA 0013; 
Neosartorya quadricincta KUFA 0081; bromoindolos; similanpironas; isocumarínicos; 
pyripyropenos; chevalonas; cyclo-hexapeptideo; pentacetideos; derivados do ácido 
benzóico 
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1.1) General Introduction 
 
Nature is the source of the pharmaceuticals for treatment many human 
diseases since ancient time. The discovery of clay tablets revealed that plants have 
been used as medicines in Mesopotamia since 2400 B.C. Initially, apothecaries 
have been used medicinal plants in a form of crude extracts, then it was developed 
to partially purified natural products, and later, to single molecule drugs. Until the 
late 1980s, the improvement of technologies and techniques moved the focus of 
drug discovery from nature to chemical synthesis in the laboratory. However, nature 
is still the valuable source of lead compounds for drug development due to the high 
diversity of organisms. This is reflected by the number of approved drugs derived 
from nature. From 1981 to 2010, there were 1,135 approved drugs, and 50 % of 
these drugs were from natural product origin (David et al., 2015). The examples of 
well-known drugs which derived from nature are penicillin G (1), an antibiotic 
isolated from fungus Penicillium notatum; paclitaxel (2), a drug for treatment breast 
cancer obtained from the bark of Taxus brevifolia; the last example is cytarabine or 
ara-C (3) (Figure 1), an anticancer drug which was modified from the C-nucleoside 
isolated from marine sponge Cryptotethya crypta (Jaspars et al., 2016). 
 
1.2) Marine Organisms as a Treasure Source of New Compounds 
 
 Not only terrestrial organisms can produce bioactive chemicals that provide 
the lead compounds in drug discovery process, but marine organisms are also the 
rich source of bioactive compounds. About 70 % of the earth’s surface is the ocean. 
The biodiversity of the marine environment is high; thus, the ocean became an 
interesting source for drug discovery. However, there were only a few studies about 
marine organisms before 1970 due to low technology in that time. Since the SCUBA 
diving technologies and deep-sea vehicles (e.g., submarine) were improved, the 
discovery of marine organisms was raised. Moreover, the laboratory techniques 
were also developed, leading to the discovery and evaluation of the huge number 
of marine-derived secondary metabolites (Gerwick & Fenner, 2013; David et al., 
2015). 
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 The secondary metabolites obtained from marine organisms have unique 
chemical structures and high bioactivities compared to the secondary metabolites 
derived from terrestrial source (Hu et al., 2015). These are because the extreme 
conditions under the sea, including temperature, pressure, nutrients, light, salinity 
and competition (Hasan et al., 2015; Jaspars et al., 2016). 
 Hundreds of new marine-derived compounds are reported every year. The 
report from Hu et al. (2015) showed that from 1985 to 2005, the number of new 
compounds reported annually was less than 600 compounds, but since 2006 the 
number were increased to more than 800 compounds, and more than 1,000 
compounds in 2008 to 2012, as shown in Figure 2. The total number of new marine-
derived compounds which were reported from 1985 to 2012 is 16,616 compounds. 
Among these compounds, 4,196 compounds (25.25 %) are bioactive compounds. 
 
    
          1      3 
 
          2 
Figure 1. Structures of penicillin G (1), paclitaxel (2) and cytarabine (3). 
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Figure 2. Variation in number of new marine natural products for 1985 – 2012 (Hu et al., 
2015). 
 
 The new compounds were divided into eight categories by chemical 
structure, including alkaloids, terpenes, ethers and ketals, steroids, lactones, 
hydroxybenzene and quinones, peptides, and others. As shown in Figure 3, the 
highest number of new compounds belongs to terpenes, followed by alkaloids, but 
the highest proportion of bioactive compounds is peptides with 40.85 %, followed 
by lactones, alkaloids, and hydroxybenzene and quinones with 32.61, 31.49 and 
31.36 %, respectively. The major bioactivity of these new compounds is anticancer 
activity (2,225 compounds; 56 % of the total bioactive compounds), followed by 
antibacterial activity (521 compounds; 13%) (Hu et al., 2015). 
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Figure 3. The quantity and proportion of bioactive compounds in each category of chemical 
compounds (Hu et al., 2015). 
 
 
1.3) Marine Sponges are a Potential Source of Novel Compounds 
 
 Marine invertebrates, mainly sponges, tunicates, bryozoans and mollusks 
provided the majority of marine natural products. Among these organisms, sponges 
(phylum Porifera) have been recognized as a rich source of novel compounds for 
drug discovery and development (Laport et al., 2009 and Mehbub et al., 2014; Hu 
et al., 2015). In the early 1950s, the nucleosides spongothymidine (4) and 
spongouridine (5) were discovered, and the first marine-derived anticancer drug, 
cytarabine (ara-C; 3), and antiviral drug used against Herpes simplex, vidarabine 
(ara-A; 6) (Figure 4), were developed from these nucleosides. Since then, the 
bioactive compounds from sponges became interesting (Laport et al., 2009). Till 
now, more than 5,300 metabolites have been isolated from marine sponges, and 
more than 200 compounds are being discovery each year (Agrawal et al., 2016). 
Metabolites isolated from marine sponges showed many interesting biological 
activities such as anticancer, antimicrobial and anti-inflammatory activities, as 
shown in Table 1 (Laport et al., 2009 and Sipkema et al., 2005).  
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Figure 4. Structures of spongothymidine (4), spongouridine (5) and vidarabine (6). 
 
Table 1. Examples of secondary metabolites derived from sponges with different 
bioactivities. 
Compound Compound class Mode of action Species References 
 
Anticancer activity 
 
 
 
 
 
 
BRS1 Diamino-dihydroxy 
polyunsaturated 
lipid 
Protein kinase C 
inhibitor 
Calcareous 
sponge 
Sipkema     
et al, 2005 
Adociasulfates Triterpenoid 
hydroquinones 
Kinesin motor 
protein inhibitors 
Haliclona (aka 
Adocia) sp. 
Discodermolide Linear tetraene 
lactone 
Stabilization of 
microtubules 
Discodermia 
dissolute 
Spongistatin 1 Bis(spiroacetal) 
macrolide 
Tubulin 
polymerization 
inhibitor 
Spongia sp. 
Latrunculin A Thiazole macrolide Actin-
depolymerization 
Latrunculia 
magnifica 
Neoamphimedine Pyridoacridine 
alkaloid 
Topoisomerase 
II inhibitor 
Xestospongia cf 
carbonaria 
Namine D Imidazole alkaloid Nitic oxide 
synthetase 
inhibitor 
Leucetta cf 
chagosensis 
Agelasphin 
(KRN7000) 
α-
Galactosylceramide 
NKT cell 
activator 
Agelas 
mauritianus 
Salicylihalamide 
A 
Salicylate 
macrolide 
v-ATPase 
inhibitor 
Haliclona sp. 
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6-Hydroximino-4-
en-3-one steroids 
Oximated steroid Aromatase 
inhibitor 
Cinachyrella sp. 
Crambescidins  
1-4 
Pentacyclic 
guanidine 
derivatives 
Ca2+ channel 
blocker 
Crambe crambe 
 
Antimicrobial activity 
 
   
Discodermins  
B, C and D 
Cyclic peptides Antibacterial Discodermia 
kiiensis 
Laport et al., 
2009 
Acanthosterol  
I and J 
Sulfated sterols Antifungal Acanthodendrilla 
sp. 
Axinellamines  
B-D 
Imidazo-
azoloimidazole 
alkaloids 
Antibacterial Axinella sp. 
Spongistatin Polyether 
macrolide lactone 
Antifungal Hyrtios erecta Sipkema et 
al., 2005 
 
Antiviral activity 
 
   
Dragmacidin F Indole alkaloid Antiviral Halicortex sp. Laport et al., 
2009 Papuamides  
C and D 
Cyclic peptide Antiviral (HIV-1) Theonella 
mirabilis 
Haplosamates  
A and B 
Sulfamated 
steroids 
Antiviral (HIV-1 
integrase 
inhibitor) 
Xestospongia sp. Sipkema et 
al., 2005 
Hamigeran B Phenolic macrolide Antiviral (herpes 
and polio) 
Hamigera 
tarangaensis 
Laport et al., 
2009 
2-5A 2’,5’ linked 
oligonucleotide 
Interferon 
mediator 
Many sponges Sipkema et 
al., 2005 
 
Anti-inflammatory activity 
 
   
Manoalide Cyclohexane 
sesterterpenoid 
Phospholipase 
A2 inhibitor 
Luffariella 
variabilis 
Sipkema et 
al., 2005 
Spongidines A-D Pyridinium 
alkaloids 
Phospholipase 
A2 inhibitor 
Spongia sp. 
Jaspaquinol Diterpene 
benzenoid 
Lipoxygenase 
inhibitor 
Jaspis splendens 
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Subersic acid Diterpene 
benzenoid 
Lipoxygenase 
inhibitor 
Suberea sp. 
 
Immunosuppressive activity 
 
   
Simplexides Glycolipids Inhibitor of T-cell 
proliferation 
Plakortis simplex Sipkema et 
al., 2005 
Polyoxygenated 
sterols 
Sterols IL-8 inhibitor Dysidea sp. 
Contignasterol Oxygenated sterol Histamine 
release inhibitor 
Petrosia 
contignata 
Pateamine A Thiazole macrolide IL-2 inhibitor Mycale sp. 
 
 
1.4) Marine Microbes are the True Treasure Source of Secondary 
Metabolites 
 
At initial studies of marine organisms, researchers were focusing on 
macroorganisms such as sponges, tunicates and mollusks. Later, there has been a 
perception that the isolated secondary metabolites might be produced by the 
symbiotic or associated microorganisms, and this hypothesis are supported in 
several cases by experimental and circumstantial evidences.  
Zhang et al. (2005) reported marine natural products in clinical trial, which 
revealed that sponges are an important source of bioactive compounds. However, 
investigation of the microbes isolated from sponges and other marine invertebrates 
revealed that they produced the same compounds as their host animals. 
Gerwick and Fenner (2013) reported the data of marine-derived agents in 
the preclinical or clinical trial. At that time, there were nine approved drugs and 
twelve compounds in clinical trial. These twenty-one agents were isolated from 
different marine sources, majority from mollusks and sponges. However, these 
compounds were also reported from symbiotic or associated microorganisms. 
In addition, Schofield et al. (2015) have been recently confirmed that 
ecteinascidin 743 (ET-743) or trabectedin (7) (Figure 5), an anticancer drug which 
was isolated from the tunicate Ecteinascidia turbinata, was truly produced by 
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bacteria Candidatus Endoecteinascidia frumentensis, by sequencing and 
assembling the genome of this bacterium. 
These data support the hypothesis that the original producer of many marine 
secondary metabolites might be the associated microbes in marine invertebrates 
because of the same chemicals were found from both marine sources.  
 
 
 
7 
 
Figure 5. Structure of trabectedin (7). 
 
1.5) Marine Pharmaceuticals: Approved Drugs and a Current 
Pipeline Perspective 
 
1.5.1) FDA-approved drugs 
  
 To date, there are seven drugs which have been approved by the Food and 
Drug Administration (FDA) (Table 2). Among them, four drugs are anticancer 
(Mayer et al., 2010). The indication of the marine-derived drugs, which will be 
discussed in the next section, reveal that they have potential activity to treat patients 
in severe state or patients who failed with the prior treatment. 
 The proportion of approved drugs from marine source is higher than another 
source. The current rate is seven approved drugs from 28,175 discovered molecular 
entities, e.g. one drug per 4,025 natural products described. Thus, it is 
approximately 1.2 to 2.5 – fold higher than the average (one in 5,000 – 10,000 tested 
compounds) (Jaspars et al., 2016).  
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Table 2. The marine-derived compounds which have been approved by FDA for 
treatment human diseases (http://marinepharmacology.midwestern.edu/ 
clinPipeline.htm). 
Compound 
name 
Trademark 
(approved 
year) 
Marine 
organism 
origin 
Chemical 
class 
Molecular 
target 
Disease Area 
Cytarabine 
(Ara-C) 
Cytosar-U® 
(1969) 
Sponge Nucleoside DNA 
polymerase 
Cancer: 
Leukemia 
Vidarabin  
(Ara-A) 
Vira-A® 
(1976) 
Sponge Nucleoside Viral DNA 
polymerase 
Antiviral: Herpes 
simplex virus 
Omega-3-
acid ethyl 
esters 
Lovaza® 
(2004) 
Fish Omega-3 
fatty acids 
Triglyceride-
synthesizing 
enzymes 
Hypertriglyceride
mia 
Ziconotide Prialt® 
(2004) 
Cone snail Peptide DNA 
polymerase 
Pain: severe 
chronic pain 
Trabectedin Yondelis® 
(2005) 
Tunicate Alkaloid Minor groove 
of DNA 
Cancer: soft 
tissue sarcoma 
and ovarian 
cancer 
Eribulin 
mesylate 
Halaven® 
(2010) 
Sponge Macrolide Microtubules Cancer: 
metastatic breast 
cancer 
Brentuxima
b vedotin 
Adcetris® 
(2011) 
Mollusk/ 
cyano-
bacterium 
ADC 
(MMAE) 
CD30 & 
microtubules 
Cancer: 
anaplastic large 
T-cell systemic 
malignant 
lymphoma and 
Hodgkin’s 
disease 
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Approved marine-derived drugs 
 
Cytarabine (Ara-C; Cytosar-U®) 
 Cytarabine (arabinosyl cytosine; cytosine arabinoside; ara-C; 3) is a 
synthetic analogue of spongothymidine (4), a nucleoside originally isolated from the 
Caribbean sponge Cryptotethya crypta (Jaspars et al., 2016; Mayer et al., 2010). 
The FDA has approved cytarabine to be used with other drugs for treatment of 
patients with acute lymphoblastic leukemia, acute myeloid leukemia and chronic 
myelogenous leukemia, and to be used alone to prevent and treat patients with 
meningeal leukemia (https://www.cancer.gov/about-cancer/treatment/drugs/ 
cytarabine).  
 
Vidarabine (Ara-A; Vira-A®) 
 Vidarabine (6) (arabinofuranosyl adenine or adenine arabinoside, Ara-A) is 
a synthetic purine nucleoside analogue of spongouridine (5), a nucleoside originally 
isolated from the Caribbean sponge Tethya crypta. Currently, this compound was 
obtained from fermentation cultures of the bacterium Streptomyces antibioticus. 
Vidarabine has been approved by the FDA for treatment of Herpes simplex virus 
infection (Jaspars et al., 2016; Mayer et al., 2010). 
 
Omega-3-acid ethyl esters (Lovasa®) 
 Omega-3-acid ethyl esters are marine products obtained from fish oils, 
typically from oily fish such as mackerel and anchovy. The FDA approved Lovaza® 
on October 11, 2004, as a lipid-regulating agent to reduce triglyceride levels in adult 
patients with severe (≥500 mg/dL) hypertriglyceridemia (Jaspars et al., 2016; 
http://www.accessdata.fda.gov/drugsatfda_docs/label/2014/021654s041lbl.pdf). 
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Ziconotide (Prialt®) 
 Ziconotide (8) (Figure 6) is a synthetic N-type calcium-channel blocker 
equivalent of conotoxin from the Magician’s cone snail, Conus magus. The FDA has 
approved ziconotide intrathecal (IT) infusion for management of intractable patients 
with severe chronic pain who neither respond to nor tolerate other treatment 
(Jaspars et al., 2016).  
 
Trabectedin (Yondelis®) 
 Trabectedin (7) (Figure 5) is a tetrahydroisoquinoline alkaloid, which was 
isolated from the tunicate Ecteinascidia turbinata found in the Caribbean and 
Mediterranean Sea (Mayer et al., 2010). On October 23, 2015, the FDA approved 
trabectedin for the treatment of patients with unresectable or metastatic liposarcoma 
or leiomyosarcoma who have already been treated with anthracycline-based 
chemotherapy (https://www.cancer.gov/news-events/cancer-currents-blog/2015/ 
fda-trabectedin-sarcoma and www.yondelis.com). 
 
Eribulin mesylate (Halaven®) 
 A pharmacophore of halichondrin B (9), a polyether metabolite isolated from 
the Japanese sea sponge Halichondria okadai, obtained synthetically gave rise to 
eribulin (10) (Figure 6) (McBride & Butler, 2012; Jaspars et al., 2016). Due to the 
results from the phase III clinical trial called EMBRACE, which revealed that eribulin 
improved survival of women with metastatic breast cancer, the FDA approved this 
drug, on November 15, 2010, for treatment of patients with metastatic breast cancer 
after at least two treatment regimens with an anthracycline and a taxane  
(https://www.cancer.gov/about-cancer/treatment/drugs/fda-eribulinmesylate).  
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Brentuximab vedotin (Adcetris®) 
  Brentuximab vedotin (11) (Figure 6) is an anti-CD30 antibody conjugated via 
a protease-cleavable linker to the potent anti-microtubule agent monomethyl 
auristatin E (MMAE) (van de Donk & Dhimolea, 2012). This drug was approved by 
the FDA on August 19, 2011, for treatment of patients with Hodgkin lymphoma after 
autologous stem cell transplant (ASCT) failure or after failure of at least two prior 
multi-agent chemotherapy regiments in patients who are not candidates for ASCT 
and patients with systemic anaplastic large cell lymphoma after failure of at least 
one prior multi-agent chemotherapy regimen (https://www.cancer.gov/about-
cancer/treatment/drugs/fda-brentuximabvedotin).  
 
1.5.2) Current Marine Pharmaceutical Clinical Pipeline 
 
 Currently, there are twenty-four marine-derived compounds in clinical 
development (phase I to phase III clinical trials), twenty-one as anti-cancer agents, 
one for neovascular disease, one for chronic pain and one for schizophrenia and 
Alzheimer’s disease, as shown in Table 3 (Mayer et al., 2010; 
http://marinepharmacology.midwestern.edu/clinPipeline.htm).   
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Figure 6. Amino acid sequence of ziconotide (8), and structures of halichondrin B (9), 
eribulin (10) and brentuximab vedotin (11). 
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Table 3. The marine-derived compounds in a current pipeline perspective. 
Clinical 
status 
Compound 
name 
Marine organism Chemical class Molecular target Disease area 
Company/ 
Institution 
 
Phase 
III 
Plinabulin 
(NPI-2358) 
Fungus Aspergillus sp. 
(Singh et al., 2011) 
Diketopiperazine Microtubules Cancer: NSCLC, brain 
tumor 
BeyondSpring 
Pharmaceuticals 
Plitidepsin Tunicate Aplidium 
albicans 
(Alonso-Álvarez et al., 
2017) 
Depsipeptide Rac1 & JNK 
activation 
Cancer: multiple 
myeloma, leukemia, 
lymphoma 
Pharmamar 
Squalamine 
lactate 
(OHR-102) 
Dogfish shark  
Squalus acanthias 
(Moore et al., 1993) 
Aminosterol Growth factors of 
neovascularization 
Neovascular disease: 
macular degeneration 
Ohr 
Pharmaceutical 
Inc. 
Tetrodotoxin Pufferfish family 
Tetradontidae  
(Lago et al., 2015) 
Guanidinium 
alkaloid 
Sodium channel Pain: chronic pain Wex 
Pharmaceutical 
Inc. 
Glembatumumab 
vendotin  
(CDX-011) 
Mollusk/cyanobacterium ADC (MMAE) GPNMB & 
microtubules 
Cancer: metastatic 
breast cancer, 
melanoma, triple 
negative breast cancer 
Celldex 
Therapeutics 
Lurbinectedin 
(PM01183) 
Tunicate  
Ecteinascidia turbinata 
(Romano et al., 2013) 
Alkaloid RAN polymerase 
II 
Cancer: ovarian 
cancer, breast cancer, 
SCLC 
Pharmamar 
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Phase II 
Depatuxizumab 
mafodotin  
(ABT-414) 
Mollusk/cyanobacterium ADC (MMAF) EGFR & 
microtubules 
Cancer: glioblastoma, 
pediatric brain tumors 
AbbVie 
GTS-21  
(DMXBA) 
Worms of Phylum 
Nemertiea 
(Kem et al., 2006) 
Alkaloid ɑ7 nicotinic 
acetylcholine 
receptor 
Schizophrenia, 
Alzheimer disease, 
attention deficit 
hyperactivity disorder, 
endotoxemia, sepsis, 
vagal activity 
 
Denintuzumab 
mafodotin  
(SGN-CD19A) 
Mollusk/cyanobacterium ADC (MMAF) CD19 & 
microtubules 
Cancer: 
relapsed/refractory and 
frontline DLBCL 
Seattle Genetics 
AGS-16C3F Mollusk/cyanobacterium ADC (MMAF) ENPP3 & 
microtubules 
Cancer: renal cell 
carcinoma 
Agensys & 
Astellas Pharma 
Polatuzumab 
vendotin  
(DCDS-4501A) 
Mollusk/cyanobacterium ADC (MMAE) CD19b & 
microtubules 
Cancer: non-Hodgkin 
lymphoma, chronic 
lymphocytic leukemia, 
lymphoma, B-cell 
lymphoma, follicular 
Genentech/Roche 
PM060184 Sponge  
Lithoplocamia lithistoides 
(Martín et al., 2013) 
Polyketide Minor groove of 
DNA 
Cancer: solid tumors Pharmamar 
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Tisotumab 
vendotin 
Mollusk/cyanobacterium ADC (MMAE) Tissue factor & 
microtubules 
Cancer: Ovary cancer, 
cervix cancer, 
endometrium cancer, 
bladder cancer, 
prostate cancer 
(CRPC), cancer of 
head and neck 
(SCCHN), esophargus 
cancer, lung cancer 
(NSCLC) 
GenMab 
Enfortumab 
vendotin  
(ASG-22ME) 
Mollusk/cyanobacterium ADC (MMAE) Nectin-4 & 
microtubules 
Cancer: tumors; 
medical oncology; 
neoplasm; metastatic 
urothelial cancer 
Seattle Genetics 
 
Phase I 
GSK2857916 Mollusk/cyanobacterium ADC (MMAF) BCMA Cancer: multiple 
myeloma 
GlaxoSmithKline 
ABBV-085 Mollusk/cyanobacterium ADC (MMAE) LRRC15 Cancer: solid tumors Abbvie 
ABBV-399 Mollusk/cyanobacterium ADC (MMAE) c-Met Cancer: solid tumors Abbvie 
ABBV-221 Mollusk/cyanobacterium ADC (MMAE) EGFR & 
microtubules 
Caner: solid tumors Abbvie 
ASG-67E Mollusk/cyanobacterium ADC (MMAE) CD37 & 
microtubules 
Cancer: refractory 
lymphoid malignancy; 
Agensys & 
Astellas Pharma 
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relapsed lymphoid 
malignancy 
ASG-15ME Mollusk/cyanobacterium ADC (MMAE) SLITRK6 & 
microtubules 
Cancer: metastatic 
urothelial cancer 
Seattle Genetics 
Bryostatin Bryozoan 
Bugula neritina  
(Manning et al., 2005) 
Macrolide lactone Protein kinase C Cancer: melanoma, 
renal cell cancer, 
lymphoma, pancreatic 
cancer, fallopian tube 
cancer, gastric cancer, 
prostate cancer kidney 
cancer, lung cancer 
Neurotrope 
BioScience 
Marizomib 
(Salinosporamide 
A; NPI-0052) 
Bacterium 
Salinispora tropica 
(Kale et al.,, 2011) 
Beta-lactone- 
gamma lactam 
20S proteasome Cancer: NSCLC, 
pancreatic cancer, 
melanoma, lymphoma, 
multiple myeloma 
Triphase 
SGN-LIV1A Mollusk/cyanobacterium ADC (MMAE) LIV-1 & 
microtubules 
Cancer: breast cancer Seattle Genetics 
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1.6) Aim and Scope of the Study 
 
 The aim of this study is to investigate the secondary metabolites of the 
marine sponge Iotrochota baculifera, collected from the Gulf of Thailand, as well as 
the secondary metabolites produced by the cultures of the marine sponge-
associated fungi, Aspergillus similanensis KUFA 0013, isolated the marine sponge 
Rhabdermia sp., and Neosartorya quadricincta KUFA 0081, isolated from the 
marine sponge Clathria reinwardti.  
 
1.6.1) Isolation and Chemical Investigation of Selected Sponge and 
Fungal Strains 
 
 In order to isolate the secondary metabolites, the crude extracts of the marine 
sponge and of the cultures of the sponge-associated fungi were fractionated by 
column chromatography. The fractions were further isolated and purified by various 
chromatographic techniques and also by crystallization. The structures of the 
isolated compounds were elucidated by 1D and 2D NMR, IR and HRMS. In case 
that the compounds were obtained as suitable crystals, the X-ray crystallography 
were used to determine the absolute configuration of the stereogenic carbons 
otherwise the molecular mechanics conformation analysis or chiral HPLC were 
used. 
 
1.6.2) Biological Evaluation of the Isolated Compounds 
 
 The isolated compounds were evaluated for their biological activities by 
various bioassays. Antibacterial and antifungal activities were evaluated by a broth 
microdilution technique. While antibacterial assay was performed using Gram-
positive and Gram-negative bacteria and the multidrug-resistant isolates from the 
environment, antifungal assay was performed using yeast, filamentous fungus and 
dermatophyte. In order to evaluate the in vitro growth inhibitory activity, the 
compounds were tested against three human cancer cell lines by SRB method
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2.1) The Marine Sponges of the Genus Iotrochota 
 
 Sponges are one of marine invertebrates in the oldest metazoan group which still 
exist on the planet. There are about 5,000 to 10,000 species reported and most of them 
are found in the Oceans. Sponges belong to the Phylum Porifera which are divided into 
3 major classes: Demospongiae, Hexactineliida and Calcarea (Van Soest et al., 2012), 
based on the morphological characteristics of their spicule and texture. 
 The marine sponges of the genus Iotrochota belong to the class Demospongiae, 
subclass Heteroscleromorpha, order Poecilosclerida and family Iotrochotidae. There are 
several reports on chemical constituents from members of this genus, including I. 
baculifera, I. birotulata, I. purpurea and some unidentified species. Herein, the chemical 
constituents and their biological activities are reviewed covering the period of 1981 to 
2016.  
 
2.1.1) Iotrochota baculifera 
 
 Iotroridoside-B (12), a glycosphingolipid, together with sphingolipid (13) and a 
four-component mixture of sphingolipid homologues (14a – d) (Figure 7) were isolated 
from the sponge Iotrochota baculifera, collected from the coast near Tuticorin, India. In 
order to determine the length of the fatty acid and spingosine chains of 14, methanolysis 
was carried out. From the NMR, HPLC and GC-MS data, 14 was a mixture of spingolipids 
containing 1,3,4-trihydroxy-2-docosanoylamino-nonadecane (14a), 1,3,4-trihydroxy-2-
docosanoylamino-eicosane (14b), 1,3,4-trihydroxy-2-docosanoylamino-heneicosane 
(14c) and 1,3,4-trihydroxy-2-docosanoylamino-docosane (14d). Compounds 14a and 
14c were reported as new metabolites while 14b and 14d were previously reported 
(Muralidhar et al., 2003). 
 
 Baculiferins A – O (16 – 30), the DOPA-derived pyrrole alkaloids, and two 
alkaloids, purpurone (15) and ningalin A (31) (Figure 7), were isolated from the marine 
sponge I. baculifera which was collected from the coral reef at Hainan Island, China. All 
isolated compounds were evaluated for their antitumor activity against HCT-8, BEL-7402, 
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BGC-823, A549 and A2780 human cancer cell lines, and anti-HIV-1 IIIB activity. 
Compounds 22, 28 and 30 showed moderate inhibitory activity against the tested cell 
lines, whereas other compounds were only weakly active. Compounds 18, 20 – 23, 26 – 
29 exhibited potent inhibitory activity against the HIV-1 IIIB virus in both, MT4 and MAGI 
cells (Fan et al., 2010). 
 
2.1.2) Iotrochota birotulata 
 
 A ecdysteroid, named 2β,3β,14α,20β-tetrahydroxy-22α-(2-hydroxyacetiloxy)-
5β-colest-7-en-6-one (32), together with ponasterone A (33), (2β,3β,5β,22R)-
2,3,14,20,24-pentahydroxy-6-oxocholest-7-pen-22-yl-glycolate (34), (2β,3β,5β,- 
22R)-2,3,14,20,24-pentahydroxy-6-oxocholest-7-pen-22-yl-acetate (35) and 
ecdysterone (36) (Figure 8), were isolated from the Caribbean sponge I. birotulata, 
collected from the coast of Little San Salvador Island (Costantino et al., 2000). 
 
 The tyrosine derivative 1,3-dibromo-5-(2-[(p-hydroxyphenyl)-acetamido] 
ethyl)-2-[3-(methyl-2-butenamido)propoxy] benzene (37) and β-sitosterol (38) 
(Figure 8) were isolated from the marine sponge I. birotulata, collected from the coast of 
Port Royal, Jamaica. The hexane, dichloromethane and methanol crude extracts of I. 
Birotulata were evaluated for their insecticidal activity against Cylas formicarius 
elegantulus. The hexane and dichloromethane extracts exhibited 100% mortality at 
concentration of 2 µg/mL after 72 hours whereas the methanol extract was inactive 
(Thompson & Gallimore, 2016). 
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     12       13                    14a, n = 14; 14b, n = 15;  
                  14c, n = 16; 14d, n = 17 
 
   
       15 R1 = R2 = R3 = R4 = H       24 R1 = SO3H, R2 = R3 = H 
        16 R1 = SO3H, R2 = R3 = R4 = H      25 R1 = R3 = H, R2 = SO3H 
        17 R3 = SO3H, R1 = R2 = R4 = H      26 R1 = R2 = R3 = H 
        18 R3 = R4 = SO3H, R1 = R2 = H 
        19 R1 = R2 = SO3H, R3 = R4 = H 
        20 R1 = R3 = SO3H, R2 = R4 = H 
        21 R1 = R4 = SO3H, R2 = R3 = H 
        22 R1 = R3 = R4 = SO3H, R2 = H 
        23 R1 = R2 = R3 = SO3H, R4 = H 
 
                         
            27 R = H               29        30 R = SO3H 
            28 R = SO3H            31 R = H 
 
 
Figure 7. Structures of iotroridoside-B (12), sphingolipid (13), sphingolipid homologues  
(14a – d), purpurone (15), baculiferins A – O (16 – 30) and ningalin A (31). 
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     32          33         34 R = -COCH2OH 
      35 R = -COCH3 
                36 R = H 
 
 
37 
 
 
38 
 
Figure 8. Structures of 2β,3β,14α,20β-tetrahydroxy-22α-(2-hydroxyacetyloxy)-5β-colest-7-en-6-
one (32), ponasterone A (33), (2β,3β,5β,22R)-2,3,14,20,24-pentahydroxy-6-oxocholest-7-pen-
22-yl-glycolate (34), (2β,3β,5β,22R)-2,3,14,20,24-pentahydroxy-6-oxocholest-7-pen-22-yl-
acetate (35), ecdysterone (36), 1,3-dibromo-5-(2-[(p-hydroxyphenyl)acetamido]ethyl)-2-[3-
(methyl-2-butenamido)propoxyl]benzene (37) and β-sitosterol (38). 
 
2.1.3) Iotrochota purpurea 
 
 A bromine-containing oxindole alkaloid, named matemone (39) was isolated along 
with 6-bromoindole-3-carbaldehyde (40) (Figure 9), from the Indian Ocean sponge I. 
purpurea, collected from the Matemo Island. Compound 39 was evaluated for its 
antimicrobial activity against Staphylococcus aureus (IPC 53146) and Candida albicans 
(IPC 1283) by the paper-disk agar diffusion method. At 50, 100 and 200 µg/disk 
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concentrations, 39 weakly inhibited the growth of S. aureus with inhibitory zones of 7, 9 
and 11 mm, respectively while it was inactive against C. albicans at the highest 
concentration tested (200 µg/disk). It also exhibited a mild cytotoxicity against NSCLC-
N6 L16, Mia PaCa-2 and Du145 cancer cell lines, and sea urchin egg with IC50 values of 
30, 24, 27 and 35 μg/mL, respectively. DNA intercalant assay, using HPLC analysis, 
showed significant binding ability of DNA (40-50%; ethidium bromide (control), 100%) 
(Carletti et al., 2000).  
 
Two brominated tyrosine derivatives, itampolins A (41) and B (42) (Figure 9), 
were isolated from the marine sponge I. purpurea which was collected from Itampolo, 
Madagascar (Sorek et al., 2006). 
 
Two ceramides, named iotrochotamide I (43) and iotrochotamide II (44), were 
isolated from the Indonesian sponge I. purpurea, together with three 6-bromoindoles, 
including 6-bromo-1H-indole-3-carbaldehyde (40), 6-bromo-1H-indole-3-carboxylic 
acid methyl ester (45) and 6-bromo-1H-indole-3-carboxylic acid ethyl ester (46) 
(Figure 9) (Ibrahim et al., 2009).  
 
Ten halogenated alkaloids, purpuroines A – J (47 – 56), together with the 
previously described O-methyl-N-trimethyl-3,5-dibromotyrosine (57) (Figure 9), were 
isolated from the marine sponge I. purpurea, collected from the inner coral reef in Sanya 
Bay, Hainan Island, China. Compounds 47 – 50, 53 – 55 and 57 were tested for their 
antimicrobial activity against human disease-related bacteria (Staphylococcus aureus, S. 
pneumoniae, Escherichia coli and Pseudomonas aeruginosa) and fungi (Candida 
albicans, Saccharomyces cerevisiae, Aspergillus fumigatus, A. flavus and Fusarium 
oxysporum). Compounds 47 and 49 selectively inhibited the growth of A. fumigatus with 
IC50 values of 28.58 ± 0.52 and 26.07 ± 0.55 mg/mL, respectively, while 50 exhibited 
inhibitory activity against A. fumigatus and C. albicans with IC50 values of 25.56 ± 0.44 
and 19.03 ± 0.12 mg/mL, respectively. Compound 55 inhibited the growth of S. 
pneumoniae with IC50 value of 18.06 ± 0.76 mg/mL. Furthermore, 47 – 50, 52 – 55 and 
57 were selected for kinase-targeted bioassay. Compound 50 showed potent inhibition 
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against lymphocyte-specific protein tyrosine kinase (LCK) and serine/threonine-protein 
kinase-1 (PLK1) with IC50 values of 0.94 and 1.45 μg/mL, respectively. Compound 47 
selectively inhibited LCK with IC50 value of 2.35 μg/mL. Compounds 49, 52 and 54 
exhibited moderate inhibition against LCK and PLK1 with IC50 values less than 8.0 μg/mL. 
Moreover, all tested compounds weakly inhibited cyclin-dependent kinase-2 (CDK2) 
(Shen et al., 2012).   
 
              
            39                 40     43  n = 10 
                         44  n = 14 
   
               41  R = H                          45 R = CH3  
                      42  R = OH                          46 R = CH2CH3  
 
               
     47 R1 = R2 = R3 = Br     52 R1 = R3 = I, R2 = CH3            57 
     48 R1 = R2 = Br, R3 = H     53 R1 = R3 = I, R2 = H 
     49 R1 = R3 = Cl, R2 = Br          54 R1 = Br, R2 = CH3, R3 = I 
     50 R1 = R2 = Br, R3 = I     55 R1 = Br, R2 = H, R3 = I 
     51 R1 = R2 = Br, R3 = Cl                56 R1 = R3 = Br, R2 = CH3     
 
Figure 9. Structures of matemone (39), 6-bromoindole-3-carbaldehyde (40), itampolins A (41) 
and B (42), iotrochotamide I (43), iotrochotamide II (44), 6-bromo-1H-indole-3-carboxylic acid 
methyl ester (45), 6-bromo-1H-indole-3-carboxylic acid ethyl ester (46), purpuroines A-J (47-56) 
and O-methyl-N-trimethyl-3,5-dibromotyrosine (57).   
 
 27 
 
 CHAPTER II: CHEMISTRY OF THE MARINE SPONGES OF THE GENUS IOTROCHOTA 
2.1.4) Iotrochota sp. 
 
 A bromoindole, named methyl (E)-3-(6-bromoindol-3-yl)prop-2-enoate (58) 
(Figure 10), was isolated from a marine sponge Iotrochota sp. Its structure was assigned 
on the basis of spectroscopic analysis, and then confirmed by synthesis (Dellar et al., 
1981). 
 
Two cinnamoyl amino acids, iotrochamides A (59) and B (60) (Figure 10), were 
isolated from the CH2Cl2/MeOH extract of the Australian marine sponge Iotrochota sp., 
collected from Curacao Island, Queensland. The isolated compounds were evaluated for 
their cytotoxicity against Trypanosoma brucei brucei and HEK293 human cancer cell line. 
Compounds 59 and 60 moderately inhibited the growth of T. b. brucei with IC50 values of 
4.7 ± 2.5 and 3.4 ± 1.9 µM, respectively, while exhibited 85 ± 14% the growth inhibition 
of HEK293 cell at 50 µM and 100 ± 0% at 70 µM, respectively. The results revealed that 
both compounds exhibited selectively moderate inhibition against T. b. brucei (Feng et 
al., 2012). 
 
 
58 
 
         
   59         60 
 
Figure 10. Structures of methyl (E)-3-(6-bromoindol-3-yl)prop-2-enoate (58) and iotrochamides 
A (59) and B (60). 
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3.1) The Fungi of the Genus Aspergillus  
 
3.1.1) Aspergillus aculeatus 
 
Aspergillusol A (61), a tyrosine-derived metabolite, together with 4-
hydroxyphenylpyruvic acid oxime (62) and secalonic acid A (63) (Figure 11), were 
isolated from the fungus Aspergillus aculeatus CRI323-04 which was isolated from the 
marine sponge Xestospongia testudinaria, collected from Phi Phi Islands, Thailand. 
Compound 61 exhibited α-glucosidase inhibitory activity toward α-glucosidases from 
Saccharomyces cerevisiae and Bacillus stearothermophilus with IC50 values of 465 ± 2 
and 1060 ± 20 µM, respectively. Moreover, 61 also exhibited weak cytotoxicity with IC50 
values of 50, 74 and 19 µM, against HuCCA-1, A549 and MOLT-3 human cancer cell 
lines, respectively, while it did not show any activity toward HepG2 cancer cell line at the 
concentration of 105 µM (Ingavat et al., 2009). 
 
Later on, Ingavat et al. (2011) isolated a sesquiterpenoid, Asperaculin A (64) 
(Figure 11), from the same fungus. Compound 64 was evaluated for its cytotoxicity 
against four human cancer cell lines: HepG2, MOLT-3, A549 and HuCCA-1. Compound 
64 was inactive at the highest concentration tested (50 µg/mL) (Ingavat et al., 2011). 
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            61                    62 
    
                 63          64 
 
Figure 11. Structures of aspergillusol A (61), 4-hydroxyphenylpyruvic acid oxime (62), secalonic 
acid A (63) and asperaculin A (64). 
 
3.1.2) Aspergillus clavatus 
  
Two coumarin derivatives, 4,4’-dimethoxy-5,5’-dimethyl-7,7’-oxydicoumarin 
(65) and 7-(γ,γ-dimethylallyloxy)-5-methoxy-4-methylcoumarin (66), a chromone 
derivative, (S)-5-hydroxy-2,6-dimethyl-4H-furo[3,4-g]benzopyran-4,8(6H)-dione (69) 
and a bicoumarin, 24-hydroxylergosta-4,6,8(14),22-tetraen-3-one (70), together with 
two previously described kotanin (67) and orlandin (68) (Figure 12), were isolated from 
the marine-derived fungus Aspergillus clavatus R7 which was isolated from a mangrove 
tree Myoporum bontioides, collected from China. The isolated compounds were 
evaluated for their antifungal activity against three plant pathogens: Fusarium oxysporum, 
Colletotrichum musae and Penicillium italicum, using the broth dilution method. All tested 
compounds exhibited antifungal activity against these three fungal strains, except for 66 
which was inactive against P. italicum. Compound 70 showed the most potent activity 
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towards three fungal strains with MIC values of 44.73, 195.79 and 61.18 µM, respectively 
(Li et al., 2017). 
 
         
            65          66     67  R1 = R2 = CH3 
  68  R1 = R2 = H 
 
    
            69       70 
 
Figure 12. Structures of 4,4’-dimethoxy-5,5’-dimethyl-7,7’-oxydicoumarin (65), 7-(γ,γ-
dimethylallyloxy)-5-methoxy-4-methylcoumarin (66), kotanin (67), orlandin (68), (S)-5-hydroxy-
2,6-dimethyl-4H-furo[3,4-g]benzopyran-4,8(6H)-dione (69) and 24-hydroxylergosta-4,6,8(14),22-
tetraen-3-one (70).  
 
3.1.3) Aspergillus fumigatus 
 
Two alkaloids, 9-deacetylfumigaclavine C (71) and 9-deacetoxyfumigaclavine 
C (72), together with twelve previously reported fumigaclavine C (73), 14-norpseurotin 
(74), pseurotin A (75), spirotryprostatin A (76), 6-methoxyspirotryprostatin B (77), 
fumitremorgin F (78), dimethylgliotoxin (79), 12α-fumitremorgin C (80), 
demethoxyfumitremorgin C (81), verruculogen (82), and tryprostatins A (83) and B 
(84) (Figure 13), were isolated from the fungus Aspergillus fumigatus CY018, which was 
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isolated from the healthy stem of Cynodon dactylon, collected from Jiangsu Province, 
China. Compounds 71 and 72 were evaluated for their cytotoxicity against three human 
cancer cell lines: KB, MCF-7 and K562, using MTT method. Compounds 71 and 72 
exhibited activity against K562 cell line with IC50 values of 41.0 ± 4.6 and 3.1 ± 0.9 μM, 
respectively. Furthermore, 74 significantly exhibited nerite outgrowth induction activity of 
PC12 cancer cell line at the concentration of 10.0 μM (Ge et al., 2009). 
 
3.1.4) Aspergillus glaucus 
 
 An anthraquinone derivative with naphtho[1,2,3-de]chromene-2,7-dione skeleton, 
aspergiolide A (85) (Figure 14), was isolated from the marine fungus Aspergillus glaucus 
HB1-19 which was isolated from the sediment around the mangrove roots, collected from 
Fujian Province, China. Compound 85 was evaluated for its cytotoxicity against four 
cancer cell lines: P388, HL-60, BEL-7402 and A-549, using MTT method. Compound 85 
exhibited selective activity to four cell lines with IC50 values of 35.0, 0.28, 7.5 and 0.13 
µM, respectively (Du et al., 2007).  
 
Eight aromatic polyketides: aspergiolide B (86), isotorachrysone-6-O-α-D-
ribofuranoside (88), 8-methoxy-3-methyl-1-naphthalenol-6-O-α-D-ribofuranoside 
(89), 8-methoxy-1-naphthalenol-6-O-α-D-ribofuranoside (90), isoasperflavin (92), 
(+)-variecolorquinones A (98) and (trans)- and (cis)-emodinphyscion bianthrone 
(100 and 101), along with eight previous reported metabolites: isotorachrysone (87), 
asperflavin (91), emodin (93), physcion (94), questin (95), catenarin (96), 
rubrocristin (97) and physcion bianthrones (99) (Figure 14), were isolated from the 
same fungus. Compounds 86-90, 92, 98, 100 and 101 were tested for their cytotoxicity 
against two human cancer cell lines: HL-60 and A-549. Compound 86 exhibited potent 
cytotoxicity against both cell lines with IC50 values of 0.51 and 0.24 µM, respectively. 
Compound 100 exhibited moderate activity with IC50 values of 7.8 and 9.2 µM, 
respectively, while its cis-isomer (101), showed cytotoxicity with IC50 values of 44.0 and 
14.2 µM, respectively. On the contrary, all other tested compounds were inactive at the 
highest concentration tested of 100 µM (Du et al., 2008). 
 33 
 
 CHAPTER III: CHEMISTRY OF THE FUNGI OF THE GENERA ASPERGILLUS AND NEOSARTORYA 
 
           
            71  R = OH             74  R = CH3               76     79 
            72  R = H             75  R = Ethyl  
            73  R = Oac 
 
   
                77    78         80   
  
                  
81     82             83  R = OCH3 
          84  R = H 
 
 
Figure 13. Structures of 9-deacetylfumigaclavine C (71), 9-deacetoxyfumigaclavine C (72), 
fumigaclavine C (73), 14-norpseurotin (74), pseurotin A (75), spirotryprostatin A (76), 6-
methoxyspirotryprostatin B (77), fumitremorgin F (78), dimethylgliotoxin (79), 12α-fumitremorgin 
C (80), demethoxyfumitremorgin C (81), verruculogen (82), and tryprostatins A (83) and B (84). 
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85          86 
 
                           
              87                88  R1 = OCH3, R2 = CH3                91  R1 = CH3, R2 = OH, R3 = OH 
        89  R1 = H, R2 = CH3                92  R1 = H, R2 = CH3, R3 = OH 
        90  R1 = R2 = H 
 
                     
93  R1 = OH, R2 = OH, R3 = H                 98             99  R1 = R3 = OCH3, R2 = R4 = OH,  
94  R1 = OCH3, R2 = OH, R3 = H                       meso and (±)-racemic C-10/C-10’   
95  R1 = OH, R2 = OCH3, R3 = H      100  R1 = R2 = R4 = OH, R3 = OCH3,  
96  R1 = R2 = R3 = OH           trans H-10/H-10     
97  R1 = OH, R2 = OCH3, R3 = OH      101  R1 = R2 = R4 = OH, R3 = OCH3,  
   cis H-10/H-10’  
 
           
Figure 14. Structures of aspergiolide A (85), aspergiolide B (86), isotorachrysone (87), 
isotorachrysone-6-O-α-D-ribofuranoside (88), 8-methoxy-3-methyl-1-naphthalenol-6-O-α-D-
ribofuranoside (89), 8-methoxy-1-naphthalenol-6-O-α-D-ribofuranoside (90), asperflavin (91), 
isoasperflavin (92), emodin (93), physcion (94), questin (95), catenarin (96), rubrocristin (97), (+)-
variecolorquinones A (98) physcion bianthrones (99) and (trans)- and (cis)-emodinphyscion 
bianthrone (100 and 101). 
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3.1.5) Aspergillus insuetus 
 
 The meroterpene derivatives, terretonins E (102) and F (103), along with 
aurantiamine (104) (Figure 15), linoleic acid and uridine, were isolated from the 
marine-derived fungus Aspergillus insuetus, which was isolated from surface of the 
marine sponge Petrosia ficiformis, collected from Punta de Santa Ana in the 
Mediterranean Sea, Spain. Compounds 102 – 104 inhibited the mammalian mitochondrial 
respiratory chain by inhibiting NADH oxidase activity with IC50 values of 3.90 ± 0.4, 2.97 
± 1.2 and 15.1 ± 1.8 μM, respectively (López-Gresa et al., 2009). 
   
102    103    104 
 
Figure 15. Structures of terretonins E (102) and F (103), and aurantiamine (104). 
 
3.1.6) Aspergillus insulicola 
 
 Five strains of the marine-derived fungus Aspergillus insulicola were isolated from 
various marine sources, including an unidentified green alga, collected from Acklins 
Island; a decaying leaf of Rhizophora mangle, collected from red mangrove, Little San 
Salvador; a green alga Penicillus sp., collected from black mangrove, Grand Bahama; a 
green alga Batophora sp., collected from Eleuthera. The investigation of these strains led 
to a discovery of a new nitrobenzoyloxy-substitued sesquiterpene, insulicolide A (105) 
and the previously reported asteltoxin (106) (Figure 16) (Rahbæk et al., 1997). 
 
 Azonazine (107) (Figure 16), a hexacyclic dipeptide, was isolated from the marine-
derived fungus Aspergillus insulicola which was isolated from a Hawaiian shallow water 
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sediment. The cytotoxicity assay revealed that 107 was inactive at the concentration of 1 
mg/mL in the disk diffusion assay and was also inactive at the concentration of 100 μM 
in MTT method, against two human cancer cell lines: PC3 and MCF-7, and a murine 
macrophage cell: RAW 264.7 (Wu et al., 2010).   
 
   
       105                     106 
 
 
107 
 
Figure 16. Structures of insulicolide A (105), asteltoxin (106) and azonazine (107). 
 
3.1.7) Aspergillus karnatakaensis 
 
 Two dibenzofurans, karnatakafurans A (108) and B (109) (Figure 17), were 
isolated from the fungus Aspergillus karnatakaensis (IBT 22154) which was obtained from 
the IBT Culture Collection at BioCentrum-DTU, the Technical University of Denmark. 
Compounds 108 and 109 were evaluated for their antimicrobial activity against four 
bacterial strains: Bacillus subtilis, Staphylococcus aureus, Escherichia coli and 
Pseudomonas aeruginosa, together with various fungal strains, including Alternaria 
infectoria, Cladosporium sp., Penicillium italicum, Penicillium digitatum, Penicillium 
expansum, Aspergillus fumigatus, Fusarium avenaceum, Fusarium culmorum, Fusarium 
solani, Fusarium sporotrichioides, Fusarium oxysporum and Botrytis cinerea. Both 
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compounds did not exhibit antimicrobial activity at the highest concentration tested (100 
µg/disk), except for P. aeruginosa. Moreover, 108 and 109 were also tested for their 
antimalarial activity against chloroquine-sensitive Plasmodium falciparum 3D7 parasite, 
using chloroquine as a positive control. Chloroquine exhibited antimalarial activity with 
IC50 value of 0.012 µg/mL while 108 and 109 showed activity with IC50 values of 3.9 and 
3.6 µg/mL, respectively (Manniche et al., 2004).   
 
     
108     109 
 
Figure 17. Structures of karnatakafurans A (108) and B (109). 
 
3.1.8) Aspergillus niger 
 
 Bicoumanigrin (111), aspernigrins A (112) and B (113), and pyranonigrins A 
– D (114 – 117), together with a fungal pigment cycloleucomelone (110) (Figure 18), 
were isolated from the marine-derived fungus Aspergillus niger which was isolated from 
the sponge Axinella damicornis, collected in the south of Elba, Italy. All isolated 
compounds, except for 117 which was isolated in a very small quantity, were evaluated 
for insecticidal property against Spodoptera littoralis, lethality toward eggs of Artemia 
salina in brine shrimp assay, antimicrobial activity using agar diffusion assay, and 
cytotoxicity against ten different human leukemia and carcinoma cell lines. All tested 
compounds exhibited neither antimicrobial activity nor toxicity to brine shrimp. Compound 
111 displayed moderate effect on the growth inhibition of tumor cells (Hiort et al., 2004). 
 
 Liu et al. (2011) described isolation of eight α-pyrone derivatives, 
nigerapyrones A – E (118 – 122) and nigerapyrones F – H (125 – 127), together with 
the previously reported asnipyrones B (123) and A (124) (Figure 18), from the marine-
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derived fungus Aspergillus niger MA-132 which was isolated from the mangrove plant 
Avicennia marina, collected from Hainan, China. All isolated compounds were evaluated 
for their cytotoxicity against eight human tumor cell lines: DU145, HeLa, HepG2, MCF-7, 
NCI-H460, MDA-MB-231, SW1990 and A549. Compound 122 exhibited strong 
cytotoxicity against SW1990, A549 and MDA-MB-231 cell lines with IC50 values of 38, 43 
and 48 µM, respectively, which was more potent than fluorouracil (positive control). This 
compound also showed weak or moderate activity against HepG2, Du145 and MCF-7 
cell lines with IC50 values of 86, 86 and 105 µM, respectively. Compounds 119 and 121 
exhibited cytotoxicity against HepG2 cell with IC50 values of 62 and 81 µM, respectively, 
while compounds 121 and 124 showed activity toward A549 cell with IC50 values of 81 
and 62 µM, respectively. Compound 121 also displayed weak activity against MCF-7 cell 
line with IC50 value of 121 µM. Moreover, all isolated compounds were also tested for 
antimicrobial activity against six microbial strains: two bacterial isolates (Staphylococcus 
aureus and Escherichia coli) and four plant-pathogenic fungal isolates (Alternaria 
brassicae, Fusarium oxysporum, Coniella diplodiella and Physalospora piricola). The 
results revealed that none of the tested compounds exhibited antimicrobial activity. 
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      110                               111               112 
           
113                    114                     115  R1 = H, R2 = CH                          117 
                                                                              116  R1 = CH3, R2 = H 
     
      118  R = H              120  R = H                            122 
      119  R = CH3              121  R = CH3 
 
   
         123  R = H              125 
         124  R = CH3 
 
   
126     127 
 
Figure 18. Structures of cycloleucomelone (110), bicoumanigrin (111), aspernigrins A (112) and 
B (113) and pyranonigrins A – D (114 – 117), nigerapyrones A – E (118 – 122), asnipyrones B 
(123) and A (124) and nigerapyrones F – H (125 – 127). 
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3.1.9) Aspergillus ochraceus 
 
Three benzodiazepine alkaloids, circumdatins A – C (128 – 130) (Figure 19) were 
isolated from the terrestrial fungus Aspergillus ochraceus (IBT 12704), which was 
obtained from sterilized milo sorghum seed buried in the soil for 1 – 4 months at Sevilleta 
National Wildlife Refuge, New Mexico (Rahbæk et al., 1999). Later on, Rahbæk and 
Breinholt (1999) further investigated the secondary metabolites from this fungus, leading 
to the discovery of another three circumdatin analogues, circumdatins D – F (131 – 133) 
(Figure 19). 
     
128  R = OCH3             130  R = OH              131  R = OCH3 
129  R = H             133  R = H              132  R = H 
 
Figure 19. Structures of circumdatins A – F (128 – 133). 
 
3.1.10) Aspergillus ostianus 
 
Three pentaketides, aspinotriols A (134) and B (135), and aspinonediol (136), 
together with the previously described aspinonene (137) and dihydroaspyrone (138) 
(Figure 20), were isolated from the marine fungus Aspergillus ostianus strain 01F313 
which was isolated from an unidentified marine sponge, collected in Pohnpei, the 
Federated States of Micronesia. Compounds 134 – 138 were evaluated for their 
antibacterial activity against methicillin-resistant Staphylococcus aureus (MRSA), and 
none of them exhibited antibacterial activity at 100 µg/disk concentration. Compounds 
134, 137 and 138 were also tested for their cytotoxicity against L1210 mouse cancer cell 
line. However, only 137 exhibited cytotoxicity at 25 ppm concentration (27% inhibition) 
(Kito et al., 2007). 
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134    135    136 
   
137    138 
Figure 20. Structures of aspinotriols A (134) and B (135), aspinonediol (136), aspinonene (137) 
and dihydroaspyrone (138). 
 
3.1.11) Aspergillus parasiticus 
 
A gabosine derivative, parasitenone (139), was isolated, together with 3-chloro-
4,5-dihydroxybenzyl alcohol (140) and gentisyl alcohol (141) (Figure 21), from a 
marine fungus Aspergillus parasiticus MFA153 which was obtained from the red alga 
Carpopeltis cornea, collected in Ulsan, South Korea. Compound 139 exhibited weak 
scavenging activity against DPPH and peroxy nitrite (ONOO-) with IC50 values of 57.0 and 
52.6 µM, respectively, while 140 and 141 showed potent activity toward DPPH (IC50 = 0.6 
and 1.4 µM, respectively) and ONOO– (IC50 = 3.1 and 2.2 µM, respectively). Moreover, 
140 also exhibited strong activity toward superoxide and nitric oxide radicals with IC50 
values of 11.0 and 0.5 µM, respectively, while 141 showed activity toward only nitric oxide 
radical with IC50 value of 0.4 µM (Son et al., 2002).  
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       139        140                  141 
 
Figure 21. Structures of parasitenone (139), 3-chloro-4,5-dihydroxybenzyl alcohol (140) and 
gentisyl alcohol (141). 
 
3.1.12) Aspergillus sydowii 
 
Three diketopiperazine alkaloids, 6-methoxyspirotryprostatin B (142), 18-
oxotryprostatin A (143) and 14-hydroxyterezine D (144), an oxaspiro[4.4]lactam, 14-
norpseurotin A (74), and a 29-nordammarane triterpenoid, (4S,5S,6S,8S,9S,10R,13R,-
14S,16S,17Z)-6,16-diacetoxy-25-hydroxy-3,7-dioxy-29-nordammara-1,17(20)-dien-
21-oic acid (145) were isolated, together with twelve previously described compounds: 
terezine D (146), pseustin A (147), helvolic acid (148), spirotryprostatin A (76), 
12,13-dihydroxyfumitremorgin C (149), fumitremorgin C (150), didehydro-
besdethiobis(methylthio)gliotoxin (151), verruculogen (82), fumigaclavine C (73), 
fumigaclavine B (152), and pyripyropenes A (153) and E (154) (Figure 22), from the 
marine fungus Aspergillus sydowii PFW1-13 which was obtained from a driftwood 
sample, collected from the beach of Baishamen, Hainan, China. Compounds 142 – 144 
weakly inhibited the growth of A-549 human cancer cell line with IC50 values of 8.29, 1.28 
and 7.31 µM, respectively. Compound 142 also exhibited cytotoxic activity against HL-60 
human cancer cell line with IC50 value of 9.71 µM. Moreover 74, 145, 146 and 148 were 
evaluated for their antibacterial activity against Escherichia coli, Bacillus subtilis and 
Micrococcus lysodeikticus, using disk diffusion method. Compounds 145 and 146 
exhibited antibacterial activity against the tested bacterial strains more potent than 74 and 
148 with MIC values of 3.74, 14.97, 7.49 µM and 10.65, 5.33, 10.65 µM, respectively, 
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while the MIC values of 74 and 148 were 14.49, 14.49, 7.24 µM and 87.92, 21.98, 10.99 
µM, respectively (Zhang et al, 2008). 
 
Three sesquiterpenes: aspergillusenes A (155) and B (156), and (+)-(7S)-7-O-
methylsydonic acid (157), and two tetrahydroxanthone  derivatives: aspergillusones A 
(158) and B (159) were isolated, together with six previously described compounds: (+)-
(7S)-sydonic acid (160), (7R,8R)-AGI-B4 (161), (7R,8R)-α-diversonolic ester (162), 
methyl 8-hydroxy-6-methyl-9-oxo-9H-xanthene-1-carboxylate (163), and 
sydowinins A (164) and B (165) (Figure 22), from the marine fungus Aspergillus sydowii 
PSU-F154 which was isolated from the sea fan Annella sp., collected from the coastal 
area in Suratthani Province, Thailand. Compounds 155 – 157 and 161 – 165 were tested 
for their antioxidant activity using DPPH assay. Only 161 exhibited antioxidant activity 
with IC50 value of 17 µM while other tested compounds were inactive (Trisuwan et al., 
2011). 
 
3.1.13) Aspergillus terreus 
 
The marine-derived fungus Aspergillus terreus PT06-2 which was isolated from 
the sediment, collected from Putian Sea Saltern, Fujian, China, was culture under a high 
salinity condition. The investigation of this fungus led to the isolation of  terremides A 
(166) and B (167), and terrelactone A (168), together with twelve previously reported 
compounds: 3,4,5-trimethoxy-2-(2-(nicotinamido)benzamido)benzoate (169), (+)-
butyrolactones I – III (170-172), 3-hydroxy-5-[[4-hydroxy-3-(3-methyl-2-buten-1-
yl)phenyl]methyl]-4-)4-hydroxyphenyl)-2(5H)-furanone (173), aspernolide A (174), 
5-[(3,4-dihydro-2,2-dimethyl-2H-1-benzopyran-6-yl)-methyl]-3-hydroxy-4-(4-
hydroxyphenyl)-2(5H)-furanone (175), territrem B (176), (-)-(1R,4R)-1,4-(2,3)-
indomethane-1-methyl-2,4-dihydro-1H-pyrazino[2,1-b]quinazoline-3,6-dione (177), 
R-(-)-6-hydroxymellein (178), trans-4,6-dihydroxymellein (179) and (+)-terrein (180) 
(Figure 23). Compounds 166 – 175 and 180 were tested for their cytotoxicity against two 
human cancer cell lines: HL-60 and BEL-7402 using MTT assay. Only 170 exhibited weak 
cytotoxicity against HL-60 cell line with IC50 values of 57.5 µM. Furthermore, 166 – 175 
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and 180 were also evaluated for their antimicrobial activity against Enterobacter 
aerogenes, Pseudomonas aeruginosa, Staphylococcus aureus and Candida albicans by 
agar dilution method, and antiviral activity against influenza virus using CPE inhibition 
assay. Compounds 166 and 169 exhibited weak antibacterial activity against S. aureus 
with MIC values of 63.9 and 52.4 µM, respectively while 167 showed weak antibacterial 
activity against E. aerugenes with MIC value of 33.5 µM. All other tested compounds 
showed neither cytotoxicity nor antimicrobial activity at the highest concentration tested 
(100 µM). Only 166 exhibited anti-H1N1 activity with IC50 and CC50 (50% cytotoxicity 
concentration) values of 143.1 and 976.4 µM, respectively (Wang et al., 2011). 
 
 Two sesterterpenoids, aspterpenacids A (181) and B (182) (Figure 23), were 
isolated from the marine-derived fungus Aspergillus terreus H010 which was isolated from 
the mangrove plant Kandelia obovata. Compounds 181 and 182 were evaluated for their 
antibacterial activity against three Gram-positive (Staphylococcus aureus, S. epidermidis 
and Bacillus subtilis) and three Gram-negative (Escherichia coli, Klebsiella pneumoniae 
and Acinetobacter calcoaceticus) bacterial strains. Both compounds were inactive at the 
highest concentration tested (50 µM). Moreover, these two compounds were also inactive 
in cytotoxicity assay against two human cancer cell lines: HeLa and MCF-7 by MTT 
method (Liu et al., 2016). 
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      142    143                     147  
 
  
                
                144  R = OH  145  R =           149  R1 = R2 = OH           151  
                146  R = H  148  R =            150  R1 = R2 = H 
 
                
152     153  R = CH3        155               156 
    154  R = OAc 
           
157  R = CH         158  R1 = β-H, R2 = R3 = double bond, R4 = H              163  R1 = R2 =H 
160  R = H       159  R1 = α-OH, R2 = R3 = H, R4 = OH              164  R1 = H, R2 = OH 
     161  R1 = β-H, R2 = R3 = double bond, R4 = OH              165  R1 = R2 = OH 
     162  R1 = α-OH, R2 = R3 = R4 = H 
 
Figure 22. Structures of 6-methoxyspirotryprostatin B (142), 18-oxotryprostatin A (143) and 14-
hydroxyterezine D (144), (4S,5S,6S,8S,9S,10R,13R,14S,16S,17Z)-6,16-diacetoxy-25-hydroxy-3,7-dioxy-
29-nordammara-1,17(20)-dien-21-oic acid (145), terezine D (146), pseustin A (147), helvolic acid (148), 
12,13-dihydroxyfumitremorgin C (149), fumitremorgin C (150), didehydrobesdethiobis(methylthio)gliotoxin 
(151), fumigaclavine B (152), pyripyropene A (153), pyripyropene E (154), aspergillusenes A (155) and B 
(156), (+)-(7S)-7-O-methylsydonic acid (157), aspergillusones A (158) and B (159), (+)-(7S)-sydonic acid 
(160), (7R,8R)-AGI-B4 (161), (7R,8R)-α-diversonolic ester (162), methyl 8-hydroxy-6-methyl-9-oxo-9H-
xanthene-1-carboxylate (163), and sydowinins A (164) and B (165). 
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166   167                      168             169 
 
          
 
    170  R =         173              174  R = CO2CH3         176   177 
    171  R = H                175  R = H 
    172  R =   
              
               178  R = H      180       181              182 
               179  R = OH 
    
Figure 23. Structures of terremides A (166) and B (167), terrelactone A (168), 3,4,5-trimethoxy-
2-(2-(nicotinamido)benzamido)benzoate (169), (+)-butyrolactones I – III (170 – 172), 3-hydroxy-
5-[[4-hydroxy-3-(3-methyl-2-buten-1-yl)phenyl]methyl]-4-)4-hydroxyphenyl)-2(5H)-furanone 
(173), aspernolide A (174), 5-[(3,4-dihydro-2,2-dimethyl-2H-1-benzopyran-6-yl)-methyl]-3-
hydroxy-4-(4-hydroxyphenyl)-2(5H)-furanone (175), territrem B (176), (-)-(1R,4R)-1,4-(2,3)-
indomethane-1-methyl-2,4-dihydro-1H-pyrazino[2,1-b]quinazoline-3,6-dione (177), R(-)-6-
hydroxymellein (178), trans-4,6-dihydroxymellein (179), (+)-terrein (180), aspterpenacids A (181) 
and B (182). 
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3.1.14) Aspergillus ustus 
 
Seven drimane sesquiterpenoids, 3β,9α,11-trihydroxy-6-oxodrim-7-ene (183), 
2α,9α,11-trihydroxy-6-oxodrim-7-ene (184), 2α,11-dihydroxy-6-oxodrim-7-ene (185), 
mono(6-strobilactone-B) ester of (E,E)-2,4-hexadienen-dioic acid (188), (6-
strobilactone-B) ester of (E,E)-6-oxo-2,4-hexadienoic acid (189), (6-strobilactone-B) 
ester of (E,E)-6,7-dihydroxy-2,4-octadienoic acid (190) and (6-strobilactone-B) ester 
of (E,E)-6,7-dihydroxy-2,4-octadienoic acid (191), together with three previously 
described deoxyuvidin B (186), strobilactone B (187) and RES-1149-2 (192) (Figure 
24), were isolated from the marine-derived fungus Aspergillus ustus 8009 which was 
isolated from the marine sponge Suberites domuncula, collected from the Adriatic Sea. 
The crude extract of A. ustus and all isolated compounds were evaluated for their 
cytotoxicity against L5178Y, PC12 and HeLa cancer cell lines using the MTT assay. The 
crude extract exhibited cytotoxicity against L5178Y at the concentration of 10 µg/mL, 
while 188, 189 and 192 displayed activity against this cell line with EC50 of 5.3, 0.6 and 
1.9 µg/mL, respectively. All other compounds were inactive at the highest concentration 
tested (10 µg/mL) (Liu et al., 2009). 
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Figure 24. Structures of 3β,9α,11-trihydroxy-6-oxodrim-7-ene (183), 2α,9α,11-trihydroxy-6-
oxodrim-7-ene (184), 2α,11-dihydroxy-6-oxodrim-7-ene (185), deoxyuvidin B (186), strobilactone 
B (187), mono(6-strobilactone-B) ester of (E,E)-2,4-hexadienendioic acid (188), (6-strobilactone-
B) ester of (E,E)-6-oxo-2,4-hexadienoic acid (189), (6-strobilactone-B) ester of (E,E)-6,7-
dihydroxy-2,4-octadienoic acid (190), (6-strobilactone-B) ester of (E,E)-6,7-dihydroxy-2,4-
octadienoic acid (191) and RES-1149-2 (192). 
 
3.1.15) Aspergillus versicolor 
 
A alkaloid, cottoquinazoline A (193), and two cyclopentapeptides, cotteslosins 
A (194) and B (195), were isolated, together with sterigmatocystin (196), violaceol I 
(197), violaceol II (198), diorcinol (199), (-)-cyclopenol (200) and viridicatol (201) 
(Figure 25), from the marine-derived fungus Aspergillus versicolor (MST-MF495) which 
was isolated from a beach sand sample collected from Cottesloe, Western Australia. 
Compound 194 showed weak cytotoxicity against three human cancer cell lines: 
MM418c5, DU145 and T47D, with EC50 values of 66, 90 and 94 µg/mL, respectively 
(Fremlin et al., 2009). 
 
183  R1 = H, R2 = OH, R3 = OH   
184  R1 = OH, R2 = H, R3 = OH 
185  R1 = OH, R2 = H, R3 = H 
186  R1 = H, R2 = OH, R3 = H 
 
187  R1 = OH, R2 = H  190,191  R1 = H, R2 =  
188  R1 = H, R2 =  192   R1 = H, R2 =  
189  R1 = H, R2 =  
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Eight prenylated indole diketopiperazines, versicamides A – H (202 – 209), and 
(-)-enamide (210), notoamide E (211) and brevianamide F (212) (Figure 25), were 
isolated from another strain (HDN08-60) of the marine-derived fungus Aspergillus 
versicolor which was isolated from the sediments, collected from the South China Sea. 
Compounds 202 – 209 were tested for their cytotoxicity against four human cancer cell 
lines: HeLa, HCT-116, HL-60 and K562, however only 209 showed moderate cytotoxicity 
with IC50 values of 19.4, 17.7, 8.7 and 22.4 µM, respectively. All other compounds were 
inactive at the highest concentration tested (50 µM) (Peng, Gao, Li, et al., 2014). 
 
3.1.16) Aspergillus wentii 
 
Three tetranorlabdane diterpenoids, asperolides A – C (213 – 215), and five 
previously reported a tetranorditerpenoid derivative (216), wentilactones A (217) and 
B (218), botryosphaerin B (219) and LL-Z1271-β (220) (Figure 26) were isolated from 
the endophytic fungus Aspergillus wentii EN-48 which was isolated from a marine brown 
alga Sargassum sp. All isolated compounds were tested for their cytotoxicity against 
seven human cancer cell lines: HeLa, HepG2, MCF-7, MDA-MB-231, NCI-H460, SMMC-
7721 and WE1990. All tested compounds did not exhibit significant activity against any 
cell lines at the concentration of 10 µM. Moreover, 213, 216 – 218 and 220 were further 
evaluated for their antimicrobial activity against the methicillin-resistant Staphylococcus 
aureus (MRSA), Pseudomonas aeruginosa, P. fluorescens, Bacillus subtilis and Candida 
albicans. Compound 216 exhibited antifungal activity against C. albicans with MIC value 
of 16 µg/mL while other tested compounds showed only weak activity (H. F. Sun et al., 
2012).   
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               196               198                199              200 
 
                      
  201               202    203            204 
  
          
            205              206              207   208 
 
                      
           209              210     211                   212 
  
Figure 25. Structures of cottoquinazoline A (193), cotteslosins A (194) and B (195), 
sterigmatocystin (196), violaceols I (197) and II (198), diorcinol (199), (-)-cyclopenol (200), 
viridicatol (201), versicamides A – H (202 – 209), (-)-enamide (210), notoamide E (211) and 
brevianamide F (212). 
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          213                 214           215                    216 
    
                           217       218                 219              220 
 
Figure 26. Structures of asperolides A – C (213 – 215), a tetranorditerpenoid derivative (216), 
wentilactones A (217) and B (218), botryosphaerin B (219) and LL-Z1271-β (220). 
 
3.1.17) Aspergillus westerdijkiae 
 
Two benzodiazepine alkaloids: circumdatins K (221) and L (222), two prenylated 
indole alkaloids: 5-chlorosclerotiamide (223) and 10-epi-sclerotiamide (224), and 
aspergilliamide B (225) were isolated, along with six previously described alkaloids: (+)-
circumdatin F (226), circumdatin G (227), sclerotiamide (228), notoamide C (229), 
notoamide I (230) (Figure 27) and cyclo-L-tryptophanyl-L-proline (212), from the 
marine-derived fungus Aspergillus westerdijkiae DFFSCS013 which was isolated from a 
marine sediment sample, collected from the South China Sea. All isolated compounds 
were investigated for their cytotoxicity against A549, HL-60, K562 and MCF-7 cancer cell 
lines. All tested compounds were inactive at the highest concentration tested (10 µm) 
(Peng et al., 2013). 
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   221  R1 = H, R2 = H, R3 = OH           222                   223  R1 = H, R2 = OH, R3 = Cl    225  
   226  R1 = H, R2 = CH3, R3 = H            224  R1 = OH, R2 = H, R3 = H 
   227  R1 = CH3, R2 = H, R3 = OH                     228  R1 = H, R2 = OH, R3 = H 
 
    
             229                              230               
 
Figure 27. Structures of circumdatins K (221) and L (222), 5-chlorosclerotiamide (223), 10-epi-
sclerotiamide (224), aspergilliamide B (225), (+)-circumdatin F (226), circumdatin G (227), 
sclerotiamide (228), notoamide C (229) and notoamide I (230). 
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3.2) The Fungi of the Genus Neosartorya 
 
3.2.1) Neosartorya fischeri 
 
 Neosartorya fischeri is the most studied species among the members of the genus 
Neosartorya. Several strains of this species have been investigated for their capacity to 
produce bioactive secondary metabolites. 
 
 Fiscalins A – C (231 – 233) (Figure 28) were isolated from the culture broth of the 
soil fungus Neosartorya fischeri which was isolated from a plant rhizosphere, collected in 
Taiwan. The isolated compoudns were examined for their substance P inhibitory activity 
using I-Bolton-Hunter-substance P binding assay. Compound 231 – 233 exhibited the 
binding inhibition of substance P ligand to the neurokinin (NK-1) receptor of U-373 MG 
cancer cell line with Ki values of 57, 174 and 68 µM, respectively (Wong et al., 1993).  
 
    
   231 R = H                     232 
         233 R = CH3 
 
Figure 28. Structures of fiscalins A (231), B (232) and C (233). 
 
 Three congeners of the dihydrogenated form of the xanthocillin group, NK372135s 
A – C (234 – 236) (Figure 29), were isolated from the culture broth of the fungus N. fischeri 
var. glabra IF09857. These three compounds exhibited the growth inhibitory activity 
against Candida albicans TIMM0144 with IC50 values of 2.12, 0.53 and 0.27 μg/mL, 
respectively. Compounds 234 – 236 showed stronger activity than xanthocillin 
dimethylether (XDE) and methoxy-xanthocillin dimethylether (XTE) which had IC50 values 
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of 12.1 and 8.2 μg/mL, respectively. From these results, it could be suggested that C2-C3 
bond of NK372135s must be related to potent inhibitory activity of these three compounds 
(Morino et al., 1994). 
 
 A yellow pigment Neosartorin (237) (Figure 29) was isolated from the soil fungus 
N. fischeri which was isolated from the river Vah sediment in Slovakia. This was the first 
report of ergochrome isolation from this fungus (Proksa et al., 1998). 
 
 The cyclopentenone derivatives, isoterrein (238) and terrein (239), were isolated, 
together with nortryptoquivalone (240) and aszonalenin (241) (Figure 29), from N. 
fischeri IFM52672 (Wakana et al., 2006). 
 
    
                XDE; R = H     234 R = H 
                  XTE; R = OCH3                235 R = OCH3 
                236 R = OH 
 
237 
     
  238 R1 = H, R2 = OH    240             241      
  239 R1 = OH, R2 =H 
 
 
Figure 29. Structures of xanthocillins, NK372135s A – C (234 – 236), neosartorin (237), isoterrein 
(238), terrein (239), nortryptoquivalone (240) and aszonalenin (241). 
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 The antifungal peptide (NFAP; N. fischeri antimicrobial protein), a small, basic and 
cysteine-rich protein consisting of 57 amino acid residues, was isolated from the culture 
supernatant of N. fischeri NRRL 181. NFAP was evaluated for its antifungal activity 
against five asco- and five zygomycetous fungal isolates, including Aspergillus nidulans 
SZMC 0307, Aspergillus niger SZMC 601, Botrytis cinerea NCAIM F00751, Fusarium 
graminearum SZMC 11030, Trichoderma longibrachiatum UAMH 7955, Absidia 
corymbifera SZMC 95033, Mucor piriformis SZMC 12078, Rhizomucor miehei CBS 
360.92, Rhizopus microsporus var. rhizopodiformis CBS 102.277 and Mortierella wolfii 
CBS 651.93, using 96-well microtiter plate bioassay. NFAP exhibited growth inhibitory 
activity against filamentous fungi in a dose-dependent manner. This compound 
completely inhibited the growth of A. niger after 48 h of incubation at the concentration of 
200 μg/mL and partially inhibited at the concentration of 12.5 µg/mL with 32 ± 5% growth 
inhibition. NFAP exhibited the growth inhibitory activity of fungi within broad pH and 
temperature ranges, and the highest activity was at pH 8.4-8.6 (Kovács et al., 2011). In 
2014, Virágh et al. investigated the heterologous expression of NFAP in the yeast Pichia 
pastoris KM71H and evaluated the growth inhibitory activity of this heterologous NFAP 
(hNFAP), and compared to the native NFAP by a 96-well microtiter plate bioassay, 
against human pathogenic filamentous fungal strains, including five zygomycetous 
(Absidia corymbifera SZMC 95033, R. miehei CBS 360.92, Rhizomucor pusillus ETH 
M4920, R. mocrosporus var. rhizopodifomis CBS 102.277 and Rhizopus oryzae CBS 
146.90) and fourteen ascomycetous (Aspergillus awamori SZMC 2390, Aspergillus flavus 
SZMC 2521, Aspergillus fumigatus SZMC 2394, A. niger SZMC 2402, Aspergillus nomius 
SZMC 2441, Aspergillus tamarii SZMC 2482, Aspergillus terreus SZMC 2535, Aspergillus 
tubingensis SZMC 2503, Fusarium incarnatum SZMC 11403, Fusarium solani SZMC 
11412, F. solani SZMC 11427, Fusarium sporotrichioides SZMC 11421, T. 
longibrachiatum UAMH 7955, T. longibrachiatum UAMH 9515) fungal isolates. The 
antifungal activity of hNFAP was not different from that of NFAP. Both compounds 
exhibited the growth inhibitory activity against only eight ascomycetous fungal isolates: 
A. awamori SZMC 2390, A. fumigatus SZMC 2394, A. niger SZMC 2402, A. nomius 
SZMC 2441, A. tamarii SZMC 2482, A. tubingensis SZMC 2503, F. incarnatum SZMC 
11403 and F. solani SZMC 11412. At 200 µg/mL concentration, NFAP and hNFAP 
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inhibited the growth of these eight fungal isolates about fifty percent, and the most 
sensitive fungal isolate was A. tubingensis which showed the growth percentage 31 ± 4.6 
and 20 ± 3.6% for NFAP and hNFAP, respectively. In 2015, Virágh et al. studied the 
mechanism of antifungal activity of NFAP by investigating a reduced cellular metabolism 
using FUN1 viability staining, apoptosis induction by Annexin V-FITC Apoptosis Detection 
Kit, membrane disruption using PI staining, changes in the actin distribution and chitin 
deposition at the hyphal tip in NFAP-sensitive Aspergillus nidulans. NFAP did not exhibit 
a direct membrane disruption, but it induced apoptosis by activating the cAMP/protein 
kinase A pathway via G-protein.  
 
 Norfumiquinazoline derivatives, Cottoquinazolines E (242) and F (243) 
(Figure 30), were isolated, together with pyripyropene A (153), from the fungus N. 
fischeri NRRL 181, which was purchased from DSMZ (DE-Braunschweig) (Shan et al., 
2015). 
 
    
242      243 
 
Figure 30. Structures of cottoquinazolines E (242) and F (243). 
 
Fischeacid (244) and fischexanthone (245) were isolated, together with 
sydowinins A (164) and B (165), AGI-B4 (246), chrysophanol (247), emodin (93), 5’-
deoxy-5’-methylamino-adenosine (248), adenosine (249) and 3,4-dihydroxybenzoic 
acid (250) (Figure 31), from the marine-derived fungus N. fischeri strain 1008F1. All 
isolated compounds were examined for their cytotoxicity on SGC-7901 and BEL-7404 
cancer cell lines, by MTT assay, and antiphytoviral activity against tobacco mosaic virus 
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(TMV) by the leaf-disc method. The results showed that 246 exhibited a potent inhibition 
of the proliferation of SGC-7901 and BEL-7404 cells with IC50 values of 0.29 ± 0.005 and 
0.31 ± 0.004 mmol L-1, respectively. Moreover, 246 and 250 exhibited inhibition of 
replication of TMV with IC50 values of 0.26 ± 0.006 and 0.63 ± 0.008 mmol L-1, respectively 
(Tan et al., 2012). 
 
      
 
             244             245 
 
 
   
 
    246                              247 
    
          
                          
           248               249         250 
 
Figure 31. Structures of fischeacid (244), fischexanthone (245), AGI-B4 (246), chrysophanol 
(247), 5’-deoxy-5’-methylamino-adenosine (248), adenosine (249) and 3,4-dihydroxybenzoic acid 
(250). 
 
 1-formyl-5-hydroxyaszonalenin (251) and sartorypyrone A (253) were isolated, 
together with aszonalenin (241), acetylaszonalenin (252), 13-oxofumitremorgin B 
(255), aszonapyrone A (256) and helvolic acid (148) (Figure 32), from the soil fungus 
N. fischeri KUFC 6344 which was isolated from the coastal forest soil, collected from 
Samaersarn Island, Thailand, by Eamvijarn et al. (2013). Compounds 241, 251 – 253 and 
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255 – 256 were tested for their cytotoxicity against MCF-7, NCI-H460 and A375-C5 
cancer cell lines. The results showed that 256 potently inhibited the growth of MCF-7, 
NCI-H460 and A375-C5 cells with GI50 values of 13.6 ± 0.9 μM, 11.6 ± 1.5 μM and 10.2 
± 1.2 μM, respectively. Compound 253 also displayed strong growth inhibitory activity 
against A375-C5 cell with GI50 value of 21.5 ± 1.9 μM, but less active against MCF-7 and 
NCI-H460 cells with GI50 values of 46.3 ± 7.6 and 37.3 ± 4.0 μM, respectively. Compound 
255 exhibited weak growth inhibitory activity against all tested cell lines with GI50 values 
of 115.0 ± 20.0, 123.3 ± 11.5 and 68.6 ± 12.9 μM, for MCF-7, NCI-H460 and A375-C5 
cell lines, respectively. In contrast, all three aszonalenin derivatives (241, 251 and 252) 
were inactive against all tested cell lines at the highest concentration tested (150 μM). 
 
The antibacterial activity of sartorypyrone A (253), which was previously isolated 
from the soil fungus N. fischeri KUFC 6344 (Eamvijarn et al., 2013), was evaluated 
against four bacterial isolates, including Staphylococcus aureus ATCC 25923, Bacillus 
subtilis ATCC 6633, Escherichia coli ATCC 25922 and Pseudomonas aeruginosa ATCC 
27853, and the multidrug-resistant bacterial isolates from the environment, including S. 
aureus B1 and B2, Enterococcus faecalis W1, Enterococcus faecium  W5 and E. coli G1, 
as well as its potential synergism with antibiotic against the methicillin-resistant S. aureus 
(MRSA) and vancomycin-resistant Enterococci (VRE) (Gomes et al., 2014). Compound 
253 inhibited the growth of S. aureus and B. subtilis with the MIC values of 32 and 64 
µg/mL, respectively, however it was inactive against the multidrug-resistant bacterial 
isolates at the highest concentration tested (256 µg/mL). The combination of 253 and 
oxacillin, and ampicillin exhibited no synergism against MRSA isolate. Compound 253 
was also found to completely inhibited biofilm formation of S. aureus ATCC 25923, B. 
subtilis ATCC 6633 and S. aureus B1 at the concentrations of 2 x MIC and MIC. However, 
at the sub-inhibitory concentration (1/2 × MIC), S. aureus and S. aureus B1 showed more 
biofilm formation. 
 
Sartorypyrone D (254), sartorypyrone A (253), aszonapyrone A (256) and 
aszonapyrone B (257) (Figure 32) were isolated from the soil fungus N. fischeri FO-5897 
which was isolated from the soil sample, collected in Chiba, Japan. All isolated 
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compounds were tested for their inhibitory activity against NADH-fumarate reductase 
(NFRD) and NADH oxidase. Compounds 253 and 254 exhibited potent inhibitory activity 
toward NFRD with IC50 values of 1.7 and 0.6 µM, respectively, while compound 256 and 
257 exhibited moderate activity, but the selectivity toward NADH oxidase was higher than 
compound 253 and 254 (Kaifuchi et al., 2015). 
 
    
 251 R1 = OH, R2 = CHO                255            
 252 R1 = H, R2 = Oac 
 
 
      253               254 
 
 
                256  R = Ac 
                257  R = H 
 
Figure 32. Structures of 1-formyl-5-hydroxyaszonalenin (251), acetylaszonalenin (252), 
sartorypyrone A (253), sartorypyrone D (254), 13-oxofumitremorgin B (255), aszonapyrone A 
(256) and aszonapyrone B (257).  
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6-Hydroxyaszonalenin (258) and six previously described compounds, 
acetylaszonalenin (252), aszonalenin (241), fumitremorgin B (259) (Figure 33), 
verruculogen (82), aszonapyrone A (256) and aszonapyrone B (257), were isolated 
from the fungus N. fischeri CGMCC 3.5378, which was obtained from the Chinese 
Academy of Science (Shan et al., 2014). 
 
 Later on, Zheng et al. (2014) reported the isolation of prenylated 2,5-
diketopiperazines, Neofipiperazines A – C (260 – 262), together with verruculogen 
(82), verruculogen TR-2 (263), 12α,13α-dihydroxyfumitremorgin C (149), 
fumitremorgin C (150), cyclotryprostatin (264) and rel-(8S)-19,20-dihydro-9,20-
dihydroxy-8-methoxy-9,18-diepifumitremorgin C (265) (Figure 33), from the same 
fungus. 
 
From the same fungus, Chen et al. (2014) isolated a prenylated indole alkaloid, 
neofipiperazine D (266), together with fumitremorgin C (150), ergosterol (267) and 
(1S,2R,5R,6R,9R,10R,13S,15S)-5-[2R,3E,5S)-5,6-dimehtyl-3-hepten-2-yl]-6,10-
dimethyl-16,17-dioxapentacyclo[12.2.2.01,9.02,6.010,15]nonadec-18-en-13-ol (268) 
(Figure 33). Compound 266 was evaluated for its cytotoxicity against four human cancer 
cell lines: MCF-7, H1299, HUVEC and MDA-MB-231, but it was inactive against all tested 
cell lines at a concentration of 20 µM. 
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258          259 
 
       260 R = α-OH              262 R = (CH3)2C=CHCH2 
    261 R = β-OH              263 R = H 
 
     
    
                  264                        265 
            
 
 
    266           267               268 
 
Figure 33. Structures of 6-hydroxyaszonalenin (258), fumitremorgin B (259), neofipiperazines A 
– C (260 – 262), verruculogen TR-2 (263), cyclotryprostatin (264), rel-(8S)-19,20-dihydro-9,20-
dihydroxy-8-methoxy-9,18-diepifumitremorgin C (265), neofipiperazine D (266), ergosterol (267) 
and (1S,2R,5R,6R,9R,10R,13S,15S)-5-[2R,3E,5S)-5,6-dimehtyl-3-hepten-2-yl]-6,10-dimethyl-
16,17-dioxapentacyclo[12.2.2.01,9.02,6.010,15]nonadec-18-en-13-ol (268). 
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Two tryptoquivaline derivatives, tryptoquivalines T (269) and U (270) (Figure 34), 
together with fiscalin B (232), were isolated from the fermentation broth of the marine-
derived fungus N. fischeri which was isolated from marine mud, collected in the intertidal 
zone of Hainan, China. The isolated compounds were evaluated for their cytotoxicity 
against HL-60 cell line. Compounds 232, 269 and 270 exhibited the growth inhibitory 
activity toward HL-60 cell with IC50 values of 8.88, 82.3 and 90.0 µM, respectively (Wu et 
al., 2015). 
 
    
   269      270 
 
Figure 34. Structures of tryptoquivalines T (269) and U (270). 
 
3.2.2) Neosartorya glabra 
 
 Three bicyclic lactones, glabramycins A – C (271 – 273) (Figure 35), were 
isolated from the soil fungus N. glabra (MF7030, F-155,700) which was isolated from the 
soil sample, collected from Candamia, Spain. All isolated compounds were evaluated for 
their antimicrobial activity against Staphylococcus aureus ATCC 29213, S. aureus 
MB2865, Streptococcus pneumoniae CL2883, Enterococcus faecalis CL8516, Bacillus 
subtilis MB964, Haemophilus influenza MB4572, Escherichia coli MB2884 and Candida 
albicans MY1055. The results showed that compound 273 exhibited better activity by 
inhibiting the growth of Streptococcus pneumoniae, S. aureus and B. subtilis with MIC 
values of 2, 16 and 16 μg/mL, respectively. None of the tested compounds exhibited the 
growth inhibitory activity against Gram-negative bacteria or C. albicans (Jayasuriya et al., 
2009). 
 63 
 
 CHAPTER III: CHEMISTRY OF THE FUNGI OF THE GENERA ASPERGILLUS AND NEOSARTORYA 
 
         
                                   
           271              272 
 
273 
 
Figure 35. Structures of glabramycins A – C (271 – 273). 
 
Sartoryglabins A – C (274 – 276) (Figure 36), the analogs of (-) ardeemins, were 
isolated from the soil-derived fungus N. glabra which was isolated from the soil sample, 
collected in Thailand. All isolated compounds were evaluated for their in vitro growth 
inhibitory activity on three human tumor cell lines: MCF-7, NCI-H460 and A375-C5. 
Compound 274 exhibited strong growth inhibitory activity against MCF-7 cell line with GI50 
value at 27.0 ± 0.57 μM while 275 and 276 exhibited moderate activity with GI50 values 
of 53.0 ± 4.7 and 44.0 ± 7.2 μM, respectively. It was found that 274 and 276 showed weak 
activity against NCI-H460 cell line (GI50 84.0 ± 2.1 and 82.3 ± 5.6 μM, respectively) while 
275 did not show any activity at the highest concentration tested (150 μM). Moreover, 276 
exhibited weak activity against A375-C5 cell line with GI50 value of 108.0 ± 7.7 μM while 
274 and 275 were inactive (Kijjoa et al., 2011). 
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          274 R = H       276 
                     275 R = OH 
 
Figure 36. Structures of sartoryglabrins A – C (274 – 276). 
 
 Neosarphenols A (277) and B (278) were isolated, together with 
methoxyvermistatin (279), 6-demethylvermistatin (280), vermistatin (281), 
penicillide (282), purpactin A (283), phialophoriol (284) and chrodrimanins A (285) 
and B (286) (Figure 37), from the fungus N. glabra CGMCC 32286 which was obtained 
from the Chinese Academy of Science. All isolated compounds were tested for their 
cytotoxicity against three human tumor cell lines: MDA-MB-231, MFC-7 and PANC-1. 
Compound 277 and 282 exhibited selective and moderate growth inhibitory activity 
against PANC-1 cell line with IC50 values of 14.38 and 10.93 μM, respectively. On the 
contrary, other compounds were inactive for all three cell lines (Liu et al., 2015). 
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      277 R = H    278       280 R = H   
      279 R = CH3         281 R = CH3  
      
          
      282 R = H                284   285 R = H 
      283 R = Ac        286 R = Ac 
 
Figure 37. Structures of neosarphenols A (277) and B (278), methoxyvermistatin (279), 6-
demethylvermistatin (280), vermistatin (281), penicillide (282), purpactin A (283), phialophoriol 
(284), and chrodrimanins A (285) and B (286). 
 
Two cyclic tetrapeptides, sartoryglabramides A (290) and B (291), and a bis-
indolylmethyldiketopiperazine, fellutanine A epoxide (293), together with aszonalenin 
(241), (3R)-3-(1H-indol-3-ylmethyl)-3,4-dihydro-1H-1,4-benzodiazepine-2,5-dione 
(287), takakiamide (288), (11aR)-2,3-dihydro-1H-pyrrolo[2,1-c] [1,4]benzodiazepine-
5,11(10H,11aH)-dione (289) and fellutanine A (292) (Figure 38), were isolated from the 
marine-derived fungus N. glabra KUFA 0702 which was isolated from the marine sponge 
Mycale sp., collected from the coral reef at Samaesarn Island, Thailand. All isolated 
compounds were evaluated for their antimicrobial activity against two bacterial isolates: 
Staphylococcus aureus ATCC 46645 and Escherichia coli ATCC 25922, and three fungal 
isolates: Aspergillus fumigatus ATCC 46645, Trichophyton rubrum ATCC FF5 and 
Candida albicans ATCC 10231. The results revealed that all tested compounds were 
inactive at the highest concentration tested (256 µg/mL for antibacterial assay and 512 
µg/mL for antifungal assay) (May Zin et al., 2016). 
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287       288 
                          
 289                          290        291 
 
                   
292                       293 
 
Figure 38. Structures of (3R)-3-(1H-indol-3-ylmethyl)-3,4-dihydro-1H-1,4-benzodiazepine-2,5-
dione (287), takakiamide (288), (11aR)-2,3-dihydro-1H-pyrrolo[2,1-c][1,4] benzodiazepine-
5,11(10H,11aH)-dione (289), sartoryglabramides A (290) and B (291), fellutanine A (292) and 
fellutamine A epoxide (293). 
 
3.2.3) Neosartorya laciniosa 
 
 Eamvijarn et al. (2013) reported the isolation of aszonapyrones A (256) and B (257), 
tryptoquivaline L (295) and 3’-(4’oxoquinazoline-3-yl)spiro[1H-indole-3,5’-oxolane]-2,2’-
dione (294) (Figure 39) from the marine-derived fungus N. laciniosa (KUFC 7896) which was 
isolated from a diseased coral Porites lutea, collected from the Gulf of Thailand. Compounds 256 
and 257 were evaluated for their in vitro growth inhibitory activity on three human cancer cell lines: 
MCF-7, NCI-H460 and A375-C5, using sulforhodamine B (SRB) assay. While aszonapyrone A 
(256) was found to exhibit potent activity with GI50 values of 13.6 ± 0.9, 11.6 ± 1.5 and 10.2 ± 1.2 
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μM, respectively, aszonapyrone B (257) which is a 3-deacetyl aszonapyrone A, did not exhibit 
any growth inhibitory activity against all tested cell lines. Later on, tryptoquivaline T (296), a new 
tryptoquivaline analogue (Figure 39), was also isolated from the same extract (Gomes et al., 
2014). All isolated compounds were evaluated for their antibacterial activity against Gram-positive 
(Staphylococcus aureus ATCC 25923 and Bacillus subtilis ATCC 6633) and Gram-negative 
(Escherichia coli ATCC 25922 and Pseudomonas aeruginosa ATCC 27853) bacteria and the 
multidrug-resistant isolates from the environment (S. aureus B1, S. aureus B2, Enterococcus 
faecalis W1 and E. faecium W5), and the synergistic effect with antibiotics, as well as antibiofilm 
activity. Only, 256 exhibited significant antibacterial activity with MIC value of 8 μg/mL against 
both S. aureus and B. subtilis, and also showed activity against both methicillin-resistant S. aureus 
(MRSA) and vancomycin-resistant Enterococci (VRE) isolates. Moreover, 256 also exhibited the 
synergistic effect with antibiotics against both Gram-negative reference strains and the multidrug-
resistant isolates from the environment. Therefore, its biofilm formation inhibitory activity was 
evaluated. The results of antibiofilm assay of 256 revealed that this compound completely 
inhibited the biofilm formation at the concentrations of 2 × MIC and MIC, but it increased the 
production of biofilm at the sub-inhibitory concentration (1/2 MIC) (Gomes et al., 2014). 
 
       
    294          295  R1 = OH, R2 = CH3    
     296  R1 = CHO, R2 = CH3 
 
Figure 39. Structures of 3’-(4’oxoquinazoline-3-yl)spiro[1H-indole-3,5’-oxolane]-2,2’-dione (294), 
and tryptoquivalines L (295) and T (296). 
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3.2.4) Neosartorya paulistensis 
 
 The meroditerpene, sartorypyrone C (298), was isolated, together with the 
previously described tryptoquivalines L (295), H (299), F (300), 3’-(4’oxoquinazolin-3-
yl)spiro[1H-indole-3,5’-oxolane]-2,2’-dione (294) and 4(3H)-quinazolinone (297)  
(Figure 40), from the marine-derived fungus N. paulistensis KUFC 7897 which was 
isolated from the sponge Chondrilla australiensis, collected from Mu Kho Lan Beach, 
Chonburi Province, Thailand (Gomes et al., 2014). 
    
          297       298       299 R1 = OH, R2 = H 
             300 R1 = H, R2 = H 
 
Figure 40. Structures of 4(3H)-quinazolinone (297), sartorypyrone C (298), and tryptoquivalines 
H (299) and F (300). 
 
3.2.5) Neosartorya pseudofischeri 
 
 Two rotamers of debenzilpiperazine derivatives: 3,8-diacetyl-4-(3-methoxy-4,5-
methylene-dioxy)benzyl-6-oxa-3,8-diazebicyclo[3.2.1]octane (301a and 301b), an 
indole alkaloid: pseudofischerine (302) ,and 3-hydroxy-5-methylphenyl-2,4-
dihydroxy-6-methylbenzoate (303), together with previously reported cadinene (304), 
euroche-valierine (305), brasiliamide B (306) (Figure 41) and pyripyropene A (153), 
were isolated from the soil-derived fungus N. pseudofischeri, collected from an 
agricultural soil sample in Thailand. All isolated compounds, except for 306, were 
evaluated for their in vitro growth inhibitory activity on the human U373 and Hs683, A549, 
MCF-7, SKMEL-28 and OE21 cancer cell lines using etoposide and carboplatin as 
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reference compounds. Compound 305 exhibited anticancer activity in the range displayed 
by etoposide and carboplatin. Although 304 was less active than 305, its activity was 
similar to that of carboplatin. Other compounds did not show any activity on all tested cell 
lines at the highest concentration tested (Eamvijarn et al., 2012). 
 
The pyrroloindole terpenoid, fischerindoline (307), together with 
eurochevalierine (305), pyripyropenes A (153) and E (154), sequiterpene (308), 
gliotoxin (309) and bis(dethio)bis(methylthio)gliotoxin (310) (Figure 41), were 
isolated from the fungus N. pseudofischeri which was obtained from Centraalbureau voor 
Schimmelcultures of Baarn. All these compounds were evaluated for their in vitro growth 
inhibitory activity against five human cancer cell lines: A549, Hs683, MCF-7, SKMEL28 
and U373, and a mouse cancer cell line: B16F10. Compound 309 exhibited the most 
potent activity with the median IC50 value for all cell lines < 0.05 μM. The growth inhibitory 
activity of 307 (the median IC50 30 ± 2 μM) was similar to that displayed by 154 and 305 
which exhibited the median IC50 values of 27.5 ± 1.6 and 38 ± 11 μM, respectively (Masi 
et al., 2013). 
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     301a     301b             302 
               
 
          303       304           305        
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             308      309         310 
 
Figure 41. Structures of 3,8-diacetyl-4-(3-methoxy-4,5-methylenedioxy)benzyl-7-phenyl-6-oxa-
3,8-diazabicyclo[3.2.1]octane (301a, 301b), pseudofischerine (302), 3-hydroxy-5-methyl-phenyl-
2,4-dihydroxy-6-methylbenzoate (303), cadinene (304), eurochevalierine (305), brasiliamide B 
(306), fischerindoline (307), sequiterpene (308), gliotoxin (309) and bis(dethio)bis 
(methylthio)gliotoxin (310). 
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 By using the glycerol-peptone-yeast extract (GlyPY) medium, Liang et al. (2014) 
was able to isolated neosartins A (311) and B (312), as well as 1,2,3,4-tetrahydro-2,3-
dimethyl-1,4-dioxopyrazino[1,2-a]indole (313), 1,2,3,4-tetrahydro-2-methyl-1,2,3-
trioxopyrazino[1,2-a]indole (314), 1,2,3,4-tetrahydro-2-methyl-1,3,4-trioxopyrazino 
[1,2-a]indole (315), N-methyl-1H-indole-2-carboxamide (316), 6-acetylbis(methyl-
thio)gliotoxin (319), bisdethiobis(methylthio)gliotoxin (320), didehydrobisdethio-
bis(methylthio)gliotoxin (321), from the culture of the marine-derived fungus N. 
pseudofischeri which was isolated from the inner tissue of the starfish Acanthaster planci, 
collected from Hainan Sanya National Coral Reef Reserve, China. However, when the 
fungus was cultured in the glucose-peptone-yeast extract (GluPY) medium, neosartin C 
(323), pyripyropene A (153), gliotoxin (309), acetylgliotoxin (317), reduced gliotoxin 
(318), 6-acetylbis(methylthio)gliotoxin (319), bisdethiobis(methylthio) gliotoxin 
(320) and bis-N-norgliovictin (322) (Figure 42) were isolated. All isolated compounds, 
except for 153 and 311, were tested for their antibacterial activity against Staphylococcus 
aureus ATCC 29213, methicillin-resistant S. aureus R3708 and Escherichia coli ATCC 
25922. Compound 153 exhibited significant antibacterial activity against these three 
bacteria with MIC values of 12.20, 1.53 and 24.53 µM, respectively. Compound 318 also 
showed antibacterial activity, but less potent than 153, with MIC values of 48.78, 1.52 and 
97.56 µM, respectively. Other tested compounds were inactive for all bacterial strains at 
the highest concentration tested (256 µg/mL) (Liang et al., 2014). 
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               311 R1 = CH3, R2 = OCH3           314 R = CH2          316  
               312 R1 = CH2OH, R2 = OCH3              315 R = O 
               313 R1 = CH3, R2 = H 
                   
      317                                318 R1=R3=SH, R2 = OH       
                            319 R1=R3=SCH3, R2 = Oac 
                           320 R1=R3=SH, R2 = OH 
 
    
   321      322               323 
             
 
Figure 42. Stuctures of neosartins A (311) and B (312), 1,2,3,4-tetrahydro-2,3-dimethyl-1,4-
dioxopyrazino[1,2-a]indole (313), 1,2,3,4-tetrahydro-2-methyl-1,2,3-trioxopyrazino[1,2-a]indole 
(314), 1,2,3,4-tetrahydro-2-methyl-1,3,4-trioxopyrazino[1,2-a]indole (315), N-methyl-1H-indole-2-
carboxamide (316), acetylgliotoxin (317), reduced gliotoxin (318), 6-acetylbis(methylthio) gliotoxin 
(319), bisdethiobis(methylthio)gliotoxin (320), didehydrobisdethiobis(methylthio)gliotoxin (321),  
bis-N-norgliovictin (322) and neosartin C (323). 
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Recently, Lan et al. (2016) reported the isolation of 5-olefin phenylpyropene A 
(324), 13-dehydroxylpyripyropene A (327), deacetylsesquiterpene (329), 5-formyl-6-
hydroxy-8-isopropyl-2-naphthoic acid (331), 6,8-dihydroxyl-3-((1E,3E)-penta-1,3-
dien-1-yl)isochroman-1-one (332), phenylpyropenes A (325) and C (326), 
pyripyropene A (153), 7-deacetylpyripyropene A (328), (1S,2R,4aR,5R,8R,8aR)-1,8a-
dihydroxy-2-acetoxy-3,8-dimethyl-5-(prop-1-en-2-yl)-1,2,4a,5,6,7,8,8a-octahydro-
naphthalene (330), isochaetominine C (333), trichodermamide A (334), indolyl-3-
acetic acid methyl ester (335), 1-acetyl-β-carboline (336), 1,2,3,4-tetrahydro-6-
hydroxyl-2-methyl-1,3,4-trioxopyrazina[1,2-a]-indole (337) and fumiquinazoline F 
(338) (Figure 43), from the same fungus. All isolated compounds, except for 334 – 336 
and 338, were evaluated for their cytotoxicity against the insect cell line Sf9 from 
Spodoptera frugiperda. All tested compounds exhibited significant cytotoxicity activity, 
especially 153, 325, 326, 329-331 and 337 which inhibited the cell growth rate more than 
90% after 48 hours of treatment at 50 mg/L concentration.  
 
3.2.6) Neosartorya quadricincta 
 
 Ozoe et al. (2004) reported the isolation of a dihydroisocoumarin derivative, 
PF1223 (339) (Figure 44), from the culture of N. quadricincta. Compound 339 was 
investigated for its inhibitory activity of the specific binding of the noncompetitive 
antagonist [3H]EBOB to housefly head membranes. At the concentration of 2.2 μM, this 
compound inhibited the [3H]EBOB binding by 65%. The result suggested that 339 might 
prove to be a lead compound for insecticides acting at the insect GABA receptor. 
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         324  325 R1 = OH, R2 = OAc, R3 = Oac     327                  328   
326 R1 = H, R2 = H, R3 = H                  
 
                    
     329 R = OH         331         332         335                  336 
       330 R = OAc 
 
                         
         333           334         337      338 
 
Figure 43. Structures of 5-olefin phenylpyropene A (324), phenylpyropenes A (325) and C (326), 
13-dehydroxylpyripyropene A (327), 7-deacetylpyripyropene A (328), deacetylsesquiterpene 
(329), (1S,2R,4aR,5R,8R,8aR)-1,8a-dihydroxy-2-acetoxy-3,8-dimethyl-5-(prop-1-en-2-yl)-1,2,-
4a,5,6,7,8,8a-octahydronaphthalene (330), 5-formyl-6-hydroxy-8-isopropyl-2-naphthoic acid 
(331), 6,8-dihydroxyl-3-((1E,3E)-penta-1,3-dien-1-yl)isochroman-1-one (332), isochaetominine C 
(333), trichodermamide A (334), indolyl-3-acetic acid methyl ester (335), 1-acetyl-β-carboline 
(336), 1,2,3,4-tetrahydro-6-hydroxyl-2-methyl-1,3,4-trioxopyrazina[1,2-a]-indole (337) and 
fumiquinazoline F (338). 
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339 
 
Figure 44. Structure of PF1223 (339). 
 
3.2.7) Neosartorya siamensis 
 
 The culture of the soil-derived fungus N. siemensis (KUFC 6349), isolated from 
forest soil sample, collected at Sameasarn Island, Thailand, furnished sartorymensin 
(341), tryptoquivaline O (343), 3’-(4-oxoquinazolin-3-yl)spiro[1H-indole-3,5’-
oxolane]-2,2’-dione (294), epi-fiscalin C (344), epi-fiscalin A (345), neofiscalin A 
(346) and epi-neofiscalin A (347), together with seven previously reported compounds: 
2,4-dihydroxy-3-methylactophenone (340), tryptoquivaline (342), tryptoquivalines L 
(295), H (299) and F (300) (Figure 45), and fiscalins A (231) and C (233). Compounds 
294 – 295, 299 – 300, 341 – 343 and 345 were examined for their growth inhibitory activity 
against the human U373, Hs683, A549, MCF-7 and SKMEL-28 cell lines, by MTT 
colorimetric assay. However, only 341 exhibited moderate growth inhibitory activity 
against five tested cell lines with IC50 values of 44, 50, 39, 43 and 73 μM, respectively 
(Buttachon et al., 2012) 
 
 Reexamined the nonpolar fractions from the column chromatography of this fungus 
led to the isolation of chevalones B (348) and C (349) (Figure 45) (Gomes et al., 2014).  
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  342        343           344 R1 = CH(CH3)2, R2 = H, R3 = R4 = CH3 
                          345 R1 = CH(CH3)2, R2 = R4 = H, R3 = CH3 
                          346 R1 = R3 = H, R2 = CH(CH3)2, R4 = CH3 
                          347 R1 = CH(CH3)2, R2 = R3 = H, R4 = CH3 
     
     
 
438                      339             
 
Figure 45. Structures of 2,4-dihydroxy-3-methylacetophenone (340), sartorymensin (341), 
tryptoquivaline (342), tryptoquivaline O (343), epi-fiscalin C (344), epi-fiscalin A (345), neofiscalin 
A (346), epi-neofiscalin A (347), and chevalones B (348) and C (349).  
 
 Chromatographic fractionation of the ethyl acetate extract of the culture of the 
marine-derived fungus N. siamensis (KUFA 0017) which was isolated from the sea fan 
Rumphella sp., collected from Similan Island, led to the isolation of 2,4-dihydroxy-3-
methylacetophenone (340), chevalone C (349), tryptoquivaline (342), 
nortryptoquivaline (240), tryptoquivalines L (295), H (299) and F (300), fiscalin A 
(231), epi-fiscalin A (345), neofiscalin A (346), epi-neofiscaline A (347), fiscalin C 
(233), epi-fiscalin C (344) and 3’-(4-oxoquinazolin-3-yl)spiro[1H-indole-3,5’-
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oxolane]-2,2’-dione (294). Compounds 231, 240, 299 – 300, 340, 344 – 345, 347 and 
349 were evaluated for their anti-proliferative activity, DNA damage induction, and 
induction of cell death. Compounds 231, 240, 344, 345, 347 and 349 exhibited the anti-
proliferative activity with IC50 values ranging from 24 to 153 μM in HepG2, HCT116 and 
HT29 cancer cell lines. Compounds 231, 240 and 349 induced cell death in HCT116 cell 
line while 231, 240, 345 and 347 induced significant cell death in HepG2. Since none of 
the compounds induced significant DNA damage, this induction of cell death is possibly 
not related to genotoxicity (Prata-Sena et al., 2016).  
 
 3’-(4-oxoquinazolin-3-yl)spiro[1H-indole-3,5’-oxolane]-2,2’-dione (294), 
nortryptoquivaline (240), tryptoquivalines L (295), H (299) and F (300), fiscalin A 
(231), epi-fiscalin A (345), neofiscalin A (346), epi-neofiscalin A (347) and epi-fiscalin 
C (344) which were isolated from the marine-derived fungus N. siamensis KUFA 0017 
(Prata-Sena et al., 2016), together with tryptoquivaline O (343), fiscalin C (223) and 
sartorymensin (341) which were previously isolated from the soil-derived fungus N. 
siamensis KUFC 6349 (Buttachon et al., 2012), were evaluated for their antibacterial 
activity against Gram-positive (Staphylococcus aureus ATCC 25923, Enterococcus 
faecalis ATCC 29212) and Gram-negative (Escherichia coli ATCC 25922 and 
Pseudomonas aeruginosa ATCC 27853) bacteria, as well as the multidrug-resistant 
isolates from environment (S. aureus B1 and E. faecalis W1). All tested compounds were 
inactive at the highest concentration tested (256 µg/mL), except for neofiscalin A (346) 
which exhibited antibacterial activity against all strains of S. aureus and E. faecalis with 
MIC 8 µg/mL. Based on the results of a screening susceptibility test for synergistic effect 
of the compounds and antibiotics against S. aureus B1 and E. faecalis W1, the synergy 
of fiscalin C (233) and oxacillin or ampicillin were evaluated against the methicillin-
resistant S. aureus (S. aureus B1) using a broth microdilution checkerboard method. The 
results revealed that there was the synergy between 233 and oxacillin (FIC index < 0.5), 
while the combination of 233 and ampicillin did not show any synergistic effect (0.5 < FIC 
index ≤ 4). Moreover, neofiscalin A (346) was tested for antibiofilm activity against S. 
aurues B1 and E. faecalis W1, and cytotoxicity toward a human brain microvascular 
endothelial cell line (hCMEC/D3). Compound 346 completely inhibited the biofilm 
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formation at the concentration of 2 x MIC and MIC, and did not exhibit cytotoxicity against 
hCMEC/D3 cell line at concentrations of 5, 10 and 20 µg/mL (Bessa et al., 2016). 
 
3.2.8) Neosartorya spatulata 
 
 Besides the production of secondary metabolites, the fungi of the genus 
Neosartorya have been also investigated for their capacity to transform other compounds 
to interesting metabolites. For example, α-Mangostin (350), a prenylated xanthone 
isolated from the fruit hull of Garcinia mangostana L., was metabolized by fungus N. 
spatulata (EYR042) to give mangostin-3-sulfate (351) (Figure 46). Compounds 350 and 
351 exhibited significant anti-mycobacterial activity against Mycobacterium tuberculosis 
with MIC values of 15.24 and 6.75 μM, respectively. (Arunrattiyakorn et al., 2011). 
 
 
      
350 R = H 
                     351 R = SO3H 
 
Figure 46. Structures of α-mangostin (350) and mangostin-3-sulfate (351). 
 
 
3.2.9) Neosartorya spinosa 
 
 Four chevalone C analogues: 1-hydroxychevalone C (352), 1-acetoxy-
chevalone C (353), 1,11-dihydroxychevalone C (354) and 11-hydroxychevalone C 
(355), together with 2S,4S-spinosate (357) and 2S,4R-spinosate (358), chevalones B 
(348), C (349), E (356), tryptoquivaline (342), nortryptoquivaline (240), 
tryptoquivaline L (295) and quinadoline A (359) (Figure 47), were isolated from the soil 
fungus N. spinosa which was isolated from a forest soil, collected around the Pha Nok 
Kao Silvicultural station, Chon Kaen Province, Thailand. Compound 342 and 353 
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exhibited weak antimalarial activity against Plasmodium falciparum with IC50 values of 
6.67 and 2.65 μM, respectively, while 352 showed antimycobacterial activity against 
Mycobacterium tuberculosis with MIC value of 26.4 μM. Moreover, 352-354 and 359 
exhibited also cytotoxicity against two human cancer cell lines, KB and NCI-H187 with 
IC50 values ranging from 32.7 to 103.3 μM (Rajachan et al., 2016). 
 
3.2.10) Neosartorya takakii 
 
 A meroditerpene, sartorenol (360), tryptoquivaline U (361) (Figure 48), and 
takakiamide (288) were isolated, together with the previously described compounds, 
including aszonalenin (241), acetylaszonalenin (252), aszonapyrone A (256), 
tryptoquivalines L (295), H (299), F (300), 3’-(4-oxoquinazolin-3-yl)spiro[1H-indole-
3,5’-oxolane]-2,2’-dione (294), chevalone B (348) and 6-hydroxymellein, from the 
algicolous fungus N. takakii KUFC 7898 which was obtained from the alga Amphiroa sp., 
collected from Samaesarn Island, Thailand. Compounds 241, 288 and 360 were tested 
for their antimicrobial activity against Gram-positive (Staphylococcus aureus ATCC 
25923 and Bacillus subtilis ATCC 6633) and Gram-negative (Escherichia coli ATCC 
25922 and Pseudomonas aeruginosa ATCC 27853) bacteria, as well as the multidrug-
resistant isolates from environment. All tested compounds were inactive at the highest 
concentration tested (256 μg/mL). Furthermore, these three compounds were also 
evaluated for antiquorum sensing activity toward Chromobacterium violaceum ATCC 
31532, however none of them exhibited the activity (May Zin et al., 2015). 
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  352 R1 = OAc,  R2 = OH,    R3 = H           357 
  353 R1 = OAc,  R2 = OAc,  R3 = H 
  354 R1 = OAc,  R2 = OH,    R3 = OH 
  355 R1 = OAc,  R2 = H,       R3 = OH 
  356 R1 = OH,    R2 = H,      R3 = H 
    
          358            359 
 
Figure 47. Structures of 1-hydroxychevalone C (352), 1-acetoxychevalone C (353), 1,11-
dihydroxychevalone C (354), 11-hydroxychevalone C (355), chevalone E (356), 2S,4S-spinosate 
(357), 2S,4R-spinosate (358) and quinadoline A (359).  
 
   
       360            361    
    
Figure 48. Structures of sartorenol (360) and tryptoquivaline U (361). 
 
 
 
 
 
 81 
 
 CHAPTER III: CHEMISTRY OF THE FUNGI OF THE GENERA ASPERGILLUS AND NEOSARTORYA 
3.2.11) Neosartorya tatenoi 
 
 A meroditerpene, tatenoic acid (362) (Figure 49), aszonapyrones A (256) and B 
(257), aszonalenin (241), ergosterol (267) and D-mannitol, were isolated from the soil 
fungus Neosartorya tatenoi KUU-2NK23 which was isolated from the forest soil, collected 
around the Pha Nok Kao Silvicultural Station, Khon Kaen Province, Thailand. Compounds 
241, 256 and 257 were evaluated for their antimalarial and cytotoxic activities. Compound 
256 exhibited antimalarial activity against Plasmodium falciparum with IC50 value of 1.34 
μg/mL, and displayed cytotoxicity against NCI-H187 and KB cancer cell lines, with IC50 
values of 4.62 and 48.18 μg/mL, respectively, while compounds 241 and 257 were found 
to be inactive for all tests (Yim et al., 2014). 
 
 
 
362 
 
Figure 49. Structure of tatenoic acid (362). 
 
 
3.2.12) Neosartorya tsunodae 
 
 
 The marine-derived fungus N. tsunodae (KUFC 9213) which was isolated from the 
marine sponge Aka coralliphaga, collected in the Similan Islands, Thailand, furnished a 
meroditerpene sartorypyrone B (363) (Figure 50) and helvolic acid (148). Compound 
363 was found to exhibit potent growth inhibitory activity against MCF-7, NCI-H460 and 
A375-C5 cancer cell lines with GI50 valeus of 17.8 ± 7.4, 20.5 ± 2.4 and 25.0 ± 4.4 μM, 
respectively (Eamvijarn et al., 2013).  
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363 
 
Figure 50. Structure of sartorypyrone B (363). 
 
3.2.13) Unspecified Neosartorya species 
 
3.2.13.1) Neosartorya sp. 
 Asami et al. (2002) reported a new angiogenesis inhibitor, azaspirene (364) 
(Figure 51), which contains a 1-oxa-7-azaspiro[4.4]non-2-ene-4,6-dione skeleton. This 
compound was isolated from the soil fungus Neosartorya sp. Compound 364 completely 
inhibited the migration of human umbilical vein endothelial cells (HUVECs) induced by 
vascular endothelial growth factor (VEGF) at concentration of 27.1 μM (ED100 = 27.1 μM) 
without any significant cell toxicity. Later on, Asami et al. (2008) continued investigating 
the in vivo antiangiogenic activity of 364, using in vivo tumor-induced angiogenesis in a 
renal carcinoma xenograft model and chicken chorioallantoic membrane assay. The 
results showed that the number of blood vessels oriented toward tumor was decreased 
with azaspirene (364) treatment, and administration of azaspirene (364) at 30 μg/egg 
resulted in the inhibition of angiogenesis (23.6-45.3 % maximum inhibition relative to the 
controls) in the chick embryo without any sign of thrombosis or hemorrhage in a chicken 
CAM assay. The mechanism of this compound was evaluated on VEGF-induced 
activation of the mitogen-activated protein kinase signaling pathway in HVEC, resulting 
in the suppression of Raf-1 activation without affecting the activation of kinase insert 
domain-containing receptor/fetal liver kinase 1 (VEGF receptor 2). In addition, 364 
inhibited the growth of HUVEC, but not of NIH3T3, MSS31, HeLa and MCF-7. 
 
 Later on, Asami et al. (2004) also discovered another angiogenesis inhibitor, RK-
805 (365) (Figure 51), from the fermentation broth of the fungus Neosartory sp. 
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Compound 365, which was identified as 6-oxo-6-deoxyfumagillol, was tested for the 
growth inhibitory activity in both HUVECs and normal human lung fibroblast (WI-38) cells. 
Compound 365 inhibited the growth of HUVECs in a dose-dependent manner with IC50 
value of 0.03 ng/mL, but did not exhibited inhibitory activity toward WI-38 cells. Compound 
365 also showed the inhibitory activity against the cell migration induced by VEGF in a 
dose-dependent manner without showing significant cell toxicity, with ED50 value of 10 
ng/mL. Moreover, this compound selectively inhibited on methionine aminopeptidase-2 
(MetAP2). 
 
             
 
   364                   365 
 
Figure 51. Structures of azaspirene (364) and RK-805 (365). 
 
3.2.13.2) Neosartorya sp. HN-M-3 
 F. Y. Sun et al., (2012) reported the isolation of tryptoquivalines P (366) and Q 
(367) (Figure 52) from the marine-derived fungus Neosartorya sp. HN-M-3 which was 
isolated from mud, collected from the intertidal zone of Hainan Province, China. 
 
 Later on, Xu et al., (2013) reported other two tryptoquivaline analogues, 
tryptoquivalines R (368) and S (369) (Figure 52), from the same fungus. Both 
compounds did not exhibit cytotoxicity against HL-60 cell line at the highest concentration 
tested (100 μM). 
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366                                                                   367 
 
       
        
368                           369 
 
Figure 52. Structures of tryptoquivalines P – S (366 – 369).  
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4.1) The Marine Sponge Iotrochota baculifera 
 
 Chromatographic fractionation and further purification of the ethyl acetate (EtOAc) 
crude extract of the marine sponge  Iotrochota baculifera, collected from the Gulf of 
Thailand, Chonburi Province, Thailand, resulted in isolation of two previously reported, 6-
bromo-1H-indole-3-carbaldehyde (40) and methyl (2E)-3-(6-bromo-1H-indol-3-yl)-prop-2-
enoate (370) (figure 53). 
 
 
40 
 
 
370 
 
Figure 53. Structures of 6-bromo-1H-indole-3-carbaldehyde (40) and methyl (2E)-3-(6-bromo-
1H-indol-3-yl)-prop-2-enoate (370). 
 
4.1.1) 6-Bromo-1H-indole-3-carbaldehyde (40) 
 
Compound 40 was isolated as a white crystal (mp, 205 – 206 °C). Its molecular 
formula, C9H6NOBr, was determined on the basis of (+)-HRESIMS m/z 223.9704 [M+H]+, 
indicating seven degrees of unsaturation. 
 The 13C NMR spectrum exhibited nine carbon signals which, in conjunction with 
the DEPTs and HSQC spectra, can be classified to one conjugated aldehyde carbonyl 
(δC 185.2), four quaternary sp2 (δC 138.0, 123.1, 118.0 and 116.0), and four methine sp2 
(δC 139.2, 125.1, 122.5 and 115.2) carbons (Table 4). 
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 The 1H NMR spectrum (Table 4) exhibited, three doublet aromatic protons at δH 
8.02, J = 8.4 Hz (δC 122.5); δH 7.71, J = 1.1 Hz (δC 115.2); δH 7.37, brd, J = 8.4 Hz (δC 
125.1), one singlet of an amine proton at δH 12.23 which was evidenced by the chemical 
shift value and HRMS data, one doublet of aldehyde proton at δH 9.93, J = 0.6 Hz (δC 
185.2), and one double doublet of olefinic proton at δH 8.33, J = 3.5, 0.7 Hz (δC 139.2). 
 Analysis of the coupling constant values of the three aromatic protons, together 
with the COSY correlation (Table 4), indicated the presence of the 1,2,4-trisubstitued 
benzene ring which confirmed by the HMBC correlations from H-4’ to the carbons at δC 
116.0 (C-6’) and δC 138.0 (C-7’a), from H-5’ to the carbons at δC 123.1 (C-3’a) and δC 
115.2 (C-7’), and from H-7’ to C-3’a and C-6’. The bromine atom was placed on C-6’ since 
its chemical shift value (δC 116.0) indicated that it was substituted by an electron 
withdrawing group. 
 
   
 
 The COSY spectrum displayed cross peak from the amine proton at δH 12.23, s 
(H-1’) to the olefinic proton at δH 8.33, dd, J = 3.5, 0.7 Hz (H-2’), together with the HMBC 
correlations from the proton at δH 9.93, d, J = 0.6 Hz (H-1) to the carbon at δC 118.0 (C-
3’) and C-3’a, and from H-2’ to the carbon at δC 185.2 (C-1), C-3’, C-3’a, and C-7’a. 
Combining the (+)-HRESIMS and NMR data, the structure of 40 was 6-bromo-1H-indole-
3-carbaldehyde. 
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Table 4. 1H and 13C NMR (DMSO, 300.13 MHz and 75.4 MHz), and HMBC assignment 
for 6-bromo-1H-indole-3-carbaldehyde (40). 
Position δC, type δH, (J in Hz) COSY HMBC 
1 185.2, CHO 9.93, d (0.6) - C-3’, 3’a 
2’ 139.2, CH 8.33, dd (3.5, 0.7) H-1’ C-1, 3’, 3’a, 7’a 
3’ 118.0, C - - - 
3’a 123.1, C - - - 
4’ 122.5, CH 8.02, d (8.4) H-5’ C-6’, 7’a 
5’ 125.1, CH 7.37, brd (8.4) H-4’, 7’ C-3’a, 7’ 
6’ 116.0, C - - - 
7’ 115.2, CH 7.71, d (1.1) H-5’ C-3’a, 6’ 
7’a 138.0, C - - - 
NH - 12.23, s H-2’ - 
 
The literature search revealed that 40 was previously isolated from several marine 
sponges, including Pseudosuberites hyalinus (Rasmussen et al., 1993), Halichondria sp. 
(Li et al., 1994), Iotrochota purpurea (Carletti et al., 2000; Ibrahim et al., 2009), 
Smenospongia sp. (McKay et al., 2002), and Rhopaloeides odorabile (Longeon et al., 
2011). Interestingly, this compound was also isolated from several bacteria, such as 
Pseudomonad sp. (Wratten et al., 1977) and Acinetobacter sp. (Olguin-Uribe et al., 1997), 
as well as from a brown alga Laminaria japonica Aresch. (Wang et al., 2013). The 
bioactivities of 6-bromo-1H-3-carbaldehyde were reported as antifungal activity against 
Mortierella ramannianus (Li et al., 1994) and antifouling activity by inhibiting the 
settlement of barnacle larvae. (Olguin-Uribe et al., 1997). 
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4.1.2) Methyl (2E)-3-(6-bromo-1H-indol-3-yl)-prop-2-enoate (370) 
 
Compound 370 was isolated as a white crystal (mp, 212 – 214 °C), and its 
molecular formula C12H10NO2Br was established based on the (+)-HRESIMS m/z 
279.9973 [M+H]+, indicating eight degrees of unsaturation. 
 The general features of the 1H and 13C of 370 resembled those of 40. The 13C NMR 
spectrum exhibited twelve carbon signals which can be classified as one conjugated ester 
carbonyl (δC 167.6), four quaternary sp2 (δC 138.2, 124.0, 115.1 and 111.8), six methine 
sp2 (δC 138.4, 132.6, 123.7, 121.7, 115.0 and 111.6), and one methoxy (δC 51.1) carbons, 
based on the data from the DEPTs and HSQC experiments (Table 5) 
 The 1H NMR spectrum, in combination with the HSQC spectrum (Table 5) of 370, 
also exhibited signals of the protons of the 3’,6’-substituted indole nucleus: one amine 
proton at δH 11.89, s, one olefinic proton at δH 7.99, d, J = 2.8 Hz (δC 132.6), and three 
aromatic protons at δH 7.85, d, J = 8.5 Hz (δC 121.7); δH 7.66, d, J = 1.8 Hz (δC 115.0); δH 
7.28, dd, J = 8.5, 1.8 Hz (δC 123.7). This was also confirmed by the COSY correlations 
(Table 5) from H-5’ to H-4’ and H-7’, as well as by the HMBC correlations (Table 5) from  
H-2’ to the carbons at δC 111.8 (C-3’), δC 124.0 (C-3’a) and δC 138.2 (C-7’a), from H-4’ to 
C-3’a, the carbon at δC 115.1 (C-6’) and C-7’a, from H-5’ to C-3’a and the carbon at δC 
115.0 (C-7’), from H-7’ to C-3’a and C-6’, and from the amine proton at δH 11.89, s (H-1’) 
to the carbon at δC 132.6 (C-2’), C-3’, C-3’a and C-7’a.  
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 Compound 370 differed from 40 only in the sidechain of the bromoindole nucleus. 
Instead of the presence of the aldehydic group, the side chain of 40 was methyl (2E)-
prop-2-enoate. This was supported by the presence of the trans double bond (δH 7.87, d, 
J = 16.1 Hz/ δC 138.4; δH 6.39, d, J = 16.0 Hz/ δC 111.6), a conjugated ester carbonyl (δC 
167.6) and a methoxyl group (δH 3.71, s, δC 51.1). Since the olefinic proton at δH 7.87, d, 
J = 16.1 Hz (H-3) exhibited the HMBC correlations to the ester carbonyl at δC 167.6 (C-
1), C-2 and C-3, 370 was identified as methyl (2E)-3-(6-bromo-1H-indol-3-yl)-prop-2-
enoate. Literature survey revealed that this compound has been previously isolated from 
the sponge Iotrochota sp. (Dellar et al., 1981). 
 
 
 
Table 5. 1H and 13C NMR (DMSO, 300.13 MHz and 75.4 MHz), and HMBC assignment 
for methyl (2E)-3-(6-bromo-1H-indol-3-yl)-prop-2-enoate (370). 
Position δC, type δH, (J in Hz) COSY HMBC 
1 167.6, CO - - - 
2 111.6, CH 6.39, d (16.0) H-3 C-1 
3 138.4, CH 7.87, d (16.1) H-2 C-1, 2’, 3’ 
2’ 132.6, CH 7.99, d (2.8) - C-3’, 3’a, 7’a 
3’ 111.8, C - - - 
3’a 124.0, C - - - 
4’ 121.7, CH 7.85, d (8.5) H-5’ C-3’a, 6’, 7’a 
5’ 123.7, CH 7.28, dd (8.5, 1.8) H-4’, 7’ C-3’a, 7’ 
6’ 115.1, C - - - 
7’ 115.0, CH 7.66 d (1.8) H-5’ C-3’a, 6’ 
7’a 138.2, C - - - 
OCH3 51.1, CH3 3.71, s - - 
NH - 11.89, s - C-2’, 3’, 3’a, 7’a 
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4.2) The Marine-Derived Fungus Aspergillus similanensis KUFA 0013 
 
 Chromatographic fractionation and further purification of the ethyl acetate extract 
of the marine-derived fungus Aspergillus similanensis KUFA 0013, which was isolated 
from the marine sponge Rhabdermia sp., collected from the coral reef of the Similan 
Islands, Thailand, resulted in discovering seven previously unreported similanpyrones A 
(375), B (373) and C (376), chevalone E (356), pyripyropenes S (378) and T (379), and 
similanamide (380), together with the previously described p-hydroxybenzaldehyde 
(371), 6,8-dihydroxy-3-methylisocoumarin (372), reticulol (374), chevalones B (348) and 
C (349), S14-95 (377) and pyripyropene E (154). The structures of the isolated 
metabolites were shown in figure 54. 
 
4.2.1) p-Hydroxybenzaldehyde (371) 
 
Compound 371 was isolated as a white solid (mp 117 – 118 °C).  The 13C NMR 
spectrum (Table 6) exhibited five carbon signals which can be classified as one aldehydic 
(δC 191.9), one oxyquaternary sp2 (δC 162.4), one quaternary sp2 (δC 129.3), and two 
methine sp2 (δC 132.7 and 116.1) carbons based on the DEPTs spectra.  
The 1H NMR spectrum, in combination with the HSQC spectrum (Table 6), showed 
one singlet of an aldehydic proton at δH 9.85 (δC 191.9), one broad singlet of hydroxyl 
proton at δH 7.06, and two doublets of four aromatic protons at δH 7.82, J = 8.7 Hz (2H; 
δC 132.7) and δH 6.99, J = 8.6 Hz (2H; δC 116.1). 
 The COSY spectrum showed correlations between the doublet at δH 7.82 and δH 
6.99, indicating that these four aromatic protons belong to the 1,4-disubstituted benzene 
ring with substituted of different electronegativity. 
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            371   372  R = H             375 
  373  R = CH3  
  374  R =OCH3 
 
     
        376            349  R = Ac 
               356  R = H 
 
 
     348               377              154 
 
   
   378  R = Ac       380 
   379  R = H 
 
Figure 54. Structures of the isolated metabolites from the marine sponge-associated fungus 
Aspergillus similanensis KUFA 0013. 
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 This hypothesis was also confirmed by the HMBC correlations from the doublet at 
δH 7.82, J = 8.7 Hz (H-2 and H-6) to the carbons at δC 132.7 (C-2 and C-6) and δC 162.4 
(C-4), and from the doublet at δH 6.99, J = 8.6 Hz (H-3 and H-5) to the carbons at δC 129.3 
(C-1), δC 116.1 (C-3 and C-5) and C-4. 
 
 
 
 That the aldehyde group was placed on C-7 was evidenced by the HMBC 
correlations from H-2 and H-6 to the aldehydic carbon at δC 191.9 (C-7), and from the 
aldehydic proton to C-1, C-2 and C-6. Therefore, the hydroxyl group was on the carbon 
at δC 162.4 (C-4). The 1H and 13C NMR of 371 correspond to those of p-
hydroxybenzaldehyde. 
 
 
 
 p-Hydroxybenzaldehyde (371) has been previously isolated from several plant 
species, including Sorghum bicolor (Woodhead, 1983), Anoectochilus roxburghii (He et 
al., 2005) and Vanilla planifolia (Shyamala et al., 2007), as well as from fungi, 
Phaeoacremonium chlamydosporum, Phaeoacremonium aleophilum, and Fomitiporia 
punctata (Tabacchi et al., 2000), marine sponge, Tedania anhelans (Parameswara et al., 
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1997), marine algae, Laurencia papillosa (Wright and Kӧnig, 1996), Corallina pilulifera, 
Porphyra tenera and Undaria pinnatifida (Onofrejová et al., 2010), and also from 
freshwater algae, Spongiochloris spongiosa and Anabaena doliolum (Onofrejová et al., 
2010). 
 
Table 6.  1H and 13C NMR (CDCl3, 300.13 MHz and 75.4 MHz), and HMBC assignment 
for p-hydroxybenzaldehyde (371). 
Position δC, Type δH, (J in Hz) COSY HMBC 
1 129.3, C - - - 
2 132.7, CH 7.82, d (8.7) H-3 C-4, 6, 7 
3 116.1, CH 6.99, d (8.6) H-2 C-1, 4, 5 
4 162.4, C - - - 
5 116.1, CH 6.99, d (8.6) H-6 C-1, 3, 4 
6 132.7, CH 7.82, d (8.7) H-3 C-2, 4, 7 
7 191.9, CHO 9.85, s - C-1, 2, 6 
OH-4  7.06, brs - - 
 
4.2.2) 6,8-Dihydroxy-3-methylisocoumarin (372) 
 
Compound 372 was isolated as a yellow solid (mp 252 – 253 °C), and its molecular 
formula C10H9O4 was established on the basis of the (+)-HRESIMS m/z 194.0496 [M+H]+, 
indicating seven degrees of unsaturation.  
The 13C NMR spectrum (Table 7) exhibited ten carbon signals which can be 
classified, according to the DEPTs and HSQC spectra, into one conjugated carbonyl (δC 
165.7), three oxyquaternary sp2 (δC 165.5, 162.7 and 154.1), two quaternary sp2 (δC 139.7 
and 97.9), three methine sp2 (δC 104.2, 102.4, and 101.4) and one methyl (δC 18.9) 
carbons. 
The 1H NMR spectrum, together with the HSQC spectrum (Table 7), displayed one 
singlet of an olefinic proton at δH 6.43 (δC 104.2), two doublets of two meta-coupled 
aromatic protons at δH 6.31, d, J = 2.0 Hz (δC 102.4) and δH 6.29, d, J = 2.0 Hz (δC 101.4), 
and one methyl singlet at δH 2.18 (δC 18.9), besides a singlet of the hydrogen-bonded 
hydroxyl proton at δH 10.95. 
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The presence of two meta-coupled aromatic protons at δH 6.31, d, J = 2.0 Hz (H-
5) and δH 6.29, d, J = 2.0 Hz (H-7), together with the HMBC correlations (Table 7) from 
the hydroxyl proton at δH 10.95, s (OH-8) to the carbons at δC 101.4 (C-7), δC 162.7 (C-
8) and δC 97.9 (C-8a), from H-5 to the carbon at δC 165.5 (C-6), C-7 and C-8a, and from 
H-7 to the carbon at δC 102.4 (C-5), C-8 and C-8a, suggested the presence of 1,2-
disubstituted 3,5-dihydroxybenzene ring. This was also supported by the low frequencies 
of the aromatic protons and the high frequencies of two quaternary sp2 carbons (δC 165.5; 
C-6 and 162.7; C-8).  
 
 
 
The COSY spectrum (Table 7) exhibited cross peak between the olefinic proton at 
δH 6.43, s (H-4) and the methyl singlet at δH 2.18 (H3-3), suggesting that they were allylic 
coupled. The HMBC correlations from H-4 to the carbon at δC 154.1 (C-3), C-5, C-8a and 
the carbon at δC 18.9 (CH3-3), from H-5 to the carbon at δC 104.2 (C-4), and from the 
methyl singlet (H3-3) to C-3 and C-4, together with the presence of the carbonyl carbon 
(δC 165.7), suggested that 372 was 6,8-dihydroxy-3-methyl-1H-isochromen-1-one. 
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Table 7. 1H and 13C NMR (DMSO, 500.13 MHz and 125.8 MHz), and HMBC assignment 
for 6,8-dihydroxy-3-methylisocoumarin (372). 
Position δC, Type δH, (J in Hz) COSY HMBC 
1 165.7, CO - - - 
3 154.1, C - - - 
4 104.2, CH 6.43, s H3-3 C-3, 5, 8a, CH3-3 
4a 139.7, C - - - 
5 102.4, CH 6.31, d (2.0) - C-4, 7, 8a 
6 165.5, C - - - 
7 101.4, CH 6.29, d (2.0) - C-5, 8, 8a 
8 162.7, C - - - 
8a 97.9, C - - - 
CH3-3 18.9, CH3 2.18, s H-4 C-3, 4 
OH-8 - 10.95, s - C-7, 8, 8a 
 
 The 1H and 13C NMR data of compound 372 were compatible with those previously 
reported for 6,8-dihydroxy-3-methylisocoumarin isolated from several microorganisms, 
such as Streptomyces sp. (Tang et al., 2000; Ben Ameur Mehdi et al., 2006; Zinad et al., 
2011), the marine filamentous fungus Keissleriella sp. (Lui et al., 2002), the scale insect 
pathogenic fungus Torrubiella tenuis (Kornsakulkarn et al., 2009), and the endophytic 
fungi Cephalosporium sp. (Shao et al., 2009) and Papulaspora immersa (Gallo et al., 
2010). Moreover, this compound was also found to inhibit the antifungal activity against 
Verticullium dahliae with inhibition zone of 12 mm (Mehdi et al., 2006) and zoosporicidal 
activity against a phytopathogenic oomycete, Plasmopara viticola, at concentration of 5 
μg/mL (Zinad et al., 2011). 
 
4.2.3) Similanpyrone B (373) 
 
 Compound 373 was isolated as a white solid (mp, 162 – 163 ˚ C), and its molecular 
formula C11H10O4 was established on the basis of the (+)-HRESIMS m/z 207.0658, 
indicating to seven degrees of unsaturation. The IR spectrum displayed absorption bands 
for hydroxyl (3243, 3160 cm-1), conjugated ester carbonyl (1677 cm-1), olefin (1635 cm-1) 
and aromatic (1617 cm-1) groups.  
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The general features of the 1H and 13C NMR spectra of 373 closely resembled to 
those of 372. The 13C NMR spectrum (Table 8) exhibited eleven carbon signals which 
can be classified, based on the DEPTs and HSQC spectra, into one conjugated ester 
carbonyl ( δC 166.1) , three oxyquaternary sp2 (δC 163.7, 160.0 and 153.3), three 
quaternary sp2 (δC 136.5, 109.6 and 97.5), two methine sp2 (δC 104.2 and 101.4) and two 
methyl (δC 18.8 and 8.0) carbons. 
 Besides a singlet of the hydrogen-bonded hydroxyl proton at δH 11.27 and a broad 
singlet of another hydroxyl proton at δH 3.45, the 1H NMR spectrum, in combination with 
the HSQC spectrum (Table 8), showed one singlet of olefinic proton at δH 6.46 (δC 104.2), 
one singlet of aromatic proton at δH 6.40 (δC 101.2), and two methyl singlets at δH 2.20 
(δC 18.8) and δH 2.00 (δC 8.0). 
Similar to 372, the COSY spectrum of 373 showed correlation from the proton at 
δH 6.46, s (H-4) to the the methyl singlet at δH 2.20 (H3-9) while the HMBC spectrum 
exhibited the cross peaks from the hydrogen-bonded hydroxyl proton at δH 11.27, s (OH-
8) to the carbons at δC 109.6 (C-7), δC 160.0 (C-8) and δC 97.5 (C-8a), from H-4 to the 
carbon at δC 101.4 (C-5) and C-8a, from the proton at δH 6.40, s (H-5) to the carbons at 
δC 104.2 (C-4), δC 163.7 (C-6), C-7 and C-8a, from H3-9 to the carbon at δC 153.3 (C-3) 
and C-4, and from the methyl singlet at δH 2.00 (H3-10) to C-6, C-7 and C-8. 
 
 
 
Therefore, the structure of 373 was identified as 6,8-dihydroxy-3,7-dimethyl-1H-
isochromen-1-one. Exhaustive literature search revealed that 373 has never been 
previously reported, and it was named similanpyrone B. 
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Table 8. 1H and 13C NMR (CDCl3, 500.13 MHz and 125.8 MHz), and HMBC assignment 
for similanpyrone B (373). 
Position δC, Type δH, (J in Hz) COSY HMBC 
1 166.1, CO - - - 
3 153.3, C - - - 
4 104.2, CH 6.46, s H3-9 C-5, 8a 
4a 136.5, C - - - 
5 101.4, CH 6.40, s - C-4, 6, 7, 8a 
6 163.7, C - - - 
7 109.6, C - - - 
8 160.0, C - - - 
8a 97.5, C - - - 
9 18.8, CH3 2.20, s H-4 C-3, 4 
10 8.0, CH3 2.00, s - C-6, 7, 8 
OH-6 - 3.45, brs - - 
OH-8 - 11.27, s - C-7, 8, 8a 
 
 
4.2.4) Reticulol (374) 
 
 Compound 374 was isolated as a white solid (mp 172 – 175 °C) and its molecular 
formula C11H10O5 was established on the basis of the (+)-HRESIMS m/z 223.0606 
[M+H]+, indicating seven degrees of unsaturation. 
The general features of the 1H and 13C NMR spectra of 374 also closely resembled 
to those of 6,8-dihydroxy-3-methyisocoumarin (372). In contrast to 372, the 1H NMR 
spectrum of 374 displayed only one aromatic proton singlet at δH 6.40 and a singlet of a 
methoxy group at δH 4.02, instead of two meta-coupled aromatic protons. 
The 13C NMR spectrum (Table 9) displayed eleven carbon signals which can be 
classified, according to the DEPTs and HSQC spectra, as one conjugated ester carbonyl 
(δC 166.7), four oxyquaternary sp2 (δC 156.3, 153.8, 153.3, and 132.7), two quaternary 
sp2 (δC 134.5 and 100.3), two methine sp2 (δC 104.3 and 101.2), one methoxy (δC 60.9), 
and one methyl (δC 19.3) carbons. 
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The 1H NMR spectrum, together with the HSQC spectrum (Table 9), displayed, 
besides one singlet of the hydrogen-bonded hydroxyl proton at δH 11.31 and one singlet 
of another hydroxyl proton at δH 6.49, one singlet of aromatic proton at δH 6.40 (δC 101.2), 
one doublet of olefinic proton at δH 6.16, J = 0.9 Hz (δC 104.3), one methoxyl singlet at δH 
4.03 (δC 60.9) and one methyl doublet at δH 2.25, J = 0.9 Hz (δC 19.3). 
Like 372 and 373, the COSY spectrum of 374 displayed the correlation from the 
proton at δH 6.16, d, J = 0.9 Hz (H-4) to the methyl doublet at δH 2.25, J = 0.9 Hz (H3-9). 
The HMBC spectrum exhibited the correlations from the hydroxyl proton at δH 6.49, s 
(OH-6) to the carbons at δC 101.2 (C-5) and δC 156.3 (C-6), from the hydrogen-bonded 
hydroxyl proton at δH 11.31, s (OH-8) to the carbons at δC 132.7 (C-7), δC 153.8 (C-8) 
and δC 100.3 (C-8a), from H-4 to the carbon at δC 153.3 (C-3), from the proton at δH 6.40, 
s (H-5) to the carbon at δC 104.3 (C-4), C-7 and C-8a, and from H3-9 to C-3 and C-4. 
 
 
 
That the methoxy group was on C-7 was confirmed by the HMBC correlation from 
the methoxyl singlet at δH 4.03 (H3-10) to C-7. 
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Compound 374 was therefore identified as 6,8-dihydroxy-7-methoxy-3-methyl-1H-
isochromen-1-one which was known as reticulol. Compound 374 was first reported by 
Mitscher et al. (1964) as a constituent of Streptomyces rubrireliculae, and was also 
reported as a cyclic adenosine 3’,5’-monophosphate phosphodiesterase (cAMP PDE) 
inhibitor with IC50 value of 4.1 × 10-5 M (Furutani et al., 1977). This compound also 
exhibited a free radical scavenging activity on ABTS and DPPH radicals (Ryoo et al., 
2009) and a cytotoxic activity. It exhibited a potent in vitro cytotoxicity against A427 (a 
human lung cancer cell line) and B16F1 (a mouse melanoma cell line) (Lim, Kwak, Kim, 
et al., 2003) by inactivating topoisomerase (topo) I (Lim, Kwak, Lee, et al., 2003). The in 
vivo assay for the lung metastasis-blocking effect in mouse model revealed that when 
374 was injected intravenously, it exhibited more metastasis inhibition than when it was 
administered via the peritoneum (Lim, Kwak, Kim, et al., 2003). In addition, treating 
B16F10 melanoma with the mixture of retuculol and adriamycin showed more cytotoxic 
efficacy than treating with adriamycin alone (Lim, Kwak, Lee, et al., 2003). 
 
Table 9. 1H and 13C NMR (CDCl3, 500.13 MHz and 125.8 MHz), and HMBC assignment 
for reticulol (374). 
 
Position δC, Type δH, (J = Hz) COSY HMBC 
1 166.7, CO - - - 
3 153.3, C - - - 
4 104.3, CH 6.16, d (0.9) H3-9 C-3 
4a 134.5, C - - - 
5 101.2, CH 6.40, s - C-4, 7, 8a 
6 156.3, C - - - 
7 132.7, C - - - 
8 153.8, C - - - 
8a 100.3, C - - - 
9 19.3, CH3 2.25, d (0.9) H-4 C-3, 4 
10 60.9, OCH3 4.03, s - C-7 
OH-6 - 6.49, s - C-5, 6 
OH-8 - 11.31, s - C-7, 8, 8a 
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4.2.5) Similanpyrone A (375) 
 
Compound 375 was isolated as a white solid (mp, 322 – 323 °C). Based on the 
HRESIMS, m/z 245.0450 [M+H]+, the molecular formula was deduced to be C13H8O5, 
indicating  ten degrees of unsaturation. The IR spectrum exhibited absorption bands for 
hydroxyl (3446 cm-1), conjugated lactone carbonyl (1748, 1698 cm-1), aromatic (1658 cm-
1) and olefin (1634, 1464 cm-1) groups.  
The 13C NMR spectrum (Table 10) exhibited thirteen carbon signals which can be 
categorized, base on the DEPTs and HSQC spectra, into two conjugated ester carbonyl 
(δC 166.3 and 159.7), six quaternary sp2 (δC 160.3, 156.2, 140.1, 130.0, 107.3 and 101.3), 
four methine sp2 (δC 137.8, 114.1, 104.6 and 102.7) and one methyl (δC 19.6) carbons. 
 The 1H NMR spectrum (Table 10) revealed the presence of two doublets of the 
cis-olefinic protons at δH 8.13, J = 9.8 Hz (δC 137.8) and 6.36, J = 9.8 Hz (δC 114.1). This 
was supported by the COSY correlation and the coupling constant values. Moreover, the 
1H NMR spectrum, together with the HSQC spectrum, also exhibited one singlet of 
aromatic proton at δH 6.70 (δC 102.7), one singlet of an olefinic proton at δH 6.33 (δC 
104.6) and one methyl singlet at δH 2.33 (δC 19.6), besides a singlet of the hydrogen-
bonded hydroxyl proton at δH 11.90. 
 The COSY correlation (Table 10) of the proton at δH 6.33, s (H-9) to the methyl 
singlet at δH 2.33 (H3-8) suggested that they were an allylic coupled. The HMBC spectrum 
(Table 10) displayed cross peaks from the hydrogen-bonded hydroxyl proton at δH 11.90, 
s (OH-5) to the carbons at δC 107.3 (C-4a), δC 160.3 (C-5) and δC 101.3 (C-5a), from H3-
8 to the carbons at δC 156.2 (C-8) and δC 104.6 (C-9), from H-9 to C-5a, C-8 and the 
carbons at δC 102.7 (C-10) and δC 19.6 (CH3-8), and from the proton at δH 6.70, s (H-10) 
to C-4a, C-5a and the carbons at δC 130.0 (C-9a) and δC 140.1 (C-10a). Taken together 
the 1H and 13C chemical values and the HMBC correlations, 375 should have the 4a,10a-
disubstituted-5-hydroxy-8-methylisochromen-6-one as its partial structure. 
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Since the proton at δH 8.13, d, J = 9.8 Hz (H-4) exhibited the HMBC correlations 
to the conjugated ester carbonyl carbon at δC 159.7 (C-2) and C-4a whereas the proton 
at δH 6.36, d, J = 9.8 Hz (H-3) showed the HMBC correlation to C-10a, the 4a,10a-
disubstituted-5-hydroxy-8-methylisochromen-6-one nucleus was fused with the pyran-2-
one moiety. Therefore, 375 was identified as 5-hydroxy-8-methyl-2H,6H-pyrano[3,4-
g]chromene-2,6-dione. To the best of our knowledge, this compound has not been 
previously described, and therefore it was named similanpyrone A. 
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Table 10. 1H and 13C NMR data (CDCl3, 500.13 MHz and 125.8 MHz), and HMBC 
assignment for similanpyrone A (375). 
Position δC, Type δH, (J in Hz) COSY HMBC 
2 159.7, CO - - - 
3 114.1, CH 6.36, d (9.8) H-4 C-10a 
4 137.8, CH 8.13, d (9.8) H-3 C-2, 4a 
4a 107.3, C - - - 
5 160.3, C - - - 
5a 101.3, C - - - 
6 166.3, CO - - - 
8 156.2, C - - - 
9 104.6, CH 6.33, s H3-8 C-5a, 8, 10, CH3-8 
9a 130.0, C - - - 
10 102.7, CH 6.70, s - C-4a, 5a, 9a, 10a 
10a 140.1, C - - - 
CH3-8 19.6, CH3 2.33, s H-9 C-8, 9 
OH-5 - 11.90, s - C-4a, 5, 5a 
 
4.2.6) Similanpyrone C (376) 
 
Compound 376 was isolated as a pale yellow viscous mass. The molecular 
formula, C19H20O6, was determined by (+)-HRESIMS (m/z 345.1342 [M+H]+), indicating 
ten degrees of unsaturation. The IR spectrum displayed absorption bands for hydroxyl 
(3443 cm-1), ketone carbonyl (1730 cm-1), conjugated lactone carbonyl (1683 cm-1), olefin 
(1647 cm-1) and aromatic (1625, 1572 cm-1) groups. 
The general features of 1H and 13C NMR spectra of 376 also assembled to those 
of 375, suggesting that it is also an isocoumarin derivative. The 13C NMR spectrum (Table 
11) exhibited nineteen carbon signals which can be categorized, according to the DEPTs 
and HSQC spectra, as one ketone carbonyl (δC 205.3) and one conjugated ester carbonyl 
(δC 166.8), six quaternary sp2 (δC 160.0, 158.3, 153.4, 136.7, 110.0 and 99.6), two 
methine sp2 (δC 104.4 and 103.0), one ketal (δC 102.9), two methine sp3 (δC 67.2 and 
33.9), three methylene sp3 (δC 48.3, 47.2 and 23.6) and three methyl (δC 21.6, 19.4 and 
15.9) carbons.  
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The 1H NMR spectrum, in combination with the HSQC spectrum (Table 11), 
exhibited one doublet of an olefinic proton at δH 6.13, J = 0.9 Hz (δC 104.4), one singlet 
of aromatic proton at δH 6.26 (δC 103.0), two multiplets of two methine protons at δH 4.15 
(δC 67.2) and 1.98 (δC 33.9), two broad doublets of two methylene protons at δH 2.81, J 
= 14.0 Hz (δC 47.2) and δH 2.57, J = 16.8 Hz (δC 23.6), two double doublets of two 
methylene protons at δH 2.81, J = 16.8, 5.6 Hz (δC 23.6) and δH 2.55, J = 14.0, 1.9 Hz (δC 
47.2), two double double doublets of two methylene protons at δH 2.48, J = 14.7, 2.9, 1.9 
Hz (δC 48.3) and δH 2.28, J = 14.7, 11.3, 0.7 Hz (δC 48.3), one methyl singlet at δH 2.24 
(δC 19.4) and two methyl doublets at δH 1.23, J = 6.2 Hz (δC 15.9) and 1.21, J = 6.2 Hz 
(δC 21.6), besides a singlet of the hydrogen-bonded hydroxyl proton at δH 11.35. 
That 376 also consisted of a 6,7-disubstituted 8-hydroxy-3-methyliso-chromene-1-
one nucleus was substantiated by the COSY correlation from the olefinic proton at δH 
6.13, d, J = 0.9 Hz (H-4) to the methyl singlet at δH 2.24 (H3-3), as well as by the HMBC 
correlations from the hydrogen-boned hydroxyl proton at δH 11.35, s (OH-8) to the 
carbons at δC 110.0 (C-7), δC 160.0 (C-8) and δC 99.6 (C-8a), from the methyl singlet (H3-
3) to the carbons at δC 153.4 (C-3) and δC 104.4 (C-4), from H-4 to C-3, the carbon at δC 
103.0 (C-5) and C-8a, and from the aromatic proton at δH 6.26, s (H-5) to C-4, the carbon 
at δC 158.3 (C-6), C-7 and C-8a. 
 
 
  
 Another portion of the molecule comprised one ketone carbonyl carbon (δC 205.3), 
one ketal (δC 102.9), one oxymethine sp3 (δC 67.2, δH 4.15, m), three methylene sp3 (δC 
48.3; δH 2.48, ddd, J = 14.7, 2.9, 1.9 Hz/2.28, ddd, J = 14.7, 11.3, 0.7 Hz, δC 47.2; δH 
2.81, brd, J = 14.0 Hz/2.55, dd, J = 14.0, 1.9 Hz and δC 23.6; δH 2.81, dd, J = 16.8, 5.6 
 105 
 
 CHAPTER IV: RESULTS AND DISCUSSION 
Hz/2.57 brd, J = 16.8 Hz), one methine sp3 (δC 33.9; δH 1.98, m) and two secondary 
methyl (δC 21.6; δH 1.21, d, J = 6.2 Hz and δC 15.9; δH 1.23, d, J = 6.2 Hz) groups.  
 The COSY spectrum exhibited correlations from the mutually coupled methylene 
protons at δH 2.81, dd, J = 16.8, 5.6 Hz (H-9α) and δH 2.57, brd, J = 16.8 Hz (H-9β) to the 
methine proton at δH 1.98, m (H-10). In turn, H-10 was also correlated to the methyl 
doublet at δH 1.23, J = 6.2 Hz (H3-10). Moreover, the HMBC spectrum exhibited cross 
peaks from H-9α and H-9β to C-6, C-7, the carbon at δC 33.9 (C-10) and the ketal carbon 
at δC 102.9 (C-11), and from the methyl singlet of H3-10 to the carbon at δC 23.6 (C-9), 
C-10 and C-11. These COSY and HMBC correlations suggested that the 3-mehtyl-3,4-
dihydro-2H-pyran was fused, through C-6 and C-7, with the 8-hydroxy-3-
methylisochromene-1-one nucleus. 
 
 
 
 Another coupling system was revealed by the COSY correlations from the proton 
at δH 4.15, m (H-15) to the mutually coupled methylene protons at δH 2.28, ddd, J = 14.7, 
11.3, 0.7 Hz (H-14α) and δH 2.48, ddd, J = 14.7, 2.9, 1.9 Hz (H-14β) and the methyl 
doublet at δH 1.21, J = 6.2 Hz (H3-15). Since the HMBC spectrum exhibited correlations 
from the mutually coupled methylene protons at δH 2.55, dd, J = 14.0, 1.9 Hz (H-12α) and 
δH 2.81, brd, J = 14.0 Hz (H-12β) to the ketone carbonyl carbon at δC 205.3 (C-13), from 
H-14α and H-14β to C-13 and the carbon at δC 67.2 (C-15), and from H3-15 to the carbon 
at δC 48.3 (C-14) and C-15, the 2-mehtyltetrahydro-4H-pyran-4-one and the 3-mehtyl-3,4-
dihydro-2H-pyran were connected through C-11 of the spiroketal.  
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Literature survey revealed that 376 is a new compound, thus it was named 
similanpyrone C. Since 376 was isolated as a viscous mass, it was impossible to obtain 
suitable crystals for the X-ray analysis. Consequently, the relative configurations of C-10, 
C-11 and C-15 were tentatively established using proton coupling constant values and 
the NOESY correlations. 
One of H2-9 appeared as a double doublet at δH 2.81 with coupling constant values 
of 16.8 Hz, typical for the geminal coupling, and 5.6 Hz, typical for the axial-equatorial 
coupling, while another appeared as a broad doublet at δH 2.57 with a geminal coupling 
constant of 16.8 Hz. Moreover, the NOESY spectrum exhibited cross peaks from H-10, 
which was in α-equatorial position, to both H-9α (δH 2.81, dd, J = 16.8, 5.6 Hz) and H-9β 
(δH 2.57, brd, J = 16.8 Hz). Therefore, CH3-10 was in the β-axial position of the half-chair 
conformation of the tetrahydropyran ring. 
On the other hand, both H2-14 appeared as double double doublet. One of them 
appeared at δH 2.28 with a geminal coupling of 14.7 Hz, a diaxial coupling of 11.3 Hz and 
a long-range coupling of 0.7 Hz, while another appeared at δH 2.48 with a geminal 
coupling of 14.7 Hz, an axial-equatorial coupling of 2.9 Hz and a long-range coupling of 
1.9 Hz. These patterns of couplings indicated that CH3-15 was in α-equatorial position of 
the half-chair conformation of the tetrahydro-4H-pyran-4-one ring. This hypothesis was 
corroborated by the NOESY correlation from H-15 to only H-14β (δH 2.48, ddd, J = 14.7, 
2.9, 1.9 Hz), but not to H-14α (δH 2.28, ddd, J = 14.7, 11.3, 0.7 Hz), as well as the higher 
chemical shift value of H-14β than that of H-14α since the former was under the 
anisotropic deshielding effect of the carbonyl group (C-13). Based on the same reasoning, 
the double doublet at δH 2.55, J = 14.0, 1.9 Hz and the broad doublet at δH 2.81, J = 14.0 
 107 
 
 CHAPTER IV: RESULTS AND DISCUSSION 
Hz was assigned as H-12α and H-12β, respectively. Consequently, the relative 
configuration of C-10 and C-15 was tentatively assigned as 10S* and 15R*. As the 
NOESY spectrum did not show the correlation between H-10 and H-15, the configuration 
of C-11 was assigned as 11S*.  
 
Table 11. 1H and 13C NMR (CDCl3, 500.13 MHz and 125.8 MHz), and HMBC assignment 
for similanpyrone C (376). 
Position δC, Type δH, (J in Hz) COSY HMBC NOESY 
1 166.8, CO - - - - 
3 153.4, C - - - - 
4 104.4, CH 6.13, d (0.9) H3-3 C-3, 5, 8a CH3-3 
4a 136.7, C - - - - 
5 103.0, CH 6.26, s - C-4, 6, 7, 8a - 
6 158.3, C - - - - 
7 110.0, C - - - - 
8 160.0, C - - - - 
8a 99.6, C - - - - 
9α 23.6, CH2 2.81, dd (16.8, 5.6) H-9β, 10 C-6, 7,10, 11 H-9β,10, CH3-10 
9β  2.57, brd (16.8) H-9α, 10 C-7,10, 11 H-9α,10, CH3-10 
10 33.9, CH 1.98, m H-9α, 9β, H3-10 - H-9α,9β,CH3-10 
11 102.9, C - - - - 
12α 47.2, CH2 2.55, dd (14.0, 1.9) H-12β C-10, 11, 13 H-12β 
12β  2.81, brd (14.0) H-12α C-10, 11, 13 H-12α 
13 205.3, CO - - - - 
14α 48.3, CH2 2.28, ddd  
(14.7, 11.3, 0.7) 
H-14β, 15 C-13, 15 H-14β, CH3-15 
14β  2.48, ddd  
(14.7, 2.9, 1.9) 
H-14α, 15 C-13 H-14β, CH3-15 
15 67.2, CH 4.15, m H-14α, 14β,  
H3-15 
- H-14β, CH3-15 
CH3-3 19.4, CH3 2.24, s H-4 C-3, 4 H-4 
CH3-10 15.9, CH3 1.23, d (6.2) H-10 C-9, 10, 11 H-9β, 10, 12α, 
12β 
CH3-15 21.6, CH3 1.21, d (6.2) H-15 C-14,15 H-14α, 14β, 15 
OH-8 - 11.35, s - C-7, 8, 8a - 
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Similanpyrone C (376) can be assumed to be derived from the acetate-malonate 
pathway (Scheme 1). Cyclization and enolization of the pentaketide (I), which is derived 
from malonyl-CoA and acetyl-CoA, give rise to 6,8-dihydroxy-3-methyl-isocoumarin (II). 
Claisen condensation of II with the tetraketide (III) leads to the formation of IV. Enolization 
of the side chain of IV, and a formation of the hemiketal by the phenolic hydroxyl group 
on C-6 of the isocoumarin nucleus and the ketone carbonyl of the side chain of IV, gives 
rise to the hemiketal (V). Formation of the ketal (VI) by hydroxyl group on C-11 and the 
ketone carbonyl of the side chain of V followed by methylation by S-adenosylmethionine 
(SAM) of VI finally leads to the formation of similanpyrone C (376). 
 
Scheme 1. Proposed biogenesis of similanpyrone C (376). 
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4.2.7) Chevalone C (349) 
 
Compound 349 was isolated as a white solid (mp 201 – 202 °C). The 13C NMR 
spectrum exhibited twenty-eight carbon signals which can be classified, according to the 
DEPTs and HSQC spectra, as one ester carbonyl (δC 170.7), one ketone carbonyl   (δC 
180.4), two oxyquaternary sp2 (δC 162.4 and 160.3), one quaternary sp2 (δC 98.2), one 
oxyquaternary sp3 (δC 84.0), three quaternary sp3 (δC 37.5, 37.1 and 36.8), one 
oxymethine sp3 (δC 80.4), one methine sp2 (δC 111.6), three methine sp3 (δC 59.9, 55.2 
and 52.0), seven methylene sp3 (δC 40.7, 39.8, 37.8, 23.3, 18.4, 17.6, and 15.1) and 
seven methyl (δC 27.7, 21.1, 20.3, 19.0, 16.2, 16.1 and 15.9) carbons. 
The 1H NMR spectrum (Table 12), together with the HSQC spectrum, exhibited 
one singlet of an olefinic proton at δH 5.93 (δC 111.6), two double doublets of two methine 
protons at δH 4.41, J = 10.8, 5.2 Hz (δC 80.4) and δH 1.46, J = 12.7, 5.0 Hz (δC 52.0), two 
doublets of two methine protons at δH 0.90, J = 11.5 Hz (δC 59.9) and δH 0.82, J = 7.3 Hz 
(δC 55.2), one double double doublet of methylene proton at δH 1.84, J = 12.9, 3.0, 3.0 
Hz (δC 40.7), four double doublets of four methylene protons at δH 2.48, J = 16.4, 4.8 Hz 
(δC 15.0), δH 2.06, J = 12.4, 5.1 Hz (δC 39.8), δH 1.53, J = 13.8, 2.6 Hz (δC 17.6) and δH 
1.30, J = 11.6, 3.2 Hz (δC 18.4), three doublets of three methylene protons at δH 1.67, J 
= 9.9 Hz (δC 18.4), δH 1.64, J = 16.4 Hz (δC 37.8) and δH 1.41, J = 13.2 Hz (δC 17.6), six 
multiplets of six methylene protons at δH 2.10 (δC 15.1), δH 1.65 (δC 39.8), δH 1.63 (δC 
23.3), δH 1.55 (δC 23.3), δH 1.01 (δC 37.8) and δH 1.00 (δC 40.7), and seven methyl singets 
at δH 2.15 (δC 19.0), δH 1.99 (δC 21.1), δH 1.23 (δC 20.3), δH 0.83 (δC 16.1), δH 0.83 (δC 
15.9), δH 0.81 (δC 16.2) and δH 0.80 (δC 27.7).  
The COSY correlation (Table 12) from the mutually coupled methylene protons at 
δH 1.63, m (H-2α) and δH 1.55, m (H-2β) to the proton at δH 4.41, dd, J = 10.8, 5.2 Hz (H-
3), together with the HMBC correlations from H-3 to the carbons at δC 170.7 (CO; OAc-
3), δC 37.5 (C-4), δC 16.1 (C-22) and δC 27.7 (CH3-23), from the proton at δH 0.90, d, J = 
11.5 Hz (H-9) to the carbon at δC 15.9 (CH3-24), from the methyl singlet at δH 0.83 (H3-
22) to the carbon at δC 55.2 (C-5) and CH3-23, from the methyl singlet at δH 0.80 (H3-23) 
to the carbon at δC 80.4 (C-3), C-4, C-5 and C-22, from the methyl singlet at δH 0.83 (H3-
24) to C-5 and the carbon at δC 59.9 (C-9), from the methyl singlet at δH 0.81 (H3-25) to 
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C-9, and from the methyl singlet at δH 1.99 (OAc-3) to the ester carbonyl carbon (CO; 
OAc-3), suggesting the presence of the 1,1,4a,6-tetramethyldecahydronaphthalen-2-yl 
acetate moiety. 
 
 
 
 Since there were the COSY correlation between H-14 and H2-15, as well as the 
HMBC correlations from the proton at δH 1.46, dd, J = 12.7, 5.0 Hz (H-14) to the carbons 
at δC 36.8 (C-8), δC 84.0 (C-13), δC 15.1 (C-15) and δC 20.3 (C-26), from the proton at δH 
2.48, dd, J = 16.4, 4.8 Hz (H-15α) to C-13 and the carbon at δC 52.0 (C-14), and from the 
proton at δH 2.10, m (H-15β) to the carbons at δC 39.8 (C-12) and δC 16.2 (C-25), the 
presence of the substituted tetradecahydrophenanthrene partial structure was proposed. 
 
 
 
The presence of the 5,6-disubstituted 2-methyl-4H-pyran-2-one was substantiated 
by the COSY correlation from the methine proton at δH 5.93, s (H-18) to the methyl singlet 
at δH 2.15 (H3-20), as well as by the HMBC correlations from H-18 to C-16, the carbons 
at δC 160.3 (C-19) and δC 19.0 (C-20), and from H3-20 to the carbon at δC 111.6 (C-18) 
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and C-19. That the 2-methyl-4H-pyran-2-one moiety was connected to the 
tetradecahydrophenanthrene portion through the ethereal bridge between C-21 of the 
former and C-13 of the latter as well as by the methylene bridge between C-16 of the 
former and C-14 of the latter was supported by HMBC correlations from H-15α to the 
carbons at δC 98.2 (C-16), δC 180.4 (C-17) and δC 162.4 (C-21). Therefore, the structure 
of 349 was identified as (4aR,4bR,6aS,12aS,12bR,14aR)-1,1,4a,6a,9,12b-hexamethyl-
11-oxo-1,2,3,4,4a,4b,5,6,6a,11,12,12a,12b,13,14,14a-hexadecahydrophaphtho[2,1-
f]pyrano[2,3-b]chromen-2-yl acetate. 
 
 
 
Literature survey revealed that the structure of 349 corresponds to chevalone C, 
which was first isolated from the fungus Eurotium chevalieri by Kanokmedhakul et al. 
(2011) and later from the fungus Neosartoyra tsunodae (Eamvijarn et al., 2013) and 
Neosartorya siamensis (Gomes et al., 2014). Chevalone C exhibited antimycobacterial 
activity against Mycobacterium tuberculosis with MIC value of 6.3 μg/mL and anticancer 
activity against BC1 (human breast) cancer cell with IC50 value of 8.7 μg/mL 
(Kanokmedhakul et al., 2011). For the antibacterial activity assay, chevalone C did not 
show any activities on Gram-positive and Gram-negative bacteria at the highest 
concentration tested (MIC > 256 mg/mL). However, it exhibited a synergism effect with 
antibiotics against multidrug-resistant isolates of Escherichia coli, Enterococcus faecium 
and Staphylococcus aureus (Gomes et al., 2014). Furthermore, this compound also 
exhibited an antimalarial activity with IC50 value of 25.0 μg/mL (Sawadsitang et al., 2015). 
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Table 12. 1H and 13C NMR (CDCl3, 300.13 MHz and 75.4 MHz), and HMBC assignment 
for chevalone C (349). 
Position δC, Type δH, (J in Hz) COSY HMBC 
1α 
1β 
37.8, CH2 1.64, d (16.4) 
1.01, m 
- 
- 
- 
- 
2α 23.3, CH2 1.63, m H-3 - 
2β  1.55, m H-3 - 
3 80.4, CH 4.41, dd (10.8, 5.2) H2-2 C-4, 22, 23, CO (OAc-3) 
4 37.5, C - - - 
5 55.2, CH 0.82, d (7.3) - - 
6α 
6β 
17.6, CH2 1.53, dd (13.8, 2.6) 
1.41, d (13.2) 
- 
- 
- 
- 
7α 40.7, CH2 1.84, ddd (12.9, 3.0, 3.0) - - 
7β  1.00, m - - 
8 36.8, C - - - 
9 59.9, CH 0.90, d (11.5) - C-24 
10 37.1, C - - - 
11α 
11β 
18.4, CH2 1.67, d (9.9) 
1.30, dd (11.6, 3.2) 
- 
- 
- 
- 
12α 
12β 
39.8, CH2 2.06, dd (12.4, 5.1) 
1.65, m 
- 
- 
- 
- 
13 84.0, C - - - 
14 52.0, CH 1.46, dd (12.7, 5.0) H2-15 C-8, 13, 15, 26 
15α 15.1, CH2 2.48, dd (16.4, 4.8) H-14 C-13, 14, 16, 17, 21 
15β  2.10, m H-14 C-12, 16, 25 
16 98.2, C - - - 
17 180.4, CO - - - 
18 111.6, CH 5.93, s H3-20 C-16, 19, 20 
19 160.3, C - - - 
20 19.0, CH3 2.15, s H-18 C-18, 19 
21 162.4, C - - - 
22 16.1, CH3 0.83, s - C-5, 23 
23 27.7, CH3 0.80, s - C-3, 4, 5, 22 
24 15.9, CH3 0.83, s - C-5, 9 
25 16.2, CH3 0.81, s - C-9 
26 20.3, CH3 1.23, s - - 
OAc-3 170.7, CO - - - 
 21.1, CH3 1.99, s - CO (OAc-3) 
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4.2.8) Chevalone E (356) 
 
Compound 356 was isolated as a white crystal (mp, 262 – 263 °C), and its 
molecular formula C26H38O4 was established on the basis of the (+)-HRESIMS m/z 
415.2851 [M+H]+, indicating eight degrees of unsaturation. The IR spectrum exhibited 
absorption bands for hydroxyl (3300 cm-1), conjugated carbonyl (1664 cm-1) and olefin 
(1607, 1570 cm-1) groups.  
The general features of 1H and 13C NMR spectra of 356 closely resembled to those 
of 349. The 13C NMR spectrum (Table 13) displayed twenty-six carbon signals which can 
be categorized, based on the DEPTs and HSQC spectra, as one conjugated ketone 
carbonyl (δC 180.6), two oxyquaternary sp2 (δC 162.6 and 160.5), one methine sp2 (δC 
111.9), one quaternary sp2 (δC 98.5), one oxyquaternary sp3 (δC 84.3), three quaternary 
sp3 (δC 38.9, 37.3 and 37.1), one oxymethine sp3 (δC 78.7), three methine sp3 (δC 60.3, 
55.3 and 52.3), seven methylene sp3 (δC 41.1, 40.1, 38.4, 27.2, 18.7, 17.9 and 15.2) and 
six methyl (δC 28.0, 20.5, 19.2, 16.4, 16.1 and 15.4) carbons.  
 The 1H NMR spectrum (Table 13), together with the HSQC spectrum, revealed the 
presence of one olefinic proton (δH 5.99, s, δC 111.9), four methine protons (δH 3.21, dd, 
J = 11.1, 5.1 Hz/δC 78.7; δH 1.50, dd, J = 12.5, 4.7 Hz/δC 52.3; δH 0.93, brd,J = 13.0 Hz/ 
δC 60.3; δH 0.79, dd, J = 11.6, 2.3 Hz/δC 55.3), fourteen methylene protons (δH 2.55, dd, 
J = 16.4, 4.9 Hz/δC 15.2; δH 2.15, m/δC 15.2; δH 2.11, dd, J = 12.9, 3.1 Hz/δC 40.1; δH 
1.90, ddd, J = 12.7, 3.0, 3.0 Hz/δC 41.1; δH 1,74, m/δC 18.7; δH 1.73, m/δC 38.4; δH 1.64, 
m (2H)/δC 27.2; δH 1.61, dd, J = 19.8, 3.1 Hz/δC 40.1; δH 1.59, m/δC 17.9; δH 1.45, m/δC 
17.9; δH 1.35, dd, J = 12.3, 3.0 Hz/δC 18.7; δH 1.04, ddd, J = 12.4, 12.4, 3.6 Hz/δC 41.1; 
δH 1.00, ddd, J = 10.6, 10.6, 3.5 Hz/δC 38.4) and six methyl singlets (δH 2.20/δC 19.2; δH 
1.28/δC 20.5; δH 0.98/δC 28.0; δH  0.89/δC 16.1; δH  0.84/δC 16.4 and δH  0.78/δC 15.2). 
The COSY and HMBC correlations shown inTable 13 are the same as those 
observed for chevalone C (349). The molecular formula and the lack of the 1H and 13C 
signals of the acetyl group led to the conclusion that 356 is a deacetyl analog of 349. 
Since H-5 appeared as a double doublet with a diaxial coupling of 11.1 Hz and an axial-
equatorial coupling of 5.1 Hz, H-5 was in the α-axial position. Consequently, the hydroxyl 
group (OH-3) was in β-equatorial position. 
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Table 13. 1H and 13C NMR (CDCl3, 500.13 MHz and 125.8 MHz) and HMBC assignment 
for chevalone E (356). 
Position δC, Type δH, (J in Hz) COSY HMBC 
1α 
1β 
38.4, CH2 1.73, m 
1.00, ddd (10.6, 10.6, 3.5) 
- 
- 
- 
-  
2 27.2, CH2 1.64, m H-3 - 
3 78.7, CH 3.21, dd (11.1, 5.1) H2-2 C-22 
4 38.9, C - - - 
5 55.3, CH 0.79, dd (11.6, 2.3) - C-23 
6α 
6β 
17.9, CH2 1.59, m 
1.45, m 
- 
- 
- 
- 
7α 41.1, CH2 1.90, ddd (12.7, 3.0, 3.0) - C-5 
7β  1.04, ddd (12.4, 12.4, 3.6) - - 
8 37.3, C - - - 
9 60.3, CH 0.93, brd (13.0) H-11 - 
10 37.1, C - - - 
11α 
11β 
18.7, CH2 1.74, m 
1.35, dd (12.3, 3.0) 
H-9 
- 
- 
- 
12α 
12β 
40.1, CH2 2.11, dd (12.9, 3.1) 
1.61, dd (19.8, 3.1) 
- 
- 
C-14 
- 
13 84.3, C - - - 
14 52.3, CH 1.50, dd (12.5, 4.7) H2-15 C-8, 13, 26 
15α 15.2, CH2 2.55, dd (16.4, 4.9) H-14 C-13, 14, 16, 17 
15β  2.15, m H-14 C-8, 14, 16 
16 98.5, C - - - 
17 180.6, CO - - - 
18 111.9, CH 5.99, s - C-19, 20, 21 
19 160.5, C - - - 
20 19.2, CH3 2.20, s - C-18, 21 
21 162.6, C - - - 
22 15.2, CH3 0.78, s H3-23 C-3, 4, 5 
23 28.0, CH3 0.98, s H3-22 C-3, 4, 5, 22 
24 16.4, CH3 0.84, s - C-5, 9, 10 
25 16.1, CH3 0.89, s - C-7, 8, 9, 14 
26 20.5, CH3 1.28, s - C-12, 13, 14 
 
 116 
 
 CHAPTER IV: RESULTS AND DISCUSSION 
Since 356 was obtained as a suitable crystal, the X-ray analysis was performed, 
and its ORTEP view was shown in Figure 55. Since the diffraction data were collected 
with a Gemini PX Ultra equipped with CuKα radiation, the absolute configurations of C-3, 
C-5, C-8, C-9, C-10, C-13 and C-14 were established as 3S, 5R, 8R, 9R, 10R, 13S and 
14S, respectively. Since this is the first report of this chevalone analog, it was named 
chevalone E. 
 
 
 
Figure 55. ORTEP diagram of chevalone E (356). 
 
4.2.9) Chevalone B (348) 
 
Compound 348 was isolated as a white solid (mp 161 – 163 °C). The general 
feature of 1H and 13C NMR spectra of 348 closely resemble those of 349, except for the 
chemical shift value of conjugated carbonyl carbon (C-17; δC 165.4) of 348 appeared at 
lower frequency than that of chevalone C (δC 180.4). 
The 13C NMR spectrum (Table 14) exhibited twenty-eight carbon signals which can 
be classified, according to the DEPTs and HSQC spectra, as two ester carbonyl (δC 171.0 
and 165.4), three quaternary sp2 (δC 163.3, 159.7 and 97.7), one methine sp2 (δC 100.6), 
four quaternary sp3 (δC 80.4, 37.7, 37.2 and 37.0), four methine sp3 (δC 80.6, 60.2, 55.4 
and 51.8), seven methylene sp3 (δC 40.8, 40.2, 37.9, 23.4, 18.6, 17.7 and 16.7) and seven 
methyl (δC 27.9, 21.2, 20.5, 19.6, 16.4, 16.3 and 16.0) carbons. 
The 1H NMR spectrum (Table 14), together with the HSQC spectrum, exhibited 
one doublet of olefinic proton at δH 5.70, J = 0.5 Hz (δC 100.6), three double doublets of 
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three methine protons at δH 4.46, J = 11.0, 5.1 Hz (δC 80.6), δH 1.45, J = 12.8, 4.8 Hz (δC 
51.8) and δH 0.93, J = 12.0, 1.6 Hz (δC 60.2), one doublet of methine proton at δH 0.86, J 
= 2.8 Hz (δC 55.4), one double double doublet of methylene proton at δH 1.85, J = 12.7, 
3.1, 3.1 Hz (δC 40.8), one double doublet of methylene proton at δH 2.43, J = 16.9, 4.9 Hz 
(δC 16.7), twelve multiplets of twelve methylene protons at δH 2.14 (δC 16.7), δH 2.06 (δC 
40.2), δH 1.71 (δC 37.9), δH 1.70 (δC 18.6), δH 1.68 (δC 23.4), δH 1.61 (δC 23.4), δH 1.61 
(δC 40.2), δH 1.57 (δC 17.7), δH 1.43 (δC 17.7), δH 1.32 (δC 18.6), δH 1.06 (δC 37.9) and δH 
1.03 (δC 40.8), and seven methyl singlets at δH 2.18 (δC 19.6), δH 2.05 (δC 21.2), δH 1.20 
(δC 20.5), δH 0.88 (δC 16.0), δH 0.87 (δC 16.3), δH 0.87 (δC 16.4) and δH 0.86 (δC 27.9).  
The similarity of the 1H and 13C chemical shift values of 348 (Table 14) to those of 
chevalone C (349), as well as the COSY and HMBC correlations observed for 348, 
indicated the presence of the 3-acetoxy-4,4,8,10,13-pentamethyltetradecahydro-
phenanthrene moiety.  
 
 
 
 However, instead of the presence of the 5,6-disubstituted 2-methyl-4H-pyran-4-
one, another moiety of 348 was 3,4-disubstituted 6-methyl-2H-pyran-2-one. This was 
confirmed by the COSY correlations from the olefinic proton at δH 5.70, d, J = 0.5 Hz (H-
20) to the protons of the methyl singlet at δH 2.18 (H3-19), indicating that they were allylic 
coupled, as well as by the HMBC correlations from the protons at δH 2.43, dd, J = 16.9, 
4.9 Hz (H-15α) to the carbons at δC 80.4 (C-13), δC 51.8 (C-14), δC 97.7 (C-16), δC 165.4 
(C-17) and δC 163.3 (C-21), from the proton at at δH 2.14, m (H-15β) to the carbon at δC 
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37.2 (C-8), C-14 and C-21, from H3-19 to the carbons at δC 159.7 (C-18) and δC 100.6 
(C-20), and from H-20 to C-16, C-18, the methyl carbon at δC 19.6 (C-19) and C-21. 
 
 
 
Literature survey revealed that 348 is a known compound, chevalone B, which was 
first isolated from the fungus Eurotium chevalieri (Kanokmedhakul et al., 2011) and later 
from Neosartorya siamensis (Gomes et al., 2014) and Neosartorya takakii (May Zin et al., 
2015). Chevalone B exhibited cytotoxicity against KB (human epidermoid carcinoma in 
the mouth) and NCI-H187 (small cell lung cancer) cell lines with IC50 values of 2.9 and 
3.9 μg/mL, respectively (Kanokmedhakul et al., 2011). 
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Table 14. 1H and 13C NMR (CDCl3, 300.13 MHz and 75.4 MHz), and HMBC assignment 
for chevalone B (348). 
Position δC, Type δH, (J in Hz) COSY HMBC 
1α 
1β 
37.9, CH2 1.71, m 
1.06, m 
- 
- 
- 
- 
2α 23.4, CH2 1.68, m H-3 - 
2β  1,61, m H-3 - 
3 80.6, CH 4.46, dd (11.0, 5.1) H2-2 C-2, 4, 22, 23, CO (OAc-3) 
4 37.7, C - - - 
5 55.4, CH 0.86, d (2.8) - C-9 
6α 
6β 
17.7, CH2 1.57, m 
1.43, m 
- 
- 
- 
- 
7α 40.8, CH2 1.85, ddd (12.7, 3.1, 3.1) - C-5, 6, 9, 14 
7β  1.03, m - - 
8 37.2, C - - - 
9 60.2, CH 0.93, dd (12.0, 1.6) H-11 C-10, 12, 14, 24 
10 37.0, C - - - 
11α 
11β 
18.6, CH2 1.70, m 
1.32, m 
- 
H-9 
- 
- 
12α 
12β 
40.2, CH2 2.06, m 
1.61, m 
- 
- 
C-9, 13, 14 
13 80.4, C - - - 
14 51.8, CH 1.45, dd (12.8, 4.8) H2-15 C-7, 8, 9, 12, 13, 25, 26 
15α 16.7, CH2 2.43, dd (16.9, 4.9) H-14 C-13, 14, 16, 17, 21 
15β  2.14, m H-14 C-8, 14, 21 
16 97.7, C - - - 
17 165.4, CO - - - 
18 159.7, C - - - 
19 19.6, CH3 2.18, s H-20 C-18, 20 
20 100.6, CH 5.70, d (0.5) H3-19 C-16, 18, 19, 21 
21 163.3, C - - - 
22 16.0, CH3 0.88, s - C-3, 4, 5, 23 
23 27.9, CH3 0.86, s - - 
24 16.3, CH3 0.87, s - C-10 
25 16.4, CH3 0.87, s - C-8, 14 
26 20.5, CH3 1.20, s - C-12, 13, 14 
OAc-3 171.0, CO - - - 
 21.2, CH3 2.05, s - CO (OAc-3) 
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4.2.10) S14-95 (377) 
 
Compound 377 was isolated as a pale yellow viscous mass and its molecular 
formula C28H34O5, was established on the basis of the (+)-HRESIMS m/z 451.2484 
[M+H]+, indicating twelve degrees of unsaturation.  
The 13C NMR spectrum (Table 15) exhibited twenty-eight carbon signals which can 
be categorized, according to the DEPTs and HSQC spectrum, as two ester carbonyl (δC 
170.9 and 164.5), two oxyquaternary sp2 (δC 163.2 and 152.8), two quaternary sp2 (δC 
131.4 and 99.3), six methine sp2 (δC 130.5, 128.8, 128.8, 125.4, 125.4 and 98.3), one 
oxyquaternary sp3 (δC 80.5), one oxymethine sp3 (δC 80.1), two methine sp3 (δC 55.0 and 
51.4), five methylene sp3 (δC 40.2, 37.1, 23.5, 19.2 and 17.2), two quaternary sp3 (δC 37.7 
and 36.7) and five methyl (δC 28.1, 21.3, 20.7, 16.6 and 15.1) carbons. 
The 1H NMR spectrum (Table 15), together with the HSQC spectrum, displayed 
five aromatic protons (δH 7.40 - δH 7.80), one olefinic proton (δH 6.37, s/δC 98.3), one 
oxymethine proton (δH 4.51, dd, J = 11.3, 5.0 Hz/δC 80.1), two methine protons (δH 1.51, 
dd, J = 12.8, 5.0 Hz/δC 51.4; δH 1.09, dd, J = 12.0, 2.0 Hz/δC 55.0), ten methylene protons 
(δH 2.52, dd, J = 17.4, 49 Hz/δC 17.2; δH 2.24, ddd, J = 16.9, 16.9, 4.0 Hz/δC 17.2; δH 
2.14, ddd, J = 12.3, 2.9, 2.9 Hz/δC 40.2; δH 1.82, m/δC 37.1; δH 1.81, m (2H)/δC 19.2; δH 
1.71, ddd, J = 14.1, 4.1, 4.1 Hz/δC 23.5; δH 1.71, m/δC 40.2; δH 1.65, m/δC 23.5; δH 1.18, 
ddd, J = 12.8, 12.8, 4.4 Hz/δC 37.1) and five methyl singlets (δH 2.06/δC 21.3; δH 1.27/δC 
20.7; δH 0.94/δC 15.1; δH 0.91/δC 28.1; δH 0.89/δC 16.6). 
 Analysis of the 1H and 13C NMR, HSQC and HMBC spectra (Table 15) revealed 
the presence of the pentasubstituted decahydronaphthalene ring system with the acetoxyl 
group on C-3, one methyl group on C-4, one methyl group on C-6 and two methyl groups 
on C-10, similar to that of chevalone C (349). This hypothesis was supported by the 
HMBC correlations from the proton at δH 4.51, dd, J = 11.3, 5.0 Hz (H-1) to the carbons 
at δC 37.7 (C-10), δC 16.6 (C-11), δC 28.1 (C-15) and δC 170.9 (CO; OAc-1), from the 
methyl singlet at δH 0.89 (H3-11) to the carbons at δC 80.1 (C-1) and δC 55.0 (C-9), from 
the methyl singlet at δH 1.27 (H3-12) to C-9, from the methyl singlet at δH 0.94 (H3-14) to 
the carbons at δC 51.4 (C-5), δC 80.5 (C-6) and the δC 37.1 (C-7), and from the methyl 
singlet at δH 0.91 (H3-15) to C-1 and C-9. 
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 The COSY spectrum exhibited cross peaks from the mutually coupled methylene 
protons at δH 2.52, dd, J = 17.0, 4.9 Hz (H-13α) and δH 2.24, ddd, J = 16.9, 16.9, 4.0 Hz 
(H-13β)/δC 17.2 to the double doublet at δH 1.51, J = 12.8, 5.0 Hz (H-5). Furthermore, the 
HMBC spectrum showed cross peaks from H-13α to the carbons at δC 36.7 (C-4), C-5 
and δC 99.3 (C-3’), from H-13β to C-5, C-6 and C-3’ and from the proton at δH 6.37, s (H-
5’) to C-3’ and the carbons at δC 163.2 (C-4’) and δC 152.8 (C-6’). These data suggested 
that the decahydronaphthalene ring system was fused with the 3,4-dihydro-2H,5H-
pyrano[4,3-b]pyran-5-one ring system through C-5 and C-6. 
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The presence of the phenyl group was corroborated by the presence of the 
multiplets of aromatic protons (δH 7.40 – 7.80) together with five methine sp2 carbons at 
δC 125.4 (2C), δC 128.8 (2C), δC 130.5 and one quaternary sp2 carbon at δC 131.4. That 
the benzene ring was connected to the pyran-2-one ring through the quaternary sp2 
carbon at δC 131.4 (C-1’’) of the former and the C-6’ of the later was supported by the 
HMBC correlation from H-5’ to C-1’’. Therefore, the structure of 377 was establisted as: 
 
 
 
The 1H and 13C NMR and other physical data including optical rotation of 377 were 
compatible with those reported for S14-95, a meroterpenoid previously isolated from 
fermentation of Penicillium sp. (Erkel et al., 2003; Yao et al., 2003). S14-95 exhibited 
inflammatory activity by inhibiting the IFN-γ mediated expression of the reporter genes, 
the proinflammatory enzymes COX-2 and NOS II and p38 MAP kinase (Erkel et al., 2003). 
In addition, this compound also inhibited cytokine-induced activation of STAT1α (Erkel et 
al., 2003; Yao et al., 2003) and iNOS-dependent NO production (Yao et al., 2003). 
 
 
 
 123 
 
 CHAPTER IV: RESULTS AND DISCUSSION 
Table 15. 1H and 13C NMR (CDCl3, 300.13 MHz and 75.4 MHz), and HMBC assignment 
for S14-95 (377). 
Position δC, Type δH, (J = Hz) COSY HMBC 
1 80.1, CH 4.51, dd (11.3, 5.0) H-2 C-10, 11, 15, CO (OAc-1) 
2α 23.5, CH2 1.71, ddd (14.1, 4.1, 4.1) - - 
2β  1.65, m H-1 - 
3α 40.2, CH2 2.14, ddd (12.3, 2.9, 2.9) - - 
3β  1.71, m - - 
4 36.7, C - - - 
5 51.4, CH 1.51, dd (12.8, 5.0) H2-13 C-4, 6, 7, 13, 14 
6 80.5, C - - - 
7α 37.1, CH2 1.82, m - - 
7β  1.18, ddd (12.8, 12.8, 4.4) - - 
8 19.2, CH2 1.81, m - - 
9 55.0, CH 1.09, dd (12.0, 2.0) - C-7, 11, 12, 15 
10 37.7, C - - - 
11 16.6, CH3 0.89, s  - C-1, 9 
12 20.7, CH3 1.27, s  - C-9 
13α 17.2, CH2 2.52, dd (17.0, 4.9) H-5 C-4, 5, 3’ 
13β  2.24, ddd (16.9, 16.9, 4.0) H-5 C-5, 6, 3’ 
14 15.1, CH3 0.94, s - C-5, 6, 7 
15 28.1, CH3 0.91, s - C-1,9 
2’ 164.5, C - - - 
3’ 99.3, C - - - 
4’ 163.2, C - - - 
5’ 98.3, CH 6.37, s - C-3’, 4’, 6’, 1’’ 
6’ 152.8, C - - - 
1’’ 131.4, C - - - 
2’’ 125.4, CH 7.79, m - - 
3’’ 128.8, CH 7.43, m - - 
4’’ 130.5, CH 7.43, m - - 
5’’ 128.8, CH 7.43, m - - 
6’’ 125.4, CH 7.79, m - - 
OAc-1 170.9, CO - - - 
 21.3, CH3 2.06, s - CO (OAc-1) 
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4.2.11) Pyripyropene E (154) 
 
Compound 154 was isolated as a white solid (mp 240 – 244 °C). The general 
feature of 1H and 13C NMR of 154 closely resembled those of S14-95 (377), except for 
the absence of one aromatic carbon and one aromatic proton. Furthermore, the chemical 
shift values of aromatic carbons and protons of 154 appeared at higher frequencies than 
those of S14-95. 
The 13C NMR spectrum (Table 16) displayed twenty-seven carbon signals which 
can be categorized, based on the DEPTs and HMBC spectra, as two ester carbonyl (δC 
170.6 and 163.7), two oxyquaternary sp2 (δC 162.6 and 155.3), five methine sp2 (δC 150.8, 
146.4, 132.5, 123.4 and 99.2), two quaternary sp2 (δC 127.3 and 100.0), one 
oxyquaternary sp3 (δC 80.6), one oxymethine sp3 (δC 79.9), two methine sp3 (54.8 and 
51.1), five methylene sp3 (δC 39.9, 36.9, 23.2, 19.0 and 17.0), two quaternary sp3 (δC 37.5 
and 36.5) and five methyl (δC 27.8, 21.0, 20.4, 16.4 and 14.9) carbons.   
The 1H NMR spectrum (Table 16), together with the HSQC spectra, revealed the 
presence of four aromatic protons at δH 8.90, d, J = 2.3 Hz (δC 146.4), δH 8.55, dd, J = 
4.8, 1.5 Hz (δC 150.8), δH 8.00, ddd, J = 8.1, 2.0, 2.0 Hz (δC 132.5) and δH 7.30, dd, J = 
8.1, 4.8 Hz (δC 123.4), one olefinic  proton at δH 6.35, s (δC 99.2), one oxymethine proton 
at δH 4.41, dd, J = 11.2, 4.9 Hz (δC 79.9), two methine protons at δH 1.42, dd, J = 12.7, 
4.8 Hz (δC 51.1) and δH 1.00, dd, J = 12.0, 1.7 Hz (δC 54.8), ten methylene protons at δH 
2.42, dd, J = 17.2, 48 Hz (δC 17.0), δH 2.14, m (δC 17.0), δH 2.05, m (δC 39.9), δH 1.72, m 
(δC 19.0), δH 1.71, m (δC 36.9), δH 1.64, m (2H; δC 23.3), δH 1.61, m (δC 39.9), δH 1.36, 
dd, J = 12.8, 2.9 Hz(δC 19.0) and δH 1.09, ddd, J = 12.9, 12.9, 4.6 Hz (δC 36.9), and five 
methyl singlets at δH 1.97 (δC 21.0), δH 1.18 (δC 20.4), δH 0.85 (δC 14.9), δH 0.82 (δC 27.8) 
and δH 0.80 (δC 16.4).  
Like S14-95 (377), the decahydronaphthalene ring system was fused with the 3,4-
dihydro-2H,5H-pyrano[4,3-b]pyran-5-one ring system through C-5 and C-6. 
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However, the substituent on C-6 of 154 was the 3-substituted pyridine ring. The 
presence of the 3-substituted pyridine ring instead of the phenyl ring in 377. The presence 
of the 3-substituted pyridine ring was supported by the COSY correlations from the proton 
at δH 8.00, ddd, J = 8.1, 2.0, 2.0 Hz (H-4’’) to the protons at δH 8.90, d, J = 2.3 Hz (H-2’’) 
and δH 7.30, dd, J = 8.1, 4.8 Hz (H-5’’), and from H-5’’ to the proton at δH 8.55, dd, J = 
4.8, 1.5 Hz (H-6’’), as well as by the HMBC correlations from H-2’’ to the carbons at δC 
127.3 (C-3’’), δC 132.5 (C-4’’) and δC 150.8 (C-6’’), from H-4’’ to the carbon at δC 146.4 
(C-2’’) and C-6’’, from H-5’’ to C-3’’ and C-6’’, and from H-6’’ to C-2’’, C-4’’ and the carbon 
at δC 123.4 (C-5’’). Since the HMBC spectrum showed cross peaks from H-2’’ and H-4’’ 
to the oxyquaternary sp2 carbon at δC 155.3 (C-6’), the 3-substituted pyridine ring was 
connected to C-6’ of the pyran-2-one ring. 
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 The 1H, 13C and other physical data of 154 allowed us to identify it as pyripyropene 
E. This commpound has been previously reported by Tomoda et al. (1995) and Masi et 
al. (2013) from the fungi Aspergillus fumigatus and Neosartorya pseudofischeri, 
respectively. Pyripyropene E exhibited weak inhibitory activity against acyl-
CoA:cholesterol acyltransferase (ACAT) activity with an IC50 value of 399 μM (Tomoda et 
al.,1995) and in vitro growth inhibitory activity in five human cancer cell lines, including 
A549, Hs683, MCF7, SKMEL28 and U373, and one mouse cancer cell line, B16F1, with 
IC50 values of 37, 36, 22, 33, 87 and 13 μM, respectively (Masi et al., 2013).  
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Table 16. 1H and 13C NMR (CDCl3, 300.13 MHz and 75.4 MHz), and HMBC assignment 
for pyripyropene E (154). 
Position δC, Type δH, (J in Hz) COSY HMBC 
1 79.9, CH 4.41, dd (11.2, 4.9) H-2 C-10, 11, 15, CO (OAc-1) 
2 23.2, CH2 1.64, m H-1 - 
3α 39.9, CH2 2.05, m - - 
3β  1.61, m - - 
4 36.5, C - - - 
5 51.1, CH 1.42, dd (12.7, 4.8) H2-13 C-4, 6, 12, 13, 14 
6 80.6, C - - - 
7α 36.9, CH2 1.71, m - - 
7β  1.09, ddd (12.9, 12.9, 4.6) - - 
8α 19.0, CH2 1.72, m H-9 - 
8β  1.36, dd (12.8, 2.9) - - 
9 54.8, CH 1.00, dd (12.0, 1.7) H-8α C-10, 12, 15 
10 37.5, C - - - 
11 16.4, CH3 0.80, s - C-9, 10 
12 20.4, CH3 1.18, s - C-3, 4 
13α 17.0, CH2 2.42, dd (17.2, 4.8) H-5 C-4, 5, 2’, 3’, 4’ 
13β  2.14, m H-5 C-6, 3’, 4’ 
14 14.9, CH3 0.85, s - C-5, 7 
15 27.8, CH3 0.82, s - C-9, 10 
2’ 163.7, C - - - 
3’ 100.0, C - - - 
4’ 162.6, C - - - 
5’ 99.2, CH 6.35, s - C-3’, 4’, 6’, 3’’ 
6’ 155.3, C - - - 
2’’ 146.4, CH 8.90, d (2.0) H-4’’ C-6’, 3’’, 4’’, 6’’ 
3’’ 127.3, C - - - 
4’’ 132.5, CH 8.00, ddd (8.1, 2.0, 2.0) H-2’’, 5’’ C-6’, 2’’, 6’’ 
5’’ 123.4, CH 7.30, dd (8.1, 4.8) H-4’’, 6’’ C-3’’, 6’’ 
6’’ 150.8, CH 8.55, dd (4.8, 2.0) H-5’’ C-2’’, 4’’, 5’’ 
OAc-1 170.6, CO - - - 
 21.0, CH3 1.97, s - CO (OAc-1) 
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4.2.12) Pyripyropene S (378) 
 
Compound 378 was isolated as pale yellow viscous mass, the (+)-HRESIMS of 
378 indicated the [M+H]+ peak at m/z 566.2416, corresponding to C31H36NO9. Thus, the 
molecular formula of 378 is C31H35NO9, indicating fifteen degrees of unsaturation. The IR 
spectrum showed absorption bands for ester carbonyl (1742 cm-1), conjugated carbonyl 
(1671 cm-1), aromatic (1586, 1508, 1465 cm-1) and olefin (1625 cm-1) groups.  
The general feature of the 1H and 13C NMR spectra of 378 resembled to those of 
pyripyropene E (154). The 13C NMR spectrum (Table 17) exhibited thirsty-one carbon 
signals which can be categorized, based on the DEPTs and HMBC spectra, as three ester 
carbonyl (δC 171.0, 170.4 and 169.8), one conjugated carbonyl (δC 161.3), five quaternary 
sp2 (δC 161.2, 157.2, 144.5, 127.4 and 101.1), six methine sp2 (δC 152.1, 146.6, 133.1, 
123.8, 111.2 and 98.6), one oxyquaternary sp3 (δC 83.9), two oxymethine sp3 (δC 77.7 
and 73.2), one oxymethylene sp3 (δC 64.7), tone methine sp3 (δC 41.1), two quaternary 
sp3 (δC 40.6 and 38.8), hree methylene sp3 (δC 35.5, 24.3 and 23.2) and six methyl (δC 
24.2, 21.3, 21.2, 21.2, 20.8 and 13.3) carbons. 
The 1H NMR spectrum (Table 17), together with the HSQC spectra, exhibited four 
aromatic protons (δH 9.02, brs/δC 146.6; δH 8.68, brd, J = 4.0 Hz/δC 151.2; δH 8.14, ddd, 
J = 7.8, 1.4, 1.4 Hz/δC 133.1; δH 7.42, dd, J = 8.0, 4.9 Hz/δC 123.8), two olefinic protons 
(δH 6.54, s/δC 98.6; δH 6.36, s/δC 111.2), two oxymethine protons (δH 5.23, dd, J = 11.9, 
5.4 Hz/δC 77.7; δH 4.79, dd, J = 11.7, 4.6 Hz/δC 73.2), one methine proton (δH 1.73, brd, 
J = 12.5 Hz/δC 41.1), two oxymethylene protons (δH 3.79, d, J = 11.9 Hz/δC 64.7; δH 3.75, 
d,  J = 11.9 Hz/δC 64.7), six methylene protons (δH 2.09, m (2H)/δC 35.5; δH 1.99, m/δC 
23.2; δH 1,82, ddd, J = 12.8, 5.1, 1.4 Hz/δC 24.3; δH 1.76, m/δC 23.2; δH 1.61, m/δC 24.3) 
and six methyl singlets (δH 2.17/δC 21.2; δH 2.10/δC 20.8; δH 2.05/δC 21.2; δH 1.59/δC 21.3; 
δH 1.26/δC 24.2; δH 0.88/δC 13.3). 
Analysis of the 1H, 13C, HSQC and HMBC spectra (Table 17) revealed the 
presence of three acetoxyl groups (δC 170.4 and δC 21.2/δH 2.05s; δC 171.0 and δC 20.8/ 
δH 2.10, s; δC 169.8 and δC 21.2/ δH 2.17, s) and a hexasubstituted decahydronaphthalene 
ring system. That the three acetoxyl groups were on C-1, C-7 and C-11, was 
substantiated by the HMBC correlations from the proton at δH 3.75, d, J = 11.9 Hz (H-
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11β) to the carbons at δC 73.2 (C-1), δC 41.1 (C-9) and δC 171.0 (CO; OAc-11), from the 
methyl singlet at δH 2.05 (H3; OAc-1) to the carbon at δC 170.4 (CO; OAc-1), from the 
methyl singlet at δH 2.17 (H3; OAc-7) to the carbon at δC 169.8 (CO; OAc-7), and from the 
methyl singlet at δH 2.10 (H3; OAc-11) to CO (OAc-11). Like other pyripyropenes, the two 
methyl groups were on C-4 and C-6 was supported by the HMBC correlations from the 
methyl singlet at δH 1.26 (H3-12) to the carbons at δC 35.5 (C-3), δC 38.8 (C-4) and C-9, 
and from the methyl singlet at δH 1.59 (H3-14) to the carbons at δC 144.5 (C-5), δC 83.9 
(C-6) and δC 77.7 (C-7). On the other hand, only one methyl group (δH 0.88, s, δC 13.3) 
was on C-10, was evidenced by the HMBC correlations from the methyl singlet at δH 0.88 
(H3-15) to C-1 and the carbon at δC 40.6 (C-10) and δC 64.7 (C-11). 
 
 
 
Since the HMBC spectrum exhibited cross peaks from H3-14 to the carbons at δC 
144.5 (C-5) and δC 83.9 (C-6), C-6 was linked to an oxygen atom and the double bond 
was on C-5. This was supported by the HMBC correlations from the proton at δH 6.36, s 
(H-13) to C-4 and C-6. On the other hand, the HMBC spectrum also displayed cross 
peaks from H-13 to the carbons at δC 161.3 (C-2’) and δC 161.2 (C-4’), and from the 
singlet at δH 6.54 (H-5’) to C-4’ and the carbons at δC 101.1 (C-3’) and δC 157.2 (C-6’), 
indicating the decahydronaphthalene ring system was fused with 2H,5H-pyrano[4,3-
b]pyran-5-one ring system through C-5 and C-6. 
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 The COSY and HMBC spectra (Table 17) also indicated the presence of the 3-
substitued pyridine ring. Like pyripyropene E (154), the 3-substituted pyridine ring was 
connected to the 2-pyranone ring through C-6’ and C-3’’ since H-5’ (δH 6.54, s) showed 
HMBC cross peak to C-3’’ (δC 127.4). 
 
 
 
Literature survey revealed that 378 was previously obtained by treatment of 
pyripyropene A with HCl under anhydrous condition (Obata et al., 1995). However, the 
1H and 13C NMR data and other description of this compound have not been reported. 
Since 379 is a new natural product, it was named pyripyropene S. 
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Table 17. 1H and 13C NMR (CDCl3, 500.13 MHz and 125.8 MHz), and HMBC assignment 
for pyripyropene S (378). 
Position δC, Type δH, (J in Hz)  COSY HMBC 
1 73.2, CH 4.79, dd (11.7, 4.6) H-2 - 
2α 23.2, CH2 1.99, m H-1 - 
2β  1.76, m - - 
3 35.5, CH2 2.09, m - - 
4 38.8, C - - - 
5 144.5, C - - - 
6 83.9, C - - - 
7 77.7, CH 5.23, dd (11.9, 5.4) H-8 C-6 
8α 24.3, CH2 1.82, ddd (12.8, 5.1, 1.4) H-7, 9 - 
8β  1.61, m - - 
9 41.1, CH 1.73, brd (12.5) H-8 - 
10 40.6, C - - - 
11α 64.7, CH2 3.79, d (11.9) - - 
11β  3.75, d (11.9) - C-1, 9, CO (OAc-11) 
12 24.2, CH3 1.26, s - C-3, 4, 9 
13 111.2, CH 6.36, s - C-4, 6, 2’, 4’ 
14 21.3, CH3 1.59, s - C-5, 6, 7 
15 13.3, CH3 0.88, s - C-1, 10, 11 
2’ 161.3, C - - - 
3’ 101.1, C - - - 
4’ 161.2, C - - - 
5’ 98.6, CH 6.54, s - C-2’, 3’, 6’, 3’’ 
6’ 157.2, C - - - 
2’’ 146.6, CH 9.02, brs H-4’’ C-3’’, 4’’, 6’’ 
3’’ 127.4, C - - - 
4’’ 133.1, CH 8.14, ddd (7.8, 1.4, 1.4) H-2’’, 5’’ C-6’, 2’’ 
5’’ 123.8, CH 7.42, dd (8.0, 4.9) H-4’’, 6’’ C-3’’, 6’’ 
6’’ 151.2, CH 8.68, brd (4.0) H-5’’ C-5’’ 
OAc-1 170.4, CO - - - 
 21.2, CH3 2.05, s - CO (OAc-1) 
OAc-7 169.8, CO - - - 
 21.2, CH3 2.17, s - CO (OAc-7) 
OAc-11 171.0, CO - - - 
 20.8, CH3 2.10, s - CO (OAc-11) 
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4.2.13) Pyripyropene T (379) 
 
Compound 379 was isolated as a pale yellow viscous mass and its molecular 
formula C29H33NO8 was established on the basis of (+)-HRESIMS m/z 524.2284 [M+H]+, 
indicating fourteen degrees of unsaturation. The IR spectrum showed absorption bands 
for hydroxyl (3418 cm-1), ester carbonyl (1732 cm-1), conjugated ester carbonyl (1667   
cm-1), olefin (1643 cm-1), aromatic (1557, 1507 cm-1).  
The general feature of 1H and 13C of 379 closely resembled those of pyripyropene 
S (378). The 13C NMR spectra (Table 18) exhibited twenty-nine carbon signals which can 
be categorized, based on DEPTs and HSQC spectra, as two ester carbonyl (δC 170.1 
and 169.8), one conjugated carbonyl (δC 161.6), five quaternary sp2 (δC 160.2, 156.8, 
146.1, 126.9 and 100.3), methine sp2 (δC 151.3, 146.5, 132.8, 123.9, 109.4 and 98.7), 
one oxyquaternary sp3 (δC 85.9), two oxymethine sp3 (δC 75.7 and 72.8), six one 
oxymethylene sp3 (δC 64.4), one methine sp3 (δC 40.7), two quaternary sp3 (δC 40.3 and 
38.4), three methylene sp3 (δC 35.2, 27.3 and 22.9) and five methyl (δC 23.8, 20.5, 20.8, 
20.1 and 12.7) carbons. 
The 1H NMR and HSQC spectra (Table 18) revealed the presence of four aromatic 
protons (δH 9.00, d, J = 1.7 Hz/δC 146.5; δH 8.68, dd, J = 4.8, 1.5 Hz/δC 151.3; δH 8.25, 
dd, J = 8.7, 2.2 Hz/δC 132.8; δH 7.54, dd, J = 7.9, 4.8 Hz/δC 123.9), two olefinic protons 
(δH 7.11, s/δC 98.7; δH 6.16, s/δC 109.4), one oxymethine proton (δH 4.64, t, J = 8.5 Hz/ 
δC 72.8), two methine protons (δH 3.85, dd, J = 10.6, 4.2 Hz/δC 75.7; δH 1.48, m/δC 40.7), 
two oxymethylene protons (δH 3.75, s (2H)/δC 64.4), six methylene protons (δH 1.98, m 
(2H)/δC 35.2; δH 1.79, m (2H)/δC 22.9; δH 1.70, m (2H)/δC 27.3) and five methyl singlets 
(δH 2.00/δC 20.8; δH 2.00/δC 20.5; δH 1.45/δC 20.1; δH 1.19/δC 23.8; δH 0.84/δC 12.7). 
 Analysis of the 1H, 13C, HSQC and HMBC data (Table 18) revealed the presence 
of the decahydronaphthalene ring system, which was fused with the 2H,5H-pyrano[4,3-
b]pyran-5-one through C-5 (δC 146.1) and C-6 (δC 85.9) whereas the 3-monosubstituted 
pyridine ring was also connected to the pyranone ring through C-6’ (δC 156.8) of the 
former and C-3’’ (δC 126.9) of the later, similar to pyripyropene S.  
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On the other hand, there were only two acetoxyl groups (δC 170.1; CO, δC 20.5; 
CH3/ δH 2.00, s and δC 169.8; CO, δC 20.8; CH3/ δH 2.00, s) in 379. That the acetoxyl 
groups were on C-1 and C-11 was supported by the similarity of the chemical shift values 
of H-1 (δH 4.64, t, J = 8.5 Hz) and H-11 (δH 3.75, s) to those of pyripyropene S. That the 
substituent on C-7 of 379 was a hydroxyl group instead of an acetoxyl group was 
evidenced by the chemical shift value of H-7 (δH 3.85, dd, J = 10.6, 4.2 Hz), which was 
about 1.4 ppm less than that of pyripyropene S, as well as by the chemical shift value of 
C-7 (δC 75.5), which was 2.00 ppm lower than that of C-7 of pyripyropene S. Moreover, 
the chemical shift values of C-6 (δC 85.9) and C-8 (δC 27.3) of 379 were ca. 2.00 and 3.00 
ppm, respectively, higher than those of pyripyropene S. As H-7 appeared as a double 
doublet with a diaxial coupling constant of 10.6 Hz and an axial-equatorial coupling 
constant of 4.2 Hz, the position of the hydroxyl group on C-7 was β. Therefore, 379 is 7-
deacetylpyripyropene S. The stereochemistry of 379 was confirmed by the NOESY 
experiments, which exhibited correlations from CH3-15 to CH3-12, but not to H-1 and H-
9, from CH3-12 to CH3-14 and CH3-15, and from CH3-14 to CH3-12, but not to H-7 (Table 
18). Thus, the stereochemistry of 379 is the same as that of pyripyropene S (378), i.e. 
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1S*, 4R*, 6S*, 7S*, 9R*, 10R*. Since 379 is a new compound, it was named pyripyropene 
T. 
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Table 18. 1H and 13C NMR (CDCl3, 500.13 MHz and 125.8 MHz), and HMBC assignment 
for pyripyropene T (379). 
Position δC, Type δH, (J in Hz)  COSY HMBC NOESY 
1 72.8, CH 4.64, t (8.5) H-2 - - 
2 22.9, CH2 1.79, m H-1, 3 - - 
3 35.2, CH2 1.98, m H-2 - - 
4 38.4, C - - - - 
5 146.1, C - - - - 
6 85.9, C - - - - 
7 75.7, CH 3.85, dd (10.6, 4.2) H-8 - - 
8 27.3, CH2 1.70, m H-7, 9 - - 
9 40.7, CH 1.48, m H-8 - - 
10 40.3, C - - - - 
11 64.4, CH2 3.75, s - C-1, 9 C-12 
12 23.8, CH3 1.19, s - C-3, 4, 5 H-14, 15 
13 109.4, CH 6.16, s - C-4, 6 - 
14 20.1, CH3 1.45, s - C-5, 6, 7 C-13 
15 12.7, CH3 0.84, s - C-1, 9, 10, 11 H-11, 12 
2’ 161.6, C - - - - 
3’ 100.3, C - - - - 
4’ 160.2, C - - - - 
5’ 98.7, CH 7.11, s - C-3’, 4’, 6’, 3’’ - 
6’ 156.8, C - - - - 
2’’ 146.5, CH 9.00, d (1.7) H-4’’, 6’’ C-3’’, 6’’ H-5’ 
3’’ 126.9, C - - - - 
4’’ 132.8, CH 8.25, dd (8.7, 2.2) H-2’’, 5’’ - H-5’, 5’’ 
5’’ 123.9, CH 7.54, dd (7.9, 4.8) H-4’’, 6’’ C-3’’ H-4’’, 6’’ 
6’’ 151.3, CH 8.68, dd (4.8, 1.5) H-2’’, 5’’ C-2’’, 4’’ H-5’’ 
OAc-1 170.1, CO - - - - 
 20.5, CH3 2.00, s - CO (OAc-1) - 
OAc-11 169.8, CO - - - - 
 20.8, CH3 2.00, s - CO (OAc-11) - 
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4.2.14) Similanamide (380) 
 
 Compound 380 was isolated as pale yellow viscous mass and its molecular 
formula C34H52N6O6 was deduced from the (+)-HRESIMS m/z 641.4053 [M+H]+, 
indicating twelve degrees of unsaturation. The IR spectrum exhibited absorption bands 
for amine (3335 cm-1), ketone carbonyl (1682, 1644 cm-1) and aromatic (1594, 1519       
cm-1). 
 The 13C NMR spectrum (Table 19) exhibited thirty-four carbon signals which can 
be classified, according to DEPTs and HSQC spectra, as six amide carbonyls (δC 174.3, 
174.2, 170.7, 170.2, 169.3 and 168.9), two quaternary sp2 (δC 137.0 and 122.7), four 
methine sp2 (δC 131.7, 127.1, 123.9 and 123.4), eight methine sp3 (δC 65.1, 61.4, 59.3, 
50.9, 47.9, 29.9, 25.5 and 24.4), six methylene sp3 (δC 52.5, 37.8, 36.2, 28.1, 27.4 and 
24.5) and eight methyl (δC 37.9, 23.3, 23.2, 22.1, 21.7, 19.8, 18.4 and 16.2) carbons. 
 The 1H NMR spectrum (Table 19), together with the HSQC spectrum, displayed 
the presence of, besides four amide protons at δH 9.41, brs; 8.02, d, J = 7.9 Hz; 7.64, d, 
J = 9.7 Hz; 7.43, d, J = 7.5 Hz, and four aromatic protons of the 1,2-disubstitued benzene 
ring at δH 8.29, d, J = 8.3 Hz (δC 123.9); δH 7.20, dd, J = 7.7, 1.5 Hz (δC 127.1); δH 7.47, 
ddd, J = 7.9, 7.9, 1.6 Hz (δC 131.7); δH 7.13, ddd, J = 7.9, 7.9, 1.0 Hz (23.4), eight methine 
protons at δH 4.82, dd, J = 7.4, 3.3 Hz (δC 47.9); δH 4.57, m (δC 50.9); δH 3.71, dd, J = 
11.3, 2.5 Hz (δC 61.4); δH 3.49, dd, J = 9.0, 4.7 Hz (δC 65.1); δH 2.68, m (δC 29.9); δH 1.77, 
m (δC 24.4); δH 1.65, m (δC 25.5), twelve methylene protons at δH 4.14, dd, J = 14.4, 2.4 
Hz (δC 52.5); δH 3.16, dd, J = 13.2, 2.3 Hz(δC 52.5); δH 2.20, m (δC 37.8); δH 2.07, m (2H; 
δC 24.5); δH 2.05, m (2H; δC 28.1); δH 2.02, m (δC 36.2); δH 1.95, m (δC 37.8); δH 1.77, m 
(δC 36.2); δH 1.56, m (2H; δC 27.4), one methyl singlet at δH 3.20 (δC 37.9), and seven 
methyl doublets at δH 1.29, J = 7.3 Hz (δC 18.4); δH 1.06, J = 6.9 Hz (δC 19.8); δH 0.99, J 
= 6.5 Hz (δC 22.1); δH 0.97, J = 6.5 Hz (δC 23.2); δH 0.97, J = 6.5 Hz (δC 23.3); δH 0.94, J 
= 7.0 Hz (δC 16.2); δH 0.88, J = 6.4 Hz (δC 21.7).   
 The COSY and HMBC spectra (Table 19) indicated the presence of a 1,2-
disubstituted benzene ring. The HMBC spectrum exhibited the correlations from the 
aromatic proton at δH 7.20, dd, J = 7.7, 1.5 Hz (H-3) to the amide carbonyl at δC 170.2 (C-
1), and from the amide proton at δH 9.41, brs (NH) to the carbons at δC 123.9 (C-6) and 
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δC 137.0 (C-7), indicating therefore the presence of the anthranilic acid residue was 
corroborated. 
 
 
 
 The presence of the valine residue was evidenced by the COSY correlations from 
the methine proton at δH 4.32, dd, J = 7.4, 3.3 Hz (H-9; δC 59.3) to the methine proton at 
δH 2.68, m (H-10; δC 29.9) and the amide proton at δH 7.43, d, J = 7.5 Hz (NH), and from 
H-10 to the methyl doublets at δH 1.06, J = 6.9 Hz (H3-11; δC 19.8) and δH 0.94, J = 7.0 
Hz (H3-12; δC 16.2), as well as by the HMBC correlations from H-9 to the amide carbonyl 
at δC 170.7 (C-8), the carbons at δC 29.9 (C-10), δC 19.8 (C-11) and δC 16.2 (C-12), from 
H3-11 to the carbon at δC 59.3 (C-9), C-10 and C-12, from H3-12 to C-9, C-10 and C-11, 
and from NH to C-9 and C-10. 
 
 
 
 That the valine residue was linked to the anthranilic acid residue through the 
carbonyl group of the former and the amino group of the latter was corroborated by the 
HMBC correlation from the brs at δH 9.42 to the carbonyl at δC 170.7 (C-8).  
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 The COSY correlations from the methine proton at δH 4.57, m (H-14; δC 50.9) to 
the methylene protons at δH 2.20, m and 1.77, m (H2-15; δC 36.2), the methine proton at 
δH 1.77, m (H-16; δC 24.4), the methyl doublets at δH 0.97, d, J = 6.5 Hz (H3-17; δC 23.3) 
and 0.88, d, J = 6.4 Hz (H3-18; δC 21.7) and the amide proton at δH 8.02, d, J = 7.9 Hz 
(NH), together with the HMBC correlations from H3-17 to the carbons at δC 36.2 (C-15), 
δC 24.4 (C-16) and δC 21.7 (C-18), from H3-18 to C-15, C-16 and the methyl carbon at δC 
23.3 (C-17), and from NH (δH 8.02, d, J = 7.9 Hz) to the amide carbonyl at δC 174.2 (C-
13), indicated the presence of the leucine residue. 
 
 
 
 That the leucine residue was linked to the valine residue through the carbonyl 
group of the former and the amino group of the latter was supported by the HMBC 
correlation from NH (δH 7.43, d, J = 7.5 Hz) to C-13 (δC 174.2). 
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 The presence of the alanine residue was substantiated by the COSY correlations 
from the methine proton at δH 4.82, dd, J = 9.7, 7.3 Hz (H-20; δC 47.9) to the methyl 
doublet at δH 1.29, J = 7.3 Hz (H3-21; δC 18.4) and the amide proton at δH 7.64, d, J = 7.9 
Hz (NH), as well as by the HMBC correlations from H-20 to the amide carbonyl at δC 
174.3 (C-19) and the methyl carbon at δC 18.4 (C-21), and from H3-21 to C-19 and the 
carbon at δC 47.9 (C-20).  
 
 
 
 That the alanine residue was linked to the leucine residue through the carbonyl 
group of the former and the amino group of the latter was evidenced by the HMBC 
correlation from the NH (δH 8.02, d, J = 7.9 Hz) to C-19. 
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 As the COSY spectrum displayed the correlations of the methylene protons at δH 
2.20, m and 1.95, m (H2-24; δC 37.8) to two methine protons at δH 3.49, dd, J = 9.0, 4.7 
Hz (H-23; δC 65.1) and 1.65, m (H-25; δC 25.5). In turn, H-25 was also correlated to the 
methyl doublets at δH 0.97, J = 6.5 Hz (H3-26; δC 23.2) and 0.99, J = 6.5 Hz (H3-27; δC 
22.1), the presence of a 2-methylbutyl moiety was suggested. This was confirmed by the 
HMBC correlations from H-23 to the carbon at δC 37.8 (C-24), from H3-26 to C-24, the 
carbons at δC 25.5 (C-25) and δC 22.1 (C-27), and from H3-27 to C-24, C-25 and the 
methyl carbon at δC 23.2 (C-26). 
 
 
 
 The HMBC spectrum also exhibited the correlations from H-23 to the amide 
carbonyl at δC 169.3 (C-22) and the methyl carbon at δC 37.9 (C-28), and from the methyl 
singlet at δH 3.20 (H3-28) to the carbon at δC 65.1 (C-23), suggesting the presence of the 
N-methyl leucine moiety. 
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 The HMBC spectrum displayed cross peak from the NH at δH 7,64, d, J = 7.9 Hz 
to C-22, indicating that the alanine residue was linked to the N-methyl leucine residue 
through the amino group of the former and the carbonyl group of the latter. 
 
 
 
 Finally, the presence of pipercolic acid was corroborated by the COSY correlations 
from the methylene protons at δH 2.05, m (H2-31/δC 28.1) to the methine proton at δH 
3.71, dd, J = 11.3, 2.5 Hz (H-30/δC 61.4) and the methylene protons at δH 2.07, m (H2-32/ 
δC 24.5), from H2-32 to the methylene protons at δH 1.56, m (H2-33/δC 27.4), from H2-33 
to H-34α (δH 3.16, dd, J = 13.2, 2.3 Hz), and from H-34α to H-34β (δH 4.14, dd, J = 14.4, 
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2.4 Hz). This was supported by the HMBC correlation from H-30 to the carbonyl at δC 
168.9 (C-29).  
 
 
 
 The HMBC correlation from H3-28 to C-29 indicated that the pipercolic acid was 
linked to the N-methyl leucine through the carbonyl group (δC 168.9) of the former and 
the amino group (δH 3.20, s) of the latter. 
 Since 380 presents twelve degrees of unsaturation, the nitrogen atom of the 
piperidine ring of the pipecolic acid moiety must link to the carbonyl carbon of the 
anthranilic acid residue, forming a cyclic structure. This hypothesis was also supported 
by the HMBC correlation from H-30 to the carbonyl of the anthranilic acid residue (C-1), 
as well as by the NOESY correlations from the NH at δH 9.41, brs (NH; anthranilic acid) 
to H-9 and H3-12, from NH at δH 7.43, d, J = 7.5 Hz (NH; Val) to H-9, H3-11, H3-12 and 
H-14, from NH at δH 8.02, d, J = 7.9 Hz (NH; Leu) to H-14, H-15 and H3-17, from NH at 
δH 7.64, d, J = 7.9 Hz (NH; Ala) to H3-21, H-23, H3-28, from H-3 to H-34β (δH 4.14, dd, J 
= 14.4, 2.4 Hz), and from H-30 to H3-28. Therefore, compound 380 was identified as cyclo 
(anthranilic acid-Val-Leu-Ala-N-methyl-Leu-pipecolic acid). 
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Extensive literature search revealed that the 1H and 13C NMR data of 380 were 
similar to those of the cyclic hexapeptide PF1171C, previously isolated from the 
fermentation of okara by the unidentified ascomycete OK-128 by Kai et al. (2010) and 
later by a total synthesis by Masuda et al. (2014). However, some of their physical 
properties are difference. Compound 380 was isolated as a pale yellow viscous mass 
while PF1171C was reported as a white solid (mp 138 – 140 °C) (Masuda et al., 2014). 
Moreover, the value of optical rotation of 380 was quite different from that of PF1171C 
(Kai et al., 2010; Masuda et al., 2014). This observation suggested that 380 and PF1171C 
could be diastereomers. 
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Table 19. 1H and 13C NMR (CDCl3, 500.13 MHz and 125.8 MHz) and HMBC assignment of similanamide (380). 
 Position δC, Type δH, (J in Hz) COSY HMBC NOESY 
Anthranilic acid 1 170.2, CO - - - - 
2 122.7, C - - - - 
3 127.1, CH 7.20, dd (7.7, 1.5) H-4 C-1, 5, 7 H-34 
4 123.4, CH 7.13, ddd (7.9, 7.9, 1.0) H-3, 5 C-2, 6 - 
5 131.7, CH 7.47, ddd (7.9, 7.9, 1.6) H-4, 6 C-3, 7 - 
6 123.9, CH 8.29, d (8.3) H-5 C-2, 4 H-12 
7 137.0, C - - - - 
NH - 9.41, brs - C-6, 7, 8 NH (Val), H-9, 12 
Val 8 170.7, CO - - - - 
9 59.3, CH 4.32, dd (7.4, 3.3) H-10, NH C-8, 10, 11, 12 H-10, 11 
10 29.9, CH 2.68, m H-9, 11, 12 - H-9, 11, 12 
11 19.8, CH3 1.06, d (6.9) H-10 C-9, 10, 12 - 
12 16.2, CH3 0.94, d (7.0) H-10 C-9, 10, 11 - 
NH - 7.43, d (7.5) H-9 C-9, 10, 13 H-9, 11, 12, 14 
Leu 13 174.2, CO - - - - 
14 50.9, CH 4.57, m H-15, NH - H-15, 18 
15 36.2, CH2 2.02, m; 1.77, m H-14, 16 - - 
16 24.4, CH 1.77, m H-15, 17, 18 - - 
17 23.3, CH3 0.97, d (6.5) H-16 C-15, 16, 18 - 
18 21.7, CH3 0.88, d (6.4) H-16 C-15, 16, 17 - 
NH - 8.02, d (7.9) H-14 C-13, 19 NH (Ala), H-14, 15, 17 
Ala 19 174.3, CO - - - - 
20 47.9, CH 4.82, dd (9.7, 7.3) H-21, NH C-19, 21 H-21 
21 18.4, CH3 1.29, d (7.3) H-20 C-19, 20 - 
NH - 7.64, d (7.9) H-20 C-22 H-21, 23, 28 
N-Me Leu 22 169.3, CO  - - - 
23 65.1, CH 3.49, dd (9.0, 4.7) H-24 C-22, 24, 28, 29 - 
24 37.8, CH2 1.95, m; 2.20, m H-23, 25 - - 
25 25.5, CH 1.65, m H-24, 26, 27 - - 
26 23.2, CH3 0.97, d (6.5) H-25 C-24, 25, 27 - 
27 22.1, CH3 0.99, d (6.5) H-25 C-24, 25, 26 - 
28 37.9, CH3 3.20, s - C-23, 29 C-23, 30, 32, 34α 
Pipecolic acid 29 168.9, CO - - - - 
30 61.4, CH 3.71, dd (11.3, 2.5) H-31 C-1, 29 H-34α 
31 28.1, CH2 2.05, m H-30, 32 - - 
32 24.5, CH2 2.07, m H-31, 33 - - 
33 27.4, CH2 1.56, m H-32, 34 - - 
34α 52.5, CH2 3.16, dd (13.2, 2.3) H-33 - H-34β 
34β - 4.14, dd (14.4, 2.4) - - H-34α 
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In order to prove this hypothesis, we have attempted to determine the 
stereochemistry of the amino acid residues of 380 by analysis of its acid hydrolysate, 
using the appropriated D- and L- amino acids standards, by chiral HPLC analysis. The 
enantioseparations of the amino acid standards were performed with the Chirobiotic T 
column under reversed-phase elution conditions. The co-injection of the acidic 
hydrolysate of 380 and the DL-amino acids standards were performed for HPLC analysis 
at a flow rate of 1 mL/min. The result revealed that 380 is a cyclo (anthranilic acid-L-Val-
D-Leu-L-Ala-N-methyl-L-Leu-D-pipercolic acid). The chromatogram and the chiral HPLC 
analysis of the acidic hydrolysate of 380 were shown in Figure 56 and Table 20, 
respectively. 
 
 
 
Figure 56. Chromatogram of the acidic hydrolysate of similanamide (380). Chromatographic 
conditions: column, Chirobiotic T; mobile phase, CH3OH:H2O:CH3CO2H (70:30:0.02 v/v/v); flow 
rate, 0.5 mL/min; detection, 210 nm. 
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Table 20. Chiral HPLC analysis of the acidic hydrolysate of similanamide (380)*. 
 Retention Time (min) 
L-valine 6.60 
D-valine 8.32 
L-alanine 7.16 
D-alanine 9.36 
L-leucine 6.78 
D-leucine 9.67 
L-pipecolic acid 8.68 
D-pipecolic acid 14.67 
N-methyl-L-leucine 8.09 
Acidic hydrolysate of similanamide (380) 6.59, 7.20, 8.09, 8.83, 9.67, 10.57, 14.69 
Acidic hydrolysate of 380 + DL-valine (coinjection) 6.61, 7.31, 8.30, 8.10, 8.84, 9.70, 10.50, 14.95 
Acidic hydrolysate of 380 + DL-alanine (coinjection) 6.59, 7.19, 8.04, 8.81, 9.37, 9.70, 10.50, 14.90 
Acidic hydrolysate of 380 + DL-leucine (coinjection) 6.60, 6.76, 7.26, 8.04, 8.83, 9.67, 10.54, 15.02 
Acidic hydrolysate of 380 + DL-pipecolic acid (coinjection) 6.58, 7.20, 8.09, 8.64, 8.84, 9.77, 10.64, 14.64 
Acidic hydrolysate of 380 + N-methyl-L-leucine (coinjection) 6.59, 7.20, 8.09, 8.83, 9.67, 10.57, 14.69 
* Chromatographic conditions: column, Chirobiotic T; mobile phase, methanol:water:acetic acid (70:30:0.02 v/v/v); flow 
rate, 0.5 mL/min; detection, 210 nm. 
 
The results showed that although the amino acid sequence of 380 is the same as 
that of PF1171C, the stereochemistry of its amino acid constituents is different from that 
of the amino acids constituents of PF1171C. While 380 contains L-Ala, D-Leu, L-Val, and 
D-pipecolic acid, PF1171C contains D-Ala, L-Leu, D-Val, and L-pipecolic acid. Therefore, 
compound 380 is a new compound, and was named similanamide. 
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                  380              PF1171C 
 
Figure 57. Structures of similanamide (380) and PF1171C. 
 
 So far, only few cyclic hexapeptides have been reported from marine-derived 
microorganisms. Zheng et al. (2009) have isolated two new antifungal cyclo-
hexapeptides, sclerotides A and B, from the culture nutrient-limited hypersaline medium 
of the marine-derived halotolerant Aspergillus sclerotiorum PT06-1. Two new cyclic 
hexapeptides, nocardiamides A and B, were isolated from the culture broth of the marine-
derived actinomycete Nocardiopsis sp. CNX037 by Wu et al. (2013). Cai et al. (2013), 
described isolation of hytramycins A and B, two anti-Mycobacterium tuberculosis 
cyclohexapeptides, from Streptomyces hygroscopicus strain ECUM 14046. Desotamides 
B-D, three new antibacterial cyclohexapeptides, were isolated from the deep South China 
sea-derived Streptomyces scopuliridis SCSIO ZJ46 (Song et al., 2014) while Peng, Gao, 
Zhang, et al. (2014) isolated versicotide C, a new and first natural cyclohexapeptide 
containing two anthranilic acids, from the marine-derived fungus Aspergillus versicolor 
ZLN-60. To the best our knowledge, compound 380 is the first cyclopeptide containing D-
pipecolic acid residue ever isolated from marine-derived fungi.  
 
 
 
 
 148 
 
 CHAPTER IV: RESULTS AND DISCUSSION 
4.3) The Marine-Derived Fungus Neosartorya quadricincta KUFA 0081 
 
 Fractionation and purification EtOAc extract of the culture of the marine sponge-
associated fungus N. quadricincta KUFA 0081 resulted in isolation of two new 
pentaketides, quadricintones A (381) and C (387), and seven new benzoic acid 
derivatives, quadricintapyrans A (382) and B (383), quadricintoxepine (384), 
quadricinctones B (386) and D (390) and quadricintafurans A (388) and B (389), together 
with the previously reported, 2,3-dihydro-6-hydroxy-2,2-dimethyl-4H-1-benzopyran-4-one 
(385). The structures of isolated metabolites are shown in Figure 58. 
 
         
                381               382  R = H             384  
            383  R = Ac 
 
    
      385  R = H     387                 388  R = H 
       386  R =                                         389  R = OH 
 
 
 
390 
 
Figure 58. Structures of the compounds isolated from the culture of marine sponge-associated 
fungus Neosartorya quadricincta KUFA 0081. 
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4.3.1) Quadricinctone A (381) 
 
Compound 381 was isolated as a white crystal (mp 176 – 177 °C), and its 
molecular formula C14H18O5 was determined based on the (+)-HRESIMS m/z 267.1332 
[M+H]+, indicating six degrees of unsaturation. The IR spectrum showed absorption 
bands for hydroxyl (3455 cm-1), conjugated ester carbonyl (1723 cm-1) and aromatic 
(1612, 1596 cm-1) groups. 
The 13C NMR spectrum (Table 21) displayed fourteen carbon signals which can 
be classified, based on DEPTs and HSQC spectra, as one conjugated ester carbonyl  (δC 
168.2), two oxyquaternary sp2 (δC 164.6 and 158.3), three quaternary sp2 (δC 152.8, 111.7 
and 105.3), one methine sp2 (δC 94.5), one oxyquaternary sp3 (δC 88.8), one oxymethine 
sp3 (δC 70.8), two methoxyl (δC 56.1 and 56.0), and three methyl (δC 21.5, 17.8 and 11.2) 
carbons. 
 The 1H NMR spectrum (Table 21), together with the HSQC spectrum, exhibited, 
besides a broad singlet of the hydroxyl proton at δH 2.15, a singlet of the aromatic proton 
at δH 6.41 (δC 94.5), a doublet of methine proton at δH 4.22, J = 6.4 Hz (δC 70.8), two 
singlets of two methoxy groups at δH 3.97 (δC 56.0) and 3.92 (δC 56.1) , two methyl 
singlets at δH 2.12 (δC 11.2) and 1.76 (δC 21.5), and one methyl doublet at δH 0.87, J = 
6.4 Hz (δC 17.8). 
Analysis 1H and 13C NMR data revealed the presence of a pentasubstitued 
benzene ring with the methoxyl groups at  δH 3.92, s (δC 56.1) and δH 3.97, s (δC 56.0), 
and a methyl group at δH 2.12, s (δC 11.2) on C-5 (δC 164.6), C-7 (δC 158.3) and C-4 (δC 
111.7), respectively, as confirmed by the HMBC correlations from the proton singlet at δH 
6.41 (H-6) to C-4, C-5 and C-7, from the methyl singlet at δH 2.12 (H3-8) to the carbon at 
δC 152.8 (C-3a), C-4 and C-5, from the methoxyl singlets at δH 3.92 (OCH3-5) and δH 
3.97, s (OCH3-7) to C-5 and C-7, respectively, as well as the NOESY correlations from 
H-6 to OCH3-5 and OCH3-7.   
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 That the 2,4-dimethoxy-1-methylbenzene was fused with 5-methyldihydrofuran-
2(3H)-one to form a 5,7-dimethoxy-3,4-dimethyl-2-benzofuran-1(3H)-one ring system 
was supported by the HMBC correlation from H-6 to the conjugated carbonyl at δC 168.2 
(C-1) as well as from the methyl singlet at δH 1.76 (H3-9) to C-3a, the carbons at δC 88.8 
(C-3) as well as the NOESY correlations between H3-8 and H3-9.  
 
  
 
 
 That another substituent on C-3 was 1-hydroxyethyl group was evidenced by the 
COSY correlations from the doublet at δH 4.22 (J = 6.4 Hz; H-10) to the methyl doublet at 
δH 0.87 (J = 6.4 Hz, H3-11), as well as by the HMBC correlations from H3-9 and H3-11 to 
C-10 (δC 70.8), and from H-10 to C-11 (δC 15.8). This was also supported by NOESY 
correlations from H3-8 to H3-9, H-10, from H3-9 to H-10, and from H3-11 to H-10 and OH-
10 (δH 2.15, br). Therefore, the structure of 381 was identified as 3-(1-hydroxyethyl)-5,7-
dimethoxy-3,4-dimethyl-2-benzofurn-1(3H)-one. 
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 In order to assign stereochemistry of 381, X-ray analysis was carried out, using a 
Gemini PX Ultra equipped with CuKα radiation to collect the diffraction data. The ORTEP 
view of 381 (Figure 59) showed clearly that the absolute configurations of C-3 and C-10 
are 3R and 10S, respectively. The literature survey revealed that 381 is a new compound, 
so we have named it quadricinctone A.  
 
 
Figure 59. ORTEP diagram of quadricinctone A (381). 
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Table 21. 1H and 13C NMR (CDCl3, 300.13 MHz and 75.4 MHz), HMBC and NOESY 
assignments for quadricinctone A (381). 
Position δC, type δH, (J in Hz) COSY HMBC NOESY 
1 168.2, CO - - - - 
3 88.8, C - - - - 
3a 152.8, C - - - - 
4 111.7, C - - - - 
5 164.6, C - - - - 
6 94.5, CH 6.41, s CH3-8, OMe-5, 7 C-1, 4, 5, 7, 7a OMe-5, 7 
7 158.3, C - - - - 
7a 105.3, C - - - - 
8 11.2, CH3 2.12, s H-6 C-3a, 4, 5, 7 H-9, 10 
9 21.5, CH3 1.76, s - C-3, 3a, 10 H-8, 9, 10 
10 70.8, CH 4.22, d (6.4) CH3-11 C-11 H-8, 9, 11 
11 17.8, CH3 0.87, d (6.4) H-10 C-3, 10 H-10 
OCH3-5 56.1 CH3 3.92, s H-6 C-5 H-6 
OCH3-7 56.0, CH3 3.97, s - C-7 H-6 
OH-10 - 2.15, brs - - H-11 
 
 
4.3.2) Quadricinctapyran A (382) 
  
Compound 382 was isolated as a white crystal (mp 147 – 148 °C), and its 
molecular formula C12H12O4 was established on the basis of the (+)-HRESIMS m/z 
221.0814 [M+H]+, indicating seven degrees of unsaturation. The IR spectrum exhibited 
absorption bands for hydroxyl (3447 cm-1), conjugated carbonyl (1696 cm-1), aromatic 
(1609 cm-1) and olefin (1647 cm-1) groups. 
 The 13C NMR spectrum (Table 22) exhibited twelve carbon signals which can be 
categorized, based on DEPTs and HSQC spectra, into one conjugated carboxyl carbonyl 
(δC 167.0), one oxyquaternary sp2 (δC 156.8), two quaternary sp2 (δC 123.0 and 120.5), 
five methine sp2 (δC 139.8, 128.6, 127.9, 122.8 and 115.7), oxyquaternary sp3 (δC 80.5), 
one one methylene sp3 (δC 67.1) and one methyl (δC 23.3) carbons. 
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 The 1H NMR spectrum, in conjunction with the HSQC spectrum (Table 22) 
exhibited the presence of, besides two broad singlets of the hydroxyl protons at δH 12.59 
and 5.07, three aromatic protons of 1,2,4-trisubstitued benzene ring at δH 7.69, dd, J = 
8.4, 2.1 Hz (δC 139.8), 7.65, d, J = 2.1 Hz (δC 127.9) and 6.79, d, J = 8.4 Hz (δC 115.7), 
two olefinic protons of a cis-double bond at δH 6.56, d, J = 10.0 Hz (δC 122.8) and 5.74, 
d, J = 10.0 Hz (δC 128.6), a singlet of two methylene protons at δH 3.54 (δC 67.1), and a 
methyl singlet at δH 1.31 (δC 23.3). 
 The presence of the 1,2,4-trisubstitued benzene ring and the cis-double bond were 
confirmed by the COSY correlations from the olefinic proton at δH 5.74, d, J = 10.0 Hz (H-
3) to another olefinic proton at δH 6.56, d, J = 10.0 Hz (H-4), and from the aromatic proton 
at δH 7.69, dd, J = 8.4, 2.1 Hz (H-7) to the other two aromatic protons at δH 7.65, d, J = 
2.1 Hz (H-5) and δH 6.79, d, J = 8.4 Hz (H-8). The HMBC spectrum displayed correlations 
from H-3 to the carbons at δC 80.5 (C-2), δC 120.5 (C-4a) and δC 127.9 (C-5), from H-4 to 
C-2, C-5 and the carbon at δC 156.8 (C-8a), from H-5 to the carbons at δC 122.8 (C-4), 
C-8a and δC 167.0 (C-11), from H-7 to C-5, C-8a and C-11, and from H-8 to C-4a, the 
carbon at δC 123.0 (C-6) and C-8a, indicating that the 1,2,4-trisubstitued benzene ring 
and the cis-double bond were part of the 2H-chromene-6-carboxylic acid moiety.  
 
 
 
 As the HMBC spectrum also showed correlations from H-3 to the carbons at δC 
23.3 (C-9) and δC 67.1 (C-10), from the methyl singlet at δH 1.31 (H3-9) to C-2, the carbon 
at δC 128.6 (C-3) and C-10, and from the methylene singlet at δH 3.45 (H2-10) to C-2, C-
3 and C-9, the methyl and hydroxymethyl groups were on C-2. In addition, the NOESY 
correlations from H-4 to H-3 and H-5, from H-7 to H-8 and H3-9, and from H3-9 to H2-10 
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confirmed the proposed planar structure. Therefore, 382 was identified as 2-
(hydroxymethyl)-2-methyl-2H-chromene-6-carboxylic acid.  
 
 
 
The stereochemistry of this compound was provided by X-ray analysis. The ORTEP view 
shown in Figure 56 revealed that the absolute configuration of C-2 is S. Since 382 has 
not been previously reported, it was named quadricinctapyran A. 
 
 
Figure 60. ORTEP diagram of quadricinctapyran A (382). 
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Table 22. 1H and 13C NMR (DMSO, 300.13 MHz and 75.4 MHz), HMBC and NOESY 
assignments for quadricinctapyran A (382). 
Position δC, type δH, (J in Hz) COSY HMBC NOESY 
2 80.5, C - - - - 
3 128.6, CH 5.74, d (10.0) H-4 C-2, 4a, 5, 9, 10 H-4 
4 122.8, CH 6.56, d (10.0) H-3 C-2, 5, 8a H-3, 5 
4a 120.5, C - - - - 
5 127.9, CH 7.65, d (2.1) H-7 C-4, 8a, 11 H-4 
6 123.0, C - - - - 
7 139.8, CH 7.69, dd (8.4, 2.1) H-5, 8 C-5, 8a, 11 H-8, H3-9 
8 115.7, CH 6.79, d (8.4) H-7 C-4a, 6, 8a H-7 
8a 156.8, C - - - - 
9 23.3, CH3 1.31, s - C-2, 3, 10 H-7, H2-10 
10 67.1, CH2 3.45, s - C-2, 3, 9 H3-9 
11 167.0, CO - - - - 
OH-10 - 5.07, brs - - - 
OH-11 - 12.59, brs - - - 
 
4.3.3) Quadricinctapyran B (383) 
 
 Compound 383 was isolated as a white solid (mp 118 – 119 °C), and its molecular 
formula C14H14O5 was established based on the (+)-HRESIMS m/z 263.0971, indicating 
eight degrees of unsaturation. 
 The general feature of the 1H and 13C NMR spectra of 383 closely resembled those 
of 382, except for an additional carbonyl carbon at δC 170.8 and a methyl singlet at δH 
1.98 (δC 20.7), characteristic of the acetoxyl group. The presence of the acetoxyl was also 
confirmed by the HMBC correlation from the methyl singlet at δH 1.98 to the carbonyl 
carbon at δC 170.8. 
 The 13C NMR spectrum (Table 23) exhibited fourteen carbon signals which can be 
categorized, according to DEPTs and HSQC spectra, as one conjugated carboxyl 
carbonyl (δC 171.7), one ester carbonyl (δC 170.8), one oxyquaternary sp2 (δC 157.8), two 
quaternary sp2 (δC 122.0 and 120.2), five methine sp2 (δC 132.2, 128.9, 126.2, 124.3 and 
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116.1), one oxyquaternary sp3 (δC 78.5), one oxymethylene sp3 (δC 68.8) and two methyl 
(δC 24.0 and 20.7) carbons. 
 The 1H NMR spectrum, together with the HSQC spectrum (Table 23), revealed the 
presence of , besides three aromatic protons of 1,2,4-trisubstituted benzene ring at δH 
7.90, dd, J = 8.5, 2.1 Hz (δC 132.2), δH 7.75, d, J = 2.1 Hz (δC 128.9) and δH 6.83, d, J = 
8.5 Hz (δC 116.1), two doublets of two protons of the cis-double bond at δH 6.51, J = 10.0 
Hz (δC 124.3) and δH 5.59, J = 10.0 Hz (δC 126.2), two doublets of the mutually coupled 
methylene protons at δH 4.24, J = 11.7 Hz and δH 4.13, J = 11.7 Hz (δC 68.8), two methyl 
singlets at δH 1.98 (δC 20.7) and δH 1.48 (δC 24.0), and one broad signal of the hydroxyl 
proton at δH 12.79. 
 That the acetoxyl group was on C-10 (δC 68.8) was corroborated by the HMBC 
correlations from the mutually coupled oxymethylene protons at δH 4.24, d, J = 11.7 Hz 
and δH 4.13, d, J = 11.7 Hz (H2-10) to the carbonyl of the acetoxyl group at δC 170.8 (CO; 
OAc-10).This hypothesis was also supported by the chemical shift values of the 
oxymethylene protons (H2-10) which were about 0.7 ppm higher than those of H2-10 in 
382. Therefore, compound 383 was identified as 2-[(acetyloxy)methyl]-2-methyl-2H-
chromene-6-carboxylic acid. 
 
 
 
 
 Since 383 could not obtained as a suitable crystal, absoluted configuration of its 
stereogenic carbon (C-2) cannot be determined by X-ray analysis. However, 383 is the 
acetate derivative of 382, it was speculated that the absolute configuration of its C-2 must 
be the same as that of C-2 of 382. This hypothesis was also supported by the fact that   
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H-8 (δH 6.38, d, J = 8.5 Hz) exhibited the NOESY correlation to CH3-9 and not to H2-10, 
similar to what was observed in 382. Moreover, acid hydrolysis of 383 also give the 
product whose 1H and 13C NMR data and optical rotation are the same as those of 382. 
Since it has never been previously reported, it wan named quadricinctapyran B. 
 
Table 23. 1H and 13C NMR (DMSO, 300.13 MHz and 75.4 MHz), HMBC and NOESY 
assignments for quadricinctapyran B (383). 
Position δC, type δH, (J in Hz) COSY HMBC NOESY 
2 75.8, C - - - - 
3 126.2, CH 5.59, d (10.0) H-4 C-2, 4a, 10 H-4, H3-9, H2-10 
4 124.3, CH 6.51, d (10.0) H-3 C-2, 5, 8a H-3, 5 
4a 120.2, C - - - - 
5 128.9, CH 7.75, d (2.1) H-7 C-4, 7, 8a, 11 H-4, 7 
6 122.0, C - - - - 
7 132.2, CH 7.90, dd (8.5, 2.1) H-5, 8 C-5, 8a, 11 H-5, 8 
8 116.1, CH 6.83, d (8.5) H-7 C-4a, 6, 8a H-7, H3-9 
8a 157.8, C - - - - 
9 24.0, CH3 1.48, s - C-2, 3, 10 H-3, 8, H2-10 
10 68.8, CH2 4.24, d (11.7) H-10 C-2, 3, 9 
CO (OAc-10) 
H-3, H3-9,   
H3(OAc-10) 
  4.13, d (11.7) H-10 C-2, 3, 9 
CO (OAc-10) 
H-3, H3-9,   
H3(OAc-10) 
11 171.7, CO - - - - 
OH-11 - 12.79, br - - - 
OAc-10 170.8, CO - - - - 
 20.7, CH3 1.98, s - CO (OAc-10) H2-10 
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4.3.4) Quadricinctoxepine (384) 
 
 Compound 384 was isolated as a white solid (mp 189 – 191 °C), and its molecular 
formula C12H12O4 was determined based on the (+)-HRESIMS 221.0819 [M+H]+, 
indicating seven degrees of unsaturation. 
 As the molecular formula of 384 is C12H12O4, it is an isomer of 384. Moreover, the 
general features of 1H and 13C NMR spectra of 384 resembled those of 382, but the 
chemical shift values of some of the protons and carbons were slightly different. 
 The 13C NMR spectrum (Table 24) exhibited twelve carbon signals which can be 
classified, according to the DEPTs and HSQC spectra, into one conjugated carboxyl 
carbonyl (δC 166.7), one oxyquaternary sp2 (δC 161.2), two quaternary sp2 (δC 125.3 and 
125.0), five methine sp2 (δC 139.5, 134.5, 129.8, 123.5 and 119.8), one oxymethylene sp3 
(δC 77.0), one oxyquaternary sp3 (δC 70.7) and one methyl (δC 26.1) carbons. 
 The 1H NMR spectrum, in combination with the HSQC spectrum (Table 24),  
exhibited, besides two broad singlets of two hydroxyl protons at δH 12.79 and 3.39, three 
aromatic protons of a 1,2,4-trisubstituted benzene ring at δH 7.89, d, J = 2.1 Hz (δC 134.5), 
δH 7.74, dd, J = 8.4, 2.1 Hz (δC 129.8) and δH 7.05, d, J = 8.4 Hz (δC 119.8), two olefinic 
protons of a cis-double bond at δH 6.31, d, J = 12.0 Hz (δC 123.5) and δH 5.95, dd, J = 
12.0, 1.2 Hz (δC 139.5), one pair of geminally-coupled methylene protons at δH 4.02, dd, 
J = 11.1, 1.6 Hz and 3.84, d, J = 11.1 Hz (δC 77.0) and one methyl singlet at δH 1.26 (δC 
26.1). 
 The HMBC spectrum exhibited the correlations from the olefinic proton at δH 5.59, 
dd, J = 12.0, 1.2 Hz (H-4) to the carbon at δC 125.0 (C-5a), from another olefinic proton 
at δH 6.31, d, J = 12.0 Hz (H-5) to C-5a, the carbons at δC 134.5 (C-6) and δC 161.2 (C-
9a), and from the aromatic proton at δH 7.89, d, J = 2.1 Hz (H-6) to C-5, the carbons at 
δC 129.8 (C-8), C-9a and δC 166.7 (C-10), indicating that the cis-double bond was on C-
5a and the carboxylic acid group was on C-7. In contrast to 382, the HMBC spectrum of 
384 displayed the correlations from the mutually coupled methylene protons at δH 4.02, 
dd, J = 11.1, 1.6 Hz and δH 3.84, d, J = 11.1 Hz (H2-2) to not only the carbon at δC 139.5 
(C-4), but also to C-9a. Consequently, the benzoic acid moiety was fused with the 2,3,6,7-
tetrahydrooxepine ring through C-5a and C-9a. 
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 Since the HMBC spectrum showed cross peaks from the methyl singlet at δH 1.26 
(H3-11) to the carbons at δC 77.0 (C-2), δC 70.7 (C-3) and C-4, as well as from H2-2 to C-
3 and the methyl carbon at δC 26.1 (C-11), the methyl and hydroxyl groups were on C-3. 
This was also supported by the NOESY correlations from H3-11 to the hydroxyl proton at 
δH 3.39, brs (OH-3), H2-2 and H-4. Thus, 384 was identified as 3-hydroxy-3-methyl-2,3-
dihydro-1-benzoxepine-7-carboxylic acid. Literature survey revealed that this compound 
is a new compound, thus it was named quadricinctoxepine. 
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Table 24. 1H and 13C NMR (DMSO, 300.13 MHz and 75.4 MHz), HMBC and NOESY 
assignments for quadricinctoxepine (384). 
Position δC, type δH, (J in Hz) COSY HMBC NOESY 
2α 77.0, CH2 3.84, d (11.1) H-2β C-3, 4, 9a, 11 H-2β, 4 (w), 11 (w) 
2β  4.02, dd (11.1, 1.6) H-2α C-3, 4, 9a, 11 H-2α, 4 (w), 11 (str) 
3 70.7, C - - - - 
4 139.5, CH 5.95, dd (12.0, 1.2) H-5 C-2, 5a H-2α(w), 5, 9(w), 11 
5 123.5, CH 6.31, d (12.0) H-4 C-3, 5a, 6, 9a H-4, 6 (str) 
5a 125.0, C - - - - 
6 134.5, CH 7.89, d (2.1) H-8 C-5, 8, 9a, 10 H-5 
7 125.3, C - - - - 
8 129.8, CH 7.74, dd (8.4, 2.1 H-6, 9 C-6, 9a H-9 
9 119.8, CH 7.05, d (8.4) H-8 C-5a, 7, 9a H-8 
9a 161.2, C - - - - 
10 166.7, CO - - - - 
11 26.1, CH3 1.26, s - C-2, 3, 4 H-2α (w), 2β (str) 
OH-3 - 3.39, brs - - H-4, 11 
OH-10 - 12.79, brs - - - 
 
Since 384 could not be obtained as a suitable crystal, its stereochemistry could not 
be determined by X-ray analysis. Therefore, the relative configuration of C-3 of 384 was 
determined by molecular mechanics conformation analysis and the NOESY experiments. 
The relative configuration of 384 was assigned as 3R configuration with the half-chair 
conformatin of the seven-membered ring which the methyl group was in axial position. 
This assignment was supported by the data from molecular mechanics conformation 
analysis and NOESY experiments. The computer modeling can generate two minimal 
energy structures of 384 as the methyl group in both axial and equatorial positions (Figure 
61). The axial position of the methyl group in 384 was confirmed by the data from the 
NOESY experiment. The NOE interaction between the protons of methyl group at C-11 
and the diastereotopic protons at C-2 can indicate the axial position of methyl group by a 
weak cross peak of H-2b (δH 3.84, d, J = 11.1 Hz) to H3-11 but the medium cross peak of 
H-2a (δH 4.02, d, J = 11.1 Hz) to H3-11. Since 384 is a new compound, it was named 
quadricinctoxepine. 
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Figure 61. The two minimal energy conformations, C1 and C2, for the structure of 
quadricinctoxepine (384), with R configuration for C-3. All calculated distances and energies are 
exactly the same for the pairs 3R-C1/3S-C2 and 3R-C2/3S-C1. The shorter predicted inter-
hydrogen distances H-2/H-11 are presented. 
  
4.3.5) 6-Hydroxy-2,2-dimethyl-2,3-dihydro-4H-chromen-4-one (385) 
 
 Compound 385 was isolated as a white solid (mp 154-156 °C). The 13C NMR 
spectrum (Table 25), in combination with the DEPTs and HSQC spectra, exhibited one 
ketone carbonyl at δC 191.6, two oxyquaternary sp2 carbons at δC 162.5 and 157.9, three 
methine sp2 carbons at δC 136.6, 127.8 and 118.7, one quaternary sp2 carbon at δC 119.3, 
one oxyquaternary sp3 carbon at δC 80.5, one methylene sp3 carbon at δC 47.6, and two 
methyl carbons at δC 26.0. 
 The 1H spectrum, together with the HSQC spectrum (Table 25), displayed, besides 
three aromatic protons of the 1,2,4-trisubstituted benzene ring at δH 8.30, d, J = 2.1 Hz 
(δC 127.8), δH 8.06, dd, J = 8.7, 2.2 Hz (δC 136.6) and δH 7.08, d, J = 8.7 Hz (δC 118.7), 
one singlet of two magnetically equivalent methylene protons at δH 2.87 (δC 47.6), and 
one singlet of two methyl groups at δH 1.42 (δC 26.0). 
 The existence of 1,2,4-trisubstitued benzene ring was confirmed by the COSY 
correlations from the proton at δH 8.06, dd, J = 8.7, 2.2 Hz (H-7) to the protons at δH 8.30, 
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d, J = 2.1 Hz (H-5) and δH 7.08, d, J = 8.7 Hz (H-8), as well as by the HMBC correlations 
from H-5 to the carbons at δC 157.9 (C-6) and 136.6 (C-7), from H-7 to the carbon at δC 
127.8 (C-5) and C-6, and from H-8 to the carbon at δC 119.3 (C-4a) and C-6. That C-6 
was connected to the hydroxyl group was evidenced by its chemical shift value (δC 157.9) 
which was also similar to that of quadricinctone B (386; δC 151.6). 
 
 
 
 The HMBC spectrum also exhibited correlations from the methylene protons at δH 
2.87, s (H2-3) to the carbons at δC 70.5 (C-2), 191.6 (C-4), 26.0 (C-9 and C-10) and C-
4a, and from the methyl singlet at δH 1.42 (H3-9/ H3-10) to C-2 and the carbons at δC 47.6 
(C-3) and 26.0 (C-10/ C-9), suggesting the presence of a 2,2-dimethyl-2,3-dihydro-4H-
chromen-4-one moiety. Therefore, 385 was identified as 6-hydroxy-2,2-dimethyl-2,3-
dihydro-4H-chromen-4-one. Extensive literature search revealed that 385 was previously 
reported from several plants, including Calea cuneifolia (Lourenço et al., 1981), Gynura 
elliptica (Lin et al., 2000) and Tussilago farfara (Jang et al., 2016), as well as from 
synthesis (El-Desoky et al., 2013). Compound 386 completely inhibited platelet 
aggregation induced by arachidonic acid at the concentration of 100 μg/mL (Lin et al., 
2000). 
 
 163 
 
 CHAPTER IV: RESULTS AND DISCUSSION 
 
 
Table 25. 1H and 13C NMR (CDCl3, 300.13 MHz and 75.4 MHz) and HMBC assignment 
for 6-hydroxy-2,2-dimethyl-2,3-dihydro-4H-chromen-4-one (385). 
 
Position δC, type δH, (J in Hz) COSY HMBC 
2 80.5, C - - - 
3 47.6, CH2 2.87, s - C-2, 4a, 9, 10 
4 191.6, CO - - - 
4a 119.3, C - - - 
5 127.8, CH 8.30, d (2.1) H-7 C-6, 7 
6 162.5, C - - - 
7 136.6, CH 8.06, dd (8.7, 2.2) H-5, 6 C-5, 6 
8 118.7, CH 7.08, d (8.7) H-7 C-4a, 6 
8a 157.9, C - - - 
9 26.0, CH3 1.42, s - C-2, 3, 10 
10 26.0, CH3 1.42, s - C-2, 3, 9 
 
4.3.6) Quadricinctone B (386) 
 
 Compound 386 was isolated as white crystals (mp 227 – 228 °C), and its molecular 
formula C12H14O4S was determined based on the (+)-HRESIMS m/z 255.0694 [M+H]+ 
(calculated 255.0691), indicating seven degrees of unsaturation. The IR spectrum 
exhibited absorption bands for hydroxyl (3442 cm-1), conjugated ketone carbonyl (1690 
cm-1) and aromatic (1622 cm-1) groups. 
The 13C NMR spectrum, together with DEPTs and HSQC spectra (Table 26), 
exhibited signals of one conjugated ketone carbonyl carbon at δC 191.2, two 
oxyquaternary sp2 carbons at δC 151.6 and 147.4, two quaternary sp2 carbons at δC 135.7 
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and 120.8, two methine sp2 carbons at δC 118.7 and 112.4, one oxyquaternary sp3 carbon 
at δC 80.9, one methylene sp3 carbon at δC 48.0, and three methyl carbons at δC 40.8, 
26.1 and 25.7. 
 The 1H NMR spectrum (Table 26), together with the HSQC spectra, exhibited one 
hydroxyl proton at δH 9.85, s, two meta-coupled aromatic protons at δH 7.35, d, J = 3.1 
Hz (δC 118.7) and 7.17, d, J = 3.1 Hz (δC 112.4), two geminally-coupled methylene 
protons at δH 2.85, d, J = 16.6 Hz and 2.80, d, J = 16.6 Hz (δC 48.0), and three methyl 
singlets at δH 2.77 (δC 40.8), 1.38 (δC 25.7) and 1.39 (δC 26.1). 
 The presence of the 1,2,3,5-tetrasubstituted benzene ring was substantiated by 
the COSY correlations (Table 26) between the two meta-coupled aromatic protons at δH 
7.17, d, J = 3.1 Hz (H-5) and δH 7.35, d, J = 3.1 Hz(H-7), as well as by the HMBC 
correlations (Table 26) from H-5 to the carbons at δC 151.6 (C-6), δC 147.4 (C-8a) and δC 
118.7 (C-7), and from H-7 to the carbons at δC 112.4 (C-5), C-6, δC 135.7 (C-8) and C-
8a. That the phenolic hydroxyl group was on C-6 was evidenced by the HMBC 
correlations from the singlet at δH 9.85 (OH-6) to C-5, C-6 and C-7. 
 
 
 
 The HMBC spectrum also gave cross peaks from H-5 to the carbon at δC 191.2 
(C-4), from H2-3 at δH 2.80, d (J = 16.6 Hz)  and δH 3.85, d (J = 16.6 Hz) to the carbons 
at δC 80.9 (C-2), C-4,  δC 26.1 (C-9) and δC 25.7 (C-10), from the methyl singlet at δH 1.39 
(H3-9) to C-2, the carbon at δC 48.0 (C-3) and C-10, and from the methyl singlet at δH 1.38 
(H3-10) to C-2, C-3 and C-9, indicating that the 1,2,3,5-tetrasubstituted benzene ring was 
fused to the 2,2-dimethyl-2,3-dihydro-4H-pyran-4-one moiety forming the 6-hydroxyl-2,2-
dimethyl-2,3-dihydro-4H-1-benzopyran-4-one ring system. 
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 Since this partial structure accounted for only C11H11O3, another part of the 
molecule must be CH3SO. Since the HMBC spectrum showed correlation from the methyl 
singlet at δH 2.77 (H3-11) to C-8, the methyl sulfoxide group was placed on C-8. This 
hypothesis was also supported by the chemical shift value of CH3-11 (δH 2.77; δC 40.8), 
indicating that it was on the electron-withdrawing group. Therefore, 386 was identified as 
6-hydroxy-2,2-dimethyl-8-(methylsulfinyl)-2,3-dihydro-4H-chromen-4-one. 
 
 
 
 
 
 
 
 
 
 166 
 
 CHAPTER IV: RESULTS AND DISCUSSION 
Table 26. 1H and 13C NMR (DMSO, 300.13 MHz and 75.4 MHz) and HMBC assignment 
for quadricinctone B (386). 
Position δC, type δH, (J in Hz) COSY HMBC 
2 80.9, C - - - 
3 48.0, CH2 2.80, d (16.6) H-3 C-2, 4, 9, 10 
  2.85, d (16.6) H-3 C-2, 4, 9, 10 
4 191.2, CO - - - 
4a 120.8, C - - - 
5 112.4, CH 7.17, d (3.1) H-7 C-4, 6, 7, 8a  
6 151.6, C - - - 
7 118.7, CH 7.35, d (3.1) H-5 C-5, 6, 8, 8a  
8 135.7, C - - - 
8a 147.4, C - - - 
9 26.1, CH3 1.39, s - C-2, 3, 10 
10 25.7, CH3 1.38, s - C-2, 3, 9 
11 40.8, CH3 2.77, s - C-8 
OH-6 - 9.85, s - C-5, 6, 7 
 
Final proof of the proposed structure and the stereochemistry assigned to 386 was 
determined by X-ray analysis. The ORTEP view of 386 shown in Figure 62 showed that 
the absolute configuration of the sulfoxide group is R. Since 386 has not been previously 
reported, it was named quadricinctone B. 
 
Figure 62. ORTEP diagram of quadricinctone B (386).  
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4.3.7) Quadricinctone C (387) 
 
 Compound 387 was isolated as white crystals (mp 223 – 224 °C), and its molecular 
formula C12H14O6 was established based on the (+)-HRESIMS m/z 255.0875 [M+H]+ 
(calculated 255.0869), indicating six degrees of unsaturation. The IR spectrum showed 
absorption bands for hydroxyl (3439 cm-1), conjugated ester carbonyl (1660 cm-1) and 
aromatic (1643 cm-1) groups. 
 The 13C NMR spectrum (Table 27) displayed twelve carbon signals which can be 
categorized, according to the DEPTs and HSQC spectra, as one conjugated ester 
carbonyl (δC 168.8), two oxyquaternary sp2 (δC 162.9 and 161.3), three quaternary sp2 
(δC 144.6, 113.5 and 98.9), one quaternary sp3 of a hemiketal (δC 104.8), one methine 
sp2 (δC 99.9), one methine sp3 (δC 34.9), one oxymethylene sp3 (δC 63.7), and two methyl 
(δC 16.3 and 9.8) carbons. 
 The 1H NMR spectrum, together with the HSQC spectrum (Table 27), revealed the 
presence of a singlet of hydrogen-bonded phenolic hydroxyl proton at δH 11.24, a broad 
singlet of phenolic hydroxyl proton at δH 10.62, two broad singlets of two hydroxyl protons 
at δH 7.07 and δH 5.26, a singlet of an aromatic proton at δH 6.27 (δC 99.9), a broad 
doublet of two geminally-coupled methylene protons at δH 3.65 (J = 16.6 Hz; δC 63.7), a 
multiplet of a methine proton at δH 3.26 (δC 34.9), a methyl singlet at δH 1.98 (δC 9.8), and 
a methyl doublet at δH 1.06 (J = 7.2 Hz; δC 16.3). 
The existence of a 3,3,4,5,6,8-hexasubstituted 3,4-dihyro-1H-isochromen-1-one 
ring system was supported by the HMBC correlations from the aromatic proton at δH 6.27, 
s (H-7) to the carbons at δC 168.8(C-1), δC 113.5 (C-5), δC 98.9 (C-8a), δC 162.9 (C-6) 
and δC 161.3 (C-8), and from the hydrogen-bonded phenolic hydroxyl at δH 11.24, s (OH-
8) to the carbon at δC 99.9 (C-7), C-8 and C-8a. Since the HMBC spectrum also exhibited 
the correlations from the methyl singlet at δH 1.98 (H3-11) to the carbon at δC 144.6 (C-
4a), C-5 and C-6, the methyl group (δC 9.8; δH 1.98, s) and another phenolic hydroxyl 
group (δH 10.62, brs) were placed on C-5 and C-6, respectively, and the carbon signals 
at δC 144.6 and δC 162.9 were assigned for C-4a and C-6, respectively. 
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The COSY spectrum exhibited correlations from the multiplet of the methine proton 
at δH 3.26 (H-4) to the methyl doublet at δH 1.06 (J = 7.2 Hz; H3-10), and from the the 
broad singlet of the hydroxyl proton at δH 5.26 (OH-9) to the broad doublet of the 
methylene protons at δH 3.65 (J = 16.6 Hz; H2-10). The HMBC spectrum also gave cross 
peaks from H3-10 to the carbons at δC 104.8 (C-3), δC 34.9 (C-4) and C-4a. Taken 
together, the methyl (δC 16.3; δH 1.06) and the hydroxymethyl (δC 63.7; δH 3.65, OH; δH 
5.26) groups were placed on C-4 and C-3, respectively. Thus, another hydroxyl group (δH 
7.07, brs) was on C-3. This was confirmed by the chemical shift value of C-3 (δC 104.8), 
which is typical for a hemiketal carbon. 
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Table 27. 1H and 13C NMR (DMSO, 300.13 MHz and 75.4 MHz) and HMBC assignment 
for quadricinctone C (387). 
Position δC, type δH, (J in Hz) COSY HMBC 
1 168.8, CO - - - 
3 104.8, C - - - 
4 34.9, CH 3.26, m H3-10 - 
4a 144.6, C - - - 
5 113.5, C - - - 
6 162.9, C - - - 
7 99.9, CH 6.27, s - C-1 (w), 5, 6, 8, 8a  
8 161.3, C - - - 
8a 98.9, C - - - 
9 63.7, CH2 3.65, brd (16.6) OH-9 - 
10 16.3, CH3 1.06, d (7.2) H-4 C-3, 4, 4a 
11 9.8, CH3 1.98, s - C-4a, 5, 6 
OH-3 - 7.07, brs - - 
OH-6 - 10.62, brs - - 
OH-8 - 11.24, s - C-7, 8, 8a 
OH-9 - 5.26, brs H2-9 - 
 
Since 387 was obtained as suitable crystal, the X-ray analysis was performed to 
confirm the proposed structure and to establish the absolute configurations of its 
stereogenic centers (C-3 and C-4). The ORTEP view shown in Figure 63 revealed that 
the absolute configurations of C-3 and C-4 are S and R, respectively. Since 387 is a new 
compound, we have named it quadricinctone C.   
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Figure 63. ORTEP diagram of quadricinctone C (387). 
 
4.3.8) Quadricinctafuran A (388) 
 
 Compound 388 was isolated as white crystals (mp 149 – 150 °C), and its molecular 
formula C12H14O4 was established based on the (+)-HRESIMS m/z 223.9067 [M+H]+, 
indicating six degrees of unsaturation. The IR spectrum displayed absorption bands for 
hydroxyl (3417 cm-1), conjugated carbonyl (1681 cm-1) and aromatic (1634 cm-1) groups.  
The 13C NMR (Table 28) showed twelve carbon signals which can be classified, 
based on the DEPTs and HSQC spectra, into one conjugated carboxyl carbonyl (δC 
167.2), one oxyquaternary sp2 (δC 163.7), two quaternary sp2 (δC 128.2 and 122.6), three 
methine sp2 (δC 130.4, 126.4 and 108.4), one oxymethine sp3 (δC 90.2), one quaternary 
sp3 (δC 70.0), one methylene sp3 (δC 29.3) and two methyl (δC 25.9 and 24.9) carbons. 
The 1H NMR spectrum, together with the HSQC spectrum (Table 28), exhibited, 
besides the signals of three aromatic protons of the 1,2,4-trisubstituted benzene ring at 
δH 7.75, d, J = 1.8 Hz (δC 126.4), 7.72, dd, J = 8.3, 1.8 Hz (δC 130.4) and 6.80, d, J = 8.3 
Hz (δC 108.4), one broad singlet of the hydroxyl proton at δH 12.49, one doublet of two 
geminally-coupled methylene protons at δH 3.17, J = 8.9 Hz (δC 29.3), one triplet of the 
methine proton at δH 4.64, J = 8.9 Hz (δC 90.2), and two methyl singlets at δH 1.14 (δC 
24.9) and 1.13 (δC 25.9). 
That the 1,2,4-trisubstituted benzene ring was part of the 2,5-disubstituted 2,3-
dihydro-1-benzofuran moiety was substantiated by the HMBC correlations from the 
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methylene protons at δH 3.17, d, J = 8.9 Hz (H2-3) to the carbons at δC 90.2 (C-2), δC 
128.2 (C-3a) and δC 163.7 (C-7a), from the aromatic proton at δH 7.75, d, J = 1.8 Hz (H-
4) to the carbon at δC 130.4 (C-6) and C-7a, from the aromatic proton at δH 7.72, dd, J = 
8.3, 1.8 Hz (H-6) to the carbon at δC 126.4 (C-4) and C-7a, and from the aromatic proton 
at δH 6.80, d, J = 8.3 Hz (H-7) to C-3, the carbon at δC 122.6 (C-5) and C-7a, as well as 
by the COSY correlations from H-6 to H-4 and H-7, and from the methine proton at δH 
4.64, t, J = 8.9 Hz (H-2) to H-3. 
 
 
 
The presence of broad signal at δH 12.49, which is typical of a hydroxyl group of 
carboxylic acid, together with the HMBC correlations from H-4 and H-6 to the carbon at 
δC 167.2 (C-8), indicated that the carboxyl group was on C-5. Since the HMBC spectrum 
displayed correlations from H-2 to the carbons at δC 70.0 (C-1’), δC 24.9 (C-2’) and δC 
25.9 (C-3’), the 2-hydroxypropyl group was placed on C-2. This hypothesis also supported 
by the HMBC correlations from the methyl singlet at δH 1.14 (H3-2’) to C-2, C-1’ and C-3’, 
and from the methyl singlet at δH 1.13 (H3-3’) to C-2, C-1’ and C-2’, as well as by the 
NOESY correlations from H-2 to H-3, H3-2’ and H3-3’.Therefore, 388 was identified as 2-
(2-hydroxypropan-2-yl)-2,3-dihydro-1-benzofuran-5-carboxylic acid. 
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Table 28. 1H and 13C NMR (DMSO, 300.13 MHz and 75.4 MHz) and HMBC assignment 
for quadricinctafuran A (388). 
Position δC, type δH, (J in Hz) COSY HMBC 
2 90.2, CH 4.64, t (8.9) H-3 C-1’, 2’, 3’ 
3 29.3, CH2 3.17, d (8.9) H-2 C-2, 3a, 7a, 1’ 
3a 128.2, C - - - 
4 126.4, CH 7.75, d (1.8) H-6 C-6, 7a, 8 
5 122.6, C - - - 
6 130.4, CH 7.72, dd (8.3, 1.8) H-4, 7 C-4, 7a, 8 
7 108.4, CH 6.80, d (8.3) H-6 C-3a, 5, 7a 
7a 163.7, C - - - 
8 167.2, C - - - 
1’ 70.0, C - - - 
2’ 24.9, CH3 1.14, s - C-2, 1’, 3’ 
3’ 25.9, CH3 1.13, s - C-2, 1’, 2’ 
OH-8 - 12.49, brs - - 
 
Literature survey revealed that 388 has the same flat structure as anodendroic acid 
[2-(1-hydroxy-1-methylethyl)-2,3-dihydrobenzofuran-5-carboxylic acid], which was first 
isolated from the stem of Anodendron affine Durce by Shima et al. (1972) and was later 
synthesized from 2-(1-hydroxy-1-mehylethyl)-2,3-dihydrobenzofuran by Yamaguchi et al. 
(1982). Anodendroic acid was also obtained by hydrolysis of its methyl ester, a constituent 
of Eriodictyon sessilifolium (Arriaga-Giner et al., 1988) and by biotransformation of 3-(γ,γ-
dimethylallyl)-p-coumaric acid (Bisogno et al., 2007). However, in all these previous 
studies, anodendroic acid were identified by comparison of the melting point, 1H NMR 
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and MS data with those reported by Shima et al., and without determination of the 
stereochemistry of C-2. Since the 1H NMR data of 388 and anodendroic acid reported by 
Shima et al. were obtained in different solvent (388 was run in DMSO-d6 while 
anodendroic acid was run in pyridine-d6), it was not possible to compare these 1H NMR 
data. Interestingly, the 1H NMR (DMSO-d6) data of anodendroic acid reported by 
Yamaguchi et al. were slightly different from those we have obtained for 388. The obvious 
differences between anodendroic acid (Shima et al., 1972) and 388 are their melting 
points and optical rotations. The melting points of anodendroic acid and 388 are 212 – 
214 °C and 149 – 150 °C, repectively, while the optical rotations are leavorotatory ([α]D26 
–19°, c 0.7, EtOH) and dextrorotatory ([α]D20 +74°, c 0.03, MeOH), repectively. Therefore, 
we concluded that the structure of 388 is different from the structure of anodendroic acid. 
Since we were able to obtaine suitable crystal of 388, its X-ray analysis was carried out 
to determine the stereochemistry of C-2. The ORTEP view in Figure 64 shows that the 
absolute configuration of C-2 is R. Since it is a new compound, it was named 
quadricinctafuran A. 
 
 
Figure 64. ORTEP diagram of quadricinctafuran A (388). 
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4.3.9) Quadricinctafuran B (389) 
 
 Compound 389 was isolated as white solid (mp 209 – 210 °C), and its molecular 
formula C12H14O5 was determined based on the (+)-HRESIMS m/z 239.0919 [M+H]+ 
(calculated239.0919), indicating six degrees of unsaturation. 
 The general features of 1H and 13C NMR spectra of 389 closely resembled those 
of 388. The 13C NMR spectrum (Table 29) exhibited twelve carbon signals which can be 
categorized, according to the DEPTs and HSQC spectra, as one conjugated carboxyl 
carbonyl (δC 167.2), one oxyquaternary sp2 (δC 163.6), two quaternary sp2 (δC 128.4 and 
122.6), three methine sp2 (δC 130.8, 126.4 and 108.4), one oxymethine sp3 (δC 86.5), one 
oxyquaternary sp3 (δC 72.5), one oxymethylene sp3 (δC 66.7), one methylene sp3 (δC 
28.7), and one methyl (δC 20.0) carbons. 
 The 1H NMR spectrum, together with the HSQC spectrum (Table 29), exhibited, 
besides the signals of three aromatic protons of the 1,2,4-trisubstituted benzene ring at 
δH 7.76, d, J = 1.8 Hz (δC 126.4), 7.71, dd, J = 8.3, 1.8 Hz (δC 130.8) and 6.79, d, J = 8.3 
Hz (δC 108.4), a broad singlet of the hydroxyl proton at δH 12.47, a singlet of two 
methylene protons at δH 3.33 (δC 66.4), a multiplet of another two methylene protons at 
3.19 (δC 28.7), a double doublet of a methine proton at 4.83 (J = 9.7, 8.1 Hz; δC 86.5), 
and a methyl singlet at δH 1.09 (δC 20.0). 
 Analysis of 1H, 13C NMR and COSY spectra led to the conclusion that 389 
contained the same 2.3-dihydro-1-benzofuran-5-carboxylic acid nucleus as 388. 
However, the 1H NMR of 389 displayed only one methyl singlet at δH 1.09 and one singlet 
of oxymethylene protons at δH 3.33, instead of two methyl singlets. Thus, the difference 
between 388 and 389 was the substitutions on C-2. That the substitutent on C-2 of 389 
was 1,2-dihydroxypropyl group was supported by the molecular formula of 389 (C12H14O5) 
which has one oxygen atom more than that of 388, as well as by the presence of the 
oxymethylene carbon at δC 66.7 (C-2’) instead of the methyl carbon. Moreover, the 
chemical shift value of C-2 (δC 86.5) was about 4 ppm lower than that of 388. This 
hypothesis was also confirmed by the HMBC correlation from the methylene protons at 
δH 3.33, s (H2-2’) to the carbons at δC 86.5 (C-2), δC 72.5 (C-1’) and δC 20.0 (C-3’), and 
from the methyl singlet at δH 1.09 (H3-3’) to C-2, C-1’ and the carbon at δC 66.7 (C-2’). 
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Therefore, compound 389 was identified as 2-(1,2-dihydroxypropan-2-yl)-2,3-dihydro-1-
benzofuran-5-carboxylic acid. 
 
 
 
Compound 389 could not be obtained as suitable crystal for X-ray analysis. 
Furthermore, the absolute configurations of C-2 and C-1’ could not be determine by 
Mosher’s NMR method, since C-1’ is a tertiary alcohol and C-2’ is a primary alcohol. 
However, since compound 389 is derived from 388, it was possible to speculate that the 
absolute configuration of C-2 should be the same as that of C-2 of 388, i.e. 2R. However, 
it is not yet possible to determine the absolute configuration of C-1’. To the best of our 
knowledge, 389 has never been previously reported. Therefore, it was named 
quadricinctafuran B. 
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Table 29. 1H and 13C NMR (DMSO, 300.13 MHz and 75.4 MHz) and HMBC assignment 
for quadricinctafuran B (389). 
Position δC, type δH, (J in Hz) COSY HMBC 
2 86.5, CH 4.83, dd (9.7, 8.1) H-3 - 
3 28.7, CH2 3.19, m H-2 C-1’, 3ª 
3a 128.4, C - - - 
4 126.4, CH 7.76, d (1.8) H-6 C-3, 6, 7a 
5 122.6, C - - - 
6 130.8, CH 7.71, dd (8.3, 1.8) H-4, 7 C-4, 7a, 8 
7 108.4, CH 6.79, d (8.3) H-6 C-3a, 5, 7a 
7a 163.6, C - - - 
8 167.2, C - - - 
1’ 72.5, C - - - 
2’ 66.7, CH2 3.33, s - C-2, 1’, 3’ 
3’ 20.0, CH3 1.09, s - C-2, 1’, 2’ 
OH-8 - 12.47, brs - - 
 
 
4.3.10) Quadricinctone D (390) 
 
 Compound 390 was isolated as white crystals (mp 196 – 197 °C), and its molecular 
formula C12H12O5 was determined on the basis of the (+)-HRESIMS m/z 237.0792 [M+H]+ 
(calculated 237.0763), indicating seven degrees of unsaturation. The IR spectrum 
exhibited absorption bands for hydroxyl (3404 cm-1), conjugated ketone carbonyl (1708 
cm-1), conjugated carboxyl carbonyl (1670 cm-1) and aromatic (1558, 1540 cm-1) group. 
 The 13C NMR spectrum (Table 30) displayed twelve carbon signals which can be 
classified, based on the DEPTs and HSQC spectra, as one conjugated ketone carbonyl 
(δC 191.0), one conjugated carboxyl carbonyl (δC 166.4), one oxyquaternary sp2 (δC 
162.9), two quaternary sp2 (δC 123.0 and 119.6), three methine sp2 (δC 136.4, 127.5 and 
118.5), one oxyquaternary sp3 (δC 80.3), one oxymethylene sp3 (δC 66.8), one methylene 
sp3 (δC 43.4) and one methyl (δC 21.2) carbons.  
The 1H NMR spectrum, together with the HSQC spectrum (Table 30), revealed the 
presence of , besides two hydroxyl protons at δH 12.69, brs and 5.26, brt, J = 5.4 Hz, 
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three aromatic protons of the 1,2,4-trisubstituted benzene ring at δH 8.04, dd, J = 8.7, 2.3 
Hz (δC 136.4), 8.26, d, J = 2.3 Hz (δC 127.5) and 7.07, d, J = 8.7 Hz (δC 118.5), and two 
pairs of geminally-coupled protons at δH 3.59, dd, J = 11.6, 4.2 Hz; δH 3.49, dd, J = 11.6, 
4.5 Hz (δC 66.8) and δH 3.00, d, J = 16.7 Hz; δH 2.74, d, J = 16.7 Hz (δC 43.4). 
 Since the HMBC spectrum gave cross peaks from the aromatic proton at δC 8.26, 
d, J = 2.3 Hz (H-5) to the conjugated ketone carbonyl at δC 191.1 (C-4), the carbons at 
δC 136.4 (C-7) and δC 162.9 (C-8a), the ketone functionality was connected to C-4a. 
Moreover, the HMBC spectrum also exhibited correlations from the aromatic proton at δH 
7.07, d, J = 8.7 Hz (H-8) to C-8a and the carbons at δC 123.0 and 119.6. Therefore, the 
carbon signals at δC 123.0 and 119.6 were assigned to C-4a and C-6, respectively. 
 
 
 
 The presence of the 1-hydroxy-2-methyl-2-oxypropyl moiety was evidenced by the 
COSY correlations from the methylene protons at δH 3.49, dd, J = 11.6, 4.5 Hz and δH 
3.59, dd, J = 11.6, 4.2 Hz (H2-10) to the hydroxyl proton at δH 5.26, brt, J = 5.4 Hz (OH-
10), as well as by the HMBC correlations from the methylene protons at δH 2.74, d, J = 
16.7 Hz and δH 3.00, d, J = 16.7 Hz (H2-3) to the carbons at δC 80.3 (C-2), δC 21.2 (C-9) 
and δC 66.8 (C-10), and from the methyl singlet at δH 1.30 (H3-9) to C-2, the carbon at δC 
43.4 (C-3) and C-10. That the methylene group (CH2-3) of the 1-hydroxy-2-methyl-2-
oxypropyl portion was connected to C-4 was supported by the HMBC correlation from H2-
3 to C-4. Since these two moieties accounted for only C11H12O4, another substituent was 
the carboxyl group (δC 166.4, δH 12.69, br). 
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 Therefore, 390 was identified as 2-(hydroxymethyl)-2-methyl-4-oxo-3,4-dihydro-
2H-chromene-6-carboxylic acid. Since 390 was obtained as a suitable crystal, X-ray 
analysis was carried out to confirm the proposed structure and determine the 
stereochemistry of this compound. The ORTEP view shown in Figure 65 revealed the 
absolute configuration of C-2 is 2S. Since 390 is a new compound, we named it 
quadricinctone D.  
 
 
Figure 65. ORTEP diagram of quadricinctone D (390). 
 
 
In order to determine the conformation of the 2,3-dihydro-4H-pyran-4-one, analysis 
of the NOESY correlations was carried out. Since, the NOESY spectrum exhibited strong 
cross peak from H-7 to H-8, and also weak cross peaks from H3-9 to H-5 and H-8, H3-9 
is in the α-axial position. Moreover, H3-9 also gave strong cross peak to the methylene 
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proton at δH 2.47, d, J = 16.7 Hz and a weak cross peak to the proton at δH 3.00, d, J = 
16.7 Hz, therefore, they were assigned as H-3α and H-3β, respectively.  
 
Table 30. 1H and 13C NMR (CDCl3, 300.13 MHz and 75.4 MHz), HMBC and NOESY 
assignments for quadricinctone D (390). 
Position δC, type δH, (J in Hz) COSY HMBC NOESY 
2 80.3, C - - - - 
3α 43.4, CH2 2.74, d (16.7) H-3 C-2, 4, 9, 10 H3-11 (str) 
3β  3.00, d (16.7) H-3 C-2, 4, 9, 10 H3-11 (w) 
4 191.1, CO - - - - 
4a 123.0, C - - - - 
5 127.5, CH 8.26, d (2.3) H-7 C-4, 7, 8a - 
6 119.6, C - - - - 
7 136.4, CH 8.04, dd (8.7, 2.3) H-5, 8 C-5, 8a - 
8 118.5, CH 7.07, d (8.7) H-7 C-4a, 6, 8a - 
8a 162.9, C - - - - 
9 21.2, CH3 1.30, s - C-2, 3, 10 H-3α (str), 3β (w), 
5, 8 (w) 
10 66.8, CH2 3.49, dd (11.6, 4.5) OH-10 - - 
  3.59, dd (11.6, 4.2) OH-10 - - 
11 166.4, CO - - - - 
OH-10 - 5.26, brt (5.4) H2-10 - - 
OH-11 - 12.69, br - - - 
 
Compounds 381 and 387 can be hypothesized as originating from the pentaketide 
intermediate (I), which is derived from acetyl-CoA and malonyl-CoA. The intermediated 
II, which is derived by methylation of I by SAM, undergoes cyclization and enolization to 
form the intermediate III. Methylation of the α-carbon of the carbonyl ketone and the 
phenolic hydroxyl groups by SAM gives the intermediate IV. Oxidation of the α-carbon of 
the side chain of IV leads to the intermediate VII, which was followed by lactonization and 
reduction of the ketone carbonyl, gives rise to 381. Alternatively, enolization of the 
intermediate IV, followed by lactonization, arises V, which undergoes hydration to give VI, 
and oxidation of one of methyl groups gives rise to 387 (Scheme 2). 
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The origin of 382, 383, 385, 386, 388, 389 and 390 is the intermediates from 
shikimate (chorismate; IX) and mevalonate (DMAPP; XI) pathways, similar to that 
proposed for fomannoxin (Hansson et al., 2012). p-Hydroxybenzoic acid (X), which is 
derived from the pyruvate elimination of IX by chorismate pyruvate-lyase, is prenylated 
by XI leads to the formation of the intermediate XII. Epoxidation of XII leads to the 
formation of XIII which after cyclization, via Route a, orginates the furan ring in 388. One 
of the methyl groups of 388 is oxidized to give rise to 389. On the other hand, cyclization 
of XIII, via Route b, originates the pyran ring in XIV. Dehydration and oxidation of one of 
the methyl groups of XIV leads to the formation of 382 which after is acetylated of the 
primary alcohol function of the side chain, leads to the formation of 383. Alternatively, 
dehydration and oxidation of the pyran ring of XIV originates the ketone function of 390. 
Compound 390 undergoes oxidative decarboxylation to give rise to 385 which after is 
sulfinylated of the benzene ring, leads to the formation of 387 (Scheme 3). 
The intermediate XVII is also derived from the prenylation of p-hydroxybenzoic 
acid (X); however, it is prenylated by IPP (XVI) instead of DMAPP (XI). Epoxidation of the 
double bond of the side chain of XVII leads to the formation of XVIII which after undergoes 
cyclization to give rise to an oxepin ring in XIX. Oxidation and dehydration of the oxepin 
ring orinates 384 (Scheme 4). 
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Scheme 2. Proposed biosynthetic pathways for quadricinctones A (381) and C (387). 
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Scheme 3. Proposed biosynthetic pathways for quadricinctapyrans A (382), B (383), 2,3-dihydro-
6-hydroxy-2,2-dimethyl-4H-1-benzopyran-4-one (385), quadricinctone B (386), quadricincta-
furans A (388), B (389) and quadricinctone D (390). 
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Scheme 4. Proposed biosynthetic pathway for quadricinctoxepine (384). 
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4.4) Biological Activity Evaluation of the Isolated Compounds from the 
Marine Sponge Iotrochota baculifera, and the Marine-Derived Fungi 
Aspergillus similanensis KUFA 0013 and Neosartorya quadricincta 
KUFA 0081  
 
 Cancer is one of world health problems which causes approximately 8.8 million 
people died in 2015. It is nearly 1 in 6 deaths is from cancer. The first leading type of 
cancer which causes death is lung cancer with approximately 1.69 million deaths 
worldwide; the Fifth leading cause of global death in 2015 (http://www.who.int/ 
mediacentre/factsheets/fs297/en/; http://www.who.int/mediacentre/factsheets/fs310/ 
en/).   
Not only cancer, but infectious diseases are also one of leading causes of global 
death. From the report of WHO in 2015, lower respiratory tract infection is the third cause 
of death worldwide, with approximately 3.19 million deaths (http://www.who.int/media-
centre/factsheets/fs310/en/). One of important causes of mortality is antimicrobial 
resistance which leads to decrease the efficacy of antimicrobial agents. The death rate of 
patients who were infected by MRSA are about 64% higher than non-resistant S. aureus 
infected patients (http://www.who.int/ mediacentre/factsheets/fs194/en/). Nowadays, the 
problem of antimicrobial resistance is growing higher. WHO has been reported that the 
world is lack of new antibiotics to treat the antimicrobial-resistant pathogens. Therefore, 
the priority pathogens list (PPL) that includes 12 families of antibiotic-resistant bacteria 
was published by WHO to guide researchers for new drug discovery and development 
(http://www.who.int/mediacentre/news/releases/2017/bacteria-antibiotics-needed/en/).     
 As described in chapter I (introduction), marine-derived secondary metabolites are 
a rich source of leading compounds. They exhibit many interesting bioactivities such as 
anticancer, antimicrobial and anti-inflamatory activities. Therefore, we decided to test the 
secondary metabolites we have isolated for their antimicrobial and anticancer activities in 
our studies. 
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4.4.1) Antibacterial Activity Evaluation 
 
Compounds 154, 356, 372 – 375 and 377 – 390 were evaluated for their 
antibacterial activity against Gram-positive (Staphylococcus aureus ATCC 25923 and 
Bacillus subtilis ATCC 6633) and Gram-negative (Escherichia coli ATCC 25922 and 
Pseudomonas aeruginosa ATCC 27853) bacteria, as well as the multidrug-resistant 
isolates from the environment [S. aureus B1 (isolated from public bus); Enterococcus 
faecalis W1 (isolated from river water); E. coli G1 (isolated from seagull feces)]. None of 
the tested compounds exhibited antibacterial activity at the highest concentration tested 
(256 μg/mL). Similar to chevalone C (349), the structure of chevalone E (356) does not 
possess the β-acetoxyl group on C-3 and the 4-hydroxy-6-methyl-2H-pyran-2-one ring on 
C-15 which are the structural requirements for the antibacterial activity of this group of 
meroditerpenes (Gomes et al., 2014). Therefore, 356 also did not exhibit the antibacterial 
activity the same as 349. However, 349 displayed synergistic effect with antibiotics 
against the multidrug-resistant isolates (S. aureus B1, E. coli G1 and E. faecalis W1; 
Gomes et al.,2014). According to this fact, 154, 356, 372 – 375 and 377 – 378 were also 
tested for their synergistic effect with antibiotics (ciprofloxacin, ampicillin, cefotaxime, 
streptomycin, oxacillin, vancomycin and erythromycin) against three multidrug-resistant 
bacteria isolated from environment, using the disc diffusion method. None of the tested 
compounds exhibited synergistic effect against the multidrug-resistant E. coli and E. 
faecalis. Only chevalone E (356) exhibited a good synergistic effect with oxacillin and 
ampicillin against MRSA (Table 31). 
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Table 31. Antibacterial efficacy of combined effect of antibiotics with the isolated 
compounds (15 μg/disc) against three environmental multidrug-resistant isolates, using 
the disc diffusion method. 
Compounds 
E. coli G1 S. aureus B1 E. faecalis W1 
Antibiotics 
CIP AMP CTX S OX AMP CIP VA AMP E 
154 - - - - - ++ - - - - 
356 - - - - +++ +++ - - - - 
372 - - - - - ++ - - - - 
373 - - - - - ++ - - - - 
374    - - ++ - - - - 
375 - - - - - - - - - - 
377   - -  ++ - - - - 
378 - - - - - ++ - - - - 
 
(-) noneffective; (+) slight efficacy – halo of inhibition or additional increase in the halo of 1 to 2.5 
mm around the disc; (++) moderate efficacy – from > 2.5 to 5 mm; (+++) good efficacy – from > 5 
to 8 mm; CIP: ciprofloxacin; AMP: ampicillin; CTX: cefotaxime; S: streptomycin; OX: oxacillin; VA: 
vancomycin; E: erythromycin. 
 
 The checkerboard method was carried out to verify if the synergism occurred with 
both oxacillin and ampicillin, or with either of them. The results, represented by the 
fractional inhibitory concentration (FIC) index (Table 32), revealed that only the 
combination of chevalone E (356) and oxacillin exhibited the synergistic effect with FIC 
index < 0.188. 
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Table 32. MIC values of chevalone E (356) in combination with oxacillin or ampicillin, and 
the respective FIC index obtained against a MRSA (S. aureus B1) using the checkerboard 
method. 
Strain MIC (μg/mL) FIC index 
S. aureus B1 
356 alone OX alone 356 with OX OX with 356 
< 0.1888 
> 1024 128 64 16 
S. aureus B1 
356 alone AMP alone 356 with AMP AMP with 356 
> 1.5 
> 1024 128 > 512 128 
 
FIC index ≤ 0.5: synergy; 0.5 < FIC index ≤ 4: no interaction; FIC index > 4: antagonism 
 
4.4.2) Antifungal Activity Evaluation 
 
 Compounds 381 – 390 were evaluated for their antifungal activity against three 
fungi, Candida albicans ATCC 10231 (yeast), Aspergillus fumigatus ATCC 46645 
(filamentous fungus) and Trichophyton rubrum FF5 (dermatophyte) while 154, 356, 372 
– 375 and 377 – 378 were tested against only C. albicans ATCC 10231. The results 
revealed that all the tested compounds did not exhibit antifungal activity at the highest 
concentration tested (382 – 391 at the concentration of 512 μg/mL and 154, 356, 372 – 
375 and 377 – 378 at 256 μg/mL). 
 
4.4.3) Cytotoxicity Evaluation  
 
 Compounds 379 – 390 were evaluated for their cytotoxicity against three human 
cancer cell lines, using SRB assay. While 379 – 380 were tested against MCF-7, NCI-
H460 and A373, other compounds were tested against MCF-7, NCI-H460 and A375-C5. 
All tested compounds, except for 380, did not show any activity (GI50 > 150 mM). 
Compound 380 weakly inhibited the growth of MCF-7, NCI-H460 and A373 cancer cell 
lines with GI50 values of 125 ± 0, 117.50 ± 3.55 and 115 ± 7.07 mM, respectively. 
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5.1) General Experimental Procedures 
 
 1H and 13C NMR spectra were recorded at ambient temperature in deuterated 
chloroform (CDCl3) or deuterated dimethylsulfoxide (DMSO-d6) on a Bruker AMC 
instrument (Bruker Biosciences Corporation, Billerica, MA, USA) operating at 500.13 
and 125.8 MHz or at 300.13 and 75.4 MHz, respectively. 
 High-resolution mass spectra were measured with a Waters Xevo QToF mass 
spectrometer (Waters Corporations, Milford, MA, USA) coupled to a Waters Aquity 
UPLC system. 
Infrared spectra were recorded in a KBr microplate in a FTIR spectrophotometer 
Nicolet iS10 from Thermo Scientific (Waltham, MA, USA) with Smart OMNI-
Transmission accessory (Software 188 OMNIC 8.3). 
Melting points were determined on a Bock monoscope and are uncorrected. 
 Optical rotations were determined on an ADP410 Polarimeter (Bellingham + 
Stanley Ltd., Tunbridge Wells, Kent, UK). 
 Silica gel 60 (0.2-0.5 mm; 70-230 mesh, Merck), LiChroPrep Si 60 (0.04-0.063 
mm, Merck) and Sephadex LH-20 were used for column chromatography. Analytical 
TLC was performed on Silica gel 60 (GF254, Merck), 0.25 mm thickness (The plates 
were activated at 110 °C in the oven Binder for 4 hours) and pre-coated silica gel 
sheets, GF254 (Macherey-Nagel), ALUGRAM®, Sil G/UV254, 20 × 20 cm. TLC plates 
were visualized under UV lamp (254 and 365 nm) or developed with iodine vapor. 
 The organic solvents (acetone, chloroform, ethyl acetate, methanol, petroleum 
ether 40-60 °C) were purchased from Merck and Fischer with analytical reagent grade. 
Solvents were evaporated at reduced pressure, using Büchi Heating Bath B-49, Büchi 
Ratavapor R-210, Büchi Vacuum Module V-801 EasyVac and Vacuum Pump V-700. 
 The weight was measured on the analytical balance AND GH-202. 
 Ultraviolet spectra were recorded on a Shimadzu mini-1240UV-VIS 
spectrophotometer using 1.000 cm quartz cells. 
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5.2) Isolation and Identification of the Marine-Derived Fungi 
 
5.2.1) Aspergillus similanensis KUFA 0013 
 
 The fungus Aspergillus similanensis KUFA 0013 was isolated from the marine 
sponge Rhabdermia sp., which was collected, by scuba diving at a depth of 10 m, from 
the coral reef of the Similan Islands, Phang Nga Province, Thailand, in April 2010. The 
sponge was identified by Dr. Jamrearn Buaruang (Division of Environmental Science, 
Faculty of Science, Ramkhamhaeng University, Bangkok, Thailand). Briefly, the 
sponge was rinsed with sterile sea water and dried on a sterile filter paper, then cut 
into small pieces (5 × 5 mm). After placing the sponge on the plates containing malt 
extract agar (MEA) medium with 70% sea water, the plates were incubated at 28 °C 
under 12 h light/ 12 h dark cycle for 7 days. The MEA medium was prepared by using 
30 g of malt extract powder (Himedia, Mumbai, India), 15 g of bacto agar, distilled water 
300 mL and sea water 700 mL, and then adjusted to the final pH at 5.5. The fungus 
was identified by Prof. Dr. Tida Dethoup (Department of Plant Pathology, Faculty of 
Agriculture, Kasetsart University, Bangkok, Thailand), based on morphological 
characteristics of ascospores, conidiogenesis and colonies, as well as by DNA 
sequence analysis of the calmodulin gene (Glass & Donaldson, 1995), and it was 
deposited at GenBank with Accession No. of KC 920702. However, the strain was not 
identified at species level due to the sequence was not identical to that deposited at 
GenBank, therefore the pure cultures were deposited as KUFA 0013 at the Department 
of Plant Pathology, Faculty of Agriculture, Kasetsart University, Bangkok, Thailand. 
Later on, this fungus was further studied by Dethoup et al. (2016) and was identified 
as Aspergillus similanensis Dethoup. 
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Figure 66. Colony on MEA, 7 days, 28 °C obverse (A), reverse (B), asci and ascospores (C) 
and scanning electron microscope of ascospores (D) of Aspergillus similanensis KUFA 0013. 
 
5.2.2) Neosartorya quadricincta KUFA 0081 
 
 The fungus Neosartorya quadricincta KUFA 0081 was isolated from the marine 
sponge Clathria reinwardti, which was collected from the coral reef at Samae San 
Island (12°34’ 36.64’’ North 100°56’ 59.69’’ East) in the Gulf of Thailand, Chonburi 
Province, by scuba diving at 15-20 m depth, in July 2013. After washing with 0.06% 
sodium hypochlorite solution for 1 min and followed by sterilized sea water 3 times, the 
sponge was dried on sterile filter paper and cut into small pieces (5 × 5 cm), then 
placed on the plates containing MEA medium with 70% seawater and 300 mg/L of 
streptomycin sulphate. The plates were incubated at 28 °C for 7 days, after which the 
hyphal tips were transferred onto a MEA slant and maintained as pure culture for 
 A 
  C D 
 B 
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further identification. The fungus was identified by Prof. Dr. Tida Dethoup, using 
morphological features, including characteristics of ascospores and colonies, as well 
as by sequence analysis of the β-tubulin, calmodulin and actin genes (Matsuzawa et 
al., 2014). 
The identification of N. quadricincta was also confirmed by the sequence 
analysis of the internal transcribed spacer (ITS) gene (MayZin et al., 2015). The gene 
sequences were deposited in GenBank (Accession No. KM095492 and KT201525, 
respectively). The pure culture was deposited as KUFA0081 at Kasetsart University 
Fungal Collection, Department of Plant Pathology, Faculty of Agriculture, Kasetsart 
University, Bangkok, Thailand. 
 
   
   
 
Figure 67. Colony on PDA, 7 days, 28 °C obverse (A), asci (B), ascospores (C), aspergilla 
(D), spores (E) of N. quadricincta KUFA 0081 and Clathria reinwardti (F). 
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5.3) Extraction and Isolation of Metabolites 
 
5.3.1) The marine sponge Iotrochota baculifera 
 
 The marine sponge Iotrochota baculifera was collected from the Gulf of 
Thailand, Chonburi province, by scuba diving, in March 2012. The sponge was 
collected and identified by Dr. Sumaitt Putchakarn, Bangsaen Institute of Marine 
Science, Burapha University. The frozen sponge (1,174 g, wet weight) was thawed 
and homogenized with EtOH (3 L), allowed to stand for 24 h in a dark chamber and 
the residue was re-extracted with EtOH (2 × 3 L). The aqueous alcoholic extracts were 
combined, evaporated under reduced pressure by rotatory evaporator to ca. 500 mL 
and then partitioned with EtOAc (3 × 500 mL). The EtOAc solutions were combined 
and concentrated under reduced pressure by rotatory evaporator to give the crude 
EtOAc extract (5.06 g) which was chromatographed over a Silica gel column (42 g) 
and eluted with mixtures of petroleum ether (petrol) – CHCl3 and CHCl3 – Me2CO, 
wherein 150 mL fractions were collected as follows: Frs 1-42 (petrol-CHCl3, 3:7), 43-
73 (petrol-CHCl3, 1:9), 74-100 (CHCl3-Me2CO, 9:1) and 101-130 (CHCl3-Me2CO, 7:3). 
Frs 47-58 were combined and recrystallized in a mixture of petrol and CHCl3 to give 
370 (10.4 mg). Frs 74-77 were combined and recrystallized in a mixture of petrol and 
CHCl3 to give 40 (7.8 mg). 
 
 
 
Figure 68. The picture of the marine sponge Iotrochota baculifera. 
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5.3.2) Aspergillus similanenesis KUFA 0013 
 
 The fungus was cultured for 7 days in 5 Petri dishes (ID 90 mm), which 
contained 25 mL of MEA with 70% sea water per dish. Thirty 1000 mL Erlenmeyer 
flasks, containing white rice (200 g), water (30 mL) and sea water (70 mL), were 
autoclaved at 121 °C for 15 min, inoculated with 10 mycelia plugs of the fungus and 
then incubated at 28 °C for 30 days. The moldy rice was macerated in EtOAc (7 L total) 
for 7 days and then filtered by filter paper and a mixture of EtOAc and H2O in the filtrate 
was separated by separating funnel. The EtOAc layer was evaporated under reduced 
pressure using rotary evaporator to yield crude ethyl acetate extract (97 g) that was 
dissolved in 500 mL of a mixture of EtOAc and CHCl3 (4:1), and then washed twice 
with 5% aqueous solution of NaHCO3 (300 mL), H2O (3 x 300 mL). The organic layer 
was dried using anhydrous Na2SO4, filtered by filter paper and the filtrate was 
evaporated under reduced pressure by rotatory evaporator to give 75 g of crude extract 
which was applied on a column chromatography of silica gel (640 g) and eluted with 
mixtures of CHCl3-petrol and CHCl3-Me2CO, wherein 250 mL fractions were collected 
as follows: Frs 1-18 (CHCl3-petrol, 3:7), 19-53 (CHCl3-petrol, 1:1), 54-114 (CHCl3-
petrol, 7:3), 115-215 (CHCl3-petrol, 9:1), 216-395 (CHCl3-Me2CO, 9:1), and 396-443 
(CHCl3-Me2CO, 7:3). Frs 185-196 were combined (654.0 mg) and purified by TLC 
(silica gel G254, CHCl3: Me2CO: HCO2H, 97: 3: 0.01) to give 4.0 mg of similanpyrone 
A (375) and 7.4 mg of similanpyrone C (376). Frs 197-221 were combined (1.2 g) and 
crystallized in a mixture of petrol and CHCl3 to give additional 17.6 mg of a yellow solid 
which was further purified by TLC (silica gel G254, CHCl3: Me2CO: HCO2H, 98: 2: 0.01) 
to give 2.5 mg of similanpyrone A (375). Fr 222 (8.1 g) was crystallized in a mixture of 
CHCl3 and Me2CO to give 238.0 mg of white precipitate, which was further purified by 
TLC (silica gel G254, CHCl3: Me2CO: HCO2H, 97: 3: 0.01) to give 32.7 mg of 
similanpyrone B (373), 4.6 mg of S14-95 (377), and 70.8 mg of chevalone B (348). The 
mother liquor of frs 197-221 and frs 223-224 were combined (9.2 g), applied on the 
silica gel column (58 g), and eluted with mixtures of CHCl3-petrol and CHCl3-Me2CO, 
wherein 100 mL sub-fractions were collected as follows: sfrs 1-59 (CHCl3-petrol, 7:3), 
60-69 (CHCl3-petrol, 9:1), and 70-76 (CHCl3-Me2CO, 9:1). Sfrs 11-22 were combined 
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(2.0 g) and crystallized in a mixture of petrol and CHCl3 to give additional 16.4 mg of 
similanpyrone A (375). Sfrs 29-42 were combined (468.0 mg) and crystallized in a 
mixture of petrol and CHCl3 to give additional 92.1 mg of similanpyrone B (373). Frs 
225-228 were combined (446.0 mg) and crystallized in a mixture of petrol and CHCl3 
to give 63.0 mg of a precipitate which was further purified by TLC (silica gel G254, 
CHCl3: Me2CO: HCO2H, 97: 3: 0.01) to give 35.4 mg of 6,8-dihydroxy-3-
methylisocoumarin (372) and 35.8 mg of similanpyrone B (373). The mother liquor of 
frs 225-228 and frs 229-230 were combined and chromatographed on a silica gel 
column (33 g) and eluted with mixtures of CHCl3-petrol and CHCl3-Me2CO, wherein 
100 mL sub-fractions were collected as follow: sfrs 1-49 (CHCl3-petrol, 7:3), 50-64 
(CHCl3-petrol, 9:1), and 65-77 (CHCl3-Me2CO, 9:1). Sfrs 4-5 were combined and 
recrystallized in a mixture of petrol and CHCl3 to give 2.4 mg of similanpyrone A (375). 
Sfrs 6-10 were combined (160.0 mg) and recrystallized in a mixture of petrol and CHCl3 
to give 7.6 mg of reticulol (374). Sfrs 11-16 were combined (108.0 mg) and 
recrystallized in a mixture of petrol and CHCl3 to give 5.0 mg of similanpyrone B (373). 
Sfrs 27-33 were combined (206.0 mg) and purified by TLC (silica gel G254, CHCl3: 
Me2CO: HCO2H, 97: 3: 0.01) to give 36.0 mg of p-hydroxybenzaldehyde (371). Frs 
231-247 were combined (6.7 g) and recrystallized in a mixture of petrol and CHCl3 to 
give 1.4 g of chevalone C (349). Frs 272-294 were combined (1.5 g) and crystallized 
in mixture of petrol and CHCl3 to yield 265 mg of pyripyropene E (154). Frs 310-327 
were combined (1.2 g), applied on a Sephadex LH-20 column (10 g) and eluted with 
methanol (MeOH), wherein 10 sub-fractions of 1 mL were collected. Sfrs 1-7 were 
combined and purified by TLC (silica gel G254, CHCl3: Me2CO: HCO2H, 19: 1: 0.01) 
to give 108.0 mg of similanamide (380). Frs 328-335 were combined (296.0 mg) and 
applied on a column of Sephadex LH-20 (10 g) and eluted with a mixture of CHCl3-
MeOH (1:1) to give 11.2 mg of chevalone E (356). Frs 336-345 were combined (165.0 
mg) and purified by TLC (silica gel G254, CHCl3: Me2CO: HCO2H, 17: 3: 0.01) to give 
additional 60.0 mg of similanamide (380). Frs 354-398 were combined (1.1 g), applied 
on a Sephadex LH-20 column (10 g) and eluted with a mixture of CHCl3-MeOH (1:1), 
wherein thirty-four sub-fractions of 1mL were collected. Sfrs 7-15 were combined 
(150.0 mg) and purified by TLC (silica gel G254, CHCl3: MeOH: HCO2H, 95: 5: 0.01) 
 196 
 
 CHAPTER V: MATERIALS AND METHODS 
to give 67.0 mg of pyripyropene S (378). Frs 435-443 were combined (377.0 mg), 
applied on a Sephadex LH-20 column (10 g) and eluted with a mixture of CHCl3-MeOH 
(1:1), wherein 14 sub-fractions of 1 mL were collected. Sfrs 8-11 were combined (62.0 
mg) and purified by TLC (silica gel G254, CHCl3: MeOH: HCO2H, 95: 5: 0.01) to give 
35.0 mg of pyripyropene T (379). 
 
5.3.3) Neosartorya quadricincta KUFA 0081 
 
 The fungus was cultured for 7 days at 28 °C in ten 90 mm Petri dishes, 
containing 25 mL of MEA with 70% sea water and 300 mg/L of streptomycin sulphate. 
In order to obtain the mycelial suspension, the mycelial plugs were transferred to two 
500 mL Erlenmeyer flasks containing 200 mL of potato dextrose broth and then 
incubated on a rotary shaker at 120 rpm at 20 °C for 4 days. Fifty 1000 mL Erlenmeyer 
flasks, containing 300 g of cooked rice with 70% sea water per flask, were autoclaved 
at 121 °C for 15 min, inoculated with 20 mL of mycelial suspension of Neosartorya 
quadricincta and then incubated at 28 °C for 30 days, after which the mouldy rice was 
macerated in EtOAc (25 L total) for 7 days and then filtered with filter paper. The two 
layers were separated using separating funnel and the EtOAc solution was 
concentrated under reduced pressure by rotatory evaporator to yield 176.5 g of crude 
EtOAc extract which was dissolved in 500 mL of CHCl3 and then washed with H2O (3 
x 500 mL). The organic layers were separated, combined and dried with anhydrous 
Na2SO4, then filtered and evaporated under reduced pressure to give 31.1 g of the 
crude CHCl3 extract, which was applied on a column of silica gel (440 g) and eluted 
with mixtures of petrol-CHCl3 and CHCl3-Me2CO, 250 mL fractions were collected as 
follows: Frs 1-15 (petrol-CHCl3, 1:1), 16-55 (petrol-CHCl3, 3:7), 56-118 (petrol-CHCl3, 
1:9), 119-284 (CHCl3-Me2CO, 9:1), 285-329 (CHCl3-Me2CO, 7:3), 330-359 (CHCl3-
Me2CO, 1:1). Frs 175-181 were combined (250 mg) and purified by TLC (silica gel 
G254, CHCl3: Me2CO: HCO2H, 3: 2: 0.01) to give 86.6 mg of quadricinctone A (381) 
and 15.0 mg of quadricinctapyran B (383). Frs 182-197 were combined (565.1 mg) and 
purified by TLC (silica gel G254, CHCl3: Me2CO: HCO2H, 17: 3: 0.02) to give 35.1 mg 
of quadricinctone A (381) and 14.3 mg of quadricinctapyran B (383). Frs 224-235 were 
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combined (249.3 mg) and purified by TLC (silica gel G254, CHCl3: Me2CO: HCO2H, 4: 
1: 0.01) to give 11.4 mg of 6-hydroxy-2,2-dimethyl-2,3-dihydro-4H-chromen-4-one 
(385). Frs 236-285 were combined (1.2 g), applied over a column chromatography of 
silica gel (42 g) and eluted with mixtures of petrol-CHCl3 and CHCl3-Me2CO, wherein 
100 mL sub-fractions were collected as follows: sfrs 1-17 (petrol-CHCl3, 1:9), 18-61 
(CHCl3-Me2CO, 9:1). Sfrs 24-33 were combined (432.4 mg) and precipitated in a 
mixture of CHCl3 and Me2CO to give a white solid (46.2 mg), which was recrystallized 
in a mixture of CHCl3 and Me2CO to give 9.4 mg of quadricinctafuran A (388), and the 
mother liquor which left from recrystallization was purified by TLC (silica gel G254, 
CHCl3: Me2CO: HCO2H, 9: 1: 0.01) to give 23.2 mg of quadricinctafuran A (388) and 
4.9 mg of quadricinctapyran A (382). The mother liquor of sfrs 24-33 from the first 
crystallization (133.0 mg) was purified by TLC (silica gel G254, CHCl3: Me2CO: 
HCO2H, 7: 3: 0.01) to give 41.1 mg of quadricinctapyran A (382) and 12.4 mg of 
quadricinctapyran B (383). Sfrs 34-39 were combined (77.7 mg) and purified with TLC 
(silica gel G254, CHCl3: Me2CO: HCO2H, 3: 1: 0.01) to give 7.9 mg of quadricinctone 
B (386) and 17.1 mg of quadricinctapyran A (382). Sfrs 40-61 were combined (496.4 
mg) and purified by TLC (silica gel G254, CHCl3: Me2CO: HCO2H, 4: 1: 0.01) to give 
22.7 mg of quadricinctone C (387). Frs 307-315 were combined (291.0 mg), applied 
over a column chromatography of Sephadex LH-20 (10 g) and eluted with a 1:1 mixture 
of CHCl3-MeOH to give twelve 1 mL sub-fractions. Sfrs 9-12 were combined and 
purified by TLC (silica gel G254, CHCl3: Me2CO: HCO2H, 3: 2: 0.01) to give 13.4 mg 
of quadricinctafuran B (389) and 9.4 mg of quadricinctone D (390). Frs 316-359 were 
combined (1.2 g), applied over a column chromatography of Sephadex LH-20 (10 g) 
and eluted with a 1:1 mixture of CHCl3-MeOH to give twenty-one 1 mL sub-fractions. 
Sfrs 12-21 were combined (645.7 mg), applied over a column chromatography of 
Sephadex LH-20 (10 g) and eluted with a 1:1 mixture of CHCl3-MeOH to give sixteen 
1 mL fractions. Ssfrs 5-16 were combined (597.5 mg), applied over a column 
chromatography of silica gel (15 g) and eluted with a mixture of petrol-CHCl3 and 
CHCl3-Me2CO, wherein 100 mL fractions were collected as follows: frs 1-8 (petrol-
CHCl3, 1:9), 9-28 (CHCl3-Me2CO, 9:1), 29-41 (CHCl3:Me2CO, 7:3). Frs 17-18 were 
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combined (47.4 mg) and purified by TLC (silica gel G254, CHCl3: Me2CO: HCO2H, 3: 
2: 0.01) to give 20.8 mg of quadricinctafuran B (389).   
 
5.4) Physical Characteristics and Spectroscopic Data 
 
6-Bromo-1H-indole-3-carbaldehyde (40): White crystal; mp 205-206 °C; 1H and 13C 
NMR see Table 4; HRESIMS m/z 223.9704 [M+H]+ (calculated for C9H7NOBr, 
223.9711). 
 
Methyl (2E)-3-(6-bromo-1H-indol-3-yl) prop-2-enoate (370): White crystal; mp 212-
214 °C; 1H and 13C NMR see Table 5; HRESIMS m/z 279.9984 [M+H]+ (calculated for 
C12H11NO2Br, 279.9973). 
 
p-Hydroxybenzaldehyde (371): White solid; mp 117-118 °C; 1H and 13C NMR see 
Table 6. 
 
6,8-Dihydroxy-3-methylisocoumarin (372): Yellow solid; mp 252-253 °C; 1H and 13C 
NMR see Table 7. 
 
Similanpyrone B (373): White crystals, mp 162-163 °C (petrol/CHCl3); UV (CHCl3); 
λmax (log ϵ) 240 (4.35), 277 (3.51), 330 (3.46) nm; IR (KBr) ʋmax 3243, 3160, 2923, 
2851, 1677, 1634, 1617, 1585, 1571, 1455, 1256, 1154, 1110 cm-1; 1H and 13C NMR 
see Table 8; HRESIMS m/z 207.0658 [M+H]+ (calculated for C11H11O4, 207.0657). 
 
Reticulol (374): White solid; mp 172-175 °C; 1H and 13C NMR see Table 9; HRESIMS 
m/z 223.0618 [M+H]+ (calculated for C11H10O5, 223.0606). 
 
Similanpyrone A (375): White solid, mp 322-323 °C (petrol/CHCl3); UV (CHCl3); λmax 
(log ϵ) 240 (4.31), 269 (4.31), 295 (3.95), 333 (4.23), 358 (4.16) nm; IR (KBr) ʋmax 3446, 
3010, 2923, 2851, 1748, 1698, 1658, 1634, 1464, 1177, 1151 cm-1; 1H and 13C NMR 
see Table 10; HRESIMS m/z 245.0455 [M+H]+ (calculated for C13H9O5, 245.0450). 
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Similanpyrone C (376): Pale yellow viscous mass; [α]D20 = -80.0 (c 0.01, CHCl3); UV 
(CHCl3); λmax (log ϵ) 239 (4.57), 245 (4.59), 332 (2.10) nm; IR (KBr) ʋmax 3443, 2923, 
2852, 1730, 1683, 1647, 1625, 1572, 1508, 1457, 1429, 1352, 1251 cm-1; 1H and 13C 
NMR see Table 11; HRESIMS m/z 345.1342 [M+H]+ (calculated for C19H21O6, 
345.1338).  
 
Chevalone C (349): White solid; mp 201-202 °C; 1H and 13C NMR see Table 12. 
 
Chevalone E (356): White crystals; mp 262-263 °C (petrol/CHCl3); [α]D20 = –146.3° (c 
0.04, CHCl3); IR (KBr) ʋmax 3300, 3016, 2979, 2950, 2871, 1664, 1607, 1570, 1444, 
1288 cm-1; 1H and 13C NMR see Table 13; HRESIMS m/z 415.2851 [M+H]+ (calculated 
for C26H39O4, 415.2848). 
 
Chevalone B (348): White crystals; mp 161-163 °C; 1H and 13C NMR see Table 14. 
 
S14-95 (377): Pale yellow viscous mass; 1H and 13C NMR see Table 15; HRESIMS 
m/z 451.2488 [M+H]+ (calculated for C28H34O5, 451.2484). 
 
Pyripyropene E (154): White solid; mp 240-244 °C; 1H and 13C NMR see Table 16. 
 
Pyripyropene S (378): Yellow viscous liquid, [α]D20 = +116.3 (c 0.04, CHCl3); IR (KBr) 
ʋmax 2923, 2851, 1742, 1671, 1624, 1586, 1508, 1465, 1374, 1242, 1043 cm-1; 1H and 
13C NMR see Table 17; HRESIMS m/z 566.2415 [M+H]+ (calculated for C31H36NO9, 
566.2390). 
 
Pyripyropene T (379): Pale yellow viscous mass; [α]D20 = +106.0 (c 0.03, CHCl3); IR 
(KBr) ʋmax 3418, 2949, 1732, 1667, 1643, 1557, 1507, 1480, 1246, 1028 cm-1; 1H and 
13C NMR see Table 18; HRESIMS m/z 524.2287 [M+H]+ (calculated for C29H34NO8, 
524.2284). 
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Similanamide (380): Pale yellow viscous mass; [α]D20 = +30.3 (c 0.03, CHCl3); IR (KBr) 
ʋmax 3335, 3054, 2958, 2870, 1682, 1644, 1594, 1519, 1449, 1292 cm-1; 1H and 13C 
NMR see Table 19; HRESIMS m/z 641.4053 [M+H]+ (calculated for C34H53N6O6, 
641.4027). 
 
Quadricinctone A (381): White crystals; mp 176-177 °C (petrol/CHCl3); [α]D20 -59° (c 
0.05, CHCl3); UV (MeOH); λmax (log ϵ) 233 (4.39), 260 (4.03), 298 (3.78) nm; IR (KBr) 
ʋmax 3455, 2981, 2490, 1723, 1612, 1596, 1499, 1467, 1432, 1228 cm-1; 1H and 13C 
NMR, see Table 21; HRESIMS m/z 267.1243 [M+H]+ (calculated for C14H19O5, 
267.1332). 
 
Quadricinctapyran A (382): White crystals; mp 147-148 °C (CHCl3/ Me2CO); [α]D20 
+30° (c 0.03, MeOH); UV (MeOH); λmax (log ϵ) 237 (4.61) nm; IR (KBr) ʋmax 3447, 2922, 
2359, 2341, 1696, 1647, 1609, 1578, 1490, 1430, 1301, 1267 cm-1; 1H and 13C NMR, 
see Table 22; HRESIMS m/z 221.0820 [M+H]+ (calculated for C12H13O4, 221.0814). 
 
Quadricinctapyran B (383): White solid; mp 118-119 °C (petrol/CHCl3); [α]D20 +58° (c 
0.07, CHCl3); UV (MeOH); λmax (log ϵ) 201 (4.13), 237 (4.47) nm; IR (KBr) ʋmax 3441, 
2986, 2943, 1745, 1678, 1640, 1607, 1574, 1453, 1419, 1297, 1264, 1228 cm -1; 1H 
and 13C NMR, see Table 23; HRESIMS m/z 263.0971 [M+H]+ (calculated for C14H15O5, 
263.0919). 
 
Quadricinctoxepine (384): White solid; mp 189-191 °C (CHCl3Me2CO); [α]D20 +21° (c 
0.07, MeOH); UV (MeOH); λmax (log ϵ) 234 (4.50) nm; IR (KBr) ʋmax 3404, 2921, 2359, 
2341, 1701, 1606, 1574, 1497, 1384, 1297, 1259, 1117 cm-1; 1H and 13C NMR, see 
Table 24; HRESIMS m/z 221.0819 [M+H]+ (calculated for C12H13O4, 221.0814). 
  
6-Hydroxy-2,2-dimethyl-2,3-dihydro-4H-chromen-4-one (385): 1H and 13C NMR 
see Table 25. 
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Quadricinctone B (386): White crystals; mp 227-228 °C (CHCl3/Me2CO); [α]D20 +30° 
(c 0.03, MeOH); UV (MeOH); λmax (log ϵ) 205 (4.27), 234 (4.22), 358 (3.64) nm; IR 
(KBr) ʋmax 3442, 2975, 2922, 1690, 1622, 1484, 1441, 1417, 1326, 1251, 1177 cm -1; 
1H and 13C NMR, see Table 26; HRESIMS m/z 255.0694 [M+H]+ (calculated for 
C12H15O4S, 255.0691). 
 
Quadricinctone C (387): White crystals; mp 223-224 °C (CHCl3/Me2CO); [α]D20 +64° 
(c 0.06, MeOH); UV (MeOH); λmax (log ϵ) 214 (4.23), 271 (3.96), 312 (3.70) nm; IR 
(KBr) ʋmax 3439, 3006, 2976, 2360, 2342, 1660, 1644, 1600, 1494, 1472, 1448, 1385, 
1157 cm-1; 1H and 13C NMR, see Table 27; HRESIMS m/z 255.0875 [M+H]+ (calculated 
for C12H15O6, 255.0869). 
 
Quadricinctafuran A (388): White crystals; mp 149-150 °C (CHCl3/Me2CO); [α]D20 
+74° (c 0.03, MeOH); UV (MeOH); λmax (log ϵ) 203 (3.40), 254 (3.49) nm; IR (KBr) ʋmax 
3417, 2920, 1681, 1634, 1491, 1261 cm-1; 1H and 13C NMR, see Table 28; HRESIMS 
m/z 223.9067 [M+H]+ (calculated for C12H15O4, 223.0970). 
 
Quadricinctafuran B (389): White solid; mp 209-210 °C (CHCl3/Me2CO); [α]D20 +20° 
(c 0.05, MeOH); UV (MeOH); λmax (log ϵ) 205 (4.27), 211 (4.03) nm; IR (KBr) ʋmax 3328, 
2984, 2941, 1673, 1610, 1599, 1495, 1362, 1290, 1247 cm-1; 1H and 13C NMR, see 
Table 29; HRESIMS m/z 239.0919 [M+H]+ (calculated for C12H15O5, 239.0919). 
 
Quadricinctone D (390): White crystals; mp 196-197 °C (CHCl3/Me2CO); [α]D20 +19° 
(c 0.05, MeOH); UV (MeOH); λmax (log ϵ) 232 (4.21), 254 (3.84) nm; IR (KBr) ʋmax 3404, 
2934, 2360, 2341, 1708, 1670, 1614, 1492, 1466, 1250 cm-1; 1H and 13C NMR, see 
Table 30; HRESIMS m/z 237.0792 [M+H]+ (calculated for C12H15O5, 237.0763). 
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5.5) X-Ray Crystallographic Analysis  
 
5.5.1) X-Ray Crystal Structure of Chevalone E (356) 
 
The crystals suitable for X-ray diffraction were obtained by slow evaporation of 
a solution in petrol/CHCl3. They were orthorhombic, space group P212121, cell volume 
2310.9(1) Å3 and unit cell dimensions a = 8.2325(2) Å, b = 11.3341(3) Å, and c = 
24.7665(6) Å. Diffraction data were collected at 293 K with a Gemini PX Ultra equipped 
with CuKα radiation (λ = 1.54181 Å). The structures were solved by direct methods 
using SHELXS-97 and refined with SHELXL-97 (Sheldrick, 2008). Carbon, oxygen, 
and nitrogen atoms using refined anisotropically. Hydrogen atoms were refined freely 
with isotropic displacement parameters. The refinement converged to R (all data) = 
6.38% and wR2 (all data) = 10.21%. Towards the end of refinement of the absolute 
structure parameter x (Flack x parameter) was refined at the same time as all other 
parameters, using the TWIN instruction with the default matrix R = (-1 0 0, 0 -1 0, 0 0 
-1) and BASF with one parameter (x), to reach the final value of x = 0.0 (3). The inverted 
structure, obtained with the instruction MOVE  1 1 1 -1, yielded x = 1.5 (3). Tables 
containing the final fractional coordinates, temperature parameters, bond distances, 
and bond angles were deposited with the Cambridge Crystallographic Data Centre: 
CCDC reference number 1002416. 
 
5.5.2) X-Ray Crystal Structure of Quadricinctone A (381), 
Quadricinctapyran A (382), Quadricinctone B (386), Quadricinctone 
C (387), Quadricinctafuran A (388), and Quadricinctone D (390)  
 
 Diffraction data were collected at 293 K with a Gemini PX Ultra equipped with 
CuKα radiation (λ = 1.54184 Å). The structures were solved by direct methods using 
SHELXS-97 and refined with SHELXL-97 (Sheldrick, 2008). Carbon, oxygen and 
Sulphur atoms were refined anisotropically. Hydrogen atoms were either placed at their 
idealized positions using appropriate HFIX instructions in SHELXL and included in 
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subsequent refinement cycles or were directly found from difference Fourier maps and 
were refined freely with isotropic displacement parameters. Full details of the data 
collection and refinement and tables of atomic coordinates, bond lengths and angles 
and torsion angles have been deposited with the Cambridge Crystallographic Data 
Centre. 
 
Quadricinctone A (381): Crystals were triclinic, space group P1, cell volume 
663.27(7) Å3 and unit cell dimensions ɑ = 7.3973(5) Å, b = 8.4830(6) Å and c = 
11.2438(6) Å and angles α = 107.541(5)°, β = 92.005(5)° and γ = 98.365(6)° 
(uncertainties in parentheses). The refinement converged to R (all data) = 3.68% and 
wR2 (all data) = 9.54%. The absolute structure was established with confidence (flack 
x parameter 0.028(18)). CCDC 1465376. 
 
Quadricinctapyran A (382): Crystals were orthorhombic, space group Pbcn, cell 
volumn 2189.45(9) Å3 and unit cell dimension ɑ = 21.3981(5) Å, b = 14.5017(3) Å and 
c = 7.05561(18) Å. The refinement converged to R (all data) = 15.06% and wR2 (all 
data) = 40.39%. CCDC 1468869. 
 
Quadricinctone B (386): Crystals were orthorhombic, space group Ibɑ2, cell volume 
2469.66(11) Å3 and unit cell dimension ɑ = 8.52510(19) Å, b = 30.2340(7) Å and c = 
9.5817(3) Å. The refinement converged to R (all data) = 5.90% and wR2 (all data) = 
15.62%. The absolute structure was established with confidence (flack x parameter      
-0.04(4)). CCDC 1468868. 
 
Quadricinctone C (387): Crystals were monoclinic, space group P21, cell volume 
1116.25(5) Å3 and unit cell dimension ɑ = 12.1131(3) Å, b = 7.0501(2) Å and c = 
13.2091(3) Å and β = 98.291(2)°. The refinement converged to R (all data) = 6.85% 
and wR2 (all data) = 17.04%. CCDC 1468170. 
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Quadricinctafuran A (388): Crystals were monoclinic, space group P21/n, cell volume 
1066.67(10) Å3 and unit cell dimension ɑ = 11.6064(7) Å, b = 5.9593(2) Å and c = 
15.8588(8) Å and β = 103.481(6)°. The refinement converged to R (all data) = 11.08% 
and wR2 (all data) = 24.01%. CCDC 1468171. 
 
Quadricinctone D (390): Crystals were orthorhombic, space group Pcɑ21, cell volume 
1081.35(13) Å3 and unit cell dimension ɑ = 19.5607(13) Å, b = 7.4646(5) Å and c = 
7.4058(5) Å. The refinement converged to R (all data) = 3.81% and wR2 (all data) = 
8.57%. CCDC 1468166. 
 
5.6) Molecular Mechanics Conformation Analysis of 
Quadricinctoxepine (383) and Quadricinctone D (390) 
 
 Molecular simulations for structures 383 and 390 were carried out in 
ChemBio3D Ultra 14 (Perkin-Elmer). Molecular mechanics energy minimizations used 
the MM2 and MMFF force fields with the ChemBio3D most recent default parameters 
and implementation, adequate for small to medium carbon-based models. Ab initio 
MP2/6-311G and semi-empirical PM3 molecular modelling was done using CS 
GAMESS interfaced by ChemBio3D. The conformational search was done by 
stochastic, dihedral driver and molecular dynamics methods. Around 60 conformations 
were stochastically created and then minimized using the PM3, MMFF and PM3 
methods. The resulting models were then grouped under the resultant two seven-
membered ring conformations (exemplified in Figure 61 for 384). A minimal energy for 
each model set was found by driving by 360° the dihedral angles of the single bonds 
that attach substituent groups to the rings. Molecular dynamics runs were also applied 
to the models to confirm the convergence to a minimal energy conformation for each 
model set. 
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5.7) Biological Activity Assays 
 
5.7.1) Cytotoxicity Bioassay 
 
5.7.1.1) Samples 
 Stock solutions of the compounds were prepared in DMSO and kept at -20 °C. 
Appropriate dilutions of the compounds were freshly prepared just before the assays. 
 
5.7.1.2) Cell cultures 
 Three human tumor cell lines were used in this study, including MCF-7 (breast 
adenocarcinoma, NCI, Bethesda, USA), NCI-H460 (non-small cell lung cancer, 
NSCLC, NCI, Bethesda, USA), and A375-C5 (melanoma, ECACC, UK). Cells were 
cultured in RPMI-1640 with Ultraglutamine (Lonza) supplemented with 10% FBS (PAA) 
and maintained in a humidified incubator at 37 °C with 5% CO2. Cell number and 
viability were determined with Trypan Blue exclusion assay. All experiments were 
performed with cells in exponential growth with viabilities over 90% and repeated at 
least three times. 
 
5.7.1.3) Cell growth inhibitory assay 
 The screening of fungal metabolites was performed with the Sulforhodamine B 
(SRB) assay adopted from the National Cancer Institute, USA (Cidade et al., 2001). 
Briefly, 5 × 103 cells of MCF-7 and NCI-H460 cell lines, and 7.5 × 103 cells of the A375-
C5 cell line were placed in 96 wells plate and incubated at 37 °C for 24 h. The growing 
cells were treated with five dilutions of each compound. After 48 h of treatment, cells 
were fixed with 10% ice-cold trichloroacetic acid, then washed and stained with SRB. 
After washing with 1% acetic acid, the bound SRB was solubilized with 10 mM Tris 
Base, and the absorbance was measured at 515 nm in a microplate reader (Biotek 
Instruments). A dose-response curve was obtained for each compound and the 
corresponding GI50 (the concentration of compound that inhibited 50% of net cell 
growth) was determined. The effect of the vehicle solvent (DMSO) on the growth of 
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these cell lines was evaluated by treating cells with the maximum concentration of 
DMSO used in each assay (0.25%). 
 
5.7.2) Antimicrobial Activity Assays 
 
5.7.2.1) Bacterial and Fungal Strains 
 For the antimicrobial assays, the compounds were tested against the reference 
strains, including four strains of bacteria (Staphylococcus aureus ATCC 25923, 
Bacillus subtilis ATCC 6633, Escherichia coli ATCC 25922, and Pseudomonas 
aeruginosa ATCC 27853), three strains of fungi (yeast; Candida albicans ATCC 10231, 
filamentous fungus; Aspergillus fumigatus ATCC 46645, and dermatophyte; 
Trichophyton rubrum FF5), and three strains of multidrug-resistant bacteria isolated 
from the environment (S. aureus B1 isolated from public bus, Enterococcus faecalis 
W1 isolated from river water, and E. coli G1 isolated from seagull feces). Bacterial 
isolates were grown in Mueller-Hinton agar (MH-BioKar diagnostics, Allonne, France) 
from stock cultures, while C. albicans was grown in Sabouraud dextrose agar (SAB-
BioDar diagnostics, Allonne, France). MH and SAB plates were incubated at 37 °C 
prior to obtain fresh cultures for each in vitro bioassay. 
 
5.7.2.2) Determination of Minimum Inhibitory and Bactericidal/Fungal 
Concentrations 
 The minimum inhibitory concentrations (MIC) of the compounds were 
determined using a broth microdilution technique, following the recommendations of 
the Clinical and Laboratory Standards Institute (Franklin and Cockerill, 2011). Stock 
solutions of 10 mg/mL, prepared in dimethylsulfoxide (DMSO-Applichem GmbH, 
Darmstadt, Germany), were serially diluted in Mueller-Hinton broth (MHB-BioKar 
diagnostics, Allonne, France) to achieve in-test concentrations ranging from 2 to 256 
μg/mL. Bacterial inoculums and C. albicans inoculum were prepared in MHB and 
RPMI-1640 with L-glutamine, respectively, with MOPS and without NaHCO3 (Lonza, 
Walkersville, MD, USA). All inocula were standardized in order to obtain a 
concentration of 5 × 105 CFU/mL in each inoculated well of the microtiter plate. The 
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concentration of DMSO in the highest in-test concentration did not affect the microbial 
growth. The MIC was defined as the lowest concentration of compound that has 
inhibited the visible growth. 
 
5.7.2.3) Synergistic Studies 
5.7.2.3.1) Screening of Combined Effect the Compounds and Antibiotics 
 A screening susceptibility test to assess the combined effect between the 
compounds and antibiotics was evaluated using the disc diffusion method on Mueller 
Hinton (MH) medium. Multidrug-resistant isolates were obtained from overnight 
cultures in MH, and suspensions were prepared in buffered peptone water (Oxoid, 
England) by adjusting the turbidity to equal a 0.5 McFarland standard. A set of antibiotic 
discs (Oxoid, England) was selected based on the resistance of the isolates towards 
those antibiotics. Antibiotic disc alone (controls) and impregnated with 15 μL of a 1 
mg/mL solution (in DMSO) of each metabolite were placed on the agar plate seeded 
with the respective bacteria. 15 μL of DMSO impregnated in a sterile filter paper disc 
(6 mm in diameter) (Oxoid, England) was used as the negative control. Inoculated MH 
plates were incubated overnight at 37 °C. Each compound was tested in duplicate. 
Potential synergism was recorded when the halo of antibiotic discs impregnated with 
metabolites was greater than the halo of antibiotic discs or compound-impregnated 
blank discs alone. 
 
5.7.2.3.2) Synergy Test: Checkerboard Method 
 Based on the result of the previous assay, potential synergy between chevalone 
E (356) and oxacillin or ampicillin (Sigma-Aldrich, St. Louis, MO, USA) was evaluated 
using a broth microdilution checkerboard method and tested against MRSA isolate (S. 
aureus B1). Briefly, the stock solutions and serial twofold dilutions of the compound 
and antibiotic to at least double the MIC were prepared according to the 
recommendations of CLSI (Franklin and Cockerill, 2011). The metabolite to be tested 
was serially diluted along the ordinate, while the antibiotic was diluted along the 
abscissa. A bacterial inoculum equal to a 0.5 McFarland turbidity standard was 
prepared in MHB. Each microtiter plate well was inoculated with 100 μL of a bacterial 
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inoculum of 5 × 105 CFU/mL, and the plates were inoculated overnight at 37 °C. The 
fractional inhibitory concentration (FIC) was calculated as follows: FIC of drug A (FIC 
A) = MIC of drug A in combination/MIC of drug A alone. The FIC index (ΔFIC), 
calculated as the sum of each FIC, was interpreted as follows: ΔFIC ≥ 0.5, synergy; 
0.5 < ΔFIC ≤4, no interaction; ΔFIC > 4, antagonism (Odds, 2003). 
 
5.8) Amino Acids Analysis of Acidic Hydrolysate of 
Similanamide (380) 
 
5.8.1) Acid Hydrolysis 
 The stereochemistry of the amino acids was determined by analysis of the acidic 
hydrolysate from 380. Five milligrams of 380 was dissolved in 5 mL of 6 N HCl, and 
heated at 110 °C, in a furnace, for 24 h in a sealed glass tube. After cooling to room 
temperature, the solution was dried under N2 for 24 h, reconstituted in methanol for 
HPLC-MS (200 μL), filtered through a 4 mm PTFE Syringe Filter F2504-4 of 0.2 μm 
pore size (Thermo Scientific, Mumbai, India), and then analyzed by HPLC equipped 
with a chiral column. 
 
5.8.2) Chiral HPLC Analysis 
  The HPLC system consisted of Shimadzu LC-20AD pump, equipped with a 
Shimadzu DGV-20A5 degasser, a Rheodyne 7725i injector fitted with a 20 μL loop, 
and an SPD-M20A DAD detector (Kyoto, Japan). Data acquisition was performed 
using Shimadzu LCMS Lab Solutions software, version 3.50 SP2. The Chiral column 
used in this study was Chirobiotic T (15 cm × 4.6 mm I.D., particle size 5 μm) 
manufactured by ASTEC (Whippany, NJ, USA). The mobile phase composition was 
MeOH: H2O: CH3CO2H, 70: 30: 0.02, v/v/v), all were LC-MS grade solvents obtained 
from Sigma-Aldrich Co (St. Luis, MO, USA). The flow rate was 0.5 mL/min and the UV 
detection wavelength was 210 nm. Analyses were performed at room temperature in 
the isocratic mode. 
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 All standards of racemic amino acids and pure amino acid enantiomers were 
purchased from Sigma-Aldrich Co (St. Louis, MO, USA). The elution order of the 
enantiomers of all the standard amino acids was confirmed by injecting the solutions 
of the racemic or enantiomeric mixtures, and then each enantiomer separately (or only 
L-amino acid in the case of N-methyl leucine) at a flow rate of 1 mL/min or 0.5 mL/min. 
Working solutions of single enantiomeric amino acids were prepared by dissolution in 
MeOH at the concentration of 1 mg/mL (10 μL sample injection), while the enantiomeric 
mixtures were prepared by mixing equal aliquots of each enantiomer (20 μL sample 
injection). Mix HPLC analyses of the acidic hydrolysate with standard amino acids (co-
injection) confirmed the stereochemistry of the amino acid of similanamide (380). 
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In this study, the marine sponge Iotrochota baculifera, collected from the Gulf of 
Thailand, together with two marine-derived fungi, Aspergillus similanensis KUFA 0013, 
isolated from the marine sponge Rhabdermia sp. and Neosartorya quadricincta KUFA 
0081, isolated from the marine sponge Clathria reinwardti, were investigated for their 
secondary metabolites. 
Chemical investigation of the marine sponge I. baculifera resulted in isolation of 
two previously described bromoindoles, 6-bromo-1H-indole-3-carbaldehyde (40) and 
methyl (2E)-3-(6-bromo-1H-indol-3-yl)prop-2-enoate (370). 
 The investigation of the ethyl acetate extract of the culture of the marine sponge-
associated fungus A. similanensis KUFA 0013 resulted in isolation of three new 
isocoumarin derivatives: similanpyrones A (375), B (373) and C (376), one new 
chevalone derivative: chevalone E (356), two new pyripyropene derivatives: 
pyripyropenes S (378) and T (379), and one new cyclohexapeptide: similanamide 
(380), together with seven previously reported: p-hydroxybenzaldehyde (371), 6,8-
dihydroxy-3-methylisocoumarin (372), reticulol (373), chevalones B (348) and C (349), 
S14-95 (377) and pyripyropene E (154). 
 Although several chevalone analogs have been reported from several members 
of the genera Aspergillus and Neosartorya, A. similanensis KUFA 0013 also produced 
analogs of chevalone, including chevalone B (348), chevalone C (349) a new 
chevalone derivative, chevalone E (356). Similanpyrone C (376), a new isocoumarin 
derivative, showed a unique structure, containing an unusual 1,7-dioxaspiro-
undecenone moiety. This is the first report of isolation of isocoumarin derivatives from 
a member of this genus. 
 Several cyclohexapeptides have been reported from marine-associated 
microorganisms. However, similanamide is the first cyclohexapeptide which was 
reported from the marine-associated fungus. 
 Pyripyropene E (154), chevalone E (356), 6,8-dihydroxy-3-methylisocoumarin 
(372), similanpyrone B (373), reticulol (374), similanpyrone A (375), S14-95 (377), 
pyripyropenes S (378) and T (379),  and similanamide (380) were evaluated for their 
antibacterial activity against Gram-positive (Staphylococcus aureus ATCC 25923 and 
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Bacillus subtilis ATCC 6633) and Gram-negative (Escherichia coli ATCC 25922 and 
Pseudomonas aeruginosa ATCC 27853) bacteria, as well as multidrug-resistant 
isolates from the environment (S. aureus B1, Enterococcus faecalis W1 and E. coli 
G1). None of the tested compounds exhibited antibacterial activity at the highest 
concentration tested (256 μg/mL). 
 Furthermore, pyripyropene E (154), chevalone E (356), 6,8-dihydroxy-3-
methylisocoumarin (372), similanpyrone B (373), reticulol (374), similanpyrone A (375), 
S14-95 (377) and pyripyropene S (378)  were further evaluated for synergistic effect 
with the antibiotics (ciprofloxacin, ampicillin, cefotaxime, streptomycin, oxacillin, 
vancomycin and erythromycin) against three multidrug-resistant isolates from the 
environment, using a disc diffusion method. However, none of the tested compounds 
exhibited any synergistic effects for multidrug-resistant E. faecalis and E. coli, except 
for chevalone E (356) which demonstrated potential synergistic effect with oxacillin 
against the MRSA strain. There for, this compound can be considered relevant for anti-
infective marine natural products research. 
 Pyripyropene E (154), chevalone E (356), 6,8-dihydroxy-3-methylisocoumarin 
(372), similanpyrone B (373), reticulol (374), similanpyrone A (375), S14-95 (377) and 
pyripyropene S (378) were tested for their antifungal activity against Candida albicans 
ATCC 10231, and all of them were inactive at the highest concentration tested (256 
μg/mL). 
 Moreover, pyripyropene T (379) and similanamide (380) were evaluated for their 
cytotoxicity against three human cell lines, including MCF-7 (breast adenocarcinoma), 
NCI-H460 (non-small cell lung cancer) and A373 (melanoma). Only similanamide (380) 
showed weak in vitro growth inhibitory activity against the three cell lines with GI50 
values of 125 ± 0, 117.50 ± 3.55 and 115 ± 7.07 mM, respectively. 
 The investigation of the ethyl acetate extract of the culture of the marine sponge-
derived fungus Neosartorya quadricincta KUFA 0081 resulted in isolation of two new 
pentaketides: a new benzofuran-1-one derivative, quadricinctone A (381), and a new 
isochromen-1-one derivative, quadricinctone C (387), together with seven new benzoic 
acid derivatives: two new benzopyran derivatives, quadricinctapyrans A (382) and B 
(383), a new benzoxepine derivative, quadricinctoxepine (384), two new chromen-4-
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one derivatives, quadrincinctones B (386) and D (390), and two new benzofuran 
derivatives, quadricinctafurans A (388) and B (389), as well as the previously reported 
compound, 6-hydroxy,2,2-dimethyl-2,3-dihydro-4H-chromen-4-one (385). 
 An isocoumarin derivative, PF1223, was first reported by Ozoe et al. (2004), 
using a GABA receptor ligand as a screening target, from the culture of the fungus N. 
quadricincta PF1223, but the source of the fungus was not revealed. Thus, this is the 
first report of the secondary metabolites from the culture of a marine-derived N. 
quadricincta (KUFA 0081). 
 The unique, but related, structures of the isolated metabolites from the fungus 
N. quadricincta KUFA 0081 has allowed us to propose the biosynthetic pathway of 
these metabolites. Interestingly, the structure of quadricinctone B (386), which 
possesses a methyl sulfinyl group in the benzopyran nucleus, revealed the capacity of 
this marine-derived fungus to introduce sulphur in to the aromatic ring. Thus, this 
fungus can have potential for biotechnological transformation.  
 Quadricinctone A (381), quadricinctapyrans A (382) and B (383), 
quadricinctoxepine (384), 6-hydroxy,2,2-dimethyl-2,3-dihydro-4H-chromen-4-one 
(385), quadrincinctones B (386) and D (390), quadricinctone C (387), and 
quadricinctafurans A (388) and B (389)  were tested for their antimicrobial activity 
against Gram positive (S. aureus and B. subtilis) and Gram negative (E. coli and P. 
aeruginosa) bacteria, the multidrug-resistant isolates from the environment (S. aureus 
B1, E. faecalis W1 and E. coli G1), yeast (C. albicans), filamentous fungus (A. 
fumigatus ATCC 46645) and dermatophyte (T. rubrum FF5). The tested compounds 
did not show any antimicrobial activity at the highest concentration tested (256 μg/mL 
for antibacterial assay and 512 μg/mL for antifungal assay). 
 The isolated metabolites were also evaluated for their in vitro growth inhibitory 
activity against MCF-7, NCI-H460 and A375-C5 cell lines by the protein binding dye 
SRB method, however, all of them were inactive against the cell lines tested (GI50 > 
150 mM). 
 Even though, all the tested compounds, except for chevalone E (356) and 
similanamide (380), exhibited neither antimicrobial activity nor growth inhibitory activity 
against three human cancer cell lines in our assay protocols, it does not mean that  
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they are devoid of other interesting biological activities. In order to prove this 
hypothesis, it is necessary to investigate their potential in other target-based assay 
protocols. 
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Abstract: Two new isocoumarin derivatives, including a new 5-hydroxy-8-methyl-2H, 
6H-pyrano[3,4-g]chromen-2,6-dione (1) and 6,8-dihydroxy-3,7-dimethylisocoumarin (2b), a 
new chevalone derivative, named chevalone E (3), and a new natural product pyripyropene 
S (6) were isolated together with 6, 8-dihydroxy-3-methylisocoumarin (2a), reticulol (2c), 
p-hydroxybenzaldehyde, chevalone B, chevalone C, S14-95 (4), and pyripyropene E (5) 
from the ethyl acetate extract of the undescribed marine sponge-associated fungus 
OPEN ACCESS 
Mar. Drugs 2014, 12 5161 
 
Aspergillus similanensis KUFA 0013. The structures of the new compounds were 
established based on 1D and 2D NMR spectral analysis, and in the case of compound 3,  
X-ray analysis was used to confirm its structure and the absolute configuration of its 
stereogenic carbons. Compounds 1, 2a–c and 3–6 were evaluated for their antimicrobial 
activity against Gram-positive and Gram-negative bacteria, Candida albicans ATCC 10231, 
and multidrug-resistant isolates from the environment. Chevalone E (3) was found to show 
synergism with the antibiotic oxacillin against methicillin-resistant Staphylococcus  
aureus (MRSA). 
Keywords: Aspergillus similanensis; similanpyrones; isocoumarins; meroditerpenes; 
pyripyropenes; chevalones 
 
1. Introduction 
Neosartorya is a teleomorphic (sexual) state of Aspergillus section Fumigati. Although Neosartorya 
species (Trichocomaceae) have not been as extensively investigated for their secondary metabolites as 
Aspergillus, they have recently been shown to be an interesting source of many bioactive compounds [1–9]. 
In our ongoing search for new natural products with antibacterial activity produced by the marine-derived 
fungi of the genus Neosartorya, we have investigated the secondary metabolites of a Thai collection of 
a new species of Neosartorya, isolated from the marine sponge Rhabdermia sp., collected from the 
Similan Islands, Phang Nga Province, Southern Thailand. However, in order to comply with the recent 
“International Code of Nomenclature for algae, fungi and plants (The Melbourne Code)”, the strain was 
renamed Aspergillus similanensis (KUFA0013). The ethyl acetate extract of its culture furnished, 
besides chevalones B and C [9,10], p-hydroxybenzaldehyde, reticulol (2c) [11], 6,8-dihydroxy-3-
methylisocoumarin (2a) [12], a meroterpenoid S14-95 (4) [13], pyripyropene E (5) [14], two new 
isocoumarins which we have named similanpyrones A (1) and B (2b), a new chevalone analog (3), and a 
new natural product which we have named pyripyropene S (6) [15] (Figure 1). Compounds 1, 2a–c, 3–6 
were evaluated for their antimicrobial activity against Gram positive (Staphylococcus aureus ATCC 
25923 and Bacillus subtilis ATCC 6633) and Gram negative (Escherichia coli ATCC 25922 and 
Pseudomonas aeruginosa ATCC 27853) bacteria, Candida albicans ATCC 10231, as well as  
multidrug-resistant isolates from the environment. 
  
Mar. Drugs 2014, 12 5162 
 
Figure 1. Secondary metabolites from Aspergillus similanensis KUFA0013. 
 
2. Results and Discussion 
Compound 1 was isolated as white solid (mp, 322–323 °C), and its molecular formula C13H8O5 was 
established on the basis of the (+)-HRESIMS m/z 245.0450 [M + H]+, indicating ten degrees of 
unsaturation. The IR spectrum showed absorption bands for hydroxyl (3446 cm−1), conjugated lactone 
carbonyl (1748, 1698 cm−1), aromatic (1658 cm−1) and olefin (1634, 1464 cm−1) groups. The 13C NMR 
(Supplementary Information, Figure S2), DEPTs and HSQC spectra (Table 1, Supplementary 
Information, Figure S4) revealed the presence of two conjugated ester carbonyls (δC 166.3 and 159.7), 
six quaternary sp2 (δC 101.3, 107.3, 130.0, 140.1, 156.2 and 160.3), four methine sp2 (δC 102.7, 104.6, 
114.1, and 137.8) and one methyl (δC 19.6) carbons. The 1H NMR spectrum (Supplementary 
Information, Figure S1) revealed, besides a singlet of the hydrogen bonded hydroxyl proton at δH 11.90, 
two doublets of the cis-olefinic protons at δH 8.13 (J = 9.8 Hz) and 6.36 (J = 9.8 Hz), two singlets at δH 
6.33 and 6.70, and one methyl singlet at δH 2.33. The COSY spectrum (Table 1; Supplementary 
Information, Figure S3) exhibited cross peak between the singlet at δH 6.33 (H-9) and the methyl singlet 
at δH 2.33 (Me-8), suggesting that they were allylically coupled. On the other hand, the HMBC spectrum 
(Table 1; Supplementary Information, Figure S5) showed cross peaks of H-9 to C-8 (δC 156.2), C-9a 
(δC 130.3), C-10 (δC 102.7), and C-5a (δC 101.3), of H-10 (δH 6.70, s) to C-5a, C-4a (δC 107.3), C-9a 
and C-10a (δC 140.1), of Me-8 to C-8 and C-9 (δC 104.6), and of OH-5 (δH 11.90) to C-5 (δC 160.3),  
C-5a and C-4a. Taking together the 1H and 13C chemical shift values and the COSY, HSQC and HMBC 
correlations (Table 1), the presence of 4a, 10a-disubstituted-5-hydroxy-8-methylisochromen-6-one was 
corroborated. That the 5-hydroxy-8-methylisochromen-6-one nucleus was fused with a pyran-2-one 
moiety on C-4a and C-10a was substantiated by the HMBC correlations of H-4 (δH 8.13, d, J = 9.8 Hz) 
to C-10a (δC 140.1), and of H-3 (δH 6.36, d, J = 9.8 Hz) to C-4a (δC 107.3) and C-2 (δC 159.7), 
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respectively. Thus, the structure of compound 1 was established as 5-hydroxy-8-methyl-2H, 
6H-pyrano[3,4-g]chromene-2,6-dione. To the best of our knowledge, this is the first report on the 
isolation of a secondary metabolite with both coumarin and isocoumarin functionalities in the same 
molecule. Thus, compound 1 is a new compound which we have named similanpyrone A. 
Table 1. 1H and 13C NMR (CDCl3, 500.13 MHz and 125.8 MHz) and HMBC assignment 
for similanpyrone A (1). 
Position δC, Type δH, (J in Hz) COSY HMBC 
2 159.7, C -   
3 114.1, CH 6.36, d (9.8) H-4 10a 
4 137.8, CH 8.13, d (9.8) H-3 C-2, 4a 
4a 107.3, C -   
5 160.3, C -   
5a 101.3, C -   
6 166.3, C -   
8 156.2, C -   
9 104.6, CH 6.33, s CH3-8 C-5a, 8, 10, Me-8 
9a 130.0, C -   
10 102.7, CH 6.70, s  C-4a, 5a, 9a, 10a 
10a 140.1, C -   
CH3-8 19.6, CH3 2.33, s H-9 C-8, 9 
OH-5 - 11.90, s  C-4a, 5, 5a 
Compound 2b was also isolated as white solid (mp, 162–163 °C), and its molecular formula C11H10O4 
was established on the basis of the (+)-HRESIMS m/z 207.0658 [M + H]+, indicating seven degrees of 
unsaturation. The IR spectrum showed absorption bands for hydroxyl (3243, 3160 cm−1), conjugated 
carbonyl (1677 cm−1), olefin (1635 cm−1) and aromatic (1617 cm−1) groups. The general feature of the 
1H (Supplementary Information, Figure S6), and 13C NMR spectra (Supplementary Information, Figure S7) 
of 2b (Table 2) closely resembled those of 1, except for the absence of the proton and carbon signals of 
the pyran-2-one moiety. Instead, there were an additional methyl (δH 2.00 s; δC 8.0) and hydroxyl (δH 
3.45 brs) groups in the structure of 2b. That the second methyl group was on C-7 and the second hydroxyl 
group was on C-6 was corroborated by the HMBC cross peaks of the methyl singlet at δH 2.20, s to the 
signals of C-6 (δC 163.7), C-7 (δC 109.6) and C-8 (δC 106.9). Thus, the structure of compound 2b was 
established as 6, 8-dihydroxy-3, 7-dimethylisochromen-1-one. Literature survey revealed that 2b is a new 
compound, and therefore we have named it similanpyrone B. 
Compound 3 was isolated as white crystals (mp, 262–263 °C), and its molecular formula C26H38O4 
was established on the basis of the (+)-HRESIMS m/z 415.2851 [M + H]+, indicating eight degrees of 
unsaturation. The IR spectrum showed absorption bands for hydroxyl (3300 cm−1), conjugated carbonyl 
(1664 cm−1) and olefin (1607, 1570 cm−1) groups. The 13C NMR (Supplementary Information, 
Figure S9), DEPTs and HSQC spectra revealed the presence of one conjugated ketone carbonyl 
(δC 180.6), three quaternary sp2 (δC 162.6, 160.5, 98.5), one methine sp2 (δC 111.9), one oxygen bearing 
quaternary sp3 (δC 84.3), one oxygen bearing methine sp3 (δC 78.7), three quaternary sp3 (δC 37.1, 37.3, 
38.9), three methine sp3 (δC 52.3, 55.3, 60.3), seven methylene sp3 (δC 15.2, 17.9, 18.7, 27.2, 38.4, 40.1, 
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41.1) and six methyl (δC 15.4, 16.1, 16.4, 19.2, 20.5, 28.0) carbons. The general feature of the 1H 
(Supplementary Information, Figure S8), and 13C NMR spectra of 3 resembled those of chevalone C [9], 
except for the chemical shift values of the oxygen bearing methine carbon (C-3) which appeared at lower 
frequencies (δC 78.7; δH 3.21, dd, J = 11.1, 5.0 Hz) than those of chevalone C [9]. Furthermore, the 1H 
and 13C NMR spectra of compound 3 did not exhibit the signals of the acetyl group. Taking together the 
IR, HRMS and NMR data, it was possible to conclude that compound 3 is a deacetyl analog of chevalone 
C. Since this is the first report of isolation of this chevalone analog, we have named it chevalone E. Final 
proof of the structure and the stereochemistry assigned to chevalone E (3) was provided by an X-ray 
analysis (Figure 2), and since the diffraction data were collected with a Gemini PX Ultra equipped with 
CuKα radiation, it was possible to establish the absolute configuration of C-3, C-5, C-8, C-9, C-10,  
C-13 and C-14, respectively as 3S, 5R, 8R, 9R, 10R, 13S and 14S.  
Table 2. 1H and 13C NMR (CDCl3, 500.13 MHz and 125.8 MHz) and HMBC assignment 
for similanpyrone B (2b). 
Position δC, Type δH, (J in Hz) COSY HMBC 
1 166.1, CO -   
3 153.3, C -   
4 104.2, CH 6.46, s CH3-3 C-5, 8a 
4a 136.5, C -   
5 101.4, CH 6.40, s  C-4, 6, 7, 8a 
6 163.7, C -   
7 109.6, C -   
8 160.0, C -   
8a 97.5, C -   
CH3-3 18.8, CH3 2.20, s  C-3, 4 
CH3-7 8.0, CH3 2.00, s  C-6, 7, 8 
OH-6 - 3.45, br   
OH-8 - 11.27, s  C-7, 8, 8a 
Figure 2. Ortep view of chevalone E (3). 
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The (+)-HRESIMS of compound 6 indicated the [M + H]+ peak at m/z 566.2416, corresponding to 
C31H36NO9. Thus, the molecular formula of compound 6 was C31H35NO9, indicating fifteen degrees of 
unsaturation. The IR spectrum showed absorption bands for ester carbonyl (1742 cm−1), conjugated 
carbonyl (1671 cm−1), aromatic (1586, 1508, 1465 cm−1) and olefin (1625 cm−1) groups. The 13C NMR 
(Supplementary Information, Figure S11), DEPTs and HSQC spectra (Table 3) revealed the presence of 
three ester carbonyls (δC 171.0, 170.4, 169.8), one conjugated carbonyl (δC 161.3), five quaternary sp2 
(δC 161.2, 157.2, 144.5, 127.4, 101.1), six methine sp2 (δC 152.1, 146.6, 133.1, 123.8, 111.2, 98.6), one 
oxyquaternary sp3 (δC 83.9), two oxymethine sp3 (δC 77.7 and 73.2), one oxymethylene sp3 (δC 64.7), 
two quaternary sp3 (δC 40.6 and 38.8), one methine sp3 (δC 41.1), three methylene sp3 (δC 35.5, 24.3 and 
23.2), and six methyl (δC 24.2, 21.3, 21.2, 21.2, 20.8 and 13.3) carbons. Analysis of the 1H 
(Supplementary Information, Figure S10), 13C, HSQC and HMBC spectra (Table 3) revealed the 
presence of, besides three acetoxyl groups (δC 170.4, 21.2, δH 2.05s; δC 171.0, 20.8, δH 2.10s; δC 169.8, 
21.2, δH 2.17, s), a hexasubstituted decahydronaphthalene ring system. That two of the acetoxyl groups 
were on C-1 and C-7, and the three methyl groups were on C-4, C-6 and C-10 of the 
decahydronaphthalene moiety was substantiated by the HMBC cross peaks of the Me-15 singlet 
(δH 0.88, s) to the carbon signals at δC 40.6 (C-10), 72.2 (C-1), 64.7 (C-11), of the Me-12 singlet (δH 1.26, s) 
to the carbon signals at δC 35.5 (C-3), 38.8 (C-4), 41.1 (C-9), and of the Me-14 singlet (δH 1.59, s) to the 
carbon signals at δC 77.7 (C-7), 83.9 (C-6), and 144.5 (C-5). That another substituent on C-10 was the 
acetoxymethylene group was evidenced by the HMBC cross peaks of H-11 signals (δH 3.75, d, J = 11.9 Hz; 
3.79, d, J = 11.9 Hz) to C-1, C-9, and the signal of the carbonyl at δC 171.0. On the other hand, since 
Me-14 singlet gave cross peaks to the signals of the oxyquaternary carbon at δC 83.9 (C-6) and the 
quaternary sp2 carbon at δC 144.5 (C-5), the double bond was on C-5, and C-6 was oxygen bearing. This 
was corroborated by the HMBC cross peaks of the signal of the olefinic proton at δH 6.36, s (H-13) to 
C-4 and C-6. Moreover, the HMBC spectrum also exhibited a cross peak of H-13 signal to the signals 
of a conjugated carbonyl carbon at δC 161.3 (C-2′) and the quaternary sp2 carbon at δC 161.2 (C-4′). On 
the other hand, there were also HMBC cross peaks of another olefinic proton at δH 6.54, s (H-5′) to C-4′ 
and the signals of another two quaternary sp2 carbon at δC 101.1 (C-3′) and 157.2 (C-6′). Taken together 
the HMBC correlations, it was clear that the decahydronaphthalene ring system was fused, on C-5 and 
C-6, with 2H, 5H-pyrano[4, 3-b]pyran-5-one ring system. The COSY and HMBC spectra also indicated 
the presence of the 3-substituted pyridine ring. That this pyridine ring was connected to the pyranone 
ring through C-3 of the former and C-6′ of the later was evidenced by the HMBC correlations of the  
H-5′ singlet to C-3″ (δC 127.4), as well as of the signal of H-2″ (δH 8.14, dt, J = 7.8, 2.4, 2.4 Hz) to C-6′. 
Literature search revealed that compound 6 was previously obtained by treatment of pyripyropene A 
with HCl under anhydrous condition [15]; however, there were neither reports of the 1H and 13C data 
nor other description of this compound. Since 6 is a new natural product, we have named it pyripyropene S. 
It is interesting to point out that 6 is the first natural pyripyropene that lacks a hydroxyl group on C-13. 
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Table 3. 1H and 13C NMR (CDCl3, 500.13 MHz and 125.8 MHz) and HMBC assignment 
for pyripyropene S (6). 
Position δC, Type δH, (J in Hz) COSY HMBC 
1 73.2, CH 4.79, dd (11.7, 4.6) H-2  
2 23.2, CH2 
1.99, m H-1  
1.76, m   
3 35.5, CH2 2.09, m H-2  
4 38.8, C -   
5 144.5, C -   
6 83.9, C -   
7 77.7, CH 5.23, dd (11.9, 5.4) H-8 C-6 
8 24.3, CH2 
1.82, ddd (12.8, 5.1, 1.4) H-7, H-9  
1.61, m   
9 41.1, CH 1.73, brd (12.5) H-8  
10 40.6, C -   
11 64.7, CH2 
3.75, d (11.9)  C-1, 9, CO (OAc-11) 
3.79, d (11.9)   
12 24.2, CH3 1.26, s  C-3, 4, 9 
13 111.2, CH 6.36, s  C-4, 6, 4′ 
14 21.3, CH3 1.59,s  C-5, 6, 7 
15 13.3, CH3 0.88, s  C-1, 10, 11 
2′ 161.3, C -   
3′ 101.1, C -   
4′ 161.2, C -   
5′ 98.6, CH 6.54, s  C-2′, 3′, 6′, 3″ 
6′ 157.2, C -   
2″ 146.6, CH 9.02, brs H-4″ C-3″, 4″, 6″ 
3″ 127.4, C -   
4″ 133.1, CH 8.14, dt (7.8, 1.4, 1.4) H-2″, 5″ C-6′, 2″, 6″ 
5″ 123.8, CH 7.42, dd (8.0, 4.9) H-4″, 6″ C-3″, 6″ 
6″ 151.2, CH 8.68, brd (4.0) H-5″ C-5″ 
OAc-1 
170.4, CO -   
21.2, CH3 2.05, s  CO (OAc-1) 
OAc-7 
169.8, CO -   
21.2, CH3 2.17, s  CO (OAc-7) 
OAc-11 
171.0, CO -   
20.8, CH3 2.10, s  CO (OAc-11) 
Compounds 1, 2a–c and 3–6 were tested for their antimicrobial activity against Gram positive 
(Staphylococcus aureus ATCC 25923 and Bacillus subtilis ATCC 6633) and Gram negative 
(Escherichia coli ATCC 25922 and Pseudomonas aeruginosa ATCC 27853) bacteria, Candida albicans 
ATCC 10231, and multidrug-resistant isolates from the environment. All the compounds tested 
exhibited neither antibacterial nor antifungal activities, i.e., their MIC values were found to be higher 
than 256 µg/mL. Like chevalone C, chevalone E (3) does not possess the structural requirements for the 
antibacterial activity of this group of meroditerpenes, i.e., the presence of the β-acetoxyl group on C-3 
and the presence of a free 4-hydroxy-6-methyl-2H-pyran-2-one ring on C-15 [9]. Therefore, it is not 
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surprising that chevalone E (3) did not exhibit significant antibacterial activity. The fact that chevalone C 
did not show significant antibacterial activity but demonstrated synergistic effect with the antibiotics 
against three multidrug-resistant isolates [9] led us explore if some of these compounds could possibly 
have synergistic effects with antibiotics, i.e., by using a disc diffusion method to assess if, in combination 
with antibiotics, they could cause an increase in the growth inhibition of multidrug-resistant strains. The 
results (Table 4) showed that no synergistic effects were observed between the tested compounds and 
antibiotics for multidrug-resistant E. coli and E. faecalis; however chevalone E (3) was found to exhibit 
potential synergy with oxacillin and ampicillin against the MRSA strain. 
Table 4. Antibacterial efficacy of combined effect of antibiotics with the compounds 
(15 µg/disc) against three multidrug-resistant isolates, using the disc diffusion method. 
Compound 
E. coli G1 S. aureus B1 E. faecalis W1 
Antibiotics 
CIP AMP CTX S OX AMP CIP VA AMP E 
1 − − − − − − − − − − 
2a − − − − − ++ − − − − 
2b − − − − − ++ − − − − 
2c    − − ++ − − − − 
3 − − − − +++ +++ − − − − 
4   − −  ++ − − − − 
5 − − − − − ++ − − − − 
6 − − − − − ++ − − − − 
(−) noneffective; (+) slight efficacy—halo of inhibition or additional increase in the halo of 1 to 2.5 mm around 
the disc; (++) moderate efficacy—from >2.5 to 5 mm; (+++) good efficacy—from >5 to 8 mm;  
CIP: ciprofloxacin; AMP: ampicillin; CTX: cefotaxime; S: streptomycin; OX: oxacillin; VA: vancomycin;  
E: Erythromycin. 
In order to verify if the synergism occurred with both antibiotics or with either of them, the 
checkerboard method was carried out. The results, represented by the fractional inhibitory concentration 
(FIC) index, shown in Table 5, confirmed the synergy between chevalone E (3) and oxacillin, and not 
between chevalone E (3) and ampicillin. It is interesting to note that while chevalone E (3) shows 
synergism with oxacillin against the MRSA isolate, the structurally related meroditerpene aszonapyrone 
exhibited synergism only with vancomycin against the VRE isolate, and not with oxacillin against the 
MRSA strain [9]. 
Table 5. MIC values of chevalone E (3) in combination with oxacillin or ampicillin,  
and the respective FIC index obtained against a MRSA (S. aureus B1) using the  
checkerboard method. 
Strain MIC (µg/mL) 
S. aureus B1 
3 alone OX alone 3 with OX OX with 3 FIC index 
˃1024 128 64 16 ˂0.188 * 
S. aureus B1 
3 alone AMP alone 3 with AMP AMP with 3 FIC index 
˃1024 128 ˃512 128 ˃1.5 
* FIC index < 0.5 indicates synergy. 
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3. Experimental Section 
3.1. General Procedures 
Melting points were determined on a Bock monoscope and are uncorrected. Optical rotations were 
determined on an ADP410 Polarimeter (Bellingham + Syanley Ltd., Tunbridge Wells, Kent, UK). 
Infrared spectra were recorded on an ATT Mattson Genesis Series FTIR™ using WinFIRST Software. 
1H and 13C NMR spectra were recorded at ambient temperature on a Bruker AMC instrument  
(Bruker Biosciences Corporation, Billerica, MA, USA) operating at 500.13 and 125.8 MHz, 
respectively. High resolution mass spectra were measured with a Waters Xevo QToF mass spectrometer 
(Waters Corporations, Milford, MA, USA) coupled to a Waters Aquity UPLC system. A Merck silica 
gel GF254 was used for preparative TLC, and a Merck Si gel 60 (0.2–0.5 mm) was used for  
analytical chromatography. 
3.2. Extraction and Isolation 
The strain KUFA0013 was isolated from the marine sponge Rhabdermia sp., which was collected 
from the coral reef of the Similan Islands, Phang Nga Province, Thailand, by scuba diving at 10 m depth, 
in April 2010, and the sponge was identified by J. Buaruang (Division of Environmental Science, Faculty 
of Science, Ramkhamhaeng University, Bangkok 10240, Thailand). Briefly, after rinsing with sterile sea 
water, the sponge was dried on sterile filter paper and cut into small pieces (5 × 5 mm) and placed on 
the plates containing malt extract agar [MEA, 30 g of malt extract powder (Himedia, Mumbai, India), 
15 g of bacto agar, distilled water 300 mL, sea water 700 mL and adjusted to the final pH at 5.5] with 
70% sea water and incubated at 28 °C under 12 h light/12 h dark cycle for seven days. The fungus was 
identified by one of us (T. Dethoup), by morphological features, including characteristic of ascospores, 
conidiogenesis and colonies, as well as by DNA sequence analysis of the calmodulin gene described by 
the previous report [16] (GenBank Accession No. KC 920702). Since the sequence was not identical to 
that deposited at GenBank, the strain was not identified at species level. The pure cultures were deposited 
as KUFA0013 at the Department of Plant Pathology, Faculty of Agriculture, Kasetsart University, 
Bangkok, Thailand. A. similanensis (KUFA 0013) was cultured for one week in five 90 mm Petri dishes 
(i.d. 90 mm) containing 25 mL of MEA with 70% sea water per dish. Thirty 1000 mL Erlenmeyer flasks, 
each containing white rice (200 g), water (30 mL) and sea water (70 mL), were autoclaved at 121 °C for 
15 min, inoculated with ten mycelia plugs of the fungus and incubated at 28 °C for 30 days. The moldy 
rice was macerated in ethyl acetate (7 L total) for seven days and then filtered by filter paper. The two 
layers were separated using a separatory funnel, and the ethyl acetate solution was evaporated under 
reduced pressure to yield 97 g of crude ethyl acetate extract that was dissolved in 500 mL of a 4:1 
mixture of EtOAc and CHCl3, and then washed with 5% NaHCO3 aqueous solution (2 × 300 mL) and 
H2O (3 × 300 mL). The organic layer was dried with anhydrous Na2SO4, filtered and evaporated under 
reduced pressure to give 75 g of crude extract, which was applied on a column chromatography of silica 
gel (640 g) and eluted with mixtures of CHCl3–petrol and CHCl3–Me2CO, 250 mL fractions were 
collected as follows: Frs 1–18 (CHCl3–petrol, 3:7), 19–53 (CHCl3–petrol, 1:1), 54–114 (CHCl3–petrol, 
7:3), 115–215 (CHCl3–petrol, 9:1), 216–395 (CHCl3–Me2CO, 9:1), 396–443 (CHCl3–Me2CO, 7:3). Frs 
185–196 were combined (654 mg) and purified by TLC (Si gel, CHCl3:Me2CO:HCO2H, 97:3:0.01) to 
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give 4 mg of 1. Frs 197–221 were combined (1.16 g) and crystallized in a mixture of petrol and CHCl3 
to give additional 107.6 mg of yellow solid which was further purified by TLC (Si gel, 
CHCl3:Me2CO:HCO2H, 98:2:0.01) to give 2.5 mg of 1. Fr 222 (8.06 g) was recrystallized in a mixture 
of CHCl3 and Me2CO to give 238 mg of white precipitate, which was further purified by TLC (Si gel, 
CHCl3:Me2CO:HCO2H, 97:3:0.01) to give 2b (32.7 mg), 4 (4.6 mg) and chevalone B (4.6 mg). The 
mother liquor was further purified by TLC (Si gel, CHCl3:Me2CO:HCO2H, 97:3:0.01) to give 2b (41.0 mg), 
4 (7.2 mg) and chevalone B (70.8 mg). The mother liquor of frs 197–221 and fr 222, and frs 223–224 
were combined (9.18 g), applied on the Si gel column (58 g), and eluted with mixtures of petrol–CHCl3 
and CHCl3–Me2CO, wherein 100 mL sfrs were collected as follows: sfrs 1-59 (petrol–CHCl3, 3:7), 60–69 
(petrol–CHCl3, 1:9), 70–76 (CHCl3–Me2CO, 9:1). Sfrs 11–22 were combined (1.97 g) and crystallized in 
a mixture of petrol and CHCl3 to give additional 16.4 mg of 1. Sfrs 29–42 were combined (468 mg) and 
crystallized in a mixture of petrol and CHCl3 to give additional 92.1 mg of 2b. Frs 225–228 were 
combined (446 mg) and crystallized in a mixture of petrol and CHCl3 to give 63 mg of a precipitate 
which was further purified by TLC (Si gel, CHCl3:Me2CO:HCO2H, 97:3:0.01) to give 2b (35.8 mg) and 
2a (35.4 mg). The mother liquor of frs 225–228 and frs 229–330 were combined and chromatographed 
on a Si gel column (33 g) and eluted with mixtures of petrol–CHCl3 and CHCl3–Me2CO, wherein 100 mL 
sub-fractions were collected as follows: sfrs 1–49 (petrol–CHCl3, 3:7), 50–64 (petrol–CHCl3, 1:9), 65–77 
(CHCl3–Me2CO, 9:1). Subfrs 4–5 were combined and recrystallized in a mixture of petrol and CHCl3 to 
give 1 (2.4 mg). Sfrs 6–10 were combined (160 mg) and recrystallized in a mixture of petrol and CHCl3 
to give 2c (7.6 mg). Sfrs 11–16 were combined (108 mg) and recrystallized in a mixture of petrol to give 
2b (5 mg). Sfrs 27-33 were combined (206 mg) and purified by TLC (Si gel, CHCl3: Me2CO. 93:7) to 
give p-hydroxybenzaldehyde (36 mg). Frs 231–247 were combined (6.7 g) and recrystallized in a 
mixture of petrol and Me2CO to give 1.39 g of chevalone C. Frs 272–294 were combined (1.54 g) and 
crystallized in a mixture of petrol and Me2CO to yield 5 (265 mg). Frs 328-335 were combined (296 mg) 
and applied on a column of Sephadex LH-20 (22 g) and eluted with a mixture of CHCl3–MeOH  
(9:1) to give 3 (11.2 mg). Frs 354–398 were combined (1.14 g) and purified by TLC (Si gel, 
CHCl3:MeOH:HCO2H, 95:5:0.01) to give 6 (27.3 mg). 
3.2.1. Similanpyrone A (1) 
White solid, Mp 322–323 °C (petrol/CHCl3); UV (CHCl3) λmax (log ε) 240 (4.31), 269 (4.31), 295 
(3.95), 333 (4.23), 358 (4.16) nm; IR (KBr) νmax 3446, 3010, 2923, 2851, 1748, 1698, 1658, 1634, 1464, 
1177, 1151 cm−1; 1H and 13C NMR (Table 1); HRESIMS m/z 245.0455 (M + H)+ (calculated for 
C13H9O5, 245.0450). 
3.2.2. Similanpyrone B (2b) 
White crystals, Mp 162–163 °C (petrol/CHCl3); UV (CHCl3) λmax (log ε) 240 (4.35), 277 (3.51), 330 
(3.46) nm; IR (KBr) νmax 3243, 3160, 2923, 2851, 1677, 1634, 1617, 1585, 1571, 1455, 1256, 1154, 
1110 cm−1; 1H and 13C NMR (Table 2); HRESIMS m/z 207.0658 (M + H)+ (calculated for  
C11H11O4, 207.0657). 
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3.2.3. Chevalone E (3) 
White crystals, Mp 262–263 °C (petrol/CHCl3); [α]D20 −146.3° (c 0.04, CHCl3); IR (KBr) νmax 3300, 
3016, 2979, 2950, 2871, 1664, 1607, 1570, 1444, 1288 cm−1; 1H NMR (CDCl3, 500.13 MHz) δ 5.99 
(1H, s, H-18), 3.21 (1H, d, J = 11.1, 5.0, H-3), 2.55 (1H, dd, J = 16.4, 4.9, H2-15), 2.20 (3H, s, H3-20), 
2.15 (1H, m, H2-15), 2.14 (1H, m, H2-12), 1.90 (1H, dt, J = 12.8, 3, H2-7), 1.74 (1H, m, H2-11), 1.73 
(1H, m, H2-1), 1.71 (1H, m, H2-12), 1.64 (2H, m, H2-2), 1.59 (1H, m, H2-6), 1.50 (1H, dd,  
J = 12.5, 4.7, H-14), 1.45 (1H, m, H2-6), 1.36 (1H, m, H2-11), 1.28 (3H, s, H3-26), 1.05 (1H, m, H2-7), 
1.00 (1H, m, H2-1), 0.98 (3H, s, H3-23), 0.93 (1H, brd, J = 13.2, H-9), 0.89 (3H, s, H3-25), 0.84 (3H, s, 
H3-24), 0.78 (1H, brd, J = 11-6, H-5), 0.78 (3H, s, H3-22); 13C NMR (CDCl3, 125.8 MHz) δ 180.6 (CO, 
C-17), 162 (C, C-16), 160.5 (C, C-21), 111.9 (CH, C-18), 98.5 (C, C-19), 84.3 (C, C-13), 78.7 (CH, C-3), 
60.3 (CH, C-9), 55.3 (CH, C-5), 52.3 (CH, C-14), 41.1 (CH2, C-7), 40.1 (CH2, C-12), 38.9 (C, C-4), 
38.4 (CH2, C-1), 37.3 (C, C-8), 37.1 (C, C-10), 28.0 (CH3, C-23), 27.2 (CH2, C-2), 20.5 (CH3, C-26), 
19.2 (CH3, C-20), 18.7 (CH2, C-11), 17.9 (CH2, C-6), 16.4 (CH3, C-24), 16.1 (CH3, C-25), 15.4 (CH3, 
C-22), 15.2 (CH3, C-15); HRESIMS m/z 415.2851 (M + H)+ (calculated for C26H39O4, 415.2848). 
3.2.4. Pyripyropene S (6) 
Yellow viscous liquid, [α]D20 +116.3 (c 0.04, CHCl3); IR (KBr) νmax 2923, 2851, 1742, 1671, 1624, 
1586, 1508, 1465, 1374, 1242, 1043 cm−1; 1H and 13C NMR (Table 3); HRESIMS m/z 566.2415  
(M + H)+ (calculated for C31H36NO9, 566.2390). 
3.3. X-ray Crystal Structure of Chevalone E (3) 
Crystals suitable for X-ray diffraction were obtained by slow evaporation of a solution in petroleum 
ether/chloroform. They were orthorhombic, space group P212121, cell volume 2310.9(1) Å3 and unit cell 
dimensions a = 8.2325(2) Å, b =11.3341(3) Å and c = 24.7665(6) Å. Diffraction data were collected at 
293 K with a Gemini PX Ultra equipped with CuKα radiation (λ = 1.54184 Å). The structures were 
solved by direct methods using SHELXS-97 and refined with SHELXL-97. Carbon, oxygen and 
nitrogen atoms were refined anisotropically. Hydrogen atoms were refined freely with isotropic 
displacement parameters. The refinement converged to R (all data) = 6.38% and wR2 (all data) = 10.21%. 
Towards the end of refinement the absolute structure parameter x (Flack x parameter) was refined at the 
same time as all other parameters, using the TWIN instruction with the default matrix R = (−1 0 0, 0 −1 
0, 0 0 −1) and BASF with one parameter (x), to reach the final value of x = 0.0 (3). The inverted structure, 
obtained with the instruction MOVE 1 1 1 −1, yielded x = 1.5 (3). Tables containing the final fractional 
coordinates, temperature parameters, bond distances, and bond angles were deposited with the 
Cambridge Crystallographic Data Centre: CCDC reference number 1002416. 
3.4. Antimicrobial Activity Assays 
3.4.1. Bacterial Strains 
For the antimicrobial assays, the compounds were tested against: bacterial reference strains 
(Staphylococcus aureus ATCC 25923, Bacillus subtilis ATCC 6633, Escherichia coli ATCC 25922 and 
Mar. Drugs 2014, 12 5171 
 
Pseudomonas aeruginosa ATCC 27853), Candida albicans ATCC 10231 and multidrug-resistant 
bacteria isolated from the environment, S. aureus B1 (isolated from public bus), Enterococcus faecalis 
W1 (isolated from river water) and E. coli G1 (isolated from seagull feces). Bacteria were grown in 
Mueller-Hinton agar (MH-BioKar diagnostics, Allonne, France) from stock cultures, while C. albicans 
was grown in Sabouraud dextrose agar (SAB-BioKar diagnostics, Allonne, France). MH and SAB plates 
were incubated at 37 °C prior to obtain fresh cultures for each in vitro bioassay. 
3.4.2. Determination of Minimum Inhibitory and Bactericidal/Fungal Concentrations 
The minimum inhibitory concentrations (MIC) of the compounds were determined using a broth 
microdilution technique, following the recommendations of the Clinical and Laboratory Standards 
Institute [17]. Stock solutions of 10 mg/mL, prepared in dimethylsulfoxide (DMSO-Applichem GmbH, 
Darmstadt, Germany), were serially diluted in Mueller-Hinton broth (MHB-BioKar diagnostics, 
Allonne, France) to achieve in-test concentrations ranging from 2 to 256 µg/mL. Each bacterial inoculum 
was prepared in MHB, while C. albicans inoculum was prepared in RPMI-1640 with L-glutamine, with 
MOPS and without NaHCO3 (Lonza, Walkersville, MD, USA). All inocula were standardized in order 
obtain a concentration of 5 × 105 CFU/mL in each inoculated well of the microtiter plate. The 
concentration of DMSO in the highest in-test concentration did not affect the microbial growth. The 
MIC was defined as the lowest concentration of compound that has inhibited the visible growth.  
3.4.3. Synergistic Studies 
3.4.3.1. Screening of Combined Effect between the Compounds and Antibiotics 
A screening susceptibility test to assess the combined effect between the compounds and antibiotics 
was conducted using the disc diffusion method on MH, according to the procedure already described by 
Gomes et al. [9]. 
3.4.3.2. Synergy Test: Checkerboard Method 
Based on the results of the previous assay, potential synergy between 3 and oxacillin or ampicillin 
(Sigma-Aldrich, St. Louis, MO, USA) was checked using a broth microdilution checkerboard method 
and tested in MRSA isolate (S. aureus B1), as has been already described [9]. Two independent 
experiments in duplicate were performed. The fractional inhibitory concentration (FIC) was calculated 
as follows: FIC of drug A (FIC A) = MIC of drug A in combination/MIC of drug A alone, and FIC of 
drug B (FIC B) = MIC of drug B in combination/MIC of drug B alone. The FIC index (ΣFIC), calculated 
as the sum of each FIC, was interpreted as follows: ΣFIC ≤ 0.5, synergy; 0.5 < ΣFIC ≤ 4, no interaction; 
4 < ΣFIC, antagonism [18]. 
4. Conclusions 
Although several analogs of chevalone have been reported from several members of the genus 
Aspergillus, this is the first report of isolation of isocoumarin derivatives from a member of this genus. 
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The synergism of chevalone E with the antibiotic oxacillin against MRSA can be considered relevant 
for anti-infective marine natural products research. 
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Abstract: A new isocoumarin derivative, similanpyrone C (1), a new cyclohexapeptide, 
similanamide (2), and a new pyripyropene derivative, named pyripyropene T (3) were 
isolated from the ethyl acetate extract of the culture of the marine sponge-associated 
fungus Aspergillus similanensis KUFA 0013. The structures of the compounds were 
established based on 1D and 2D NMR spectral analysis, and in the case of compound 2 the 
stereochemistry of its amino acid constituents was determined by chiral HPLC analysis of 
the hydrolysate by co-injection with the D and L amino acids standards. Compounds 2 and 
3 were evaluated for their in vitro growth inhibitory activity against MCF-7 (breast 
adenocarcinoma), NCI-H460 (non-small cell lung cancer) and A373 (melanoma) cell lines, 
OPEN ACCESS 
Mar. Drugs 2015, 13 1433 
 
as well as antibacterial activity against reference strains and the environmental  
multidrug-resistant isolates (MRS and VRE). Only compound 2 exhibited weak activity 
against the three cancer cell lines, and neither of them showed antibacterial activity. 
Keywords: Aspergillus similanensis; cyclic hexapeptide; similanamide; isocoumarin; 
similanpyrone C; pyripyropene T 
 
1. Introduction 
In recent years, there has been an increasing interest in marine-derived fungi as a target source of 
bioactive marine natural products because many consider them among the world’s greatest untapped 
resources for new biodiversity as well as chemodiversity [1–3]. Moreover, through established culture 
methods, the compounds can be produced in quantity needed for medicinal chemistry development, 
clinical trials and even marketing. Among the marine fungal strains investigated, the fungi of the genus 
Aspergillus are the most prolific source of bioactive secondary metabolites, including sterols [4], 
cerebrosides [5], sesquiterpenoids [6,7], sesterterpenoids [8,9], diterpenoids [10], meroterpenoids [11], 
anthraquinone derivatives [12,13], nucleoside derivatives [14], indole alkaloids [15–17], prenylated 
indole alkaloids [18–21], quinazolinone alkaloids [22,23], pyrrolidine alkaloids [8], and cyclic 
peptides [24–28]. 
In our ongoing search for new natural products with antibacterial and anticancer activities produced 
by the marine-derived fungi of the genera Neosartorya and Aspergillus, we have recently reported the 
isolation of new isocoumarins similanpyrones A and B, a new chevalone (chevalone E), and a new 
natural product pyripyrone S; besides the previously reported chevalone B and C, a meroterpenoid 
S14-95, and pyripyropene E, from the crude ethyl acetate extract of the undescribed marine  
sponge-associated fungus Aspergillus similanensis KUFA 0013 [29]. Reexamination of the  
fractions remaining from the previous study of this fungus led to the isolation of a new  
8-hydroxy-3-methylisocoumarin derivative, which we have named similanpyrone C (1), a new cyclic 
hexapeptide, similanamide (2), and a new pyripyropene analog, pyripyropene T (3) (Figure 1). 
Hydrolysis of compound 2, followed by HPLC analysis of its hydrolysate using a chiral column, led to 
the elucidation of its amino acid constituents. Compounds 2 and 3 were evaluated for their 
antibacterial activity as well their cytotoxicity against three human cancer cell lines. 
Mar. Drugs 2015, 13 1434 
 
 
Figure 1. Secondary metabolites from Aspergillus similanensis KUFA0013. 
2. Results and Discussion 
Compound 1 was isolated as pale yellow viscous mass, and its molecular formula C19H20O6 was 
established on the basis of the (+)-HRESIMS m/z 345.1342 [M + H]+, indicating ten degrees of 
unsaturation. The IR spectrum showed absorption bands for hydroxyl (3443 cm−1), ketone carbonyl 
(1730 cm−1), conjugated lactone carbonyl (1683 cm−1), olefin (1647 cm−1) and aromatic (1625, 1572 cm−1) 
groups. The 13C NMR (Supplementary Information, Figure S3), DEPTs and HSQC spectra (Table 1, 
Supplementary Information, Figure S4) revealed the presence of one ketone carbonyl (δC 205.3), one 
conjugated ester carbonyl (δC 166.8), six quaternary sp2 (δC 160.0, 158.3, 153.4, 136.7, 110.0 and 
99.6), two methine sp2 (δC 104.4 and 103.0), one ketal (δC 102.9), two sp3 methine (δC 67.2 and 33.9), 
two sp3 methylene (δC 48.3 and 47.2), and three methyl (δC 21.6, 19.4 and 15.9) carbons. The 1H NMR 
spectrum (Supplementary Information, Figure S1) revealed, besides a singlet of the hydrogen bonded 
hydroxyl proton at δH 11.35, one doublet at δH 6.13 (J = 0.9 Hz) and one singlet at δH 6.26, two 
multiplets at δH 4.15 and δH 1.98, two double double doublets at δH 2.48 (J = 14.7, 2.9, 1.9 Hz) and δH 
2.28 (J = 14.7, 11.3, 0.7 Hz), two double doublets at δH 2.81 (J = 16.8, 5.6 Hz) and δH 2.55 (14.0, 1.9), 
two broad doublets at δH 2.81 (J = 14.0 Hz) and δH 2.57 (J = 16.8 Hz), one methyl singlet at δH 2.24, 
and two methyl doublets at δH 1.23 (J = 6.2 Hz) and δH 1.21 (J = 6.2 Hz). 
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Table 1. 1H and 13C NMR (CDCl3, 500.13 MHz and 125.8 MHz) and HMBC assignment for 1. 
Position δC, Type δH, (J in Hz) COSY HMBC NOESY 
1 166.8, CO -    
3 153.4, C -    
4 104.4, CH 6.13, d (0.9) CH3-3 C-3, 5, 8a CH3-3 
4a 136.7, C -    
5 103.0, CH 6.26, s  C-4, 6, 7, 8a  
6 158.3, C -    
7 110.0, C -    
8 160.0, C -    
8a 99.6, C -    
9α 23.6, CH2 2.81, dd (16.8, 5.6) H-9β, H-10 C-6, 7, 10, 11 H-9β, H-10, CH3-10 
9β  2.57, brd (16.8) H-9α, H-10 C-7, 10, 11 H-9α, H-10, CH3-10 
10 33.9, CH 1.98, m H-9α, H-9β, CH3-10  H-9α,H-9β, CH3-10 
11 102.9, C -    
12α 47.2, CH2 2.55, dd (14.0, 1.9) H-12β C-10, 11, 13 H-12β 
12β  2.81, brd (14.0) H-12α C-10, 11, 13 H-12α 
13 205.3, CO -    
14α 48.3, CH2 2.28, ddd (14.7, 11.3, 0.7) H-14β, H-15 C-13, 15 H-14β, CH3-15 
14β  2.48, ddd (14.7, 2.9, 1.9) H-14α, H-15 C-13 H-14β, CH3-15 
15 67.2, CH 4.15, m H-14α, H-14β, CH3-15  H-14β, CH3-15 
CH3-3 19.4, CH3 2.24, s H-4 C-3, 4 H-4 
CH3-10 15.9, CH3 1.23, d (6.2) H-10 C-9, 10, 11 H-9β, H-10, H-12α, 2β 
CH3-15 21.6, CH3 1.21, d (6.2) H-15 C-14, 15 H-14α, H-14β, H-15 
OH-8 - 11.35, s  C-7, 8, 8a  
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Analysis of the 1H, 13C NMR, HSQC and HMBC spectra (Table 1) revealed the presence of a  
6,7-disubstituted 3-methyl-1H-isochromen-1-one nucleus, similar to that of similanpyrone B [29]. 
Thus, another portion of the molecule consisted of one ketone (δC 205.3), one ketal (δC 102.9), one 
methine (δH 1.98, m; δC 33.9), one oxymethine (δH 4.15, m; δC 67.2), three methylene (δH 2.81, dd,  
J = 16.8, 5.6 Hz and δH 2.57, brd, J = 16.8 Hz, δC 23.6; δH 2.81, brd, J = 14.0 Hz and 2.55, dd,  
J = 14.0, 1.9 Hz; δC 47.2; δH 2.48, ddd, J = 14.7, 2.9, 1.9 Hz and 2.28, ddd, J = 14.7, 11.3, 0.7 Hz,  
δC 48.3), two methyl (δH 1.21, d, J = 6.2 Hz; δC 21.6 and δH 1.23, d, J = 6.2 Hz, δC 15.9) groups. That 
this portion was 2,10-dimethyl-1,7-dioxaspiro[5.5]undec-8-en-4-one was evidenced by the COSY 
correlations (Table 1, Supplementary Information, Figure S2) of H2-9 (δH 2.81, dd, J = 16.8, 5.6 Hz 
and 2.57, brd, J = 16.8 Hz) to H-10 (δH 1.98, m), of H-10 to CH3-10 (δH 1.23, d, J = 6.2 Hz), of H2-14  
(δH 2.48, ddd, J = 14.7, 2.9, 1.9 Hz and 2.28, ddd, J = 14.7, 11.3, 0.7 Hz) to H-15 (δH 4.15, m), and of 
H-15 to CH3-15 (δH 1.21, d, J = 6.2 Hz), as well as by the HMBC cross peaks (Table 1, Supplementary 
Information, Figure S5) of H2-9 to C-10 and C-11 (δC 102.9), of H2-12 (δH 2.81, brd, J = 14.0 Hz  
and 2.55, dd, J = 14.0, 1.9 Hz) to C-10, 11, 13 (δC 205.3), and of H-14 to C-13 and 15, respectively  
(Figure 2). That the 1,7-dioxaspiro[5.5]undec-8-en-4-one ring system was fused with the  
3-methyl-1H-isochromen-1-one nucleus, through C-8 and C-9 of the methyldihydropyran ring of the 
former and C-6 and C-7 of the latter, was supported by the HMBC correlations of H2-9 to C-6, 7 
(Table 1, Supplementary Information, Figure S5). Literature search revealed that 1 is a new compound, 
and in compliance with our previous work, we have therefore named it similanpyrone C. Since 1 was 
isolated as viscous mass, it was not possible to obtain suitable crystals for the X-ray analysis. 
Consequently, the absolute configuration of C-10, C-11 and C-15 is still undetermined. 
 
Figure 2. Key HMBC correlations of compound 1. 
In an attempt to determine the stereochemistry of C-10 and C-15, we have sorted out the coupling 
constants of both H2-9 and H2-14. The fact that H2-9 appeared as a double doublet at δH 2.81 with a 
germinal coupling of 16.8 Hz, and a small coupling at δH 5.6 Hz, typical of axial-equatorial coupling, 
and a broad doublet at δH 2.57 with a germinal coupling constant of 16.8 Hz, we concluded that  
CH3-10 was in the β-axial position of the half-chair conformation of the tetrahydropyran ring. This was 
corroborated by the correlations of H-10, which was in α equatorial position, to both H-9β (δH 2.57, 
brd, J = 16.8 Hz) and H-9α (δH 2.81, dd, J = 16.8, 5.6 Hz) in the NOESY spectrum (Table 1, 
Supplementary Information, Figure S6). On the contrary, one of H-14 appeared as a double double 
doublet at δH 2.28, with a germinal coupling of 14.7 Hz and a diaxial coupling of 11.3 Hz, as well as a 
small coupling (long range) of 0.7 Hz, while another appeared also as a double double doublet at  
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δH 2.48, with a germinal coupling of 14.7 Hz and an axial-equatorial coupling of 2.9 Hz, as well as a 
small coupling (long range) of 1.9 Hz. These patterns of couplings revealed that CH3-15 was in α 
equatorial position of the chair conformation of the tetrahydro-4H-pyran-4-one ring. This analysis was 
corroborated by the NOESY spectrum (Table 1, Supplementary Information, Figure S6), which 
exhibited a correlation only between H-15 and H-14β (δH 2.48, ddd, J = 14.7, 2.9, 1.9 Hz) and not 
between H-15 and H-14α (δH 2.28, ddd, J = 14.7, 11.3, 0.7 Hz). This assignment was also supported by 
the higher chemical shift value of H-14β than that of H-14α since the former is under the anisotropic 
deshielding of the C-13 carbonyl group. Based on the same reasoning, we assigned the broad doublet 
at δH 2.81 (J = 14.0 Hz) as H-12β, and the double doublet at δH 2.55 (J = 14.0, 1.9 Hz) as H-12α. 
Consequently, the relative configuration of C-10 and C-15 was tentatively assigned as 10S* and 15R*. 
The relative configuration of C-11 was tentatively assigned as 11S* based on the fact that the NOESY 
spectrum (Table 1, Supplementary Information, Figure S6) did not exhibit any correlation between  
H-10 and H-15. According to the molecular model, when the configuration of C-11 is S*, the 
substituents on C-11 are arranged in a way that H-10 and H-15 are pointing toward the opposite 
directions. On the contrary, the R* configuration of C-11 would have H-10 and H-15 close enough to 
give a strong NOESY correlation. 
Similanpyrone C (1) can be assumed to be derived from the acetate-malonate pathway  
(Scheme 1). Cyclization and enolization of the pentaketide (I) leads to the formation of  
6,8-dihydroxy-3-methylisocoumarin (II), which, after Claisen condensation with the tetraketide (III), 
gives rise to IV. Enolization of the side chain, together with a formation of the hemiketal by the 
phenolic hydroxyl group on C-6 of the isocoumarin nucleus and the ketone carbonyl of the side chain, 
leads to the formation of a hemiketal V. Formation of the ketal and methylation by SAM in the side 
chain finally gives rise to similanpyrone C (1). 
Compound 2 was isolated as pale yellow viscous mass, and its molecular formula C34H52N6O6 was 
established on the basis of the (+)-HRESIMS m/z 641.4053 [M + H]+, indicating twelve degrees of 
unsaturation. The IR spectrum showed absorption bands for amine (3335 cm−1), carbonyl (1682,  
1644 cm−1) and aromatic (1594, 1519 cm−1). The 13C NMR (Supplementary Information, Figure S8), 
DEPTs and HSQC spectra (Table 2, Supplementary Information, Figure S10) revealed the presence of 
six amide carbonyls (δC 174.3, 174.2, 170.7, 170.2, 169.3, 168.9), two quaternary sp2 (δC 137.0, 
122.7), four methine sp2 (δC 131.7, 127.1, 123.9, 123.4), eight methine sp3 (δC 65.1, 61.4, 59.3, 50.9, 
47.9, 29.9, 25.5, 24.4), six methylene sp3 (δC 52.5, 37.8, 36.2, 28.1, 27.4, 24.5) and eight methyl  
(δC 37.9, 23.3, 23.2, 22.1, 21.7, 19.8, 18.4, 16.2) carbons. The 1H NMR spectrum (Table 2, 
Supplementary Information, Figure S7) revealed, besides four NH signals at δH 7.43, d (J = 7.4 Hz), 
7.64, d (J = 9.8 Hz), 8.02, d (J = 7.9 Hz) and 9.41, brs, the signals of the aromatic protons of the  
1,2-disubstituted benzene ring at δH 7.20, dd (J = 7.7, 1.5 Hz), 7.13, ddd (J = 7.9, 7.9, 1.0 Hz), 7.47, 
ddd, (J = 7.9, 7.9, 1.6 Hz) and 8.29, d (J = 8.3 Hz). That the 1,2-disubstituted benzene ring belonged to 
the anthranilic acid residue was corroborated by the HMBC correlations of the NH signal at δH 9.41, 
brs to the carbon signal at δC 123.9 (C-6), and of the double doublet at δH 7.20 (J = 7.7, 1.5 Hz, H-3) to 
the carbons at δC 131.7 (C-5), 137.0 (C-7) and 170.2 (CO-1) (Table 2, Figure 3, Supplementary 
Information, Figure S11). The anthranilic acid residue was linked to the valine residue, through the 
amino group of the former and the carboxyl group of the latter, since the HMBC spectrum 
(Supplementary Information, Figure S11) showed correlations of the NH signal at δH 9.41, brs to the 
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carbonyl carbon at δC 170.7 (C-8), of the methine proton at δH 4.32 dd, J = 7.4, 3.3 Hz (H-9) to the 
methine carbon at δC 29.9 (C-10), the methyl carbon at δC 16.2 (C-12) and C-8, and of the NH signal at 
δH7.43, d (J = 7.5 Hz) to C-9 (δC 59.3) and C-10 (Table 2, Figure 3). The presence of the leucine 
residue was supported by the coupling system from CH-14 (δH 4.57, m; δC 50.9) through CH3-17  
(δH 0.97, d, J = 6.5 Hz; δC 23.3) and CH3-18 (δH 0.88, d, J = 6.4 Hz; δC 21.1), and of NH at δH 8.02 d 
(J = 7.9 Hz) to H-14, as observed in the COSY spectrum (Table 2, Supplementary Information,  
Figure S9), as well as by the HMBC correlations of the NH signal at δH 8.02 d (J = 7.9 Hz) to C-14 
(Table 2, Figure 3). That the valine residue was linked to the leucine residue was supported by the 
HMBC cross peak between the NH signal of the former (δH7.43, d, J = 7.5 Hz) to the signal of the 
carbonyl carbon (δC174.2, C-13) of the latter. In turn, the leucine residue was linked to the alanine 
residue, as evidenced by the HMBC cross peaks of the NH signal of the former to the carbonyl carbon 
signal (δC174.3, C-19) of the latter, and of the proton signal at δH 4.82, dd, J = 9.7, 7.3 Hz (H-20) to  
C-19 and the methyl carbon at δC 18.4 (C-21), as well as by the COSY cross peaks of H-20 to CH3-21 
(δH 1.29, d, J = 7.3 Hz), and of H-20 to NH at δH 7.64, d (J = 7.9 Hz). The presence of the N- methyl 
leucine moiety was evidenced by the coupling system from H-23 (δH 3.49, dd, J = 9.0, 4.7 Hz) through 
CH3-26 (δH 0.97d, J = 6.5; δH 23.2) and CH3-27 (δH 0.99, d, J = 6.5; δH 22.1), as observed in the COSY 
spectrum (Table 2, Supplementary Informatscheion, Figure S9), as well as by the HMBC correlations 
of H-23 to C-22 (δC 169.3) and CH3-28 (δC 37.9). Finally, the presence of the pipecolic acid residue 
was supported by the coupling system from CH-30 (δH 3.71, dd, J = 11.3, 2.5; δC 61.4) through CH2-34  
(δH 3.16, dd, J = 13.2, 2.3; 4.14, dd, J = 14.4, 2.4; δC 52.5), as observed in the COSY spectrum  
(Table 2, Supplementary Information, Figure S9). Since both H-30 and CH3-28 gave HMBC cross 
peaks to C-29 (δC 168.9), the pipecolic acid residue was linked to the N-methyl leucine residue through 
the carboxyl group of the former and a nitrogen atom of the latter. Since 2 presents twelve degrees of 
unsaturation, the nitrogen atom of the piperidine ring of the pipecolic acid residue was linked to the 
carbonyl of the anthranilic acid residue. The proposed structure was supported by the NOESY 
correlations which showed cross peaks of NH at δH 9.41, brs to H-9, CH3-12, of NH at δH 7.43  
(d, J = 7.5 Hz) to H-9, CH3-11 (δH 1.06, d, J = 6.9 Hz), CH3-12, H-14, of NH at δH 8.02 (d, J = 7.9 Hz) 
to H-14, H-15 (δH 2.02, m; 1.77, m), CH3-17, of NH at δH 7.64 (d, J = 7.9 Hz) to CH3-21, H-23,  
CH3-28, of H-3 to H-34β (δH 4.14, dd, J = 14.4, 2.4 Hz), and of H-30 to CH3-28 (Table 2, 
Supplementary Information, Figure S12). Combining this information, it was possible to conclude that 
2 was cyclo (anthranilic acid-Val-Leu-Ala-N-methyl-Leu-pipecolic acid). 
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Scheme 1. Proposed biogenesis of similanpyrone C (1). 
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Table 2. 1H and 13C NMR (CDCl3, 500.13 MHz and 125.8 MHz) and HMBC assignment for 2. 
 Position δC, Type δH, (J in Hz) COSY  HMBC NOESY 
Anthranilic acid 
1 170.2, CO -    
2 122.7, C -    
3 127.1, CH 7.20, dd (7.7, 1.5) H-4 C-1, 5, 7 H-34 
4 123.4, CH 7.13, ddd (7.9, 7.9, 1.0) H-3, 5 C-2, 6  
5 131.7, CH 7.47, ddd (7.9, 7.9, 1.6) H-4, 6 C-3, 7  
6 123.9, CH 8.29, d (8.3) H-5 C-2, 4 H-12 
7 137.0, C -    
NH - 9.41, brs  C-6, 7, 8 NH (Val), H-9, 12 
Val 
8 170.7, CO -    
9 59.3, CH 4.32, dd (7.4, 3.3) H-10, NH C-8, 10, 11, 12 H-10, 11 
10 29.9, CH 2.68, m H-9, 11, 12  H-9, 11, 12 
11 19.8, CH3 1.06, d (6.9) H-10 C-9, 10, 12  
12 16.2, CH3 0.94, d (7.0) H-10 C-9, 10, 11  
NH - 7.43, d (7.5) H-9 C-9, 10, 13 H-9, 11, 12, 14 
Leu 
13 174.2, CO -    
14 50.9, CH 4.57, m H-15, NH  H-15, 18 
15 36.2, CH2 2.02, m; 1.77, m H-14, 16   
16 24.4, CH 1.77, m H-15, 17, 18   
17 23.3, CH3 0.97, d (6.5) H-16 C-15, 16, 18  
18 21.7, CH3 0.88, d (6.4) H-16 C-15, 16, 17  
NH - 8.02, d (7.9) H-14 C-13, 19 NH (Ala), H-14, 15, 17 
Ala 
19 174.3, CO -    
20 47.9, CH 4.82, dd (9.7, 7.3) H-21, NH C-19, 21 H-21 
21 18.4, CH3 1.29, d (7.3) H-20 C-19, 20  
NH - 7.64, d (7.9) H-20 C-22 C-21, 23, 28 
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Table 2. Cont. 
N-Me Leu 
22 169.3, CO -    
23 65.1, CH 3.49, dd (9.0, 4.7) H-24 C-22, 24, 28, 29  
24 37.8, CH2 1.95, m; 2.20, m H-23, 25   
25 25.5, CH 1.65, m H-24, 26, 27   
26 23.2, CH3 0.97, d (6.5) H-25 C-24, 25, 27  
27 22.1, CH3 0.99, d (6.5) H-25 C-24, 25, 26  
28 37.9, CH3 3.20, s  C-23, 29 23, 30, 32, 34α 
Pipecolic acid 
29 168.9, CO -    
30 61.4, CH 3.71, dd (11.3, 2.5) H-31 C-1, 29 H-34α 
31 28.1, CH2 2.05, m H-30, 32   
32 24.5, CH2 2.07, m H-31, 33   
33 27.4, CH2 1.56, m H-32, 34   
34α 52.5, CH2 3.16, dd (13.2 2.3) H-33  H-34β 
34β  4.14, dd (14.4, 2.4)   H-34α 
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Figure 3. Key HMBC correlations of compound 2. 
The 1H and 13C NMR data of compound 2 resembled those of PF1171C, a cyclic hexapeptide 
isolated from extracts of the unidentified ascomycete OK-128 fermented with okara by Kai et al. [30], 
and later by a total synthesis by Masuda et al. [31]; however, its value of optical rotation was  
quite different from that of PF1171C [30,31]. Moreover, PF1171C was reported as white solid  
(mp 138–140 °C) [31], while compound 2 is pale yellow viscous mass. This observation suggested that 
compound 2 and PF1171C could be diastereomers. 
The stereochemistry of the amino acid residues of compound 2 was determined by chiral HPLC 
analysis of its acidic hydrolysate, using appropriate D and L amino acids standards, according to the 
previously described method [32]. The enantioseparations of the standard amino acids were successfully 
performed with the Chirobiotic T column under reversed-phase elution conditions [33]. Actually, the 
teicoplanin selector of this column has several characteristic features that make it suitable for amino 
acid analysis [33–35]. The elution order of the enantiomers of all the standard amino acids was 
confirmed by injecting the solutions of the racemic or enantiomeric mixtures and then each enantiomer 
separately at a flow rate of 1 mL/min (Supplementary Information, Figure S18). As predicted, the D 
enantiomer was always more strongly retained than the corresponding L enantiomer on the Chirobiotic 
T column [33]. Based on mix HPLC analyses of the acidic hydrolysate with standard amino acids  
(co-injection) (Supplementary Information, Figure S19 and Table S1), compound 2 was elucidated 
unambiguously as cyclo (anthranilic acid-L-Val-D-Leu-L-Ala-N-methyl-L-Leu-D-pipecolic acid). 
Although the amino acid sequence of compound 2 is the same as that of PF1171C, the stereochemistry 
of its amino acid constituents is different from that of the amino acids constituent of PF1171C. While 
PF1171C contains D-Ala, L-Leu, D-Val, and L-pipecolic acid, compound 2 contains L-Ala, D-Leu,  
L-Val and D-pipecolic acid. Thus compound 2 is a new compound, and we have named it similanamide.  
It is interesting to note that Kai et al. [30] has firstly assigned the stereochemistry of the amino acid 
constituents of PF1171C using the reversed phase HPLC analysis of the Marfey derivatives of the 
amino acids. Since the retention times for the Marfey derivatives of D-Ala (19.4 min) and L-Ala  
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(20.0 min) were too close for resolution, they had wrongly assigned D-Ala for L-Ala. However, in our 
chiral HPLC analysis using the Chirobiotic T column under reversed-phase elution conditions, not 
only the retention time of L-Ala (7.16 min) was very different from that of D-Ala (9.36 min),  
but also the retention times of the D/L pair of other amino acid constituents (Supplementary 
Information, Table S1). 
So far, only few cyclohexapeptides have been reported from marine-derived microorganisms.  
Wu et al. [36] have isolated two cyclohexapeptides, nocardiamides A and B, from the culture broth of 
the marine-derived actinomycete Nocardiopsis sp. CNX037, isolated from sediment. Cai et al. [37] 
have isolated two anti-Mycobacterium tuberculosis cyclohexapeptides from a Streptomyces 
hygroscopicus Strain, while Song et al. [38] reported isolation of three new cyclopeptides, desotamides 
B–D, from the deep South China Sea-derived Streptomyces scopuliridis SCSIO ZJ46. To the best of 
our knowledge, compound 2 is the first cyclopeptide containing D-pipecolic acid residue ever isolated 
from marine fungi. 
Compound 3 was isolated as pale yellow viscous mass, and its molecular formula C29H33NO8 was 
established on the basis of (+)-HRESIMS m/z 524.2287 [M + H]+, indicating fourteen degrees of 
unsaturation. The IR spectrum showed absorption bands for hydroxyl (3418 cm−1), ester carbonyl 
(1732 cm−1), conjugated ester carbonyl (1667cm−1), olefin (1643 cm−1), aromatic (1557, 1507 cm−1). 
The 13C NMR (Supplementary Information, Figure S15), DEPTs and HSQC spectra (Table 3, 
Supplementary Information, Figure S16) revealed the presence of two ester carbonyl (δC 170.1 and 
169.8), one conjugated carbonyl (δC 161.6), five quaternary sp2 (δC 160.2, 156.8, 146.1, 126.9, 100.3), 
six methine sp2 (δC 151.3, 146.5, 132.8, 123.9, 109.4, 98.7), one oxyquaternary sp3 (δC 85.9), two 
oxymethine sp3 (δC 75.7 and 72.8), one oxymethylene sp3 (δC 64.4), two quaternary sp3 (δC 40.3, 38.4), 
one methine sp3 (δC 40.7), three methylene sp3 (δC 35.2, 27.3, 22.9), and five methyl (δC 23.8, 20.8, 
20.5, 20.1 and 12.7) carbons. The general feature of 13C and 1H spectra of compound 3 closely 
resembled those of pyripyropene S, previously isolated from the same fungus [29]. Analysis of the 1H 
(Supplementary Information, Figure S13), 13C, HSQC and HMBC spectra (Table 3, Supplementary 
Information, Figure S17) revealed the presence of the ring system comprising of the 
decahydronaphthalene fused, on C-5 and C-6, with the 2H,5H-pyrano[4,3-b]pyran-5-one, which 
connected to the pyridine ring through C-6′ of the former and C-3″ of the latter, similar to 
pyripyropene S [29]. However, there were only two acetoxyl groups (δC 170.1, CO; δC 20.5, CH3, δH 
2.00, s and δC 169.8, CO; δC 20.8, CH3; δH 2.00, s) in compound 3. That the acetoxyl groups were on 
C-1 and C-11 was supported by the fact that the chemical shift values of H-1 (δH 4.64, t, J = 8.5 Hz) 
and H-11 (δH 3.75, s) were very similar to those of pyripyropene S, whereas the chemical shift of H-7 
(δH 3.85, dd, J = 10.6, 4.2 Hz) was nearly 1.4 ppm less than that of pyripyropene S. On the other hand, 
the 13C chemical shift values of C-6 (δH 85.9) and C-8 (δC 27.4) of compound 3 were 2.00 and  
3.00 ppm, respectively, higher than those of the corresponding carbons in pyripyropene S, while the 
13C chemical shift value of C-7 (δC 75.5) of compound 3 was 2.00 ppm lower than that of C-7 of 
pyripyropene S. Since H-7 appeared as a double doublet with coupling constants of 10.6 and 4.2 Hz, 
the position of the hydroxyl group on C-7 was β. Thus, compound 3 is 7-deacetylpyripyropene S. In 
order to prove the stereochemistry of compound 3, the NOESY experiment was carried out. As the 
NOESY spectrum (Table 3) clearly exhibited correlations of CH3-15 to CH3-12, but not to H-1 and  
H-9; of CH3-12 to CH3-14 and CH3-15, and of CH3-14 to CH3-12, but not to H-7 (Table 3, 
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Supplementary Information, Figure S18), the stereochemistry of compound 3 is the same as that of 
pyripyropene S [29], i.e., 1S*, 4R*, 6S*, 7S*, 9R*, 10R*. Since it is a new compound we have named 
it pyripyropene T. 
Table 3. 1H and 13C NMR (DMSO, 300.13 MHz and 75.47 MHz) and HMBC assignment for 3. 
Position δC, Type δH, (J in Hz) COSY  HMBC  NOESY 
1 72.8, CH 4.64, t (8.5) H-2   
2 22.9, CH2 1.79, m  H-1, 3   
3 35.2, CH2 1.98, m  H-2   
4 38.4, C  -    
5 146.1, C -    
6 85.9, C  -    
7 75.7, CH 3.85, dd (10.6, 4.2) H-8   
8 27.3, CH2 1.70, m  H-7   
9 40.7, CH 1.48, m  H-8   
10 40.3, C  -    
11 64.4, CH2 3.75, s  C-1, 9 H3-15 
12 23.8, CH3 1.19, s  C-3, 4, 5 H3-14, 15 
13 109.4, CH 6.16, s  C-4, 6, 2″, 4″  
14 20.1, CH3 1.45, s  C-5, 6, 7 H3-12 
15 12.7, CH3 0.84, s  C-1, 9, 10, 11 H2-11, H3-12 
2′ 161.6, C -    
3′ 100.3, C -    
4′ 160.2, C -    
5′ 98.7, CH 7.11, s  C-3′, 4′, 6′, 3″  
6′ 156.8, C -    
2″ 146.5, CH 9.0, d (1.7) H-4″ C-3″, 6″ H-5′ 
3″ 126.9, C -    
4″ 132.8, CH 8.25, dt (8.7, 2.2) H-2″, 5″  H-5′, 5″ 
5″ 123.9, CH 7.54, dd (7.9, 4.8) H-4″, 6″ C-3″ H-4″, 6″ 
6″ 151.3, CH 8.68, dd (4.8, 1.5) H-2″, 5″ C-2″, 4″ H-5″ 
OAc-1 170.1, CO -    
 20.5, CH3 2.00, s  CO (Ac)  
OAc-11 169.8, CO -    
 20.8, CH3 2.00, s  CO (Ac)  
Since compound 1 was isolated in a very small amount, only compounds 2 and 3 were evaluated for 
their cytotoxicity and antibacterial activity. Compounds 2 exhibited weak in vitro growth inhibitory 
activity, by Sulforhodamine B (SRB) assay [39], against the MCF-7 (breast adenocarcinoma,  
GI50 = 125 ± 0), NCI-H460 (non-small cell lung cancer, GI50 = 117.50 ± 3.55) and A373 (melanoma, 
GI50 = 115 ± 7.07) cell lines. Compounds 2 and 3 were also tested for their antibacterial activity against 
four reference strains (Staphylococcus aureus, Bacillus subtilis, Escherichia coli and Pseudomonas 
aeruginosa), as well as the environmental multidrug-resistant isolates, according to the previously 
described method [40], and neither of them showed activity (MIC values higher than 256 µg/mL). 
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3. Experimental Section 
3.1. General Procedure 
Melting points were determined on a Bock monoscope and are uncorrected. Optical rotations were 
determined on an ADP410 Polarimeter (Bellingham + Stanley Ltd., Tunbridge Wells, Kent, UK). 
Infrared spectra were recorded in a KBr microplate in a FTIR spectrometer Nicolet iS10 from Thermo 
Scientific (Waltham, MA, USA.) with Smart OMNI-Transmission accessory (Software 188 OMNIC 8.3). 
1H and 13C-NMR spectra were recorded at ambient temperature on a Bruker AMC instrument (Bruker 
Biosciences Corporation, Billerica, MA, USA) operating at 500.13 and 125.8 MHz or at 300.13 and 
75.4 MHz, respectively. High-resolution mass spectra were measured with a Waters Xevo QToF mass 
spectrometer (Waters Corporations, Milford, MA, USA) coupled to a Waters Aquity UPLC system. A 
Merck (Darmstadt, Germany) silica gel GF254 was used for preparative TLC, and a Merck Si gel 60 
(0.2–0.5 mm) was used for analytical chromatography. 
3.2. Extraction and Isolation 
Isolation and identification of the fungus as well as fractionation of the crude extract of the culture 
of A. similanensis KUFA0013 have been previously described by us [29]. Frs 185–196 were combined 
(654 mg) and purified by TLC (Si gel, CHCl3:Me2CO:HCO2H, 97:3:0.1) to give 7.4 mg of 1.  
Frs 310–327 were combined (1.19 g), applied on a Sephadex H-20 column (10 g) and eluted MeOH, 
wherein ten sfrs of 1 mL were collected. Sfrs 1–7 were combined and purified by TLC (Si gel, 
CHCl3:Me2CO:HCO2H, 19:1:0.01) to give 108 mg of 2. Frs 336–345 were combined (165 mg) and 
purified by TLC (Si gel, CHCl3:Me2CO:HCO2H, 17:3:0.01) to give additional 60 mg of 2. Frs  
354–398 were combined (1.15 g), applied on a Sephadex LH-20 column (10 g) and eluted with 
MeOH, wherein thirty four sfrs of 1 mL were collected. Sfrs 7–15 were combined (150 mg) and 
purified by TLC (Si gel, CHCl3:Me2CO:HCO2H, 4:1:0.01) to give 67 mg of pyripyropene S [29]. Frs 
435–443 were combined (377 mg), applied on a Sephadex LH-20 column (10 g) and eluted with a 
mixture of 1:1 v/v of CHCl3: MeOH, wherein fourteen sfrs of 1 mL were collected. Sfrs 8–11 (62 mg) 
were combined and purified by TLC (Si gel, CHCl3:Me2CO:HCO2H, 19:1:0.01) to give 35 mg of 3. 
3.2.1. Similanpyrone C (1) 
Pale yellow viscous mass; [α]D20 = −80.0 (c 0.01, CHCl3); λmax (log ε) 239 (4.57), 245(4.59), 332 
(2.10) nm; IR (KBr) νmax 3443, 2923, 2852, 1730, 1683, 1647, 1625, 1572, 1508, 1457, 1429, 1352, 
1251 cm−1; 1H and 13C NMR (Table 1); HRESIMS m/z 345.1342 (M + H)+ (calculated for  
C19H21O6, 345.1338).  
3.2.2. Similanamide (2) 
Pale yellow viscous mass; [α]D20 = +30.3 (CHCl3, c 0.03), IR (KBr) νmax 3335, 3054, 2958, 2870, 
1682, 1644, 1594, 1519, 1449, 1292 cm−1; 1H and 13C NMR (Table 2); HRESIMS m/z 641.4053 
(calculated for C34H53N6O6, 641.4027). 
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3.2.3. Pyripyropene T (3) 
Pale yellow viscous mass; [α]D20 = +106 (CHCl3, c 0.03), IR (KBr) νmax 3418, 2949, 1732, 1667, 
1643, 1557, 1507, 1480, 1246, 1028 cm−1; 1H and 13C NMR (Table 3); HRESIMS m/z 524.2287  
(M + H)+, calcd for C29H34NO8, 524.2284. 
3.3. Amino Acids Analysis of Acidic Hydrolysate of Compound 2 
3.3.1. Acid Hydrolysis 
The stereochemistry of the amino acids was determined by analysis of the acidic hydrolysate from 
compound 2. Compound 2 (5.0 mg) was dissolved in 6 N HCl (5 mL) and heated at 110 °C, in a 
furnace, for 24 h in a sealed glass tube. After cooling to room temperature, the solution was dried 
under N2 for 24 h, reconstituted in methanol for HPLC-MS (200 µL), filtered through a 4 mm PTFE 
Syringe Filter F2504-4 of 0.2 µm pore size (Thermo Scientific, Mumbai, India), and then analyzed by 
HPLC equipped with a chiral column. 
3.3.2. Chiral HPLC Analysis 
The HPLC system consisted of Shimadzu LC-20AD pump, equipped with a Shimadzu DGV-20A5 
degasser, a Rheodyne 7725i injector fitted with a 20 µL loop, and a SPD-M20A DAD detector (Kyoto, 
Japan). Data acquisition was performed using Shimadzu LCMS Lab Solutions software, version 3.50 
SP2. The chiral column used in this study was Chirobiotic T (15 cm × 4.6 mm I.D., particle size 5 µm) 
manufactured by ASTEC (Whippany, NJ, USA). The mobile phase composition was 
MeOH:H2O:CH3CO2H (70:30:0.02, v/v/v), all were LC-MS grade solvents obtained from  
Sigma-Aldrich Co (St. Louis, MO, USA). The flow rate was 0.5 mL/min and the UV detection 
wavelength was 210 nm. Analyses were performed at room temperature in an isocratic mode. 
All standards of racemic amino acids and pure amino acid enantiomers were purchased from 
Sigma-Aldrich Co (St. Louis, MO, USA). The elution order of the enantiomers of all the standards 
amino acids was confirmed by injecting the solutions of the racemic or enantiomeric mixtures, and 
then each enantiomer separately (or only L- amino acid in the case of N-methyl leucine) at a flow rate 
of 1 mL/min or 0.5 mL/min. Working solutions of single enantiomeric amino acids were prepared by 
dissolution in MeOH at the concentration of 1 mg/mL (10 µL sample injection), while the 
enantiomeric mixtures were prepared by mixing equal aliquots of each enantiomer (20 µL sample 
injection). Mix HPLC analyses of the acidic hydrolysate with standard amino acids (co-injection) 
confirmed the stereochemistry of the amino acids of compound 2. 
4. Conclusions 
Following our first report of the isolation of new isocoumarin derivatives and merotepenoids from 
the ethyl acetate crude extract of the culture of the undescribed marine sponge-associated fungus 
Aspergillus similanensis KUFA 0013, we have reexamined its remaining column fractions and have 
isolated a new isocoumarin derivative containing an unusual 1,7-dioxaspiro-undecenone moiety, 
together with a new cyclohexapeptide and a new pyripyropene analog. Although several cyclopeptides 
Mar. Drugs 2015, 13 1447 
 
 
have been reported from many fungi of the genus Aspergillus, this is the first report of isolation of 
cyclohexapeptide from the marine-derived fungus. The fact that these new cyclohexapeptide and 
pyripyropene analog did not exhibit relevant antibacterial and the in vitro growth inhibitory activities 
on human cancer cell lines does not mean that they are void of other interesting biological activities. In 
order to prove this hypothesis, it is necessary to explore their potential in a broader biological or 
pharmacological assay system. 
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Abstract: Two new pentaketides, including a new benzofuran-1-one derivative (1) and a new
isochromen-1-one (5), and seven new benzoic acid derivatives, including two new benzopyran
derivatives (2a, b), a new benzoxepine derivative (3), two new chromen-4-one derivatives (4b, 7)
and two new benzofuran derivatives (6a, b), were isolated, together with the previously reported
2,3-dihydro-6-hydroxy-2,2-dimethyl-4H-1-benzopyran-4-one (4a), from the culture of the marine
sponge-associated fungus Neosartorya quadricincta KUFA 0081. The structures of the new compounds
were established based on 1D and 2D NMR spectral analysis, and in the case of compounds 1, 2a, 4b,
5, 6a and 7, the absolute configurations of their stereogenic carbons were determined by an X-ray
crystallographic analysis. None of the isolated compounds were active in the tests for antibacterial
activity against Gram-positive and Gram-negative bacteria, as well as multidrug-resistant isolates
from the environment (MIC > 256 µg/mL), antifungal activity against yeast (Candida albicans ATTC
10231), filamentous fungus (Aspergillus fumigatus ATTC 46645) and dermatophyte (Trichophyton
rubrum FF5) (MIC > 512 µg/mL) and in vitro growth inhibitory activity against the MCF-7
(breast adenocarcinoma), NCI-H460 (non-small cell lung cancer) and A375-C5 (melanoma) cell
lines (GI50 > 150 µM) by the protein binding dye SRB method.
Keywords: Neosartorya quadricincta KUFA 0081; marine-derived fungus; polyketides; pentaketides;
benzoic acid derivatives; Clathria reinwardti
1. Introduction
Aspergillus section Fumigati and its teleomorph Neosartorya include many important species
because they can be pathogenic or allergenic to man, as well as causing food spoilage and producing
mycotoxins. Certain species are also found to produce interesting bioactive secondary metabolites
Mar. Drugs 2016, 14, 134; doi:10.3390/md14070134 www.mdpi.com/journal/marinedrugs
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that can be considered to have potential for drug development [1]. For this reason, we have
investigated the bioactive secondary metabolites produced from the cultures of four Neosartorya
species collected from soil in Thailand, i.e., Neosartorya glabra KUFC 6311 [2], N. pseudofischeri KUFC
6422 [3], N. siamensis KUFC 6349 [4] and N. fischeri KUFC 6344 [5], as well as six marine-derived
species of Neosartorya, including N. paulistensis KUFC 7898 [6], N. laciniosa KUFC 7896 [5], N. spinosa
KUFC 8104, N. tsunodae KUFC 9213 [5], N. siamensis KUFA 0017 and N. takakii KUFC 7898 [7],
as well as one marine-derived Aspergillus species (Aspergillus similanensis KUFA 0013) [8,9]. Recently,
we have also reported the antifungal activity of the crude extract of N. quadricincta KUFA 0064,
isolated from an agricultural soil in Southern Thailand, against plant pathogenic fungi, which are
causative agents of diseases of economically-important plants of Thailand [10]. So far, the only
report on secondary metabolites of N. quadricincta was by Ozoe et al., who described the isolation of
dihydroisocoumarin derivative, PF1223, from the culture of N. quadricincta strain PF1223 (unidentified
source). This compound was shown to inhibit the [3H] EBOB binding by 65% [11]. Thus, in our
ongoing search for bioactive secondary metabolites from marine-derived fungi from Thai waters,
we have investigated the culture of N. quadricincta KUFA 0081, isolated from the marine sponge
Clathria reinwardti, which was collected from the Coral reef at Samae San Island in the Gulf of Thailand.
The ethyl acetate extract of the culture of this fungus yielded, besides the previously described
2,3-dihydro-6-hydroxy-2,2-dimethyl-4H-1-benzopyran-4-one (4a) [12], two new polyketide derivatives
(1, 5) and seven new benzoic acid derivatives (2a, 2b, 3, 4b, 6a, 6b and 7) (Figure 1). All of the isolated
compounds were tested for their antibacterial activity against Gram-positive and Gram-negative
bacteria, as well as multidrug-resistant isolates from the environment and for their antifungal activity
against yeast (Candida albicans ATCC 10231), filamentous fungus (Aspergillus fumigatus ATCC 46645)
and dermatophyte (Trichophyton rubrum FF5). Additionally, these compounds were also evaluated
for their in vitro growth inhibitory activity against the MCF-7 (breast adenocarcinoma), NCI-H460
(non-small cell lung cancer) and A375-C5 (melanoma) cell lines by the protein binding dye SRB method.
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The 1H NMR spectrum (Table 1, Supplementary Information, Figure S1) revealed the presence of, 
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and 1.76 s, a methyl doublet at δH 0.87 (J = 6.4 Hz) and a broad band of the hydroxyl proton at δH 2.15. 
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to H-10, OH-10 and of H3-9 to H-10 (Table 1, Figure 2b, Supplementary Information, Figure S6). Final 
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Figure 1. Secondary metabolites of N. quadricincta KUFA0081.
2. Results and Discussion
Compoun 1 was isol ted as white crystals (mp, 176–1 7 ˝C), and its molecular formula C14H18O5
was es abli he on the basis of the (+)-HRESIMS m/z 267.1243 [M + H]+ (calculated 267.1332), indicating
six degrees of unsatu ation. The IR spectrum showed absorption bands for hydroxyl (3455 cm´1),
conjug te ester carbonyl (1723 cm´1) and aromatic (1612, 1596 cm´1) groups. The 13C NMR, DEPT
and HSQC spectra (Table 1, Supplementary Information, Figures S2 and S ) exhibited the signals of
one conjugated ester carbonyl (δC 168.2), five quaternary sp2 (δC 164.6, 158.3, 152.8, 111.7, 105.5), one
ethine sp2 (δC 94.5), one oxygen bearing quaternary sp3 (δC 88.8), one oxygen bearing methine sp3
(δC 70.8), two methoxyl (δC 56.1 and 56.0) and three methyl (δC 21.5, 17.8 and 11.2) groups. The 1H NMR
spectrum (Table 1, Supplementary Information, Figure S1) revealed the presence of, besides a singlet
of one aromatic proton at δH 6.41, a quartet of the oxymethine proton at δH 4.22 (J = 6.4 Hz), two
singlets of the methoxyl groups at δH 3.97 s and 3.92 s, two methyl singlets at δH 2.12 s and 1.76 s,
a methyl doublet at δH 0.87 (J = 6.4 Hz) and a broad band of the hydroxyl proton at δH 2.15. The 1H and
13C data (Table 1) revealed the presence of a pentasubstituted benzene ring. That this pentasubstituted
benzene ring was part of the 5,7-dimethoxy-3,4-dimethyl-2-benzofuran-1(3H)-one ring system was
corroborated by the HMBC correlations (Table 1, Figure 2a, Supplementary Information, Figure S5)
of H-6 (δH 6.41, s) to C-7a (δC 105.3), C-4 (δC 111.7), C-7 (δC 158.3), C-5 (δC 164.6) and C-1 (δC 168.2),
of OMe-5 (δH 3.92, s) to C-5, of OMe-7 (δH 3.97, s) to C-7, of H3-8 (δH 2.12, s) to C-4, C-3a (δC 152.8)
and C-5, of H3-9 (δH 1.76, s) to C-3a and of the NOESY correlations of H-6 to OMe-5 and OMe-7. That
another substituent f C-3 was a 1-hydroxyethyl group was supported by the COSY correlations of
H-10 (δH 4.22, q, J = 6.4 Hz) to H3-11 (δH 0.87, d, J = 6.4 Hz), by the MBC correlations of H3-9 to
C-10 (δC 70.8), C-3 (δC 88.8) and C-3a and of H3-11 (δH 0.87, d, J = 6.4 Hz) o C-3 and C-10 (T ble 1,
Figure 2a), as well as by the NOESY orrela ions of H3-8 to H-10, H3-9, of H3-11 to H-10, OH-10 and of
H3-9 to H-10 (Table 1, Figur 2b, Supplement ry Information, Figure S6). Fi al proof of the structure
and the stereochemistry assigned to compound 1 was provided by its X-ray analysis (Figure 3), and
since the diffraction data were collected with a Gemini PX Ultra equipped with CuKα radiation, it was
possible to establish the absolute configurations of C-3 and C-10, respectively, as 3R and 10S. Since 1 is
a new compound, we have named it quadricinctone A.
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Table 1. 1H and 13C NMR (CDCl3, 300.13 MHz and 75.4 MHz), HMBC and NOESY assignments for 1.
Position δC, type δH, (J in Hz) HMBC NOESY
1 168.2, CO -
3 88.8, C -
3a 152.8, C -
4 111.7, C -
5 164.6, C -
6 94.5, CH 6.41, s C-1, 4, 5, 7, 7a OMe-5, 7
7 158.3, C -
7a 105.3, C -
8 11.2, CH3 2.12, s C-3a, 4, 5, 7 H-9, 10
9 21.5, CH3 1.76, s C-3, 3a, 10 H-8, 9
10 70.8, CH 4.22, d (6.4) C-11 H-8, 9, 10
11 17.8, CH3 0.87, d (6.4) C-3, 10 H-10
OMe-5 56.1, CH3 3.92, s C-5 H-6
OMe-7 56.0, CH3 3.97, s C-7 H-6
OH-10 - 2.15, br - H-11
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Compound 2a was also isolated as white crystals (mp. 147–148 ˝C), and its molecular formula
C12H12O4 was determined based on the (+)-HRESIMS m/z 221.0820 [M + H]+ (calculated 221.0814),
indicating seven degrees of unsaturation. The IR spectrum showed absorption bands for hydroxyl
(3447 cm´1), a conjugated carbonyl (1696 cm´1), aromatic (1609 cm´1) and olefin (1647 cm´1) groups.
The 13C NMR, DEPT and HSQC spectra (Table 2, Supplementary Information, Figures S8 and S10)
exhibited the signals of one conjugated carboxyl carbonyl (δC 167.0), three quaternary sp2 (δC 156.8,
123.0, 120.5), five methine sp2 (δC 130.8, 128.6, 127.9, 122.8, 115.7), one oxy-quaternary sp3 (δC 80.5),
one oxymethylene sp3 (δC 67.1) and one methyl (δC 23.3) groups. The 1H NMR spectrum (Table 2,
Supplementary Information, Figures S7) revealed, besides the presence of three aromatic protons
of the 1,2,4 trisubstituted benzene ring at δH 6.79, d (J = 8.4 Hz), 7.65, d (J = 2.1 Hz) and 7.69, dd
(J = 8.4, 2.1 Hz), two doublets of the protons of a cis-double bond at δH 6.56, d (J = 10.0 Hz) and 5.74,
d (J = 10.0 Hz), a methyl singlet at δH 1.31, a singlet of two protons at δH 3.46 and two broad signals
of the hydroxyl protons at δH 12.59 and 5.07, respectively. The COSY spectrum (Table 2, Figure 4a,
Supplementary Information, Figures S9) exhibited cross-peaks of H-4 (δH 6.56, d, J = 10.0 Hz) to
H-3 (δH 5.74, d, J = 10.0 Hz), of H-7 (δH 7.69, dd, J = 8.4, 2.1 Hz) to H-5 (δH 7.65, d, J = 2.1 Hz) and
H-8 (δH 6.79, d, J = 8.4 Hz), confirming the presence of the 1,2,4 trisubstituted benzene ring and
the cis-double bond. That the 1,2,4-trisubsituted benzene ring and the cis-double bond were part of
the 2H-chromene-6-carboxylic acid moiety was corroborated by the HMBC correlations (Figure 4a,
Supplementary Information, Figures S11) of H-5 to C-4 (δC 122.8), C-7 (δC 130.8), C-8a (δC 156.8) and
C-11 (δC 167.0), of H-7 to C-5 (δC 127.9), C-8a, C-11, of H-8 to C-4a (δC 120.5), C-6 (δC 123.0) and C-8a,
as well as of H-3 to C-4a and of H-4 to C-4a, C-5 and C-8a. As the HMBC spectrum also exhibited
correlations of the methyl singlet at δH 1.31 (H3-9) to C-3, C-2 (δC 80.5) and C-10 (δC 67.1) and of the
singlet at δH 3.46 (H-10) to C-2, C-3 and CH3-9 (δC 23.3), the methyl and hydroxymethyl groups were
placed on C-2. The NOESY correlations (Figure 4b, Supplementary Information, Figures S12) of H-4 to
H-3 and H-5, of H-3 to H-4, H3-9 and H2-10, of H-8 to H-7, H2-10 and H3-9 and of H3-9 to H-8, H-10
also confirmed this hypothesis. Since compound 2a was obtained in a suitable crystal, X-ray analysis
was carried out, and the ORTEP view shown in Figure 5 revealed that the absolute configuration of
C-2 is S. A literature search indicated that 2a has never been previously reported; therefore, it was
named quadricinctapyran A.
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Table 2. 1H and 13C NMR (DMSO, 300.13 MHz and 75.4 MHz) for 2a and 2b.
Position
2a 2b
δC, type δH, (J in Hz) COSY HMBC δC, type δH, (J in Hz) COSY HMBC
2 80.5, C - 78.5, C -
3 128.6, CH 5.74, d (10.0) H-4 C-2, 4a, 5, 9, 10 126.2, CH 5.59, d (10.0) H-4 C-2, 4a, 10
4 122.8, CH 6.56, d (10.0) H-3 C-2, 5, 8a 124.3, CH 6.51, d (10.0) H-3 C-2, 5, 8a
4a 120.5, C - 120.2, C -
5 127.9, CH 7.65, d (2.1) H-7 C-4, 8a, 11 128.9, CH 7.75, d (2.1) H-7 C-4, 7, 8a, 11
6 123.0, C - 122.0, C -
7 139.8, CH 7.69, dd (8.4, 2.1) H-5, 8 C-5, 8a, 11 132.2, CH 7.90, dd (8.5, 2.1) H-5, 8 C-5, 8a, 11
8 115.7, CH 6.79, d (8.4) H-7 C-4a, 6, 8a 116.1, CH 6.83, d (8.5) H-7 C-4a, 6, 8a
8a 156.8, C - 157.8, C -
9 23.3, CH3 1.31, s - C-2, 3, 10 24.0, CH3 1.48, s - C-2, 3, 10
10 67.1, CH2 3.45, s - C-2, 3, 9 68.8, CH2 4.13, d (11.7) H-10 C-2, 3, 9
4.24, d (11.7) H-10 C-2, 3, 9
11 167.0, CO - 171.7, CO -
OH-10 - 5.07, br - - -
OH-11 - 12.59, br - - 12.79, br -
OAc - 170.8, CO -
20.7, CH3 1.98, s - CO (Ac)
Mar. Drugs 2016, 14, 134 7 of 26
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Compound 2b was isolated as a white solid (mp. 118–119 ˝C), and its molecular formula C14H14O5
was established on the basis of the (+)-HRESIMS m/z 263.0971 [M + H]+ (calculated 263.0919), indicating
eight degrees of unsaturation. The 1H and 13C NMR spectral features (Supplementary Information,
Figures S13 and S14) of compound 2b resembled those of compound 2a, except for an additional
carbonyl carbon at δC 170.8 and a methyl group at δC 20.7 (δH 1.98, s), characteristic of the acetoxyl
group (Table 2). Moreover, since the signals of the oxymethylene protons (H2-10) of compound 2b
appeared as two doublets at δH 4.13 (J = 11.7 Hz) and 4.24 (J = 11.7 Hz), ca. 0.7 ppm higher than that of
H2-10 in compound 2a, it was clear that the acetoxyl group was on C-10. This was also corroborated by
the HMBC correlations (Table 2, Figure 6a, Supplementary Information, Figure S17) of H2-10 and the
methyl singlet at δH 1.98 to the carbonyl of the acetoxyl group (δC 170.8). Since Compound 2b could
not be obtained as a suitable crystal for X-ray analysis, the absolute configuration of its C-3 could not
be determined with certainty. However, as compound 2b is the acetate derivative of compound 2a,
it was speculated that the stereochemistry of its C-2 should be the same as that of C-2 of compound 2a,
i.e., 2S. In order to confirm this hypothesis, the NOESY experiments were carried out. The NOESY
spectrum of compound 2b showed a weak correlation of H-8 to H3-9 and not to H2-10 (Figure 6b,
Supplementary Information, Figure S18), similar to what has been observed for compound 2a. Acid
hydrolysis of 2b gave the product whose structure was confirmed as 2a by 1H and 13C NMR data,
as well as the optical rotation. Therefore, the absolute configuration of C-2 of 2b is assigned as 2S.
Compound 2b is also a new compound, thus we named it quadricinctapyran B.
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The molecular formula C12H12O4 of compound 3, a white solid (mp 189–191 ˝C), was established
based on the (+)-HRESIMS m/z 221.0819 [M + H]+ (calculated 221.0814), and thus, it is an isomer of
compound 2a. Furthermore, the general features of its 1H and 13C NMR spectra resembled those of
compound 2a. However, the chemical shift values of some of the proton and carbon signals were
slightly different from those observed in compound 2a. The 13C NMR, DEPT and HSQC spectra
(Table 3, Supplementary Information, Figures S20 and S22) exhibited the signals of one conjugated
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carboxyl carbonyl (δC 166.7), three quaternary sp2 (δC 161.2, 125.3, 125.0), five methine sp2 (δC 139.5,
134.6, 129.8, 123.5, 119.8), one oxy-quaternary sp3 (δC 70.7), one oxymethylene sp3 (δC 77.0) and one
methyl (δC 26.1) groups. The 1H NMR spectrum (Table 3, Supplementary Information, Figure S19)
revealed the existence of three aromatic protons of the 1,2,4-trisubstituted benzene ring, similar to
that of compound 2a, at δH 7.05, d (J = 8.4 Hz), 7.74, dd (J = 8.4, 2.1 Hz), 7.89, d (J = 2.1 Hz), two
olefinic protons of the cis-double bond at δH 5.95, dd (J = 12.0, 1.2 Hz) and 6.31, d (J = 12.0 Hz), two
oxymethylene protons at δH 3.84, d (J = 11.1 Hz) and 4.02, dd (J = 11.1, 1.6 Hz), and a methyl singlet
at δH 1.26. That the carboxylic acid functionality was on C-7, and the substituent with a cis-double
bond was on C-5a was substantiated by the HMBC correlations of H-6 (7.89, d, J = 2.1 Hz) to C-10
(δC 166.7), C-9a (δC 161.2), C-8 (δC 129.8) and C-5 (δC 123.5), of H-5 (δH 6.31, d, J = 12.0 Hz) to C-6
(δC 134.5) and C-9a and of H-4 (δH 5.95, dd, d, J = 12.0, 1.2 Hz) to C-5a (δC 125.0) (Table 3 and Figure 7a,
Supplementary Information, Figure S23). However, contrary to compound 2a, compound 3 showed
the HMBC correlations of H2-2 (δH 3.84, d, J = 11.1 Hz and 4.02, dd, J = 11.1, 1.6 Hz) to not only
C-4 (δC 139.5), but also to C-9a (Table 3 and Figure 7a). Consequently, the benzoic acid moiety was
fused with the 2,3,6,7-tetrahydro-oxepine ring through C-5a and C-9a. That the methyl group and the
hydroxyl group were on C-3 of the oxepin ring was confirmed by the HMBC correlations of the methyl
singlet at δH 1.26 (H-11) to C-3 (δC 70.7), C-2 (δC 77.0) and C-4, as well as of H2-2 to C-11 (δC 26.1) and
C-3 (Table 3 and Figure 7). This was also corroborated by the NOESY correlations of H3-11 to OH-3
(δH 3.39, br), H2-2 and H-4 (Table 3 and Figure 7b, Supplementary Information, Figure S24). Therefore,
Compound 3 was identified as 3-hydroxy-3-methyl-2,3-dihydro-1-benzoxepine-7-carboxylic acid.
Table 3. 1H and 13C NMR (DMSO, 300.13 MHz and 75.4 MHz) and HMBC assignment for 3.
Position δC, type δH, (J in Hz) COSY HMBC NOESY
2α 77.0, CH2 3.84, d (11.1) H-2β C-3, 4, 9a, 11 H-2β, 4 (w), 11 (w)
β 4.02, dd (11.1, 1.6) H-2α C-3, 4, 9a, 11 H-2α, 4 (w), 11 (str)
3 70.7, C -
4 139.5, CH 5.95, dd (12.0, 1.2) H-5 C-2, 5a H-2α (w), 5, 9 (w), 11
5 123.5, CH 6.31, d (12.0) H-4 C-3, 5a, 6, 9a H-4, 6 (str)
5a 125.0, C -
6 134.5, CH 7.89, d (2.1) H-8 C-5, 8, 9a, 10 H-5
7 125.3, C -
8 129.8, CH 7.74, dd (8.4, 2.1) H-6, 9 C-6, 9a H-9
9 119.8, CH 7.05, d (8.4) H-8 C-5a, 7, 9a H-8
9a 161.2, C -
10 166.7, C -
11 26.1, CH3 1.26, s - C-2, 3, 4 H-2α (w), 2β (str)
OH-3 - 3.39, br - H-4, 11
COOH - 12.79, br -
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Figure 7. Key COSY (–), HMBC (Ñ) (a) and NOESY (Ø) (b) correlations for compound 3.
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As compound 3 could not be obtained as a suitable crystal for X-ray analysis, an effort to
tentatively determine the relative configuration of the stereogenic carbon (C-3) by molecular mechanics
conformation analysis and the NOESY experiments was carried out. Stochastic conformational search
on the computational models of the structure of 3 with C-3 in R configuration, followed by energy
minimization, converged to two half-chair conformations for the seven-membered ring C1 and C2, as
depicted in Figure 8, regardless of the modelling level of the theory used (MP2/6-311G, PM3, MMFF
and MM2). All methods, except for PM3, also agree that conformation C2, with the methyl group in
the equatorial position, is more stable by ca. 2 kcal/mol. However, this difference can be attributed to a
weak intramolecular hydrogen bond in conformation C2, between HO-3 and O-1, which is not possible
in conformation C1. The semi-empirical PM3 method gives less weight to non-ideal intramolecular
hydrogen bonds, as compared to the other methods, and assigns virtually the same energy to both
conformations of 3, while still orienting HO-3 towards the seven-membered ring. Since DMSO solvent
molecules compete for HO-3 hydrogen bonding, it is more likely that the intramolecular bond is not an
important feature of ring conformation C2 and that, in reality, both conformations have approximately
the same energy.
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Assuming that the cross-relaxation rate is similar in both cases, the NOE intensities should also have 
a similar ratio [14]. Since the observed intensities ratio is actually closer to two, the evidence points 
towards the predominance of the conformation C1. Since, as stated previously, both conformations 
have similar conformational energy, the higher stability of 3R-C1 of 3 (or of its stereoisomer 3S-C2) 
must originate from the ready interaction of the equatorial HO-3 with the hydrogen-bonding solvent 
and also from a higher entropic rotational freedom of the hydroxyl and methyl groups. The NOESY 
spectrum also revealed the correlations of both H2-2 to H-9. However, only one of the H2-2, i.e., the 
doublet at δH 3.84 (J = 11.1 Hz), showed a weak cross-peak to H-4, while the double doublet at δH 4.02 
(J = 11.1, 1.6 Hz) did not give any cross-peak to H-4. This observation led to the conclusion that the 
plucked oxepin ring should adopt the conformation in which H-2 at δH 3.84 is near H-4, i.e., in the α 
(axial), while H-2 at δH 4.02 is in β (equatorial) positions, which is in agreement with our 
Figure 8. The two minimal energy conformations, C1 and C2, for the structure of 3, with R configuration
for C-3. All calculated distances and energies are exactly the same for the pairs 3R-C1/3S-C2 and
3R-C2/3S-C1. The shorter predicted inter-hydrogen distances H-2/H-11 are presented; for a discussion
of the average, NOE effective distances, please refer to the main text.
Both model conformations of 3 predict hydrogen-hydrogen distances that are similar to within
0.2 Å, with the exception of some distances to the methyl group (H3-11). The most notable are to
the diastereotopic hydrogens (H2-2), partially presented in Figure 8. While both conformations show
almost the same distance between H-2a and H-11, a difference is predicted between H-2b and H-11
if the conformation C1 predominates, which should be apparent in the build-up rate of NOESY
cross-peaks for small mixing times. Alternatively, the predominance of the conformation C2 would
be indicated by two equal strength cross-peaks for H-2a and H-2b in cross-relaxation with H-11. It is
observed that the H-2b (δH 3.84, d, J = 11.1 Hz)/H-11 NOESY cross-peak is weak while the H-2a
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(δH 4.02, dd, J = 11.1, 1.6 Hz)/H-11 is medium, suggesting that the conformation C1 predominates.
NOE effective distances, reff, are calculated by [13] :
re f f “
˜
1
3
ÿ
i
r´6H´2{H´10i
¸´1{6
The average effective positions of the three methyl H-11i protons are relative to H-2a or H-2b.
The predicted ratio reff (H-2a/H-11)/reff (H-2b/H-11) is 1.40 (1.36, if r´3 averages are used instead of
r´6). Assuming that the cross-relaxation rate is similar in both cases, the NOE intensities should also
have a similar ratio [14]. Since the observed intensities ratio is actually closer to two, the evidence points
towards the predominance of the conformation C1. Since, as stated previously, both conformations
have similar conformational energy, the higher stability of 3R-C1 of 3 (or of its stereoisomer 3S-C2) must
originate from the ready interaction of the equatorial HO-3 with the hydrogen-bonding solvent and also
from a higher entropic rotational freedom of the hydroxyl and methyl groups. The NOESY spectrum
also revealed the correlations of both H2-2 to H-9. However, only one of the H2-2, i.e., the doublet at δH
3.84 (J = 11.1 Hz), showed a weak cross-peak to H-4, while the double doublet at δH 4.02 (J = 11.1, 1.6 Hz)
did not give any cross-peak to H-4. This observation led to the conclusion that the plucked oxepin ring
should adopt the conformation in which H-2 at δH 3.84 is near H-4, i.e., in the α (axial), while H-2 at δH
4.02 is in β (equatorial) positions, which is in agreement with our conformational analysis. A literature
search revealed that compound 3 is also a new compound, so we named it quadricinctoxepine.
Compound 4b was isolated as white crystals (mp, 227–228 ˝C), and its molecular formula
C12H14O4S was established on the basis of the (+)-HRESIMS m/z 255.0694 [M + H]+ (calculated
255.0691). The IR spectrum showed absorption bands for hydroxyl (3442 cm´1), conjugated ketone
carbonyl (1690 cm´1) and aromatic (1622 cm´1) groups. The 13C NMR, DEPT and HSQC spectra
(Table 4, Supplementary Information, Figures S26 and S28) exhibited the signals of one conjugated
ketone carbonyl (δC 191.2), four quaternary sp2 (δC 151.6, 147.4, 135.7, 120.8), two methine sp2 (δC 118.0,
112.4), one oxy-quaternary sp3 (δC 80.9), one methylene sp2 (δC 48.0) and three methyl (δC 40.8, 26.1
and 25.7) groups. The 1H NMR spectrum (Table 4, Supplementary Information, Figure S25) exhibited,
besides a broad singlet of the phenolic hydroxyl group at δH 9.85, the signals of two meta-coupled
aromatic protons at δH 7.17, d (J = 3.1 Hz) and δH 7.35, d (J = 3.1 Hz), two geminally-coupled methylene
protons at δH 2.80, d (J = 16.6 Hz) and 2.82, d (J = 16.6 Hz) and three methyl singlets at δH 1.38, s,
1.39, s, and 2.77, s. The chemical shift value of the methyl singlet at δH 2.77, s (δC 40.8), indicated
that it was on the electron-withdrawing moiety. That compound 4b was a 2,2,6,8-tetrasubstituted
2,3-dihydro-4H-chromen-4-one derivative was supported by the HMBC correlations of H-5 (δH 7.17, d,
J = 3.1 Hz) to C-4 (δC 191.2), C-7 (δC 118.0) and C-8a (δC 147.4), of H-7 (δH 7.35, d, J = 3.1 Hz) to C-5
(δC 112.4), C-8 (δC135.7), C-8a, as well as of H-2 (δH 2.80, d, J = 16.6 Hz and 2.82, d, J = 16.6 Hz) to C-3
(δC 80.9) and C-4 (Table 4, Figure 9, Supplementary Information, Figure S28). As the HMBC spectrum
also exhibited cross-peaks of a broad singlet of the phenolic hydroxyl proton at δH 9.85 to C-5, C-6
(δC 151.6) and C-7 and of the singlets of the methyl groups at δH 1.38 and 1.39 to C-2 (δC 48.0) and
C-3, the hydroxyl group was placed on C-6, and the two methyl groups were placed on C-2. Since
this partial structure accounted for only C11H11O3, another portion of the molecule must contain
CH3SO. That the methyl sulfoxide group was on C-8 was supported by the presence of the deshielded
methyl group at δH 2.77, s (δC 40.8), as well as by the HBMC cross-peak of H3-11 (δH 2.77, s) to C-8.
Final proof of the structure of compound 4b was provided by its X-ray analysis, and its ORTEP view
is shown in Figure 10. Moreover, the ORTEP view also revealed that the absolute configuration of
the sulfoxide group in compound 4b is R. A literature search showed that compound 4b is a new
compound, and thus, we have named it quadricinctone B.
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Table 4. 1H and 13C NMR (DMSO, 300.13 MHz and 75.4 MHz) and HMBC assignment for 4b.
Position δC, type δH, (J in Hz) COSY HMBC
2 80.9, C -
3 48.0, CH2 2.80, d (16.6) H-3 C-2, 4, 9, 10
2.85, d (16.6) H-3 C-2, 4, 9, 10
4 191.2, CO -
4a 120.8, C -
5 112.4, CH 7.17, d (3.1) H-7 C-4, 6, 7, 8a
6 151.6, C -
7 118.7, CH 7.35, d (3.1) H-5 C-5, 6, 8, 8a
8 135.7, C -
8a 147.4, C -
9 26.1, CH3 1.39, s - C-2, 3, 10
10 25.7, CH3 1.38, s - C-2, 3, 9
11 40.8, CH3 2.77, s - C-8
OH-6 - 9.85, s C-5, 6, 7Mar. Drugs 2016, 14, 134 12 of 29 
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The molecular formula C12H14O6 of compound 5 was determined based on the (+)-HRESIMS
m/z 255.0875 (calculated 255.0869), indicating six degrees of unsaturation. The IR spectrum exhibited
absorption bands for hydroxyl (3439 cm´1), conjugated ester carbonyl (1660 cm´1) and aromatic
(1643 cm´1) groups. The 13C NMR, DEPT and HSQC spectra (Table 5, Supplementary Information,
Figures S31 and S33) exhibited the signals of one conjugated ester carbonyl (δC 168.8), five quaternary
sp2 (δC 162.9, 161.3, 144.6, 113.5, 98.9), one methine sp2 (δC 99.9), one quaternary sp3 of a hemiketal
(δC 104.8), one methine sp3 (δC 34.9), one oxymethylene sp3 (δC 63.7) and two methyl (δC 16.3 and 9.8)
carbons. The 1H NMR spectrum (Table 5, Supplementary Information, Figure S30) exhibited, besides a
singlet of one aromatic proton at δH 6.27, a singlet of a hydrogen-bonded phenolic hydroxyl at δH 11.24
and a broad signal of another phenolic hydroxyl at δH 10.62, two broad signals of the hydroxyl groups
at δH 5.26 and 7.07, one broad doublet of two methylene protons at δH 3.65 (J = 16.6 Hz), a broad signal
of one methine proton at δH 3.26, one methyl doublet at δH 1.06 (J = 7.2 Hz) and one methyl singlet at
δH 1.98. That compound 5 was a 3,3,4,5,6,8-hexasubstituted 3,4-dihydro-1H-isochromen-1-one was
supported by the HBMC correlations of OH-8 (δH 11.24, s) to C-8 (δC 161.3), C-7 (δC 99.9), C-8a (δC 98.9)
and of H-7 (δH 6.27, s) to C-5 (δC 113.5), C-6 (δC 162.9), C-8 and C-8a (Table 5, Figure 11, Supplementary
Information, Figure S34). Since the methyl singlet at δH 1.98 gave HMBC cross-peaks to C-5 and the
carbons at δC 144.6 and 162.9 (Table 5, Figure 11), the methyl group (δH 1.98; δC 9.8) and another
hydroxyl group (δH 10.62, br) were placed on C-5 and C-6, respectively, and the carbon signals at δC
144.6 and 162.9 were assigned for C-4a and C-6, respectively. On the other hand, the COSY spectrum
(Table 5, Supplementary Information, Figure S32) showed cross-peaks of the broad signal at δH 3.26 to
the methyl doublet at δH 1.06 (J = 7.2 Hz) and of the broad signal at δH 5.26 to the broad doublet at
δH 3.65 (J = 16.6 Hz), while the HMBC spectrum (Table 5, Figure 11) gave cross-peaks of the methyl
doublet at δH 1.06 (J = 7.2 Hz) to C-4a, C-4 (δC 34.9), and the signal of the quaternary carbon at δC
104.8 (C-3), the methyl and the hydroxymethyl substituents were placed on C-4 and C-3, respectively.
Therefore, another hydroxyl group (δH 7.07, br) was on C-3. This was supported by the chemical shift
value of C-3, which is typical for a hemiketal carbon. Since compound 5 could be obtained as a suitable
crystal (mp. 223–224 ˝C), its X-ray analysis was performed. The ORTEP view of compound 5, shown in
Figure 12, not only confirmed the proposed structure, but also determined the absolute configuration
of C-3 and C-4 as 3S, 4R. Since compound 5 is a new compound, it was named quadricinctone C.
Table 5. 1H and 13C NMR (DMSO, 300.13 MHz and 75.4 MHz) and HMBC assignment for 5.
Position δC, type δH, (J in Hz) COSY HMBC
1 168.8, C -
3 104.8, C -
4 34.9, CH 3.26, m H3-10
4a 144.6, C -
5 113.5, C -
6 162.9, C -
7 99.9, CH 6.27, s - C-1 (w), 5, 6, 8, 8a
8 161.3, C -
8a 98.9, C -
9 63.7, CH2 3.65, brd (16.6) OH-9
10 16.3, CH3 1.06, d (7.2) H-4 C-3, 4, 4a
11 9.8, CH3 1.98, s - C-4a, 5, 6
OH-3 - 7.07, br -
OH-5 - 10.62, br -
OH-8 - 11.24, s - C-7, 8, 8a
OH-9 - 5.26, br -
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anodendroic acid by Shima et al. [15], it was found that the 1H NMR data of anodendroic acid (in 
pyridine-d6)[15] were slightly different from those of compound 6a (in DMSO-d6). Therefore, it was 
Figure 12. TEP diagra of co pound 5.
Compound 6a was also isolated as white crystals (mp. 149–150 ˝C), and its molecular formula
C12H14O4 was determined based on the (+)-HRESIMS m/z 223.9067 [M + H]+ (calculated 223.9070),
indicating six degrees of unsaturation. The IR spectrum showed absorption bands for hydroxyl
(3417 cm´1), a conjugated carbonyl (1681 cm´1) and aromatic (1634 cm´1) groups. The 13C NMR,
DEPT and HSQC spectra (Table 6, Supplementary Information, Figures S36 and S38) exhibited the
signals of one conjugated carboxyl carbonyl (δC 167.2), two quaternary sp2 (δC 128.2, 122.6), one
oxy-quaternary sp2 (δC 163.7), three methine sp2 (δC 130.4, 126.4, 108.4), one oxy-quaternary sp3
(δC 70.0), one oxymethine sp3 (δC 90.2), one methylene sp2 (δC 29.3) and two methyl (δC 25.9 and
24.9) carbons. The 1H NMR spectrum (Table 6, Supplementary Information, Figure S35) showed
signals of three aromatic protons of the 1,2,4-trisubstituted benzene ring at δH 7.75, d (J = 1.8 Hz), 7.72,
dd (J = 8.3, 1.8 Hz), 6.80, d (J = 8.3 Hz), in addition to a broad signal of the hydroxyl proton at δH
12.49, a triplet of one proton at δH 4.64 (J = 8.9 Hz), a doublet of two protons at δH 3.17 (J = 8.9 Hz)
and two methyl singlets at δH 1.13 and 1.14. That the 1,2,4-trisubstituted benzene ring was part of
2,5-disubstituted 2,3-dihydro-1-benzofuran was supported by the COSY correlations of H-6 (δH 7.72,
dd, J = 8.3, 1.8 Hz) to H-4 (δH 7.75, d, J = 1.8 Hz) and H-7 (δH 6.80, d, J = 8.3 Hz) and of H-2 (δH 3.17,
J = 8.9 Hz) to H-3 (δH 4.64, J = 8.9 Hz)(Table 6, Figure 13a, Supplementary Information, Figure
S37), as well as of the HMBC correlations of H-4 to C-6 (δC 130.4) and C-7a (δC 163.7), of H-6 to
C-4 (δC 126.4), of H-3 to C-2 (δC 90.2), C-3a (δC 128.2) and C-7a and of H-7 to C-3a, C-7a and C-5
(δC 122.6) (Table 6, Figure 13a, Supplementary Information, Figure S39). That the carboxyl group
was on C-5 was supported by the HMBC correlations of H-4 and H-6 to the conjugated carbonyl
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at δC 167.2 (Table 6, Figure 13a), along with the presence of a broad signal at δH 12.49, which is
characteristic of a hydroxyl group of carboxylic acid. In the same manner, that the 2-hydroxypropyl
substituent was placed on C-2 was evidenced by the HMBC correlations of H-2 (δH 4.64, J = 8.9 Hz)
to C-3 (δC 29.3), C-11 (δC 70.0), C-21 (δC 24.9), C-31 (δC 25.9) (Table 6, Figure 13a), as well as by the
NOESY correlations of H-2 to H-3, H3-21 (δH 1.14, s) and H3-31 (δH 1.13, s)(Figure 13b). Therefore,
compound 6a was identified as 2-(2-hydroxypropan-2-yl)-2,3-dihydro-1-benzofuran-5-carboxylic
acid. A literature search revealed that compound 6a has the same flat structure as anodendroic
acid (2-(1-hydroxy-1-methylethyl)-2,3-dihydrobenzofuran-5-carboxylic acid), which was first isolated
from the stem of Anodendron affine Durce [15]. Anodendroic acid was later synthesized by
Yamaguchi et al. [16]; however, its 1H NMR data (DMSO-d6) were slightly different from those
reported by Shima et al. [15]. Anodendroic acid was also obtained by basic hydrolysis of
its methyl ester, a constituent of Eriodictyon sessilifolium [17], and also by biotransformation of
3-(γ,γ-dimethylallyl)-p-coumaric acid [18]. It is interesting to note that, in all of these reports, the
identity of anodendroic acid was achieved by comparing its melting point, 1H NMR and MS data
with those reported by Shima et al. [15], while no stereochemistry of C-2 was indicated. However,
when compared to the 1H NMR and other physical data of compound 6a with those reported for
anodendroic acid by Shima et al. [15], it was found that the 1H NMR data of anodendroic acid
(in pyridine-d6) [15] were slightly different from those of compound 6a (in DMSO-d6). Therefore,
it was not possible to compare these 1H NMR data, since they were obtained in different solvents.
Interestingly, the 1H NMR data, obtained in DMSO-d6 by Yamaguchi et al. [16], were also slightly
different from those of compound 6a. The obvious differences between anodendroic acid [15] and
compound 6a are their melting points and optical rotations. While anodendroic acid (mp. 212–214 ˝C)
is laevorotatory (rαs26D ´19˝, c 0.7, EtOH) [15], compound 6a (mp. 149–150 ˝C) is dextrorotatory
(rαs20D +74˝, c 0.03, MeOH). Consequently, we concluded that the structure of compound 6a is different
from that of anodendroic acid. This fact has prompted us to investigate the stereochemistry of
compound 6a. Since Compound 6a was obtained as a suitable crystal for X-ray diffraction, its X-ray
analysis was carried out. The ORTEP view of compound 6a shown in Figure 14 not only confirmed its
proposed structure, but also revealed the absolute configuration for C-2 as 2R. Therefore, compound
6a is a new compound, and we have named it quadricinctafuran A. Since anodendroic acid exhibited
the opposite sign of rotation to that of compound 6a, it is probable that the absolute configuration of
its C-2 is 2S. This is not unusual, since fomannoxin, another 2,3-dihydrobenzofuran derivative, also
showed the opposite optical rotation and has the opposite absolute configuration to tremetone, even
though they have very similar structures [16].Mar. Drugs 2016, 14, x FOR PEER REVIEW 18 of 29 
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Figure 13. Key COSY (–), HMBC (Ñ) (a) and NOESY (Ø) (b) correlations for compound 6a.
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Table 6. 1H and 13C NMR (DMSO, 300.13 MHz and 75.4 MHz) and HMBC assignment for 6a and 6b.
Position
6a 6b
δC, type δH, (J in Hz) COSY HMBC δC, type δH, (J in Hz) COSY HMBC
2 90.2, CH 4.64, t (8.9) H-3 C-11, 21, 31 86.5, CH 4.83, dd (9.7, 8.1) H-3
3 29.3, CH2 3.17, d (8.9) H-2 C-11, 2, 3a, 7a 28.7, CH2 3.19, m H-2 C-11, 3a
3a 128.2, C - 128.4, C -
4 126.4, CH 7.75, d (1.8) H-6 C-6, 7a, 8 126.4, CH 7.76, d (1.8) H-6 C-3, 6, 7a
5 122.6, C - 122.6, C -
6 130.4, CH 7.72, dd (8.3, 1.8) H-4, 7 C-4, 7a, 8 130.8, CH 7.71, dd (8.3, 1.8) H-4, 7 C-4, 7a, 8
7 108.4, CH 6.80, d (8.3) H-6 C-3a, 5, 7a 108.4, CH 6.79, d (8.3) H-6 C-3a, 5, 7a
7a 163.7, C - 163.6, C -
8 167.2, C - 167.2, C -
11 70.0, C - 72.5, C -
21 24.9, CH3 1.14, s - C-11, 2, 31 66.7, CH2 3.33, s - C-11, 2, 31
31 25.9, CH3 1.13, s - C-11, 2, 21 20.0, CH3 1.09, s C-11, 2, 21
OH-8 - 12.49, br - - 12.47, br -
Mar. Drugs 2016, 14, 134 16 of 26
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Figure 14. ORTEP diagram of 6a.
The (+)-HRESIMS of compound 6b gave the [M + H]+ at m/z 239.0919 (calculated 239.0919),
indicating its molecular formula C12H14O5 and, therefore, six degrees of unsaturation. The general
features of its 1H and 13C NMR spectra resembled those f compou d 6a. The 13C NMR, DEPT and
HSQC spectra (Table 6, Supplementary Information, Figures S42 and S44) exhibited the signals of one
conjugated carboxyl carbonyl (δC 167.2), tw quaterna y sp2 (δC 128.4, 122.6), on oxy-quaternary sp2
(δC 163.6), three methine sp2 (δC 130.8, 126.4, 108.4), one oxy-quaternary sp3 (δC 72.5), one oxymethine
sp3 (δC 86.5), one m thylen sp2 (δC 28.7), one oxymethylene sp2 (δC 66.7) and one methyl (δC 20.0)
carbons. The 1H NMR and COSY spectra (Table 6, Supplementary Information, Figures S41 and S43)
showed similar proton signals of e 2,3-dihydro-1-benzofuran-5-carboxylic acid nu leus to those of 6a.
However, it exhibited only one methyl singlet at δH 1.09 and another singlet of oxymethylene protons
at δH 3.33, instead of two methyl singlets as in compound 6a. Therefore, the difference between the
structures of compounds 6a and 6b resides in the substitutions on C-2. That the substituent on C-2 of
compound 6b was 1,2- ihydroxypr pyl wa evidenced by not on y its molecular formula (C12H14O5),
which has one more oxygen atom than that of compound 6a (C12H14O4), but also the presence of the
oxymethylene carbon a δC 66.7 (C-21; δH 3.33, s). Moreove , th chemical shift value of C-2 (δC 86.5)
was nearly 4 ppm lower than that of compound 6a (δC 90.2). Thus, compound 6b was identified as
2-(1,2-dihydroxypropan-2-yl)-2,3-dihydro-1-benzofuran-5-carboxylic acid. This was confirmed by the
HMBC correlations of H3-31 (δH 1.09) to C-11 (δC 72.5) and C-21 (δC 66.7), as well of H2-21 (δH 3.33, s) to
C-11 (δC 72.5) and C-31 (δC 20.0) (Figure 15, Supplementary Information, Figure S45). Since compound
6b could not be obtained as suitable crystals for X-ray crystallography, it was not possible to determine
the absolute configuration of C-2 by X-ray analysis. Moreover, as compound 6b also has a tertiary
hydroxyl group on C-11 and a primary hydroxyl group on C-21, it was not possible to determine the
absolute configurations of C-2 and C-11 by Mosher’s method. On the other hand, since the methyl
group on C-1 in compound 6a was replaced by the hydroxymethyl group incompound 6b, it is
legitimate to postulate that compounds 6b is derived from compound 6a. Consequently, the absolute
configuration of C-2 of compound 6b should be the same as that of compound 6a, i.e., 2R. However,
it is not yet possible to determine the absolute configuration of C-11. Compound 6b is also a new
compound, and we have named it quadricinctafuran B.
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Figure 15. Key COSY (–) and HMBC (Ñ) correlations for compound 6b.
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Compound 7 was also isolated as white crystals (mp. 196–197 ˝C), and its molecular formula
C14H12O5 was established on the basis of the (+)-HRESIMS m/z 237.0792 [M + H]+ (calculated 237.0763),
indicating seven degrees of unsaturation. The IR spectrum showed absorption bands for hydroxyl
(3404 cm´1), conjugated ketone carbonyl (1708 cm´1), conjugated carboxyl carbonyl (1670 cm´1) and
aromatic (1558, 1540 cm´1) groups. The 13C NMR, DEPT and HSQC spectra (Table 7, Supplementary
Information, Figures S48 and S50) exhibited the signals of one conjugated ketone carbonyl (δC 191.1),
one conjugated carboxyl carbonyl (δC 166.4), one oxy-quaternary sp2 (δC 162.9), two quaternary
sp2 (δC 123.0, 119.6), three methine sp2 (δC 136.4, 127.5, 118.5), one oxy-quaternary sp3 (δC 83.0),
one oxymethylene sp2 (δC 66.8), one methylene sp2 (δC 43.4) and one methyl (δC 21.2) carbons.
The 1H NMR spectra (Table 7, Supplementary Information, Figure S47) exhibited, besides the signals of
three aromatic protons of the 1,2,4-trisubstituted benzene ring at δH 8.26, d (J = 2.3 Hz), 8.04, dd (J = 8.7,
2.3 Hz), 7.07, d (J = 8.7 Hz), a methyl singlet at δH 1.30, two pairs of geminally-coupled methylene
protons at δH 2.74, d (J = 16.7 Hz)/3.00, d (J = 16.7 Hz) and δH 3.49, dd (J = 11.6, 4.5 Hz)/3.59, dd
(J = 11.6, 4.2 Hz); the latter showed COSY correlations with the broad triplet of the hydroxyl proton
at δH 5.26 (Table 7, Figure 16a, Supplementary Information, Figure S49). As the HMBC spectrum
exhibited correlations of the aromatic proton signal at δH 8.26, d (J = 2.3 Hz, H-5) to the oxy-quaternary
sp2 carbon at δC 162.9 (C-8a), as well as to the conjugated ketone carbonyl carbon at δC 191.1 (C-4)
and the methine sp2 at δC 136.4 (C-7) (Table 7, Figure 16a, Supplementary Information, Figure S51),
the ketone moiety was placed on C-4a. Additionally, the HMBC spectrum also showed correlations
of H-8 (δH 7.07, d, J = 8.7 Hz) to C-8a and the quaternary sp2 carbons at δC 123.0 and 119.6; they
were therefore assigned to C-4a and C-6, respectively (Table 7, Figure 16a). The presence of the
1-hydroxy-2-methyl-2-oxypropyl moiety was supported by the HMBC correlations of the methyl
singlet at δH 1.30 (CH3-9) to the oxy-quaternary sp3 carbon at δC 83.0 (C-2), the oxymethylene sp3
carbon at δC 66.8 (C-10) and the methylene sp3 carbon at δC 43.4 (C-3), as well as of the H2-3 (δH 2.74,
d, J = 16.7 Hz/3.00, d, J = 16.7 Hz) to C-2, C-9 (δC 21.2) and C-10 (Table 7, Figure 16a). Since H2-3
also gave a HMBC cross-peak to C-4, the 1-hydroxy-2-methyl-2-oxypropyl moiety was linked to
C-4. Due to the fact that these two moieties accounted for only C11H12O4, it was concluded that
the carboxyl group (δC 166.4, δH 12.69 br) was on C-6. Therefore, compound 7 was identified as
2-(hydroxymethyl)-2-methyl-4-oxo-3,4-dihydro-2H-chromene-6-carboxylic acid. As compound 7 was
obtained as a suitable crystal for an X-ray diffraction, its X-ray analysis was carried out. The ORTEP
view of compound 7, shown in Figure 17, revealed the absolute configuration for C-2 as 2S. A literature
search revealed that compound 7 is also a new compound, so we named it quadricinctone D.
Table 7. 1H and 13C NMR (CDCl3, 300.13 MHz and 75.47 MHz) and HMBC assignment for 7.
Position δC, Type δH, (J in Hz) COSY HMBC NOESY
2 80.3, C -
3α 434, CH2 2.74, d (16.7) H-3 C-2, 4, 10, 11 H3-11 (str)
β 3.00, d (16.7) H-3 C-2, 4, 10, 11 H3-11 (w)
4 191.1, CO -
4a 123.0, C -
5 127.5, CH 8.26, d (2.3) H-7 C-4, 7, 8a
6 119.6, C -
7 136.4, CH 8.04, dd (8.7, 2.3) H-5, 8 C-5, 8a
8 118.5, CH 7.07, d (8.7) H-7 C-4a, 6, 8
8a 162.9, C -
9 21.2, CH3 1.30, s - C-2, 3, 10 H-3α (str), H3β (w), H-5, 8 (w)
10 66.8, CH2 3.49, dd (11.6, 4.5) OH-10
3.59, dd (11.6, 4.2)
11 166.4, CO -
OH-10 - 5.26, brt (5.4) -
OH-11 - 12.69, br -
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Figure 17. ORTEP di f compound 7.
In order to establish the conformation of the 2,3-dihydro-4H-pyran-4-one, analysis of the NOESY
correlations was carried out. The NOESY spectrum (Table 7, Figure 16b, Supplementary Information,
Figure S52) exhibited not only a strong correlation of H-7 to H-8, but also week correlations of H3-9
to H-5 and H-8. Therefore, CH3-9 is in the α-axial p sition. Additi nally, since H3-9 also exhibited
a strong cross-peak with the signal of the methylene proton at δH 2.74, d (J = 16.7 Hz), and a weak
cross-peak with the proton signal at δH 3.00, d (J = 16.7 Hz), the former was assigned to H-3α and
the latter to H-3β. It is interesting to observe that the structure of compound 7 is analogous to the
structure of compound 3 in that it also exhibits the same methyl-methylene bridge structural feature
(at C-9 and C-3), with the same relative intensity of NOESY cross-peaks between the protons of the
two groups and with similar conformational energies for the two half-chair conformations of the
non-aromatic ring. Therefore, the conclusions drawn for compound 3 are also valid for compound 7,
whose stereochemistry is unequivocally defined by X-ray analysis.
Compounds 1 and 5 can be hypothesized as originating from the pentaketide intermediate (I).
Methylation (by SAM) gives II, which undergoes cyclization and enolization to give the intermediate
III. Methylation of the phenolic hydroxyl groups and the α-carbon of the carbonyl ketone leads to the
intermediate IV. Enolization, followed by a lactonization, originates V, which undergoes hydration to
give VI, and oxidation of one of the methyl groups gives rise to compound 5. Alternatively, oxidation
of the α-carbon of the side chain of IV leads to the intermediate VII, which, after lactonization and
reduction of the ketone carbonyl, gives rise to compound 1 (Figure 18).
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Figure 18. Proposed biosynthetic pathways for compounds 1 and 5.
Biosynthetically, compounds 2a, 2b, 4a, 4b, 6a, 6b and 7 are of mixed origin, i.e., shikimic acid
and mevalonic acid pathways, similar to that proposed for fomannoxin [19], as depicted in Figure 19.
Elimination of pyruvate from chorismate (IX) by chorismate pyruvate lyase leads to the formation of
p-hydroxybenzoic acid (X), which after prenylation by DMAPP (XI), originates the intermediate XII.
Epoxidation and cyclization of XII, via Route a, leads to a formation of the furan ring in compound
6a and after oxidation of one of the methyl groups leads to compound 6b. On the other hand,
cyclization via Route b leads to the formation of the pyran ring in XIV. Dehydration and oxidation
of one of the methyl groups originates compound 2a, which after acetylation of the primary alcohol
function of the side chain will originate compound 2b. Alternatively, the intermediate XIV can also
undergo dehydration, reduction and oxidation to give the ketone function in compound 7. Oxidative
decarboxylation of compound 7 leads to the formation of compound 4a, which after sulfinylation of
the benzene ring originates compound 4b. However, it is possible that the introduction of the methyl
sulfoxide group to the aromatic ring could happen before cyclization.
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Figure 19. Prop sed biosynthetic path f pounds 2a, 2b, 4a, 4b, 6a, 6b and 7.
Compound 3 is also derived from a prenylation of p-hydroxybenzoic acid (X); however, it can
occur with IPP (XVI) instead of DMAPP (XI). Epoxidation of the double bond of the side chain of
XVII, followed by cyclization of XVIII leads to the formation of an oxepin ring in XIX. Oxidation and
dehydration of the oxepin ring will lead to the formation of compound 3, as depicted in Figure 20.
Compounds 1–7 were evaluated for their antibacterial activity against Gram-positive and
Gram-negative bacteria, as well as multidrug-resistant isolates from the environment, according
to the previously described protocol [6], as well as for their antifungal activity against yeast
(Candida albicans ATCC 10231), filamentous fungus (Aspergillus fumigatus ATCC 46645) and
dermatophyte (Trichophyton rubrum FF5) in the antifungal assay [20]. The results showed that none of
the tested compounds exhibited significant antibacterial activity (MIC > 256 µg/mL) or antifungal
activity (MIC > 512 µg/mL). These compounds were also evaluated for their in vitro growth inhibitory
activity against the MCF-7 (breast adenocarcinoma), NCI-H460 (non-small cell lung cancer) and
A375-C5 (melanoma) cell lines by the protein binding dye SRB method [21], and they did not show
any activity in this assay (GI50 > 150 mM).
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3. Experimental Section
3.1. General Procedure
Melting points were determined on a Bock monoscope and are uncorrected. Optical rotations
were measured on an ADP410 Polarimeter (Bellingham + Stanley Ltd., Tunbridge Wells, Kent,
U.K.). Infrared spectra were recorded in a KBr microplate in a FTIR spectrometer Nicolet iS10 from
Thermo Scientific (Waltham, MA, USA) with the Smart OMNI-Transmission accessory (Software
188 OMNIC 8.3). UV spectra were taken in CHCl3 and were recorded on a Varian CARY 100
spectrophotometer. 1H and 13C NMR spectra were recorded at ambient temperature on a Bruker
AMC instrument (Bruker Biosciences Corporation, Billerica, MA, USA) operating at 300.13 and
75.4 MHz, respectively. High resolution mass spectra were measured with a Waters Xevo QToF
mass spectrometer (Waters Corporations, Milford, MA, USA) coupled to a Waters Acquity UPLC
system. A Merck (Darmstadt, Germany) silica gel GF254 was used for preparative TLC, and a Merck Si
gel 60 (0.2–0.5 mm) was used for column chromatography.
3.2. Extraction and Isolation
The strain KUFA 0081 was isolated fr m the marine s onge Clathria reinwardti, whic was
collected, by scuba diving at a depth of 15–20 m, fro the coral reef at Samae San Island
(12˝341 36.64” N 100˝561 59.69” E) in the Gulf of Thailand, Chonburi Province, in July 2013. The sponge
was washed with 0.06% sodium hypochlorite solution for 1 min, f llowed by sterilized seawater 3 times
and then dried on sterile filter p per, cut into small pieces (5 ˆ 5 mm) and placed on a malt extract
agar (MEA) edium containing 70% seawater and 300 mg/L of strept mycin sul hate, then incubated
at 28 ˝C for 7 days, after which the hyphal tips were transferred onto a slant MEA and maintained as
pure culture for further identification. The fungus was identified as Neosartorya quadricincta (E. Yuill)
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Malloch & Cain by one of us (T.D.), based on morphological characteristics, such as colony growth rate
and growth pattern on standard media, namely Czapek’s agar, Czapek yeast autolysate agar and malt
extract agar. Microscopic characteristics, including size, shape and the ornamentation of ascospores,
were examined under light and scanning electron microscopes. This identification was supported by
sequence analysis of the β-tubulin, calmodulin and actin genes as described in the previous report [22].
Neosartorya quadricincta was also confirmed by the analysis sequence of the internal transcribed spacer
(ITS) gene according the procedure previously described by us [7]. Its gene sequences were deposited
in GenBank with Accession Numbers KM095492 and KT201525, respectively. The pure cultures were
deposited as KUFA0081 at Kasetsart University Fungal Collection, Department of Plant Pathology,
Faculty of Agriculture, Kasetsart University, Bangkok, Thailand.
The fungus was cultured for one week at 28 ˝C in 10 Petri dishes (i.d. 90 mm) containing 25 mL
of MEA. In order to obtain the mycelial suspension, the mycelial plugs were transferred to two 500-mL
Erlenmeyer flasks containing 200 mL of potato dextrose broth and then incubated on a rotary shaker
at 120 rpm at 28 ˝C for 4 days. Fifty 1000-mL Erlenmeyer flasks, each containing 300 g of cooked
rice, were autoclaved at 121 ˝C for 15 min, then inoculated with 20 mL of mycelial suspension of
N. quadricincta and incubated at 28 ˝C for 30 days, after which the mouldy rice was macerated in
ethyl acetate (25 L total) for 7 days and then filtered. The ethyl acetate solution was concentrated
under reduced pressure to yield 176.5 g of crude ethyl acetate extract, which was dissolved in 500 mL
of CHCl3 and then washed with H2O (3 ˆ 500 mL). The organic layers were combined and dried
with anhydrous Na2SO4, filtered and evaporated under reduced pressure to give 31.1 g of the crude
chloroform extract, which was applied on a column of silica gel (440 g) and eluted with mixtures of
petrol-CHCl3 and CHCl3-Me2CO; 250-mL fractions were collected as follows: Frs 1–15 (petrol-CHCl3,
1:1), 16–55 (petrol-CHCl3, 3:7), 56–118 (petrol-CHCl3, 1:9), 119–284 (CHCl3-Me2CO, 9:1), 285–329
(CHCl3-Me2CO, 7:1), 330–359 (CHCl3-Me2CO, 1:1). Frs 175–181 were combined (250 mg) and purified
by TLC (silica gel G254, CHCl3-Me2CO-HCO2H, 3:2:0.01) to give 86.8 mg of 1 and 15.0 mg of 2b. Frs
182–197 were combined (565.1 mg) and purified by TLC (silica gel G254, CHCl3-Me2CO-HCO2H,
17:3:0.02) to give 35.1 mg of 1 and 14.3 mg of 2b. Frs 224–235 were combined (249.3 mg) and purified
by TLC (silica gel G254, CHCl3-Me2CO-HCO2H, 4:1:0.01) to give 11.4 mg of 4a [12]. Frs 236–285
were combined (1.2 g), applied over a column chromatography of silica gel (42 g) and eluted with
mixtures of petrol-CHCl3 and CHCl3-Me2CO, wherein 100-mL subfractions were collected as follows:
sfrs 1–17 (petrol-CHCl3, 1:9), 18–61 (CHCl3-Me2CO,9:1). Sfrs 24–33 were combined (423.4 mg) and
precipitated in a mixture of CHCl3 and Me2CO to give a white solid (46.2 mg), which was further
recrystallized in a mixture of CHCl3 and Me2CO to give 9.4 mg of white crystals of 6a, and the mother
liquor was purified by TLC (silica gel G254, CHCl3-Me2CO-HCO2H, 9:1:0.01) to give 23.2 mg of 6a
and 4.9 mg of 2a. The mother liquor of sfrs 24–33 (133.0 mg) was purified by TLC (silica gel G254,
CHCl3-Me2CO-HCO2H, 7: 3:0.01) to give 41.1 mg of 2a and 12.4 mg of 3. Sfrs 34–39 were combined
(77.7 mg) and purified with TLC (silica gel G254, CHCl3-Me2CO-HCO2H, 3: 1:0.01) to give 7.9 mg
of 4b and 17.1 mg of 2a. Sfrs 40–61 were combined (496.4 mg) and purified by TLC (silica gel G254,
CHCl3-Me2CO-HCO2H, 4: 1:0.01) to give 22.7 mg of 5. Frs 307–315 were combined (291.0 mg), applied
over a column chromatography of Sephadex LH-20 (10 g) and eluted with a 1:1 mixture of CHCl3:
MeOH to give twelve 1-mL sub-fractions. Sfrs 9–12 were combined and purified by TLC (silica gel
G254, CHCl3-Me2CO-HCO2H, 3: 2:0.01) to give 13.4 mg of 6b and 9.4 mg of 7. Frs 316–359 were
combined (1.2 g), applied over a column chromatography of Sephadex LH-20 (10 g) and eluted with
a 1:1 mixture of CHCl3: MeOH to give twenty-one 1-mL sub-fractions. Sfrs 12–21 were combined
(645.7 mg), applied over a column chromatography of Sephadex LH-20 (10 g) and eluted with a 1:1
mixture of CHCl3: MeOH to give sixteen 1-mL fractions. Ssfrs 5–16 were combined (597.5), applied
over a column chromatography of silica gel (15 g) and eluted with a mixture of petrol-CHCl3 and
CHCl3-Me2CO, wherein 100-mL fractions were collected as follows: frs 1–8 (petrol-CHCl3, 1:9), 9–28
(CHCl3-Me2CO, 9:1), 29–41 ((CHCl3-Me2CO, 7:3). Frs 17–18 were combined (47.4 mg) and purified by
TLC (silica gel G254, CHCl3-Me2CO-HCO2H, 3: 2:0.01) to give 20.8 mg of 6b.
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3.2.1. Quadricinctone A: 3-(1-Hydroxyethyl)-5,7-dimethoxy-3,4-dimethyl-2-benzofuran-1(3H)-one (1)
White crystals; mp 176–177 ˝C (petrol/CHCl3); rαs20D ´59˝ (c 0.05, CHCl3); UV (MeOH) λmax
(log ε) 233 (4.39), 260 (4.03), 298 (3.78) nm; IR (KBr) υmax 3455, 2981, 2490, 1723, 1612, 1596, 1499,
1467, 1432, 1228 cm´1; 1H and 13C NMR, see Table 1; HRESIMS m/z 267.1243 [M + H]+ (calculated for
C14H19O5, 267.1332).
3.2.2. Quadricinctapyran A: 2-(Hydroxymethyl)-2-methyl-2H-chromene-6-carboxylic acid (2a)
White crystals; mp 147–148 ˝C (CHCl3/Me2CO); rαs20D +30˝ (c 0.03, MeOH); UV (MeOH) λmax (log ε)
237 (4.61) nm; IR (KBr) υmax 3447, 2922, 2359, 2341, 1696, 1647, 1609, 1578, 1490, 143, 1301, 1267 cm´1;
1H and 13C NMR, see Table 2; HRESIMS m/z 221.0820 [M + H]+ (calculated for C12H13O4, 221.0814).
3.2.3. Quadricinctapyran B: 2-[(Acetyloxy)methyl]-2-methyl-2H-chromene-6-carboxylic acid (2b).
White solid; mp 118–119 ˝C (petrol/CHCl3); rαs20D +58˝ (c 0.07, CHCl3); UV (MeOH) λmax (log ε)
201 (4.13), 237 (4.47) nm; IR (KBr) υmax 3441, 2986, 2943, 1745, 1678, 1640, 1607, 1574, 1453, 1419, 1297,
1264, 1228 cm´1; 1H and 13C NMR, see Table 2; HRESIMS m/z 263.0971 [M + H]+ (calculated for
C14H15O5, 263.0919).
3.2.4. Quadricinctoxepine: 3-Hydroxy-3-methyl-2,3-dihydro-1-benzoxepine-7-carboxylic acid (3)
White solid; mp 189–191 ˝C (CHCl3/Me2CO); rαs20D +21˝ (c 0.07, MeOH); UV (MeOH) λmax (log ε)
234 (4.50) nm; IR (KBr) υmax 3404, 2921, 2359, 2342, 1701, 1606, 1574, 1497, 1384, 1297, 1259, 1117 cm´1;
1H and 13C NMR, see Table 3; HRESIMS m/z 221.0819 [M + H]+ (calculated for C12H13O4, 221.0814).
3.2.5. Quadricinctone B: 6-Hydroxy-2,2-dimethyl-8-(methylsulfinyl)-2,3-dihydro-4H-chromen-4-one (4b)
White crystals; mp 227–228 ˝C (CHCl3/Me2CO); rαs20D +30˝ (c 0.03, MeOH); UV (MeOH) λmax
(log ε) 205 (4.27), 234 (4.22), 358 (3.64) nm; IR (KBr) υmax 3442, 2975, 2922, 1690, 1622, 1484, 1441, 1417,
1326, 1251, 1177 cm´1; 1H and 13C NMR, see Table 4; HRESIMS m/z 255.0694 [M + H]+ (calculated for
C12H15O4S, 255.0691).
3.2.6. Quadricinctone C: 3,6,8-Trihydroxy-3-(hydroxymethyl)-4,5-dimethyl-3,4-dihydro-1H
-isochromen-1-one (5)
White crystals; mp 223–224 ˝C (CHCl3/Me2CO); rαs20D +64˝ (c 0.06, MeOH); UV (MeOH) λmax
(log ε) 214 (4.23), 271 (3.96), 312 (3.70) nm; IR (KBr) υmax 3439, 3006, 2976, 2360, 2342, 1660, 1644, 1600,
1494, 1472, 1448, 1385, 1157 cm´1; 1H and 13C NMR, see Table 5; HRESIMS m/z 255.0875 [M + H]+
(calculated for C12H15O6, 255.0869).
3.2.7. Quadricinctafuran A: (2R)-(2-Hydroxypropan-2-yl)-2,3-dihydro-1-benzofuran-5-carboxylic acid (6a)
White crystals; mp 149–150 ˝C (CHCl3/Me2CO); rαs20D +74˝ (c 0.03, MeOH); UV (MeOH) λmax (log
ε) 203 (3.40), 254 (3.49) nm; IR (KBr) υmax 3417, 2920, 1681, 1634, 1491, 1261 cm´1; 1H and 13C NMR,
see Table 6; HRESIMS m/z 223.9067[M + H]+ (calculated for C12H15O4, 223.0970).
3.2.8. Quadricinctafuran B: (2R)-2-(1,2-Hihydroxypropan-2-yl)-2,3-dihydro-1-benzofuran-5-carboxylic
acid (6b)
White solid; mp 209–210 ˝C (CHCl3/Me2CO); rαs20D +20˝ (c 0.05, MeOH); UV (MeOH) λmax (log ε)
205 (4.27), 261 (4.03) nm; IR (KBr) υmax 3328, 2984, 2941, 1673, 1610, 1599, 1495, 1362, 1290, 1247 cm´1;
1H and 13C NMR, see Table 6; HRESIMS m/z 239.0919[M + H]+ (calculated for C12H15O5, 239.0919).
3.2.9. Quadricinctone D: 7-Hydroxy-3-(hydroxymethyl)-3-methyl-3,4-dihydro-2-benzoxepine-1, 5-dione (7)
White crystals; mp 196–197 ˝C (CHCl3/Me2CO); rαs20D +19˝ (c 0.05, MeOH); UV (MeOH) λmax
(log ε) 232 (4.21), 254 (3.84) nm; IR (KBr) υmax 3404, 2934, 2360, 2341, 1708, 1670, 1614, 1492,
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1466, 1250 cm´1; 1H and 13C NMR, see Table 7; HRESIMS m/z 237.0792 [M + H]+ (calculated for
C12H15O5, 237.0763).
3.3. X-Ray Crystal Structure of Compounds 1, 2a, 4b, 5, 6a and 7
Diffraction data were collected at 293 K with a Gemini PX Ultra equipped with CuKα radiation
(λ = 1.54184 Å). The structures were solved by direct methods using SHELXS-97 and refined with
SHELXL-97 [23]. Carbon, oxygen and sulphur atoms were refined anisotropically. Hydrogen atoms
were either placed at their idealized positions using appropriate HFIX instructions in SHELXL and
included in subsequent refinement cycles or were directly found from difference Fourier maps and
were refined freely with isotropic displacement parameters. Full details of the data collection and
refinement and tables of atomic coordinates, bond lengths and angles and torsion angles have been
deposited with the Cambridge Crystallographic Data Centre.
Quadricinctone A (1): Crystals were triclinic, space group P1, cell volume 663.27(7) Å3 and unit cell
dimensions a = 7.3973(5)Å, b =8.4830(6)Å and c = 11.2438(6) Å and angles α = 107.541(5)˝, β = 92.005(5)˝
and γ = 98.365(6)˝ (uncertainties in parentheses). The refinement converged to R (all data) = 3.68%
and wR2 (all data) = 9.54%. The absolute structure was established with confidence (flack x parameter
0.028(18)). CCDC 1465376.
Quadricinctapyran A (2a): Crystals were orthorhombic, space group Pbcn, cell volume 2189.45(9) Å3
and unit cell dimensions a = 21.3981(5)Å, b = 14.5017(3)Å and c = 7.05561(18)Å. The refinement
converged to R (all data) = 15.06% and wR2 (all data) = 40.39%. CCDC 1468869.
Quadricinctone B (4b): Crystals were orthorhombic, space group Iba2, cell volume 2469.66(11) Å3 and
unit cell dimensions a = 8.52510(19)Å, b = 30.2340(7)Å and c = 9.5817(3)Å. The refinement converged
to R (all data) = 5.90% and wR2 (all data) = 15.62%. The absolute structure was established with
confidence (flack x parameter ´0.04(4)). CCDC 1468868.
Quadricinctone C (5): Crystals were monoclinic, space group P21, cell volume 1116.25(5) Å3 and unit
cell dimensions a = 12.1131(3)Å, b = 7.0501(2)Å and c = 13.2091(3)Å and β = 98.291(2)˝. The refinement
converged to R (all data) = 6.85% and wR2 (all data) = 17.04%. CCDC 1468170.
Quadricinctafuran A (6a): Crystals were monoclinic, space group P21/n, cell volume 1066.67(10)Å3
and unit cell dimensions a = 11.6064(7)Å, b = 5.9593(2)Å and c = 15.8588(8)Å and β = 103.481(6)˝.
The refinement converged to R (all data) = 11.08% and wR2 (all data) = 24.01%. CCDC 1468171.
Quadricinctone D (7): Crystals were orthorhombic, space group Pca21, cell volume 1081.35(13) Å3 and
unit cell dimensions a = 19.5607(13)Å, b = 7.4646(5)Å and c = 7.4058(5)Å. The refinement converged to
R (all data) = 3.81% and wR2 (all data) = 8.57%. CCDC 1468166.
3.4. Molecular Mechanics Conformation Analysis of 3 and 7
Molecular simulations for Structures 3 and 7 were carried out in ChemBio3D Ultra 14
(Perkin-Elmer). Molecular mechanics energy minimizations used the MM2 and MMFF force fields with
the ChemBio3D most recent default parameters and implementation, adequate for small to medium
carbon-based models. Ab initio MP2/6-311G and semi-empirical PM3 molecular modelling was done
using CS GAMESS interfaced by ChemBio3D. The conformational search was done by stochastic,
dihedral driver and molecular dynamics methods. Around 60 conformations were stochastically
created and then minimized using the PM3, MMFF and PM3 methods. The resulting models were
then grouped under the resultant two seven-membered ring conformations (exemplified in Figure 8
for 3). A minimal energy for each model set was found by driving by 360˝ the dihedral angles of the
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single bonds that attach substituent groups to the rings. Molecular dynamics runs were also applied to
the models to confirm the convergence to a minimal energy conformation for each model set.
4. Conclusions
Although Ozoe et al. had first reported the isolation of an isocoumarin derivative from the
culture of the fungus N. quadricincta strain PF1223, using a GABA receptor ligand as a screening target,
the source of the fungus was not revealed. Therefore, this is the first report on the secondary metabolites
of the culture of a marine-derived N. quadricincta (KUFA 0081). Among the nine new isolated
compounds, two are polyketide derivatives, and seven are benzoic acid derivatives. The isolation of
these structurally-unique, but related, metabolites from this fungus has allowed us to propose the
biosynthetic pathways leading to these metabolites. Interestingly, the unprecedented structure of
quadricinctone B (4b), which possesses a methyl sulfinyl group in the benzopyran nucleus, reflects
the capacity of this marine-derived strain to introduce sulphur into the aromatic ring. Therefore, this
marine strain of N. quadricincta (KUFA 0081) can have potential for biotechnological transformation.
Even though the isolated metabolites did not exhibit either antifungal/antibacterial activities or growth
inhibitory activity against the three cancer cell lines in our assay protocols, it does not mean that
they are devoid of other interesting biological activities. Therefore, it is necessary to investigate these
metabolites in other target-based assay protocols.
Supplementary Materials: The supplementary materials are available online at www.mdpi.com/1660-3397/14/
7/134/s1.
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